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ABSTRACT 
Autosomal  recessive d i sorders have devastat ing effects on patients 
and  their  fam i l ies .  E lucidat ing the genetic bases of such d isorders is essent ia l  
to improve their  c l in ical outcome and for i mplement ing effective prevention 
programs .  I n  th is d issertation ,  the genetic bases of seven autosomal 
recessive d i sorders i n  consangu ineou s  fam i l ies were investigated us ing 
homozygosity m apping fo l lowed by cand idate genes or whole-exome 
sequencing .  Consequently ,  novel genomic loci and novel mutations have 
been revealed . The m utations u nderly ing S i lver-Russel l  syndrome in th ree 
fami l ies were found in OBSL 1 and CUL 7 genes,  known to cause 3-M 
synd rome.  I n  add it io n ,  the mutat ions identified i n  COL 1 1A 1 i n  two fami l ies 
were the first to l i n k  this gene with fib rochondrogenes is .  Furthermore, the 
m utat ions detected in JAM3 i n  u n re lated fami l ies confirmed the importance of 
this gene in ma in ta in i ng  b lood vessels in tegrity. Whi le ,  sp l ic ing defects in 
L1NS and TTC23 genes provided evidence on the possible involvement of 
these genes in human cogn it ion . N ovel m utat ions in POMGNT1 and PRG4 
have been found  in fam i l ies affected by congenita l  m uscu lar  dystrophy and  
camptodactyly-arth ro pathy-coxa-vara-pericardit is syndrome ,  respectively. 
F ina l ly ,  a neonatal progero id syndrome has been mapped to a novel s ing le 
locus on chromosome 1 9p 1 3 .3- 1 3 . 2 .  These find ings contr ibuted s ign ificantly 
to our u nderstand ing of the stud ied d isorders and  their  under ly ing molecular 
mechan isms .  
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C H APTE R  1 :  I NTRODUCTION 
1 
1 . 1 .  Overview 
1 . 1 . 1 .  The U n ited Arab Emirates : cou ntry and population 
The Un ited Arab Em i rates (UAE) is a union of seven emirates located 
in the Midd le East, borderi ng the Arabian Gulf, the Gulf of Oman ,  the 
Sultanate of Oman and the Kingdom of Saudi Arabia .  I t  occupies an a rea of 
approximate ly 83,600 square ki lometers (km) with 867 km of land boundaries 
with Oma n (41 0 km) and Saudi Arabia (457 km) and 1 ,31 8 km of coastl ine 
stretches. The city of Abu Dhabi is  the capital of the country and is located in  
the largest Emi rate (Abu Dhab i )  of the confederation . The UAE populat ion is  
estimated to be around 8 mi l l ion (http://www.worldbank.org/), with an a nnual  
g rowth rate of 3 .055%, b i rth rate of 1 5 . 76 b irths/1 ,000 population (20 1 2  est. ) 
and I nfant mortal ity rate of 1 1 . 59 deaths/1 ,000 l ive b i rths (20 1 2  est . ) 
( http ://www . cia .gov/ l ibrary/publ ications/the-world-factbook/geos/ae.htm l ) .  
However, the growth rate of  the UAE population is mainly due to  the inflow of 
expatriates [Alwash and Abbas, 1 999] . Of the total popu lation, Em i rati 
nat ionals constitute a round 1 5% with other Arabs and I ranians constitut i ng 
23% South Asians 50% with the rest being expatriates from European and , 
East Asians countries [AI-Gazal i and Al i ,  201 0] . 
UAE remains tr ibal in  nature. Belonging to a tribe is  sti l l  considered 
important, socia l ly and economica l ly. Therefore, to mainta in  this tr ibal 
structure, marriages occurred mainly between close relatives of the same 
t ri be or  even extended fami ly [Heard-Bay, 1 976; 1 999] . However, interm ixing 
with adjacent Arabs of the Arabian Peninsula and with the Persians as well as 
2 
the East Africans of the Omani  Empire territories has occurred for decades 
[Abdu l la ,  1 978).  I n  addit ion,  cont inuous migrations to the UAE have been 
tak ing p lace for centuries from Baluchistan and other neighboring countries, 
of whom many have become UAE nationals [AI-Gazal i  and Ali, 201 0). 
I ntermarriages between the local population and expatriates are l imited and 
the majority of the local Bedou in  population sti l l  forms tribal commun it ies that 
a re quite isolated . Therefore, the population of the UAE is fa i rly 
heterogeneous and ethn ica l ly d iverse embracing several isolated 
subpopu lations of d ifferent orig ins .  
1 . 1 .2 .  Consangu in ity and genet ic diseases i n  the Un ited Arab 
Emi rates 
Notab ly, Arab societies place a great emphasis on the role and 
importance of the fami ly .  Thus in  addition to the tribal and c lan endogamy, 
consangu ineous marriages are customary in  most Arab commu nit ies 
includ ing the UAE ( Figure 1 -1 )  [AI-Gazal i  et a I . ,  2006) . For instance, it was 
estimated that approximately 50% of al l marriages among Emirati nationals 
are of the consangu ineous type [AI-Gazali et a I . ,  1 995; AI-Gazal i  et a I . ,  1 997]. 
Of the total marriages, 26% were between first cousins, 3 .5% were between 
double fi rst cousins ,  3 .1 % were between first cousins once removed, and 3% 
were between second cousins [AI-Gazali et a I . ,  1 997; AI-Gazal i  and Al i ,  
201 0]. T h e  nationa l  populat ion o f  UAE i s  a lso characterized by large fami ly 
s ize and h igh b i rth rates, wi th an average of five chi ldren per fami ly [AI-Gazal i  
et a I . ,  2006] . Furthermore ,  women continue to reproduce after the age of 
3 
F igure 1 -1 .  Average rates of marriages between fi rst cous i ns among 
various Arab popu lations. (Adapted from AI-Gazal i  et al  , 2006). 
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40 years and men into their 60s. This style contributes to the morbidity and 
morta l i ty of newborns and leads to increases i n  the prevalence of genetic 
d isorders and congenita l malformations [AI-Gazali et a I . ,  2006] . Severa l 
stud ies i n  the Arab world ,  i nc luding the UAE, d i rectly compared the 
prevalence of major congenital defects in  consanguineous and non-
consanguineous progeny [AI -Gazal i  e t  a I . ,  1 995; 1 997; Abdulrazzaq et a I . ,  
1 999; Bromiker e t  a I . ,  2004; Dawodu et a I . ,  2005; A I  Hosani e t  a I . ,  2005] . 
They found a h igher  frequency of congenital malformations among offspring 
of biologica l ly related couples. 
1 . 1 .3. Magn itude and burden of genetic disorders in  the Un ited Arab 
Emirates 
The magnitude of genetic d isorders and b i rth defects is re latively h igh 
g iven the smal l  popu lat ion s ize of the UAE [Christianson et  a I . ,  2006]. More 
than 300 genetic d isorders have been d iagnosed among the UAE national 
populat ion , with rare and previously unreported syndromes and metabol ic 
defects being especia l ly apparent [AI-Gazal i  et a I . , 2005; Tadmouri et a I . ,  
2004; 2006] (www . cags.ac.ae) .  The majority of these genetic d isorders are 
monogenic and recessively inherited , presumably due to increased 
consanguinity [AI-Gazal i  et a I . ,  2005; Tadmouri et a I . ,  2006] . . 
The burden of genetic d iseases is s ignifi cant in the UAE [AI-Gazal i  and 
Al i ,  201 0]. For instance, congeni ta l  malformations were found to be the fourth 
cause of death i n  the country and half of these anoma lies were caused by 
specific recessive m utations [AI-Gazal i  et a I . ,  1 995; 1 997; Dawodu et a I . ,  
2000] .  Furthermore,  a substantial proportion o f  the physical and  mental 
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handicaps in  th is country were also found to be inherited in  a recessive 
manner [AI-Gaza l i  and Al i ,  20 1 0] .  For example, 92% of non -syndromic and 
57% of syndromic ch i ldhood deafness assessed in  the UAE were attributed to 
autosomal recessive genes [AI -Gazal i ,  1 998]. Another study in the UAE has 
shown that 36 out of 38,046 b i rths (about 1 : 1 000) examined i n  the UAE had 
some type of skeletal dysplasia [AI -Gazal i  et a I . ,  2003] . Out of these 36 
cases , 1 8  were attributed to autosomal recessive genes [AI-Gazal i  et a I . ,  
2003] . 
1 . 1 .4. C u rrent genetic faci l ities in  the Un ited Arab Emirates 
Although UAE has made a considerable progress in the healthcare 
sector, genetic d isorders' d iagnosis and counsel ing remain chal lenging [AI ­
Gaza l i  et a i . ,  2005 ;  AI-Gazal i  and A l i ,  20 1 0) .  There are very l imited d iagnostic 
faci l i t ies for genet ic and metabol ic  d isorders. Most samples a re currently 
being sent to d iagnostic laboratories abroad . Genetic counsel ing in the 
avai lab le genetic centers is provided by a very smal l  number of specia l ized 
c l in i ca l  Geneticists who are not supported by genetic counselors, health 
visitors, or socia l  workers. 
The fi rst governmental Genetic service in  UAE was specifica l ly  for 
thalassemia and other hemoglobinopathies and was establ ished in Dubai  by 
the Dubai  Department of Health in 1 989. This Genetic and thalassemia center 
is  currently provid ing services for tha lassemia patients from all over the UAE. 
Proper general c l in ical genet ic service was establ ished in  AI-Ain in the 
Col lege of Medic ine and Health Sciences (CMHS) in 1 990, at the United Arab 
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Emi rates Un ivers i ty ( UAEU).  This was supported by a smal l  diagnostic 
Cytogenetic laboratory .  This serv ice ,  has evolved over the years and IS 
currently the main genetic research and service faci l ity In  the country. I n  
add it ion t o  th is service there are 2 other genetic service provide rs , one i s  i n  
Dubal  a t  the Ped iatric Department of Latlfa hospital and the other one , is  in  
Abu Dhab i  under the Maternity and Ch i ld  Health Department of  the M in istry 
of Hea lth and located in  two Primary Health Care Centers supported by a 
smal l  Cytogenetic laboratory. 
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1 .2 .  Statement of  the problem 
The magnitude and burden of genetic condit ions on the UAE 
population and hea l th care system are highly sign ificant with many of the 
cond it ions being sti l l  of unknown causes. The overa l l  aim of this study is to 
identify the genes and m utations underlying rare autosomal recessive 
d isorders and congenita l malformations in fami l ies resid ing in the UAE . The 
basic hypothesis is that the large fami ly  s ize, in conjunction with clan/tri be 
endogamy and h igh consanguin ity rates in the UAE heterogeneous 
population i ncreases the expression of autosomal recessive tra its inc luding 
d isease phenotypes.  That is  because carrier rates of specific genetic defects 
a re h igh with in  tribes or extended fami l ies compared to the general 
population ,  and therefore the probabi l i ty of expression of autosomal recessive 
d isorder is increased when both parents have some common ancestor(s}. 
Thus, the demog raphic and other characteristics with in the UAE 
subpopu lat ions a re su itable to u ndertake this type of project. 
Two main strategies were used in th is study to elucidate the molecular 
defects in the investigated fami l ies with autosomal recessive d isorders. Both 
approaches started by homozygosity mapping to identify the blocks of 
homozygosity that can be ana lyzed for l inkage with the d isease phenotype. If  
the detected homozygous regions were a few in  number and sma l l  in terms of 
the number of genes and harbored some good cand idates , then d i rect DNA 
sequencing for the candidate gene(s) was performed. However, to exped ite 
the molecular bases of cl i n ical ly heterogeneous genetic disorders with 
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apparently recessIve mode of i nheritance, whole-exome sequencing was 
carried out with the focus on the homozygous regions at the analysis stages. 
These strategIes a re explained in detai ls in section 1 .4 .2 .2  of the introduction .  
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1 .3 .  Objectives 
The overal l  goal of this project was to e lucidate the genes and/or 
mutations that a re responsible for congenita l  autosomal recessive cond it ions. 
The aim IS  to expand the knowledge regard ing the etiology of recessive 
condit ions. The information wi l l  be usefu l to facI l itate diagnosis, prevention 
and therapies. The specific objectives are to: 
• Recruit Inbred fam i l ies from the residents of the UAE with 
estab l ished or deduced consanguinity prod ucing mu lt iple affected 
chi ld ren exhibit ing a congen ital genetic d isorder or malformation. 
• Map the d isease locus using genome-wide genotYPlng on a l l  the 
avai lab le fami ly members with the a im of identifying homozygous 
segments that are un ique and only shared between the affected 
i nd ividuals .  
• Identify d isease causing gene(s) and/or mutation(s) by either d i rect 
DNA Sanger sequencing of the strong candidate genes with in  the 
mapped locus/loci or by performing whole-exome sequencing .  
• Va l idate the pathogenicity of the identified candidate variants using 
bioinformatics tools and/or experimenta l  functional assays. 
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1 .4. 
1 .4. 1 .  
L iterature review 
Biolog ical  concepts 
The human body IS bu i l t  up of tri l l ions of cel ls  that carry out a l l  the 
biologica l  functions Includ ing ,  but not l im ited to , provid ing structure and 
stab i l i ty to provid ing energy and means for reproduction .  Most cel ls in  the 
body are general ly special ized to perform specific biolog ical functions. 
However, a l l  nucleated somatic cel ls  conta in the same genetic information in 
the form of long cha ins of deoxyribonucleic acid (DNA). DNA is packaged with 
specific prote ins in to thread- l ike structures cal led chromosomes.  These 
chromosomes are respons ible for transferring genetic information from one 
generation to the next. Chromosomes are also responsible for the expression 
of the encoded prote ins that perform the majority of the cel lu lar  biological 
functions. 
Humans have 23 pairs of chromosomes located in  the nucleus of every 
n ucleated cel l .  Out of the 23 pairs, there are 22 pairs of autosomes numbered 
from 1 to 22 and a pair of sex chromosomes (the X and Y chromosomes). 
The sex chromosomes determ ine the gender of the i ndividual (male or 
female) .  Each chromosome is constructed of DNA tightly coi led many t imes 
around prote ins ca l led h istones that support its structure . I nd iv idual  
chromosomes harbor hundreds to thousands of genes. Express ion of 
ind iv idual  genes is t ightly regulated with each gene expressed at a specific 
developmental stage, with specific quantity and cel lu la r  ci rcumstances. 
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Proteins a re macromolecules consisti ng of one or more cha ins of 
am ino acids l i nked together by peptide bonds and play fundamental ro les in  
mainta in i ng the structure and function of  the organisms' cells, t issues, and 
organs. The pr imary am ino aCids sequence of  each protein is un ique and 
d iffers from other proteins.  This sequence is dedicated by the nucleotide 
sequence of their corresponding genes located on specific 
chromosomes. There are a lternative forms of each gene that occur at the 
same locus on homologous chromosomes called a l leles. Different 
combination of a l le les may resul t  in  d ifferent observable phenotypic traits. A 
person may inherit two identica l  a l leles of the same gene from either parents 
(homozygous) or two d ifferent a l leles, one from each parent (heterozygous).  
DNA is composed of four  types of nucieotides l i nked together by 
phosphodiester bonds with two a nti-paral le l  compl imentary strands forming 
the doub le hel ix .  Th is  a rrangement is ensured by pai ring adenine (A)  with 
thymine (T) and cytosine (C) with guanine (G). In the coding parts of each 
gene, a three-letter sequence (codon) codes for a particu lar amino aCid of a 
particu lar prote in .  Therefore, the sequence of those codons determines the 
sequence of the encoded prote in .  Any error in  the DNA sequence of a gene is 
commonly termed as  a m utation ,  especial ly when it is associated with a 
d isease. Some of these m utations a lter the am ino acid sequence of the 
prote in  encoded by the gene ,  while others may affect its expression .  If that 
a ltered prote in  is  vital or crucial  for the operations of the human body, a 
d isease state may occur and is referred to as a "genetic d isorder". Ge
netic 
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diseases especia l ly the condit ions that are present from birth (congenita l )  can 
be caused by s imple alterations such as single nucleotide substitut ions 
(synonymous, non-synonymous or nonsense), delet ions or i nsertions. 
1 .4 . 1 . 1 .  M onogen ic  d isorders 
A monogenic or s ingle gene d isorder is a genetic condition exhibit ing a 
Mendel ian pattern of i nheritance (dominant or recessive), and caused by 
mutations in  a s ing le gene occurring in  a l l  cel ls  of the body. The nature of the 
d isease depends on the biological function(s) performed by the mutated 
gene. Though ind iv idual ly relatively rare, monogenic d isorders a re 
responsib le for a substant ia l  loss of l ife worldwide [Penchaszadeh et a I . ,  
1 999; Boycott e t  a I . , 201 3] .  The g lobal prevalence o f  a l l  monogenic diseases 
at b i rth is approximately 1 0/ 1 000 l ive b i rths [Penchaszadeh et a I . ,  1 999] . More 
than 7000 human d iseases are now known to be caused by single gene 
defects [Bel l  et a I . ,  201 1 ;  Bru nham and Hayden , 201 3; Boycott et a I . ,  201 3] .  
With s ign ificant advances i n  sequencing technologies the number of these 
d iseases is g rowing at a rapid and unprecedented pace. Pathogenic 
mutations have been reported i n  around 5 ,000 human genes in the human 
gene mutation database [Brunham and Hayden, 201 3]. However, genetic 
man ipu lat ions experi ments in other organisms suggest that a much h ig her 
percentage of the known human genes (-22,000) m ight be associated with 
phenotypes [Bru nham and Hayden,  201 3] . For example, trad it ional genetic 
man ipu lat ions of yeast and m ice genomes demonstrated that most of the 
genes in  those organ isms are associated with a noticeable phenotype 
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[Winzeler et a l  , 1 999, H i l lenmeyer et a I . ,  2008, Ayadi et al , 2012 ;  Brunham 
and Hayden,  201 3] .  
Based on the chromosomal location of the mutated gene, monogenic 
d isorders a re categorized i nto sex- l inked and a utosoma l .  As the names 
suggest , sex-l inked d isorders a re caused by mutations in genes located on 
the sex chromosomes (X and V). These d isorders are then cal led X-l inked 
and Y- l inked d isorders. On the other hand , autosoma l monogenic d isorders 
resu lt from errors in  s ingle genes located on one of the 22 pa i rs of 
autosomes. I n  d ip lo id organisms l ike humans, each autosomal gene has two 
copies (cal led a l le les)  in the same ind ividual with one a l lele inherited from the 
father and the other a l lele inherited from the mother. For autosomal recessive 
condit ions to develop, mutations in  the two a l leles are essential whereas a 
m utation In  on ly  one a l le le is suffic ient for the development of an autosomal 
dominant cond it ion .  
1 .4 . 1 . 1 . 1 .  Autosomal recess ive d isorders 
Autosomal  recessive d isorders are monogenic d isorders caused by 
m utat ions in  a s ingle autosomal gene. An affected chi ld with a recessive 
d isease must carry two mutated copies of a gene, one from each parent 
( Figure 1 -2) .  In other words, to be affected by an autosoma l recessive 
d isorder, the person needs to have two defective a l leles. The mutated a l leles 
of a specif ic gene can be either identical (homozygous) or d ifferent 
(compound heterozygous) .  The parents of an affected chi ld carry a single 
copy of the mutated gene and typ ica l ly do not exhib i t  the d isease phenotype 
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F igure 1 -2.  Autosomal recess ive mode of i nheritance. The main 
criteria for a utosomal recessive i nheritance are the fol lowing 1 )  the 
parents of an affected ch i ld are obl igate carners of the recessive 
d lsease- causing a l le le ,  2) the pathogenic recessive d isease 
characteristical ly appears i n  one out of four  chi ldren (the recurrence risk 
IS  1 4 or 25% for each pregnancy) ,  3) there IS a 2 in 4 chance that a 
chi ld w i l l  I nherit a S ing le copy of the mutated gene and therefore be 
carner 4) males and fem ales are equal ly l ikely to be affected 
(http /lvwvvv d iscern-genetics org/) 
A 
A A A  
A 
Ca rrie r  Fat h e r  
A A 
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and therefore a re referred to as heterozygous carriers The chi ldren of two 
carrier parents for a mutated gene have one in four  chance of inherit ing both 
defective copies and therefore exhibit ing the autosomal recessive d isorder. 
This risk (25% or 1 In  4)  IS  the same for every pregnancy regardless of the 
outcome of previous pregna ncies. One child out of two of the chi ldren of two 
carrier parents has the chance of being a healthy carrier by Inherit ing a S ingle 
defective copy of that gene. One chi ld out of fou r  of their  chi ldren has the 
chance of being neither affected nor a carrier and referred to as a normal 
chi ld . The occurrence of the autosomal recessive d isorder is not affected by 
the sex of the ch i ld . 
Of the 7028 d isorders with suspected Mendel ian mode of Inheri tance 
described in  Onl ine Mendel ian I nheritance i n  Man database (OM I M) ,  4000 
are autosomal recessive. Around 1 1 39 have an establ ished molecular basis 
and many d isorders have yet to be identified [Bel l  et a I . ,  201 1 ] .  
1 .4.2.  Identification of d isease gene 
1 .4.2 . 1 . Why study rare a utosomal recess ive d iseases? 
Taking in to account that the primary causes of many ped iatric 
cond it ions remain  e lus ive, it is  l i kely that many of them are manifestations of 
ra re recessive monogenic d i sorders [H i ldebrandt et a I . ,  2009] . For example, 
severa l studies have demonstrated that recessive mutations in the autosomal 
gene NPHS2 (OMI M*604766) a re the molecular defects underlying up to 25% 
of a l l  cases with steroid-resistant nephrotic syndrome (SRNS) in chi ldhood 
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[Boute et a I . ,  2000; Ruf et a l .  2004, H lnkes et al , 2007, H lnkes et aI . ,  2008] 
SRNS IS a heterogeneous group of monogenic d isorders each caused by a 
d ifferent gene (Table 1 - 1 ) . Therefore, identification of the causative genes 
and mutations for recessive d isorders faci l itates accurate d iagnosis In the 
patients and carrier testing i n  their fami l ies which are prerequis ites for 
provid ing effective genetic counse l ing .  
I n  add it ion , genetic d iagnosis of  recessive d isease IS of  s ign ificant 
Importance for pat ient management and some cases serves as a start ing  
po in t  for therapeutic i ntervent ions. Th is  IS exemplified i n  the treatable d isorder 
acrodermatit is enteropathica (OM I M#201 1 00) which is a rare autosomal 
recessive d isorder of z inc deficiency [Ki l ic  et a I . ,  20 1 2] .  The condit ion is  
caused by mutat ions i n  the i ntestinal  zinc-specific transporter encoded by 
SLC39A4 (OM IM*607059) el im inati ng i ts  ab i l i ty to  transport z inc .  Affected 
i nfants usual ly exhib i t  acrodermatit is, alopecia ,  and d ia rrhea. Once 
acrodermatit is enteropath ica is  correctly d iagnosed , patients a re s imply 
treated with oral ly admin istered zinc su lphate [Coromi las et a I . ,  201 1 ] .  
Deta i led stud ies have h igh l ighted the importance of characterizing the 
m utat ions caus ing rare autosomal recessive d isorder. For example,  it has 
been demonstrated experimenta l ly  that some mutations can have drastica l ly 
d ifferent  consequences even when occurring at the same site. For i nstance ,  
i n-depth ana lysis o f  the molecular consequences o f  specific patient mutations 
in  hya l ine  fibromatosis syndrome (OM I M#228600) revealed the necess i ty of 
personal ized therapy. This cond it ion is  a rare autosomal recessive d isorder 
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Table 1 - 1 . The stero id-resistant nephrotic  syndrome (SRNS) subtypes . 
Phenotype O M I M  number 
Nephrotic syndrome, tyoe 2 I 
Nephrotic syndrome, type 5 
Ne�hrotlc stndrome,JyRe 3 
Nephrotic syndrome , type 4 
Nephrotic syndrome, pe 6 
Nephrotic �nd rome, type:LI-� Ne�hrotic �yndrome. e 8 
Nephrotic syndrome, type 1 
600995 
6 1 4 1 99 
6 1 0725 
256370 
6 1 4 1 96 
-
6 1 5008 
6 1 5244 
256300 
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Gene I OMIM number I 
NPHS2 604766 
NPHS5 1 50325 
NPHS3 6084 1 4  
NPHS4 607 1 02 
NPHS6 600579 -
NPHS 7 60 1 440 
NPHS8 601 925 
NPHS 1 6027 1 6  
caused by homozygous mutations in the gene encod ing a protein  involved in  
extrace l lu lar  matrix homeostasis (ANTXR2; OM I M*608041 ). Yan et  al  [20 1 3] 
were able to rescue ANTXR2 protein In  patients carrying one base Insertion 
but not In  those carry ing two base I nsertions at the same site of the gene by 
ta rget ing the nonsense med iated decay pathway. 
Furthermore, studYing the genetic basis of rare recessive d isorders 
contri butes to our  understanding of gene functions and biological pathways 
underlying health and d isease in genera l  [Ropers, 2007]. The molecular  
information ga ined from i nvestigating monogenic d isorders has provided 
clues to the pathogenesis of common and complex d iseases as wel l  as 
therapies for them [Dietz, 201 0] . Spl itting complex d isorders into many s ing le ,  
often monogenic ,  entit ies has significantly increased the chances for 
understand ing the underlying pathogenetic mechanisms of those 
mult ifactorial d isorders [Ropers ,  2007] . This was main ly achieved by defin ing 
novel cand idate genes that a re part of the same pathway. For example ,  
fancon i  anemia ( FA; O M I M#227650), the most common genomic instab i l ity 
syndrome,  that is  caused by recessive autosomal or X-l inked mutation in one 
of 1 5  genes in the FA pathway l isted in table 1 -2 .  This pathway plays an 
important role i n  g uard ing the genome by coord inat ing a complex mechan ism 
that joi ns  proteins  of three different DNA repair pathways in  response to 
genotoxic insu lts [Deakyne and Mazin ,  201 1 ] . The pathway is a very wel l  
appreciated model system for several b io logical processes includ ing DNA 
repair, cancer progression and protein ubiquit ination [Moldovan and 
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D'Andrea,  2009] . The current knowledge of the FA pathway has been 
accumulat ing as a result  of examin ing FA patients harboring homozygous 
mutations in  the genes that encode the core complex of the pathway. The first 
FA gene to be cloned is FANCA being defective in more than 60% of FA 
cases [Moldovan and D'Andrea , 2009] . Mutations in 1 4  more genes encod ing 
other core complex members were later identified in d ifferent FA patients 
(Table 1 -2 ) .  Furthermore, a lthough FA is a rare recessive d isorder, 
understand ing the functional role of the FA proteins and the i r  interactions with 
other DNA d a mage response proteins provided broader opportunities for new 
cancer therapeutics [Jenkins et a I . ,  201 2] .  
1 .4.2 .2.  Approaches for the identification of recessive d isease-caus ing 
genes and mutations 
Recessive d isorders a re most commonly seen in communities with 
h igher rates of consanguineous marriages [Ropers, 201 0]. Consanguineous 
marriages a re a common practice i n  a number of communities worldwide 
inc lud ing most Arab countries where marriages commonly occur between first 
cousins.  Consangu in ity i ncreases the coefficient of inbreed ing, which 
increases the l ike l ihood of presence of pathogenic mutations in  the 
homozygous state [Alkuraya et a I . ,  201 0] .  Th is has made homozygosity 
mapping the strategy of choice for e lucidating the genetic defects underlying 
autosoma l  recessive d isorders in  extended consanguineous fami l ies [Ropers, 
2007; H i ldebrandt  et a I . ,  2009] . Subseq uently, gene identification and 
mutat ional screen ing is achieved either by cand idate genes approach ( the 
selection of the most l i kely d isease-causing genes residing with in  the 
20 
Table 1 -2 .  Fanconi anemia (FA) reported genes. 
r=-Gene symbol O M I M  number Chromosomal position Prevalence* I 
I FANCA 607 1 39 1 6  24.3 66% -
FA NCB c-- 3005 1 4  - Xp22.31 2% --
FANCC - 227645 9q22 .31  1 0% 
t FANC0 1 605724 1 3q 1 2- 1 3  2% 
t FANC02 227646 3q25-3 2% 
FANCE 60090 1 6p2 1 -22 2% 
FANCF 603467 1 1  p1 5 2% 
FANCG 602956 9p1 3 9% 
FANCI 609053 �q25-26 2% -
FANCJ 609054 1 7q22-24 2% 
_.-
r-- 6 1 4083 FANCL 2p1 6 . 1  0 .2% FANCM 6 1 4087 1 4q2 1 .3 0.2% 
FANCN 6 1 0832 1 6p1 2 . 1  2% 
FANCO 6 1 3390 1 7q22 NA 
FANCP 6 1 395 1 1 6p1 3.3 NA 
*Moldovan and D'Andrea, 2009. 
�he only X-l inked gene of the FA genes. 
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homozygous regions) uS ing Sanger sequencing or by massively para l lel 
sequencing techniques [Hi ldebrandt et a I . ,  2009] . A two steps approach 
(homozygosity mapping fo l lowed by sequencing) has proved to be the most 
robust strategy for unmasking numerous recessive mutations [Hi ldebrandt  et 
a l .  2009; Alkuraya et a I . ,  201 2] . Several hundred successful stones have 
been recently reported i n  the l i terature descnbing the identification of 
recessive d isease causing genes and mutations in  consanguineous fam i l ies 
using the aforementioned two step approach [Tukel et a I . ,  2010 ;  Abou Jamra 
et a I . ,  201 1 ;  Bloch-Zupan et a I . ,  201 1 ;  Najmabadi et a I . ,  201 1 ;  Dussai l lant et 
a I . ,  20 1 2 ; Casey et a I . ,  201 2;  Coussa et a l .  201 3, Grosch et a l .  20 1 3; 
Bonnefond et a I . ,  20 1 3; Capo-Chichi  et a I . ,  201 3] .  
1 .4.2.2. 1 .  Homozygos ity mapping 
The homozygosity mapping concept was first recogn ized in 1 953 by 
Smith [Smith, 1 953] . However, in 1 987,  Lander and Botstein formulated a 
technique to search for homozygous regions by descent in  consanguineous 
fami l ies and cal led i t  homozygosity mapping [Lander and Botstein ,  1 987] .  
S ince then the homozygosity mapping technique has been used successfu l ly 
for mapping autosomal  recessive d isorders in  numerous consanguineous 
fami l ies worldwide [for example see, Faivre et a I . ,  2003] . Currently, 
homozygosity mapping is considered to be one of the most powerful gene 
d iscovery approaches in  the recent h istory of human genetics [Alkuraya et a I . ,  
201 0] .  
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1 .4 .2 .2 . 1 . 1 .  Pr inc ip les of homozygos ity mapping 
The main assumption i n  this approach IS that the parents are related 
and therefore harbor pieces of identical DNA Inherited from a common 
ancestor [Sheffield et a i . ,  1 995a] . Therefore, the homozygosity mapping 
approach la rgely rel ies on us ing consanguineous fami l ies, in  which the 
parents are related , and have chi ldren exhibit ing the same disease 
phenotype.  I t  assumes that they inherited an identical homozygous dupl icate 
of chromosomal  D NA harboring a segment of identica l  markers or DNA 
polymorph isms (hap lotype) inc lud ing a homozygous disease-causing 
mutation .  It a lso assumes that the recessive-d isease causing mutation is 
" identical by descent" segregating to the affected chi ldren from a common 
ancestor through both parents. Subsequently, the mutated copies were joined 
together through the mat ing of the carrier parents in  the affected chi ldren ,  
caus ing the pathogenic phenotype ( Figure 1 -3) .  The homozygosity mapping 
approach scans the whole genome of the affected chi ldren and their fam i l ies, 
us ing single nucleotide or  short tandem repeat polymorphisms, to locate 
those homozygous blocks which are supposed to carry the d isease-causing 
mutated gene. I t  is  p red icted that offspring of first cousin un ions are 
homozygous i n  approximately 6% of their genomes. However, Woods et a l  
[2006] elegantly demonstrated that offspring o f  first cousin un ions from h igh ly 
inbred consangu ineous fami l ies are homozygous i n  about 1 1  % of thei r  
genomes. I n  add it ion ,  the a uthors showed that these offspring carried a round 
20 homozygous segments each with a size of more than 3 cM. They also 
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F igure 1 -3 .  I l l ustration of homozygosity mapping approach for 
recess ive d isease-genes identification. Chromosomal segment 
carrying a rare recessive m utation may segregate to a chi ld from a 
common ancestor through the father and the mother If they were 
consang ui neous I n  that Chi ld ,  the combination of the two Identica l  by 
decent chromosomal  segments carrying the same mutation renders the 
child to be homozygous for that mutation Although for each generation 
succession there IS an opportun i ty for a crossing over between sister 
chromatids to occur In the parents' gametes , there IS a h igh l ike l ihood 
that In the affected chi ld consecutive genetic markers surround ing the 
m utation wi l l  not have recombined and wi l l  be Identica l  (homozygous) by 
descent This segment of homozygous markers can be mapped leading 
to successfu l mapping of the d isease gene (http "//autozygoslty.org/) . 
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observed I n  their study that the d isease gene is usua l ly located in  the longest 
homozygous segment. 
1 .4.2.2. 1 . 1 . 1 .  M icrosate l l ite markers 
M icrosatel l i te markers or short tandem repeats (STRs) polymorphlsms 
are mu lt iple repeats of d l ,  tr i or  tetra nucleotides [Sheffield et a I . ,  1 995b] . They 
are extremely polymorphic, a characteristic that makes them useful as genetic 
markers to Identify a specific chromosome or locus.  The number of repeats 
with in  a m icrosatel l i te marker varies between individuals and in most 
occasions even between paired chromosomes in  the same ind ividua l .  They 
are main ly found in  non-cod ing regions with in  the genome and are present 
approximately every 1 0-50 ki lobases ( kb) .  Typica l ly ,  around 400 microsate l l ite 
markers a re used in such mapping studies spaced at an average 1 0  kb 
dens ity throughout the genome. I n  this technique, genomic DNA from each 
ind ividua l  in a fam i ly is  ampl ified using fl uorescently labe led primers for each 
microsate l l ite marker. D ifferent a l leles for each marker are pooled together 
based on their s izes and labe l ing .  Then,  they are separated by size using an 
automated e lectrophoresis system.  F ina l ly, the e lectrophoresis resu lts a re 
analyzed and the s ignals a re visual ized using specific software. Many 
recessive d isorders loci and genes have been mapped by scanning the whole 
genome using polymorphic m icrosatel l ite markers to track the blocks of 
homozygosity [for exa mple see , Al ig ianis et aI . ,  2005]. 
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1 .4 .2 .2 . 1 . 1 .2 .  S i ngle nucleot ide polymorphisms (SN Ps) 
A single nucleotide polymorphism (SNP) is a variation at a single base 
pair In DNA. S N Ps are the most abundant genetic variants and provide the 
most comprehensive resource for ascerta in ing genetic d iversity. Mi l l ions of 
SNPs are d lstnbuted over the whole genome [Zhao et aI . ,  2003 , Puffenberger 
et a I . ,  2004] . In add it ion , physica l ly l inked SNPs are co- inherited as a series of 
a l le les in a pattern known as a haplotype [Puffenberger et a I . ,  2004] . 
Therefore, currently SNPs are most commonly used in  h igh-density high­
throughput genotyping strategies for recessive disease-gene mapping. To do 
th iS ,  a rrays that assess homozygosity or heterozygosity of mi l l ions of SNPs 
that cover the whole genome are employed . Many successful homozygosity 
mapping projects were achieved using the h igh-density SNP genotyping 
arrays ( F igure 1 -4) [for example see, Fabbro et a I . ,  201 1 ] .  For example, the 
affymetrix genome-wide human SNP Array 6.0 conta ins more than 906,600 
SNPs and more than 946 ,000 probes for the detection of copy number 
variations (CNVs). 
1 .4.2.2 . 1 .2 .  P i tfa l ls  of homozygosity mapping 
The majority of autosomal recessive genetic d isorders worldwide are 
extremely rare where on ly a smal l  number of cases are avai lable [Ku e t  a I . ,  
201 1 ] .  Thus i t  is  often very d ifficu l t  to  ascertain a sufficient number o f  fam i l ies 
with the same phenotype to investigate us ing the homozygosity mapping 
approach. Moreover, smal l  fami ly  s ize, which is the norm nowadays in many 
popu lat ions, is a nother problem in  homozygosity mapping studies where on ly  
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F igure 1 -4.  Schematic representation of genome-wide SNP 
genotyping workflow. ThIs method Involves specIfic yet d Isti nct 
enzymatIc react Ions to reproducIbly ampl ify, label and then capture the 
h u man genome on an array ta I led wIth specIfIc probes 1 )  GenomIc DNA 
IS d Igested wIth restnctlon enzymes Styl/NSPI (6 0 array) that WI l l  cut 
genomIc D NA at specIfIc s I tes (b lack tnangles) 2) The d Igested 
fragments are l igated to a common adaptor wIth T 4 DNA l igase 3) The 
fragments conta In Ing the adaptor undergo PCR uSing TITAN I U M TMTaq 
DNA polymerase and adaptor specIfIc primer 4) The ampllcons are then 
fragmented by DNAse I e nzyme 5) The end of each DNA fragment IS 
labeled USIng termI na l  deoxynucleotldyl transferase (TdT) 6) Capture al l  
labeled DNA Into a predesigned array conta in ing a subset of a l lele­
specIfIc o l igonucleotIdes (probes) ThIS array WI l l  then be scanned by a 
detect Ion system that records and In terprets the hybrid izatIon s ignals 
(http Ilwww affymetnx com) 
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one or two affected ch i l d ren are avai lable [Ku et a I . ,  201 1 ] . The refore, for the 
very rare autosomal recessive d isorders the cha l lenge, even In h igh ly 
consangu ineous populations l i ke the UAE, is to find enough fami l ies with 
ch i ldren affected by the same phenotype [Romdhane et a I . ,  201 2] .  In these 
cases It IS sometimes d ifficult to find other fami l ies even if exhibit ing s imi lar 
phenotypes that carry m utations in  the same gene making i t  cha l lenging to 
prove pathogenicity. 
Although u ncommon,  sometimes these recessively inherited d isorders 
in  consangu ineous fami l ies may be caused by compound heterozygous 
mutations . In th is case, the d i sease locus may not be identifiable with in  a 
homozygous haplotype when performing a genome-wide scan for 
homozygous regions .  This is exempl ified in a study on a consanguineous 
fami ly from Jordan exhibit ing the autosomal  recessive Karak 
syndrome (OM I M# 6 1 02 1 7) described orig ina l ly by Mubaid in  et al [2003] . In  
th is  fam i ly ,  Morgan et a l  [2006] detected the same compound heterozygous 
d isease-caus ing m utat ions in  PLA2G6 gene (OM I M*603604) in the two 
affected s ib l ings us ing d i rect DNA sequencing. The author genotyped the 
gene vicin ity on chromosome 22 us ing microsatel l ite markers reveal ing that 
both affected ch i ld re n  shared a common heterozygous haplotype surround ing 
the d isease-caus ing gene that was d ifferent to the i r  parents. Thus, in this 
fami ly, anyone search ing for homozygous reg ions using homozygosity 
mapping wou ld have missed the d isease locus as i t  was not contained within 
a homozygous region in the affected ind ividuals. 
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The occurrence of a l le l ic heterogeneity and/or locus heterogeneity 
with in  a consangu ineous fami ly  is another chal lenge faced in some occasions 
when search ing for homozygous stretches [Ku et a I . ,  20 1 1 ] .  This 
phenomenon may occur when the recessive d isorder segregated in that 
fami ly  is  caused by d ifferent mutations in  the same gene or in  d ifferent genes 
respectively. For example,  the mapping of Bardet-Biedl syndrome ( BBS; 
OM I M#209900) in an extended consanguineous Lebanese fami ly uncovered 
a complex pattern of mutations [Laurier et a I . ,  2006] . One sibship of the 
ped igree was fou nd to be carrying a homozygous mutation in the BBS2 gene 
(OM I M*606 1 5 1 ) on chromosome 1 6. Other sibships of the extended pedigree 
carried a homozygous m utation in another gene called BBS 10 
(OMI M*6 1  0 1 48) located on chromosome 1 2 . I nteresting ly, a s ing le patient in  
the last s ibship carried compound heterozygous mutations in the BBS 10 gene 
causing the d isease. The former observation chal lenged l i nkage analysis due 
to the expectation of a s ingle locus and mutation , whi le the latter resu lted in  
loss of  homozygosity i n  the markers flanking the BBS 10 gene and led to  a 
fa lse negative result .  
1 .4.2 .2 .2 .  DNA sequencing 
The proposal to map and sequence the entire human genome (-3 
b i l l ion  nucleotides) was in i t iated and started to  be implemented in  the mid-
1 980s in  the form of  "the human genome project" [Lewin ,  1 987;  Bentley, 
2000] . To achieve th is g rand goa l ,  substantial academic and commercia l 
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efforts were instigated to develop sequencing platforms capable of de livering 
relatively fast, accurate and high-throughput DNA sequencing data . 
1 .4.2.2.2 . 1 . Ear ly DNA sequencing technolog ies 
Two DNA sequencing techniques were invented at the end of 1 970's . 
These were the Maxam-Gi lbert (chemica l  cleavage) method and the Sanger 
(or d ideoxy) method [Gi l bert and Maxam, 1 973; Sanger et a I . ,  1 977] .  The 
Maxam-Gi lbert method involves radioactive label ing of one end of the DNA 
fragment to be sequenced [Franga et a I . ,  2002] . Chemical treatment 
generates breaks at a smal l  proportion of one or two of the four  
deoxynucleotides (dNTPs) in  fou r  separate reactions.  These cleavages lead 
to the generat ion of a series of labeled fragments, from the radiolabel led end 
to the fi rst 'cut' site in  each molecule. The four reactions can then be ana lyzed 
by gel e lectrophoresis side by side for s ize separation and visual ization .  The 
Maxam-Gi lbert approach is best su ited for sequencing short ol igonucleotides. 
The Sanger method on the other hand is based on chain  termination 
by the incorporation of a d ideoxynucleotide (ddNTP), which lacks the 3'­
hydroxyl g roup of a normal d NTP, during the DNA polymerase elongation 
reactions ( Figure 1 -5)  [Franga et a I . ,  2002 ; Shendure and J i ,  2008]. This 
produces DNA strands of varying lengths that can be separated by gel 
electrophoresis by their s ize depend ing on which base is at the end of each 
fragment. With the advent of PCR and automation of the Sanger sequencing 
technique each of the fou r  ddNTPs was labeled with a d ifferent fluorescent 
dye, each of which emit l ight at d ifferent wavelength . These modifications 
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al lowed longer reads of DNA strands (800- 1 000 nucleotides) includ ing some 
entire genes. The automated Sanger sequencing a l lowed researchers to 
sequence the ent i re 3 .2  b i l l ion nucleotides of the human genome which was 
com pleted in 2003 [Yavartanoo and Choi , 201 3] .  
1 .4 .2 .2 .2 .2 .  Recent adva nces in DNA sequencing technologies 
Recent technical advances inc lud ing automation and new chemistries 
have d ra matica l l y  changed the speed and sequencing range from 1 000 base 
sequencing to massively paral lel sequencing of the whole-genome 
[Stranneheim and Lundeberg ,  201 2] .  These advances resulted in massive 
and unparal leled red uctions i n  the cost of DNA sequencing. Several 
Fig ure 1 -5 .  S chematic representation of the Sanger sequencing 
workflow. I n  th is protocol a specific part of the genome is ampl ified by 
PCR (step1 ) us ing target specific primers (Forward and Revers), 
deoxyribonucleotides (dNTPS; dC, dA, dT, dG) and Taq DNA 
polymerase; generat ing m i l l ions of copies of that part icu lar sequence. 
After purification , th is sequence is used as a template for a cha in  
term inat ion react ion (step2). This react ion is  very much simi lar to norma l  
PCR i n  reagents and cycl ing except for the use of  s ingle primer (either 
forward or reverse) i nstead of two and the addit ion of fluorescently 
labeled d ideoxynucleotides (ddNTPs; ddC, ddA, ddT, ddG) in  specific 
ratios. These ddNTPs lack the 3'-OH group found in normal dNTPs and 
thus unable to form 3'-5 '  phosphod iester bonds with other dNTPs 
causing the DNA strand to be terminated when they are incorporated i n  
the growing cha in .  This reaction generates DNA strands of vary ing 
length each end ing with a d ifferently labeled ddNTP. Then these strands 
are i njected i n  a capi l lary where they migrate accord ing to their sizes in  
an electrophoresis gel passing a laser beam which wi l l  excite the 
label ing dyes to emit  d i fferent wave lengths col lected by a digital 
camera. The signal then is translated i nto sequencing chromatogram s  
showing each n ucleotide with in  the in it ia l  sequence (-800 nucleotides) 
with a d ifferent color using specific software (step 3). 
(http://www . genomebc.ca/education/articles/sequencing/). 
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sequencing platforms that are current ly i n  use have inherited many features 
of the Sanger sequencing [Stran neheim and Lundeberg ,  201 2]. This i ncludes 
the use of polymerases for synthesis ,  mod ified nucleotides and fluorescent 
automated detection .  However, the main d ifference compared to the Sanger 
method is that al l  the massive ly paral lel sequencing platforms requ i re the 
DNA of the whole genome to be clonal ly ampl ified formi ng a consensus 
template p rior to sequencing [Ratan et al "  201 3]. To achieve that, the 
genomic DNA sample is fragmented , l igated to an adaptor, ampl ified by peR 
then captu red , re-amplified , labeled and sequenced as i l lustrated in Figure 1 -
6 [Neiman et a I . ,  201 2] .  These steps may vary depending on d ifferent 
platforms .  M i l l ions  of short reads of the in it ia l  target are generated per run. 
The first massively para l le l  sequencing technology was released in 2005 
[Stranneheim and Lundeberg, 201 2] . This technology was based on the 
concept of sequencing-by-synthesis (SBS) or pyrosequencing that was first 
conceived in  the mid of 1 980's [Melamede et a I . ,  1 985; Nyren, 2007] . SBS is 
un l i ke the Sanger method , chai n  elongation can be resumed with the add ition 
of nuc/eotides generating a l ight by enzymatic action which is recorded. 
The second and the most successful massively para l lel sequencing 
platform to be commercia l ized was the I I l umina platform based on a 
reversible dye terminator SBS approach [Shendure and J i ,  2008; 
Stranneheim and Lundeberg ,  201 2] . In this chemistry ,  the incorporation of 
each labeled terminator in  the DNA template is detected by fluorescence 
imaging of the surface of a flow cel l .  Then this labeled term inator is 
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F igure 1 -6 .  Schematic representation of massively para l le l  
sequencing workflow. The general  work ing flow of th is approach is the 
fol lowing ' 1 )  the whole genomic DNA is randomly fragmented by 
d ifferent methods such as son ication and enzymatic d igestion, 2) l igation 
of the generated fragments to a specific adaptor, 3) DNA template IS 
c lonal ly ampl ified by peR to produce higher yields of the DNA l ibrary, 4) 
capture or hybridize the prepared DNA l ibrary on flow cell surface then 
re-ampl ify it aga in ,  4) the label ing and detection steps usual ly occur 
S imu ltaneously in the genome ana lyzer machine.  These steps may vary 
depend ing on d i fferent platforms. (http://www. i l lumina .com/) . 
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chemical ly removed , generat ing an extendable base that is ready for a new 
round of sequencing.  More recently, several other massively paral le l  
sequencing approaches have been developed revolutionizing the sequencing 
technology and consequently genet ic research [for review see, Stranneheim 
and Lundeberg , 201 2] . 
1 .4.2.2.2.3.  The i �tegration of DNA sequencing with homozygosity 
mappmg 
Sanger sequencing has complemented homozygosity mapping 
successfu l l y  in  the identifi cation of recessive d isease-causing genes and 
mutat ions with i n  homozygous regions for severa l years [for example, Barnes 
et a I . ,  201 3] .  However, mapping approaches in  consanguineous fam i l ies 
wou ld often identify mu l t iple or too large homozygous regions encompassing 
substantial numbers of candidate genes [Dussa i l lant et a I . ,  201 2] . This made 
the ident ification of d isease-causing genes by candidate genes screen ing 
strategy using Sanger sequencing lengthy, laborious, and expensive. 
Thereby, too many accurately mapped autosomal recessive d isorders 
remained unsolved for a long t ime [for examples, Tukel et a I . ,  2005; Tetreault  
et a i . ,  2006] . This has changed in  the recent years due to the development of 
massively paral lel sequencing technologies and thei r  efficient integration with 
homozygosity mapping to accelerate the investigation of recessive d isord ers 
i n  consangu ineous fami l ies [Ku et a i . ,  201 1 ] . Currently with the fa l l ing costs of 
h igh throughput sequencing technologies, whole-exome sequencing has 
become the most commonly used approach for recessive disease gene 
d iscovery [Bamshad et a i . ,  201 1 ;  G i l issen et a I . ,  20 1 2] .  
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1 .4.2.2.2 .4. Whole-exome sequencing 
Whole-exome sequencing (WES) is massively paral le l  sequencing of 
all the exons of a l l  the prote in-coding genes in the human genome [Bamshad 
et a I . ,  201 1 ] . The ent ire exome e ncompasses less than 2% of the 3.2 b i l l ion 
bases of the human genome [Oett ing ,  201 1 ] .  Hence, it is possible to get deep 
coverage sequencing with relatively few reads which is necessary for the 
detection of rare variants underlying recessive disorders [Bamshad et a I . ,  
201 1 ;  Carr e t  a I . ,  201 3] . Moreover, i t  i s  well accepted that the majority of 
genetic variants that under l ie Mendel ian d isorders d isrupt exonic sequences 
where they can cause deleterious effects [Botste in et a I . ,  2003; Gi l issen et a I . ,  
201 1 ] .  Seq uencing the genes' exons should include the flanking spl ice sites in  
which there is h igh functiona l  variation . Therefore, the whole-exome 
represents an enriched portion of the genome that can be used to search for 
variants with large effect s izes . 
Nevertheless, WES techn ique has important l imitations that shou ld be 
kept in mind when this approach is used to study recessive disorders. These 
l im i tations include the inabi l ity to detect intron ic mutations, structural or CNVs 
which cause substant ial number of recessive d isorders. Despite the advances 
in sequencing technologies, some exons resid ing in  repetitive or high CG rich 
a reas of the genome are not wel l  covered in  the WES chips [for example see, 
Bloch-Zupan et a I . ,  201 1 ] .  
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1 .4.2.2.2 .4. 1 .  The fi lter ing strategy i n  whole-exome sequencing 
The main cha l lenge of WES is to identify the d isease-causing variant 
among the substant ia l  number of variants detected in  each exome. Therefore, 
a fi ltering strategy to reduce the in i t ial number of detected variants is essential 
to identify the causal mutation ( Figure 1 -7) [for review see, Gi l issen et a I . ,  
20 1 2] .  Approximately 50,000 variants are detected from each sequenced 
exome [Gi l issen et a l . ,  201 0 ;  Becker et a I . ,  201 1 ] . Based on the number of 
reads for each var iant ( read ing depth) some variants can be excluded 
( usual ly if < f ive reads) [Gi l issen et a I . ,  20 1 2] .  Fi ltering a l l  the detected 
variants against ava i lable  variat ion databases such as dbSNP, 1 000 Genome 
project and exome variants database reduces the ir  number substantia l ly .  This 
exclusion is based on the assumption that for a very rare recessive d isorder, 
the d isease causing mutat ion is un ique in  patients or at  least very rare in the 
general  population . In add i tion , in tron ic and synonymous mutations that do 
not a lter the prote in  sequence can be fi ltered out, based on the mai n  
assumption o f  exome sequencing approach that the d isease-causing 
mutation is most l i kely located with in  the protein-coding regions of the 
genome. The most S igni ficant reduction fol lows from excluding heterozygous 
variants based on parental consanguin ity which impl ies that the causal 
mutation is i nherited from a common ancestor and thus found in  a 
homozygous state i n  patients. This step typica l ly  reduces the number of 
potential candidate mutations to 1 50-500 of novel non-synonymous, non­
sense, indels ,  or spl ice-site variants [Stitziel et a I . ,  201 1 ] . To identify the 
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F igure 1 -7 .  F i lter ing steps of whole-exome sequencing data. A 
substant ia l  number of variants are identified in every exome sequencing 
run .  Therefore .  in order to reduce this number and to identify the 
recessive d isease causing m utation we have to fi l ter this data in the 
fo l lowing order 1 )  exclude a l l  common variants (frequency>5%) ,  2) 
exclude variants that wi l l  not a lter the prote in  sequence ( intronic and 
synonymous) ,  3) exclude heterozygous variants, 4) exclude variants that 
are not detected in all the affected s ib l ings exhibit ing s imi lar phenotype, 
4) exclude variants that are not located in the pre-mapped d isease 
homozygous reg ion(s) .  (http '//www .goldenhel ixcom/) . 
Exclude variants not 
shared between affected 
siblings 
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causative mutation among these variants tradit ional mapping strategies such 
as homozygosity mapping have been adapted for WES. Thereby, the 
candidate variants a re only selected when contained with in a large 
homozygous stretch . For example,  G i l i ssen et a l  [201 0] successfu l ly used this 
strategy to reduce the number of candidate variants from around 1 40 to only 
3 or 4 in  two patients exhibit ing the autosomal recessive Sensenbrenner 
syndrome (OM I M#2 1 8330). 
1 .4 .2 .2 .3 .  Se lection  of cand idate genes and recognition of pathogenic  
mutations 
I n  the trad it ional cand idate strategy, computational prioritization is  
usual ly used to reduce the number of  genes resid ing with in the mapped 
homozygous regions [Masoudi-Nejad et a I . ,  20 1 2] .  Several bioinformatics 
tools a re avai lab le on l ine to prioritize cand idate genes based on information 
re lat ing to the genes' functions or their expression profi les lOti et a I . ,  201 1 ] .  
Examples of such priori tizi ng programs are GeneDisti l ler2 , Suspects , and 
ToppGene S uite. Further p riorit ization of candidate genes can be gained from 
what is known or inferred about their pathophysiology in avai lable genes 
databases such as the Un iversity of Cal iforn ia Santa Cruz (UCSC) Genome 
Browser and the National Center for B iotechnology I nformation (NCB I )  or 
from previous stud ies .  
In  analyzing WES data,  researchers usual ly prioritize the variants 
res id ing with in  the homozygous reg ions [Gi l issen et a I . ,  201 2] .  In this strategy 
variants wi l l  be priorit ized on the basis of the predicted impact of the variant 
on prote in  function and structure in  the fo l lowing order: stop mutations, frame-
39 
shift ing m utat ions,  and m utations in  the canonical spl ice-sites [Ku et a I . ,  201 1 ;  
Gi l issen et a I . ,  20 1 2] .  These m utations a re known to cause deleterious effects 
on the correspond ing protein  [Ku et a I . ,  201 1 ] .  On the other hand, the i mpact 
of non-synonymous mutat ions on the i r  proteins is less predictable and thus 
severa l  computational  programs have been developed for their priorit ization 
[Oo l led-Fi lhart et a I . ,  201 3] . Such programs include MutationTaster,  
Polymorphism Phenotyping v2 ( Polyphen2) ,  and Sorting Intolerant From 
Tolerant (S I FT). The main criterion currently appl ied on priorit izing non­
synonymous m utations is conservation of the substituted amino acid a cross 
species [Kumar et a I . ,  2009; Adzhubei  et a I . ,  201 3] .  These programs presume 
that important  am ino acids wi l l  be conserved in  the protein fami ly, and so 
changes at h igh ly conserved positions tend to be predicted as deleterious. 
These programs a lso consider the type of amino acid change. For example,  if 
the changed amino acid is  a hydrophobic substituted with another 
hydrophobic residue it is  usual ly pred icted to be tolerated . However, 
substituting a hydrophobic amino acid with another charged or pola r residue 
is predicted to affect prote in  function and therefore is deleterious [Ool led­
F i lhart et a I . ,  20 1 3] .  
A s  a fina l  step i n  this p rocess, even candidate variants should be 
sequenced by trad it ional Sanger sequencing in a l l  fam i ly members to va l idate 
their segregation with the pathogenic phenotype [Gi l issen et a I . ,  20 1 2] .  I n  
add ition, defi n i te proof o f  pathogen icity req u i res novelty verification in 
ethn ical ly matched healthy controls and/or functional experiments. 
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1 .4.3. Conclusion 
I n  th is  chapter, I have given a broad overview of  autosomal recessive 
d isorders and the methods by which d isease-causing genes and mutations 
may be identified . It is  strik ing that, for the majority of these severe d isorders 
the underlying molecular causes remain unknown . U ndoubtedly, current  and 
future advances i n  sequencing technologies and bioinformatics are l ikely to 
accelerate the identifi cation of d isease-causing genes in monogenic 
d isorders. Evidently, the chal lenge of d isease gene identification is sh ifting 
from the identification to the interpretation phase and a l though numerous 
genomic a nd exon ic variants are found in  each patient only one or two may 
explain the monogenic d isease. 
4 1  
1 .5. Potential  contri butions and l im itations of the study 
The research described in this d issertation has primari ly focused on 
the mapping and identification of novel d isease genes and causal mutations 
of rare autosomal recessive d isorders among main ly consanguineous fami l ies 
resid ing in  the UAE.  
1 .5 . 1 .  Limitat ions 
• Autosomal recessive d isorders are individual ly rare, making it d ifficult 
to col lect s ign ificant numbers of unrelated patients or fami l ies with 
s imi lar  phenotype to further verify the pathogenicity of some d isease­
causing genes. 
• The UAE population is ethn ical ly heterogeneous encompassing 
several isolated subpopu lations and most stud ied fami l ies were not 
orig inal ly Em i rati making i t  d ifficult to va l idate rarity or prevalence of 
some candidate variants i n  their original populations. 
• Limited functional data can be generated for some of the identified 
genes and m utations d ue main ly  to sampl ing difficulties for the 
fol lowing reasons: 1 )  fami l ies cooperation and local izat ion, 2) severity 
of the syndrome (many affected chi ldren die with no sufficient or l imited 
samples to study), 3) i naccessib i l i ty of relevant tissues to study gene 
expression . 
• U navai lab i l i ty of an imal  models to study the identified genes and 
mutations in vivo. This is  ma in ly because of l imited resou rces,  t iming 
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1 .5.2.  
and l imi ted expertise at  C M HS. Knock out models are expensive and 
beyond the resources that we have at our disposal .  
Potential  contributions 
The i mportance of my study is that I have elucidated the genetic, 
molecular and in  some cases the cel lu lar  bases of several rare autosomal 
recessive d isorders segregating i n  h igh ly- inbred consanguineous fam i l ies. 
The find ings from this d issertat ion are anticipated to: 
• Facil itate genetic counse l ing ,  carrier testing , prenatal and even pre­
implantation genet ic d iagnosis for at-risk fami ly members.  
• Allow more accurate d iagnosis for other patients exhibit ing one of the 
studied phenotypes. 
• Shed some l ight  on some pathophysio logical processes thereby 
enhancing understand ing of normal physiology and d isease 
mechanisms,  faci l i tat ing the development of therapeutic targets for 
future possib ly curative treatments for some d iseases. 
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C HA PT E R  2 :  G E N E RAL M ETHODS 
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2. 1 .  Fami l i es 
2 . 1 . 1 .  Consent and eth ics approva l 
A" the investigat ions included In this d issertation have been approved 
by the ethics committee at AI -Ain Med ica l Human Research EthicS Committee 
accord ing to the national  regulat ions (protocol number 1 0/09). A" individuals 
part ic ipated i n  th is study or the i r  guard ians provided written informed consent 
before being enro l led in the genetic study. 
2 . 1 .2. Fami l ies recru itment and patients assessment 
For the UAE-based fami l ies, a deta i led cl in ical assessment includ ing a 
fu l l  medica l  history and systemic examination was performed for each fami ly 
by Prof. L ihadh AI-Gazal i  e i ther at Tawam Hospital or at AI-Ain Hospita l .  
B lood samples were taken from most affected ind ividuals ,  both parents and 
any avai lab le u naffected s ib l ings.  For fami l ies based outside the UAE, cl in ical 
data were acqu i red by l ia is ing with the referring cl in ic ians. For such 
in te rnationa l ly  acquired cases, the referring cl i n ic ian sent consent forms ,  fu l l  
c l in ica l  report, fami ly's ped igree , h istory a n d  pictures a s  well a s  DNA sam ples 
for genetic test ing.  
2.2. Methods 
2 .2. 1 . D N A, R N A  & prote in  extraction 
2 .2 .1 . 1 . DNA extraction  
Whole blood samples were col lected i n  ethylenediam ine tetra-acetic 
acid (EDT A)  tubes. Genomic D NA was extracted us ing the Flexigene DNA 
extraction kit (Qiagen ,  U SA) fol lowing the manufacturer's i nstructions. Briefly, 
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the blood sample was m ixed thoroughly with red blood cel ls (RBCs)-lysis 
buffer fol lowed by centrifugation to recuperate the leukocytes. Then, the white 
blood cel ls  (WBCs) were l ysed using the denaturation buffer and treated with 
Proteinase K (Sigma Aldrich,  USA) to d igest the proteins. The genomic DNA 
was precipitated using isopropanol (Sigma Aldrich, USA) fo l lowed by a 
washing step us ing 70% of ethanol (Sigma Aldrich , USA). Final ly, the pel let 
was a l lowed to a i r  d ry for a few minutes and at the end the DNA was 
suspended in D Nase-free water (Sigma Aldrich, USA). The DNA yields and 
qual it ies were determined,  as measured by absorbance at 260 nm, using a 
Nanodrop Spectrophotometer 1 000 (ND-1 000; Thermo Fisher Scientific, 
USA). High q ua l ity DNA has an  A260/A280 ratio of 1 . 7 to 1 .9 .  A ratio of > 1 .7 
ind icates that the DNA is free of protein contamination. 
2.2. 1 .2 .  R N A  extraction 
Total RNA was extracted from blood using Qiazol reagent (Qiagen, 
USA) fol lowing the manufacturer's instructions .  Blood was mixed thoroughly 
with red b lood cel ls  ( RBCs)-lysis buffer (Qiagen, USA) followed by 
centrifugation to recover the leukocytes. Then, 1 x 1  06 white blood cel ls  
(WBCs) were mixed with 1 m l  Qiazol reagent. 200 � I  chloroform (Sigma 
Aldrich, USA) was added and mixed vigorously then centrifuged for 1 0  
m inutes at  - 1 3,000 xg. The aqueous layer was then taken and mixed with 
600 �I isopropanol ( Sigma Aldrich, USA) and centrifuged to precipitate the 
RNA. Then the RNA pel let was washed with 70% ethanol (Sigma Aldrich, 
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USA),  a i r  d ried and then d issolved in DNase- and RNase- free water (Sigma 
Ald rich, USA). 
2 .2 . 1 .3 .  Protei n  extraction 
Total p rote ins were extracted from adherent ce l ls (skin fibroblasts, 
HeLa,  Hek293 and COS7). The cel l culture medium was removed and cel ls  
were washed once with a phosphate buffered sal ine (PBS; Gibco Life 
Technologies ,  U SA) .  Cel ls were detached using 1 x trypsin solution (Gibco 
Life Technologies ,  USA) by incubation at 37°C for 5 minutes or unt i l  they were 
vis ib ly detached . Two mi l l i l i ters of cul tu re media with feta l bovine serum ( FBS; 
Gibco Life Technologies, USA) was added to stop the protease reaction then 
cells were col lected and centrifuged . The supernatant was decanted and cel ls  
were lysed by incubating i n  1 50 IJ I  rad io immunoprecipitation assay buffer 
( R I PA; Thermo Scientific Pierce, USA) contain ing 1 x  Protease inh ibitor 
(Sigma Aldrich,  U SA) for 1 5  minutes on ice. The cel l Iysates were col lected 
and transferred to a m icro-centrifuge tube. The samples were then 
centrifuged at maximum speed - 1 3, 000 xg to pellet the cel l  debris. The 
supernatant was transferred to a new tube and quantified using bicinchon inic 
acid ( BCA) protein assay kit (Thermo Scientific Pierce, USA). After m ixing 
reagents A and B of the kit , the samples were added and incubated for 30 
m inutes then were read against prote in standards at 562 nm. 
2.2.2.  Polymerase chain react ion (PCR) ampl ification 
2.2.2 . 1 .  Standard PCR 
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PCR amp l ification of a DNA fragment of interest was performed on a 
2720 thermal  cycler (Appl ied BioSystems, USA). A total vol ume of 20 �I of 
PCR reactions were prepared conta in ing 1 x PCR buffer (Qiagen, USA),  0 .2 
mM d NTPs (Promega , U SA), 5 �M of each forward and reverse primers 
( Metabion,  Germany), 1 00 ng of template DNA and 0.5 un i ts of Taq DNA 
polymerase (Qiagen, USA).  The standard reactions were subjected to an 
in i t ia l  denaturation period of 5 minutes at 95 °C fol lowed by 40 cycles of 95 °c 
for 30 seconds, 56 °C-60 °C for 45 seconds and 72 °C for 45 seconds and 
fi nal  extension of 72 °c for 1 0  minutes. 
2.2 .2 .2 .  Reverse tra nscr iption 
The cDNA was prepared by using GoScript reverse transcription 
system (Promega, USA) accord ing to the manufacturer's instructions. A tota l 
volume of 50 � I  of reactions were prepared conta in ing 1 x buffer, 0 .2 m M  
d NTPs, 2 . 5  � I  o f  random primers, 1 � g  o f  template RNA a n d  0 . 5  un i ts of 
reverse transcriptase and RNase inh ib itor. The standard reverse transcription 
reaction was composed of an in it ia l  annea l ing period of 5 m inutes at 25 °C 
fol lowed by 1 hour extension at 40 °C then the reverse transcriptase was 
inactivated at 70 °C for 1 5  m inutes. 
2.2 .2 .3 .  Rea l-time pe R 
The expression levels of m RNA were ana lyzed using target specific 
TaqMan gene expression assays (Hs01 089850_m 1 for LlNS and 
Hs0 1 097626_m 1 for COL 1 1A 1 ; Applied B iosystems, USA) using the 7500 
Rea l Time PCR system (Appl ied B iosystems, USA).  Human HPRT1 
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(hypoxanthine phosphoribosyltransferase 1;  Hs99999909_m 1 ;  Appl ied 
Biosystems,  USA) was used as an endogenous control . Al l  reactions were 
run in d upl icates and repeated in two different ampl ification experiments to 
ensure reproducib i l i ty. Target m RNA was ampl ified and quantified in a tota l 
volume of 20 �I conta in ing :  1 0 �I of 2X TaqMan gene expression master mix 
(Appl ied Biosystems,  USA),  1 � I  of TaqMan assay, 2 � I  of the cDNA samples 
and 7 � I  of nuclease-free water. The standard ampl ification conditions a re as 
fol lows: 1 0  m inutes activation at  95 eC, followed by 40 cycles of ampl ification 
at 95 eC for 1 5  seconds and 60 eC for 1 minute. The th reshold cycle (CT) and 
relative expression or  q uantification (RQ) va lues were calculated using the 
7500 ana lysis SDS software v2 (Appl ied Biosystems,  USA). 
2.2.2 .4.  S ite d i rected mutagenes is 
The m utations were introduced in the ready-made JAM3-pCMV6 
plasmid tagged C-termina l ly Myc-Flag-tagged commercial construct 
( RC21 6073; OriGene Technologies, USA, see Append ix-A) using the 
Qu ickChange s ite-d i rected mutagenesis kit (Stratagene, USA). The primers 
used to introduce p . E 1 1 6K m utation in the cDNA of JAM3 in pCMV6 plasmid 
a re the forward : 5' CCCTTT A TCGCTGT AAGGTCGTTGCTCG 3' and the 
reverse: 5' CGAGCAACGACCTTACAGCGATAAAGGG 3'.  While, the pr imers 
used to introduce the p .C2 1 9Y mutation were the forward : 5' 
CTGGGCAGTACTACTACA TTGCTTCCAA TG 3' and the reverse: 5' 
CATTGGAAGCAATGTAGTAGTACTGCCCAG 3'. PCR ampl ification was 
performed on a 2720 thermal  cycler (Applied BioSystems, USA). A tota l 
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volume of 20 IJI of PCR reactions were prepared contain ing 1 x PCR buffers 
(Qiagen, USA), 0 .6 m M  d NTPs, 5 IJM of each forward and reverse primers 
( Metabion , Germany),  50 ng of template DNA and 1 .25 un its of Pfu Turbo 
DNA polymerase (Stratagene, USA). The reactions were subjected to an 
in it ial denaturation period of 5 minutes at  95°C fol lowed by 1 6- 1 8  cycles of 
95°C for 30 seconds,  60°C for 1 m inute and 72°C for 1 8  minutes and a final  
extension of 72°C for 20 minutes.  The parental DNA templates were d igested 
using the Opnl ( Promega, USA) endonuclease treatment for 3 hours at 3rC. 
2.2.3. Sequencing 
2 .2 .3. 1 .  Sanger sequencing 
2 .2 .3 . 1 . 1 . p e R  products sequencing 
The PCR products were cleaned up using 1 un i t  of Exonuclease I -
Shrimp Alka l ine Phosphatase solut ion (USB ExoSAP-IT; Affymetrix, USA) at 
37 ·C for 30 m inutes fo l lowed by 80 ·C for 1 5  m inutes in thermocycle 
machine. Sanger cycle sequencing was performed using the BigDye 
Terminator k i t  v3. 1 (Appl ied B iosystems,  USA) in a reaction contain ing 1 . 5 IJ I  
of PCR products, 0 .5  IJ M  of either forward or reverse primers, 2 IJ I  of 5x 
BigDye Term inator sequencing buffer and 2 IJI of BigDye terminator Taq mix 
(Appl ied Biosystems, USA). Cycle sequencing reactions were performed as 
fol lows: 96 °C for 1 minute, fol lowed by 25 cycles of 96 °c for 1 0  seconds, 50 
°c for 5 seconds,  and final  extension of 60 °C for 4 minutes. F luorescent PCR 
products were purified by adding 1 . 25 IJ I  of 1 25 m M  EDTA ( Promega, USA) 
and 25 IJI  of 95% ethanol ( Promega, USA) to precip i tate the DNA. After 30 
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minutes incubation i n  -20°C the PCR plates were centrifuged for 20 minutes 
at 4°C at 4000 rpm .  The plates were fl ipped on t issue papers and centrifuged 
briefly to decant the supernatants. 50 IJI of ?O% ethanol was added to each 
wel l  and previous steps were repeated to wash the pel lets. The plates were 
left to d ry for 1 5  m inutes in the a ir. The DNA pel lets were then d issolved and 
denatured i n  1 5  IJ I  of H iDi-Formamide reagent (Appl ied Biosystems, U SA). 
The purified products were then separated and electrophoresed in the POP?­
fi l led 1 6  cap i l la ries of the 3 1 30xl Genetic Analyzer system (Appl ied 
Biosystems,  U SA).  The results were analyzed using Sequencing Analysis 
v5.3 software (Appl ied Biosystems, USA). 
2.2 .3. 1 .2 .  P lasmid sequencing 
Plasmid DNA sequencing was performed using the Sanger d ideoxy 
method on the 3 1 30xl Genetic Analyzer (Applied B iosystems,  USA). A tota l 
volume of 4iJ i  of purified plasmids, 5 iJ M  of e i ther forward or  reverse primers, 
2iJi of 5x Big Dye Terminator sequencing buffer and 2 iJ l  of BigDye terminator 
cycle sequencing mix (Appl ied Biosystems, USA). The reactions were 
subjected to a n  i n it ia l  denaturation period of 5 minutes at 95DC fol lowed by 35 
cycles of elongation at 95 DC for 30 seconds and anneal ing at 60 DC for 4 
m inutes. PCR products were cleaned u p  using the above described ethanol 
purification method and then were run on the 3 1 30xl Genetic Analyzer 
(Appl ied Biosystems, USA). The results were ana lyzed using Seq uencing 
Analysis v5. 3  software (Appl ied B iosystems, USA). 
2.2 .3 . 1 .3 .  Whole-exome sequencing 
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Whole-exome sequencing (WES) selectively sequences a l l  the coding 
regions (exons and intron/exon boundaries) of al l the genome. L ibrary 
construct ion, whole-exome capturing, whole-exome sequencing, variant 
ca l l ing and annotation were performed by two commercial  companies 
( Macrogen ,  South Korea ; Oxford Gene Technology; UK) .  The l ibrary 
construction was performed using SureSelect human a l l  exon Kit (Agi lent 
Technologies, USA) and sequencing was performed by I l ium ina H iSeq 2000 
( I l i um ina,  USA )  accord ing to the manufacturer' s protocol .  Paired end (2x 1 00 
bases) DNA sequence reads that passed the qua l i ty control were mapped to 
the human reference genome bu i ld  hg 1 g  using the Burrows-Wheeler Al igner 
( BWA) and Sequence Al ignment/Map (SAM ) tools .  
2.2.4. Genotyping 
2 .2 .4. 1 . Genome wide S N P  genotyping 
Genome-wide homozygosity mapping us ing the Genome-Wide H uman 
SNP Arrays 250K and 6 .0  (Affymetrix ,  USA) was performed on the DNA 
samples from the recruited fami ly  members .  SNP genotypes were obtained 
from several commercial companies (ATLAS Biolabs; Germany; Expression 
Analysis; U K ;  and Aros Applied Biotechnology, Denmark) and from academic 
institut ions (Geoff Woods' laboratory, Cambridge Institute for Medical 
Research; U K). Briefly, total genomic DNA (250 ng) was d igested with Nspl  
and Spyl  restriction enzymes and l inked to adaptors. Generic primers that 
recognize the adaptor sequence were used to ampl ify adaptor- l igated DNA 
fragments. Standard PCR condit ions preferentia l ly  ampl ify fragments in the 
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200-1 1 00 bp size range. The a mpl ified DNA was then fragmented with the 
Affymetrix fragmentation reagent fol lowing the manufacturer's protocol. 
Genotype cal l i ng was performed by the Genotyping Console software 
(Affymetrix ,  U SA) using the defau l t  sett ings. 
2.2 .4.2 .  M icrosatel l ite genotyping 
Fine mapping to confirm and reduce the homozygous regions identified 
in section 3 . 1 was performed using fl uorescently-Iabeled microsate l l ite 
markers or STRs designed and analyzed in Professor Geoff Woods' 
laboratory (Cambridge I nstitute for Medical Research ; U K) .  STRs used for 
genotyping the fami ly  in section 3 .6  were selected accord ing to their locations 
and frequencies us ing the Marshfield genetic map. STRs ampl ification was 
performed using GoTaq Flexi DNA Polymerase kit ( Promega, USA) in a 2720 
thermocycler (Appl ied B iosystems,  USA). PCR mix of 20 1-11 was prepared 
conta in ing :  2 .5  1-1 1 5x buffer,  1 1-1 1 MgCI2, 0 . 1 1-11 dNTPs, 0 .251-1 1  DNA, 0 .06251-11  
GoTaq DNA polymerase, 0 .4  1-1 1  forward STR primer, 0. 1 1-1 1  reverse STR 
primer, 0 .41-1 1  M 1 3  u n iversa l fluorescently labeled forward primer and 1 5.21-1 1  
nuclease free water. The  ampl ification conditions were as  fo l lows: hold at  94 
°c for 5 m inutes, then 30 cycles of 94 °C for 30 seconds, 57 °C for 45 
seconds, 72 °C for 45 seconds,  fol lowed by 8 cycles of 94 °c for 30 seconds, 
53 °C for 45 seconds, 72 °C for 45 seconds, with fi nal extension hold at 72 °c 
for 1 0  minutes. Labeled PCR product a l iquots were denatured in H iDi­
Formamide (Appl ied B iosystems, USA) and electrophoresed using the 3 1 30x/ 
Genetic Ana lyzer system (Appl ied Biosystems, USA). PCR products s izes 
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were determined by reference to GeneScan-500 L IZ s ize standard (Promega, 
USA) and GeneMapper software (Appl ied Biosystems,  USA). 
2 .2 .5. E lectrophores is 
2 .2 .5 . 1 .  Agarose gel e lectrophores is  
PCR prod ucts (-5 1-1 1 )  were separated accord ing to  size on  2% agarose 
gel ( Promega, USA) in 1 x  TBE buffer (Tris/Borate/EDTA). Eth id ium bromide 
( EtBr) usual ly is  added to the gel to a fi nal concentration of approximately 0.2-
0 .5  I-Ig/m L.  EtBr b inds to the DNA and a l lows the DNA visual ization under 
ultraviolet ( UV) l ight. Where needed , specific PCR products bands were 
s l iced from the gel with a clean ,  sharp scalpel and purified using QIAquick gel 
extraction Kit (Qiagen, Germany) accord ing to the manufacturer's protocol .  
Briefly, 3 volumes o f  buffer Q X 1  was added to 1 volume gel and incubated at 
50 °C for 1 0  m inutes to d issolve the gel. Then, 1 gel vo lume of isopropanol 
was added to the sample,  m ixed, and centrifuged in a spin column.  The 
col lected DNA was washed and d issolved in nuclease free water. 
2.2 .5 .2 .  Western b lot ana lysis 
Total protein extracted from cel ls  (-1 00 I-Ig) was mixed with a 1 x 
reducing sample loading buffer [2 ml  of Glycero l ,  6 ml  of 20% sod ium dodecyl 
su lfate (SDS),  1 . 8 ml of 2-mercaptoethanol , 5 ml of 1 M Tris-HCL 6.8 ,  0 . 1  % 
bromophenol b lue and 3 .8ml  ddH20] (Sigma Aldrich, USA). The mix was 
denatured at 1 00 DC for 5 m inutes and then e lectrophoresed in 8% SDS­
polyacry lamide gel electrophoresis ( PAGE). The gel was then blotted to a 
nitroce l lu lose membrane (Thermo Scientific Pierce, USA) using a transfer 
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apparatus accord ing to the manufacturer's protocols (B io-Rad , USA). After 
incubation with 5% nonfat m i lk  in Tris-buffered sal ine with Tween 20 [TBST; 
1 0m M  Tris, pH 8 .0 ,  1 50mM NaCI, 0 .5% Tween 20] (Sigma Ald rich , USA) for 
60 minutes, the membrane was then washed once with TBST and incubated 
with 1 In  500 d i lut ion of rabbit polyclonal Anti-COL 1 1  A 1 antibody 
(ab64883;Abca m ,  U SA) at 4°C for 1 2  hours .  Membranes were washed three 
t imes for 1 0  m inutes and incubated with a 1 :30,000 d i l ution of horseradish 
peroxidase (HRP)-conjugated anti-rabbit antibody (Santa Cruz Biotechnology, 
USA) for 2 hours at room temperature. B lots were washed with TBST three 
times and developed with enhanced chemi luminescence ( ECl Plus;  Thermo 
Scientific Pierce, U SA) and visual ized by the Typhoon imaging system (GE 
Healthcare,  USA) .  
2.2 .6. Ce l lu lar  stud ies 
2.2.6. 1 .  C u lture of h u ma n  cel l  l ine 
H uman ce l l  l ines ( Hela;  H E K293; COS7) were cultured i n  Dulbecco's 
mod ified Eagle's mediu m  (DMEM ; I nvitrogen,  USA) supplemented with 1 0% 
heat inactivated feta l bovine serum ( FBS; I nvitrogen,  USA) , 2mM l-g lutamine 
and 1 00U/ml penic i l l in/streptomycin ( I nvitrogen,  USA) at 37 °C with 5% CO2. 
When the cel ls  were confluent they were detached by trypsin treatment as  
described i n  prote in extraction (see 2 .2 . 1 .3) and  then p lated in 24  well p lates 
for confoca l microcopy or 6 wel l  plates for western blotting analysis. 
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2.2 .6 .2 .  Trans ient transfect ion of cu ltured ce l ls  
H uman ce l l  l i nes were grown for 24 hours on steri le cover s l ips ( I b id i ,  
Mart insried , Germany) i n  2 4  wel l  p lates ( Nalge N unc I nternational ,  USA) in 
the culture media described above. Upon reaching 60-70% confluency,  cel ls  
were transfected using 1 . 7 1-1 1 of  the non-l iposomal transfection reagent 
FuGENE H D  (Promega,  USA) and incubated for 5 minutes at room 
temperature with 26 1-1 1 of Optimem ( I nvitrogen, USA) and 1 I-Ig of the purified 
cDNA plasmids.  Co-transfection with 0 .2 I-Ig of hRas-GFP ( Harvey rat 
sarcoma viral oncogene homolog - green fluorescent protein )  plasmid was 
performed to serve as a transfection ind icator and a plasma membrane (PM)  
marker. Twenty-fou r  hours after transfection, the cel ls were fixed and stained 
for confocal m icroscopy with specific ant ibodies. 
2 .2 .6 .3 .  Confocal  f luorescence microscopy 
For i m m unofluorescence , cel ls  cu ltured on cover sl ips were washed 
with PBS and fixed by methanol at -200 C for 4 m inutes.  Before blocking, 
covers l ips were washed in PBS three t imes. Then the coversl ips were 
incubated in blocking solution of 1 % Bovine serum albumin (BSA; Sigma 
Ald rich , U SA) in PBS for 30 minutes at  room temperature. After blocking , ce l ls  
were i ncubated for 1 hour at  room temperature with the relevant monoclonal 
or polyclonal  primary ant ibod ies. Mouse anti-flag (Sigma Ald rich , USA) and 
rabbit a nti-ca lnexin ( Santa Cruz Biotechnology, USA) were used at 1 :  1 ,000 
and 1 :  1 00 d i l ut ions, respectively .  Then the cover s l ips were washed with PBS 
and re- incubated in the dark with the appropriate rohdamine/fluorescein 
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labeled secondary ant ibod ies for 45 minutes at room temperature. Secondary 
antibodies (fluorescence-labeled "Alexa-Fluor-568" [anti-mouse] and "Alexa­
Fluor-488" [ant i-rabbit] ; Santa Cruz Biotechnology, USA) were used . F ina l ly, 
the cover s l ips were washed several t imes with PBS and mounted in 
mount ing medium ( ICN Biomedica ls ,  USA) .  Data were acquired using a N ikon 
confocal m icroscope ( Ni kon I nstru ments, Japan). The images were presented 
as s ing le sections in the z-plane,  using Adobe Photoshop (Adobe, U SA).  
Control experiments without the pr imary antibodies or with non-transfected 
cel ls  were carried out and revea led very low-level background sta in ing.  
2 .2 .6.4. F ibroblast cu lturing 
Skin biopsies from patients and control samples were s l iced into 
smal ler  pieces and cultured i n  6 wel l  plates in DMEM supplemented with 20% 
FBS, 2 mM L-glutam ine and 1 00 U/ml Penici l l in/Streptomycin at  37 DC with 
5% CO2. After reaching confluency, cel ls  were trypsinzed using 1 x of trypsin 
solut ion and transferred to T25 (25 cm2) flasks in the same media to be 
fu rther analyzed and mainta ined . 
2.2.7.  B io informatics ana lysis 
2 .2 .7 . 1 .  Website addresses for internet resources 
A number of websites were ut i l ized for various aspects of experimental 
design and data analysis (Table 2 - 1 ) .  
2.2 .7.2.  P rimer des ign  
Primers for DNA and  cDNA PCR ampl ification were designed using 
Primer3 or ExonPrimer (Table 2-1 ) .  Primers for site d i rected mutagenesis 
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were designed using PrimerX (Table 2- 1 ) . TaqMan assays were selected 
from the TaqMan gene expression assays l isted in the company's website 
(Appl ied Biosystems, U SA). A l ist of a l l  the primers used in this d issertation 
are i l l ustrated in Appendix-B. 
2.2 .7 .3 .  Homozygos ity mapping analysis 
Generated SNPs derived from the fam i ly members DNA were loaded 
into the software package HomozygosityMapper or into the software package 
dChip and subjected to computational homozygosity mapping analysis. Copy 
number variat ions (CNVs)  ana lysis was carried out using the affymetrix 
genotyping console software 4. 1 .4 (Affymetrix, USA). 
2.2.7.4. Prioritization of genes and variants 
Candidate genes within homozygous regions were prioritized 
accord ing to their expression profi les, interactions, functions, s imi larity and 
other criteria ,  us ing several pred iction programs such as GeneDsti l ler2, 
Suspects, ToppGene Su i te .  I n  addit ion ,  those genes were ranked based on 
the knowledge gained from previous studies in PubMed, UCSC, OM I M  and 
NCB I .  
2.2.7.5.  Analysis of Sanger sequences and exome sequencing data 
Exome variant fi ltering was performed against NHLB I  exome variant  
database, Ensembl ,  1 000 Genome project, and dbSNP. Ciusta lW2 and B last 
were used for al igning sequences generated from Sanger sequencing with 
the corresponding Ref Seq sequences from the UCSC and NCBI .  On l ine 
ava i lable software tools such as Polyphen2, S IFT, and m utation Taster were 
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used to predict the possible pathogenic effect of mutations,  whi le to predict 
the effects of intron ic mutations on spl ic ing efficiency, human spl icing finder -
v2.4. 1 ,  and GeneSpl icer software were used. 
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Table 2-1 . Web-based resou rces. 
UCSC http://genome.ucsc.ed u/ 
NCBI  h ttp ://www . ncbi .n lm .n ih .Qov./ 
Ensembl www .ensembl .org 
Primer3 http://frodo.wi .m it .edu/primer3/ 
PrimerX http://www . bioinformatics.org/primerxf 
CiustalW2 http://www .ebi .ac .ukITools/clustalw2/index. html 
dbSNP http://www . ncbi .n lm .n ih .Qov./projects/SNP/ 
Affymetrix http ://www .affymetrix. com/estore/ 
Blast http ://blast. ncbi . nlm .n ih .gov/Blast .cQi 
ExonPrimer http ://ihg2.helmholtz-
muenchen.de/ihQ/ExonPrimer. html 
Onl ine Mendel ian http://www . ncb i . n lm .n ih .gov'/sites/entrez?db=OM I 
Inheritance in Man M&itool=toolbar 
(OM I M) 
PubMed http ://www . ncbi . n lm.n ih .qov./pubmed/ 
Knockout Mouse http ://www . knockoutmouse.org/data .shtm l .  
Project 
PolyPhen-2 http://genetics .bwh.harvard .ed u/pph2/ 
S I FT http ://sift.jcvi .org/ 
MutationTaster http://www .mutationtaster.orq/ 
GeneDisti l ier  2 http://www .gened ist i l ler.orq/ 
1 000 Genome project http://www . 1 000genomes.orQ/ 
NHLB I  exome http ://evs.gs.washington .ed u/EVS/ 
sequencing Project 
(ESP) 
Suspects http://www .Qenetics .med.ed .ac.uk/suspects/ 
ToppGene Suite http://toppgene.cchmc.org/ 
ExPASy http://www . expasy.org/ 
HomozyqosityMapper www . homozygositymapper.org/ 
Affymetrix http ://www .affymetrix .com/estore/ 
TaqMan Gene http ://www . invitrogen .com/site/us/en/home/Product 
Expression Assays s-and-Services/Appl ications/PCRlrea l-time-
pcr/real-t ime-pcr-assays/taqman-gene-
expression. html 
GeneSpl icer  http://www . cbcb. umd .edu/software/GeneSpl icer/ge 
ne spl . shtml 
Human Spl icing http ://www. umd . be/HSF/ 
Finder - Version 2 .4. 1 
dChip software http ://www .dchip.org 
HGMD http ://www . hgmd .cf.ac .uk/ac/hahaha .php 
M utalyzer 2 .0 .beta-27 https://muta lyzer.n l/ 
Marshfie ld human http ://research .marshfieldcl in ic .org/genetics/Geneti 
genetic map cResearch/compMaps.asp 
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C H APTER 3 :  R E S U LTS AN D D I SS C U S S I O N  
6 1  
S ECTI O N  1 :  Is a utosomal  recessive S i lve r­
R usse l l  syndrome a separate e ntity 
o r  is it  pa rt of the Th ree-M sy ndrome s pectru m ?  
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3. 1 . 1 .  Background 
3 . 1 . 1 . 1 .  Three M syndrome 
3 . 1 . 1 . 1 . 1 .  C l i n ical  features 
Three M syndrome (3-M; O M I M# 273750, 6 1 292 1 and 6 1 4205) is a 
rare a utosomal  recessive d isorder fi rst described by M i l ler et a l .  [ 1 975] . The 
disorder is  characterized by low b irth weight, proportionate dwarfism,  
dysmorphic facial features, and rad io logical abnorma l it ies. The typical facial 
features include a relatively large head, frontal bossing,  triangular face with a 
pointed ch in ,  u pturned nose with a long phi ltrum ,  and hypoplastic midface 
[Winter et a l . , 1 984] . Radiological features i nclude slender long bones and 
ribs, foreshortened vertebral bod ies, and smal l  pelvis [van der Wal et a I . ,  
200 1 ] . 
3 . 1 . 1 . 1 .2 .  Genetic heterogeneity 
The 3-M syndrome is a genetica l ly  heterogeneous.  Studying a series 
of 29 fam i l ies with 3-M syndrome, Huber et a l  [2005] mapped the d isease 
locus and the d isease-causing mutations to chromosome 6p2 1 . 1  and in 
CULL lN7 ( CUL 7; O M I M*609577).  Later on, Hanson et a l  [2009] described the 
mapping of a second locus for 3-M syndrome at 2q35-q36. 1 and the 
subsequent i dentification of mutations in the OBSL 1 gene (OMI M*6 1 099 1 ) 
that encodes obscur in- l ike protein 1 (OBSL 1 ), a putative cytoskeletal adaptor 
prote in .  In 201 1 ,  the same group used homozygosity mapping in five 
unrelated patients from consanguineous Asian fami l ies and identified another 
3-M syndrome locus 1 9q 1 3. 2-q 1 3. 32 [Hanson et a I . ,  20 1 1  a] .  The region was 
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of 7 .9  Mb and conta ined 301 protein-coding genes. Therefore the authors 
used exome sequencing to identify the causative gene and identified different 
homozygous mutations in the coi led-co i l  domain contain ing protein 8 
(CCDC8; OM I M*6 1 4 1 45)  i n  a l l  five patients. As a result ,  the authors proposed 
that CUL7 ,  OBSL 1 ,  and CCDC8 are members of the same pathway that 
control mammal ian growth . 3-M patients without a m utation in any of the 
aforementioned genes and who a re not l i nked to any of the mapped regions 
have a lso been identified , ind icating the involvement of add itional genes in 
the pathway and causing this growth d isorder [Hanson et a I . ,  2009; Clayton et 
a I . ,  201 2]. 
3 .1 . 1 .2 .  S i lver-Russe l l  syndrome 
3 . 1 . 1 .2 . 1 . C l i n ical  features 
Si lver-Russel l  syndrome (SRS; O M I M#1 80860) is a c l in ica l ly 
heterogeneous d i sorder characterized by severe intrauterine and postnatal 
g rowth retardation , re lative macrocephaly and a characteristic smal l ,  
triangular face [H itch ins et a I . ,  200 1 ] .  Add it ional features i nclude body o r  l imb  
asymmetry ,  C \ inodactyly, and severe feeding d ifficu lt ies in infancy 
[Eggermann,  201 0 ; Wakel ing et a I . ,  201 0]. No specific rad iological 
abnormal it ies have been described i n  th is syndrome [Gal l i -Tsinopoulou et  a I . ,  
2008; Rossignol e t  a l . ,  2008] .  Although Bruce et a l  [2009] reported abnormal ly 
h igh l umbar  vertebrae in hypomethylated SRS patients; it remains possible 
that some of the patients in their series had 3-M rather than SRS. 
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3 . 1 . 1 .2 .2 .  Genetic heterogeneity 
SRS is a genetical ly heterogeneous d isorder, with different suggested 
modes of inheritance [H itch ins et a I . ,  200 1 ] . Autosomal recessive inheritance 
of SRS i n  several fami l ies with more than one affected chi ld was suggested 
on the basis of parental consanguin ity, affected s ib l ing of both sexes and 
normal  appearing parents [Ca l laghan , 1 970; Robichaux et a I . ,  1 98 1 ; Teebi ,  
1 992; Gouda et a l . ,  1 996; Ounap et a l . , 2004] . Autosomal and X-l inked 
dominant inheritance patterns have a lso been suggested in several SRS 
cases [Part ington ,  1 986 ; AI-Fifi et a I . ,  1 996] . Maternal un iparental d isomy 
(mUPO) of chromosome 7 accounts for 1 0% of SRS cases, and up to 50% of 
cases have methylat ion defects in imprinted regions on chromosome 1 1  p 1 5 
[Abu-Amero et a l . , 2008]. The remain ing 40% of SRS cases have an 
unknown genetic etiology [Abu-Amero et a I . ,  2008] . 
3 . 1 .2 .  The purpose of the study 
Since the phenotypes of 3-M syndrome and SRS are overlapp ing ,  the 
conclusive d iagnosis of e i ther syndrome can be chal lenging . However, lack of 
rad iologica l  changes in SRS has usua l ly  been used to d ifferentiate the two 
syndromes [van der Wal et a I . ,  200 1 ] .  In th is study, four  consanguineous 
fami l ies from the UAE and Jordan were recru i ted . Three out of the fou r  
fami l ies were orig ina l ly d iagnosed with autosomal recessive SRS while the 
fou rth fami ly  was showing clear rad io log ica l  find ings and therefore was 
diagnosed as a 3-M case with an unknown molecu lar cause. In order  to 
further i nvestigate these d isorders in these fami l ies, molecu lar genetic 
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i nvestigations were undertaken using homozygosity mapping strategy (based 
on parents' consanguin ity) and candidate gene sequencing approach . 
3 . 1 .3 .  Resu l ts 
3 . 1 .2 . 1 .  C l i n ica l  assessment of probands and fami l ies 
3 . 1 .2 . 1 . 1 .  Fami ly A 
The parents a re first cousins Emirati nationals of Omani origin ( Figure 
3 . 1 - 1 a ) .  The father was short with short fi ngers (no exact measurements were 
avai lab le)  and the mother was of normal height. Six chi ldren out of 1 2  were 
affected but only three affected chi ldren were ava i lab le for cl i n ical evaluat ion. 
Three out of the six affected i nd ividua ls are married and have apparently 
normal chi ld ren .  
Patient 1 ( 1 1 1 - 1 0) was the product of  a pregnancy compl icated by 
o l igohydramn ios. He was noted to be smal l  and short with short l imbs but no 
b irth measurements were avai lab le .  He was eva luated in the Genetics Cl in ic 
at  3 months of age. H is weight was 3 ,OOO g (-2 SO),  length 48 cm ( -6 SO) ,  and 
head ci rcumference was 43.5 cm (+2 SO).  He had feeding problems and was 
fa i l ing to thrive. His head was d isproport ionately big for his body, but his bra in 
CT scan was normal .  He had several dysmorphic features includ ing 
prominent forehead,  a triangular face, large eyes, a depressed nasal bridge, a 
short neck, and a pectus excavatum.  His thorax was short. There was 
b i latera l  c l inodactyly. His skeletal survey and chromosome analysis were 
normal .  He was eva luated again at 5 years of age. H is  weight was 1 4  kg (-2 
SO),  height 86 cm (-5 SO),  and head ci rcumference 54 cm (+2 SO). He had 
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normal developmenta l  m i lestones and had normal inte l l igence (Table 3 . 1 - 1 ) . 
H is mother complained of excessive sweating. Echocard iography and repeat 
skeletal survey were normal apart from delayed bone age ( Figure 3. 1 - 1 c) .  He 
was evaluated by endocrinologist and his growth hormone analysis was 
norma l .  Patient 2 ( 1 1 1 - 1 1 )  is  the brother of Patient 1 .  He was the product of a 
pregnancy compl icated by o l igohydramnios ,  with a normal del ivery. H is  b i rth 
weight was 2 ,000 g (- SO) ,  length 41 cm (-5 SO), and head circumference 
34 cm « 50th cent i le) .  He had feeding problems and fa i lure to thrive with 
dysmorphic features s im i lar  to patient 1 (Table 3 . 1 - 1 ) . Patient 3 ( 1 1 1 - 1 2 )  is  the 
sister of Patient 1 and was the product of a pregnancy compl icated by 
ol igohydramn ios, with a normal del ivery. Her birth weight was 2 ,000 g (- SO),  
length 43 cm (-4 SO) ,  and head ci rcumference 35 cm (50th cent i le) .  
Oysmorph ic features were s imi lar  to those of her brothers (Table 3. 1 -1 , F igure 
3 . 1 - 1 c). 
Given the described phenotype above, the affected members of th is 
fami ly were in it ia l ly d iagnosed as autosomal recessive SRS cases. 
3 . 1 .2. 1 .2 .  Fam i ly B 
The parents a re first cousins Emi rati nationals of Omani origin ( Figure 
3 . 1 -2a) .  The mother was short ( 1 49 cm) and the father was apparently of 
average height. 
Patient 1 ( 1 1 1 -3) ,  a female ,  was the product of a pregnancy compl icated 
by o l igohydramn ios  with a normal del ivery at 36 weeks gestat ion. Intrauteri ne 
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F igure 3. 1 -1 .  C l i n ical  features of some affected members from 
fam i ly A. a )  Pedigree of fam i ly A showing consangu in i ty.  b) X-ray of the 
lower l imb  of patient 1 (5 years , 1 1 1 - 1 0) from fami ly A showing normal 
bones. c)  Patient 3 (3 years; 1 1 1 - 1 2) from fami ly A showing triangu lar face 
with large  head 
I I  
I 
I I  0 
1 2 3 4 5 6 7 8 9 1 0  1 1  1 2  
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Table 3 . 1 - 1 . C l i n ical  and rad iolog ica l  features of the studied 
patients compared to S R S  and 3-M syndrome. 
F amil ies F a m i l y  A I Family B Family C I Family 0 
Patients 1 1 1 1 0  1 1 1 1 1  1 1 1 1 2  1 1 1 3  1 1 14 1 1 15  IV6 IV7 IV9 IV4 IV9 IV3 IV1 0 
General Cl inical  Features 
Intrauterine I growth + + + + + + + - - + ? ? ? restnctlon �RL 
Postnatal + + + + + + + + + + + + + short stature 
Normal I 
IntelllQence + + + + + + + + + + + + + 
Feeding + + problems + + + + + + + + + + + 
Excessive 
sweatlnQ 
+ - - - - - - - - -
Cafe-au-Iaite -
spots - - - - - -
Craniofacial  Features 
Relative + + + I + - - + + + ? + + + macroceDhalv 
High & 
prom inent + + + + + + + + + + + + + 
forehead 
Tnangular + + + + + + + + + + - + face 
Long face - - - - - - - + + -
Depressed 
nasal brldae 
+ + + + + + + + + + + + + 
Thin UDDer liD + + + + + + - - - - - -
Postenorly + + + + + + - - - - -
rotated ears 
Short neck + + + + + + - - - + + + 
Skeleta l Features 
Deformed + + + + - - + - - - - -
sternum 
Cllnodactyly + + + + + + + + + + + + + 
Body/facial - - - - - - - - - - -
asym metrv 
Prominent - - - - - - - - - - -
heels 
RadioloQical Features 
Slender - - + - - + NA NA - - - - -
tubular bones 
Tall vertebral · - - - + NA NA - - - - -bodies 
NA=Not available 
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S R S  3M 
+ + 
+ + 
+/- + 
+ 
+ -
+ -
+ + 
+ + 
+ + 
- + 
+ + 
+ -
+ -
+ -
-/+ + 
+ -/+ 
+ -
- + 
- + 
-/+ + 
F igure 3 . 1 -2. C l i n ical  features of some affected members from 
fam i ly B .  a) Pedigree of fami ly B showing consanguin i ty b) and c)  
Photographs of head and hand of  patient 1 (2 years ;  1 1 1 -3) from fam i ly B 
showing triangu lar  face, frontal bossing and c1 inodactyly .d )  Latera l X-ray 
of the vertebrae of patient 1 (2 years; 1 1 1 -3) showing normal vertebrae. 
I I  
2 
I I I  
2 3 4 5 
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g rowth restriction ( I UGR) was d iagnosed prenata l ly. Her b irth weight was 
1 ,570 g (-2 SO), length 42 cm (-4 SO), and head ci rcumference 34 cm ( + 1  
SO). At b i rth she was noted to have short l imbs, a narrow and short thorax 
with a d istended a bdomen with a palpable l iver and spleen. She has a 
triangu lar  face with a prominent forehead,  large eyes, a depressed nasa l  
br idge, a thin upper l ip ,  a short neck, and a b i lateral cl inodactyly (F igure 3 . 1 -
2b ,  2c; Table 3 . 1 - 1 ) . Her skeletal survey ( F igure 3. 1 -2d) ,  abdominal  
u ltrasound ,  and chromosome ana lysis were norma l .  She had feed ing 
d ifficu l ties and fa i l u re to thrive and was tube fed d uring i nfancy. Bone age at 
the age of 1 .4 years was delayed (at the wrist it was 3 months and a t  the 
hands it was 1 year) .  At the age of 2 years her weight was 6 .7  kg ( -3 SO) ,  and 
height was 70 .2  cm ( -5 SO) .  Otherwise , she had normal developmental 
m i lestones. Endocrine evaluat ion revealed normal resul ts including growth 
hormone. However, she was started on growth hormone therapy at the age of 
3 years but the response was poor and therefore it was stopped . 
Patients 2 ( 1 1 1 -4) and 3 ( 1 1 1-5) ,  are brothers of Patient 1 .  Both were the 
products of pregnancies compl icated by ol igohydramnios and norma l 
de l iveries. Both had I UG R  and dysmorphic features with feedi ng d ifficu lt ies 
s im i lar  to their sister (Table 3 . 1 - 1 ). 
The d iagnoses of the affected members of th is fam i ly were in it ia l ly assigned 
as autosomal recessive SRS. 
7 1  
3 . 1 .2 . 1 .3 .  Fami ly  C 
A Jordan ian fami ly with three affected chi ldren and consanguineous 
first-cousin parents was evaluated cl in ica l ly in  Jordan and UAE (F igure 3 . 1 -
3a) .  Patient 1 ( IV-6 ; Table 3. 1 - 1 ) , a g i rl of 1 1  years, the e ldest of four  s ib l ings 
was the product of a fu l l-term caesarean for breech presentation . Her b i rth 
weight was 2 , 400 g (5th cent i le) ,  b irth length was 47 cm (-2 SO),  and head 
c i rcumference was 37 cm (+2 SO). The main problem of the fami ly is  the 
symmetrical short stature of patient 1 and her two brothers ( Patients 2, IV-7 
and 3, IV-9; Table 3. 1 - 1 ) . At 1 1  years, her weight was 28 kg (>1 0 th cent i le) ,  
height was 1 23 cm (-3 SO), and head ci rcumference was 59 cm (+2 SO). She 
a lso had a s imi larly affected cousin ( Patient 4 ,  IV-4; Table 3 . 1 - 1 ) , the son of 
her paternal aunt ( Figure 3 . 1 -3a), whose parents a re also consanguineous.  
Her dysmorphic features are summarized in Table 3 . 1 - 1 .  I n  add it ion , she had 
part ia l  syndactyly of the 2nd and 3rd toes, and hyper-extensib le joints (Table 
3. 1 - 1 ) . Her  skeletal survey at the age of 1 2  years showed delayed bone age.  
Her a bdomina l  ultrasound showed mi ld  hepatosplenomegaly. Her bra i n  M R I  
showed m i ld bifrontal bra in  atrophy a n d  no a bnormal i ties were detected on 
her pitu itary MRI .  Her karyotype was normal .  Both affected brothers had 
s imi lar  features (Table 3. 1 - 1 ). The younger brother had in add it ion , 
m icrognathia and b lu ish sclerae. H is  voice was a lso unusual , but s imi lar to h is  
mother's. S keleta l surveys on both were reported norma l (a t  10  and 5 years, 
respectively) ( Figure 3 . 1 -3b). E ndocrine investigation includ ing g rowth 
hormone stimu lation test, thyroid funct ion tests, and 
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F igure 3 .1 -3. C l in ical  data of some affected mem bers from fami ly C .  
a )  Pedigree of  fami ly C showing consangu in i ty. b)  X-ray of  the lower 
l imbs of patient 3 ( 1 2  years, IV-9) showing normal bones . 
I I  
I I I  
IV 
1 2 3 4 5 6 7 8 9 
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adrenocorticotropic hormone (ACTH) were norma l .  
The d iagnosis of  the affected members of  this fami ly was in i t ia l ly 
assigned as autosomal recessive SRS. Following the identification of a 
mutation i n  OBSL 1 i n  th is fami ly ,  the X-ray fi lms were re-evaluated by the 
rad iologist. I t  was concluded that the long bones on Patient 2 ( IV-7) were 
s lender. There were no vertebra l  abnormal it ies. 
3 . 1 .2 . 1 .4 .  Fami ly  D 
The parents a re Emirat i  second cousins of Baluchi or ig in ( Figure 3. 1 -
4a).  They have a tota l of 1 1  chi ld ren ,  3 of them are affected . The parents a nd 
the other chi ld ren are a l l  of normal height. 
Patient 1 ( IV-9) is a 1 2-year-old chi ld who was the product of a normal 
pregnancy and del ivery. No b i rth measurements were avai lable.  The parents 
noted short stature in the fi rst year  of her l ife. She was eva luated by d ifferent 
ped iatr icians and severa l i nvestigations were done but no d iagnosis was 
provided . She was re-eva luated at the age of 1 2  years. Her weight was 1 7  kg 
(-2 SO), height 1 1 5 cm ( -5 SO) ,  and head ci rcumference 5 1 .5 cm (50th 
centi le) .  Her dysmorphic featu res are summarized in Table 3. 1 - 1 and shown 
in F igure 3 . 1 -4b. Her skeletal survey showed slender long bones and  
foreshortened vertebrae ( Figure 3. 1 -4c; Table 3. 1 - 1 ) . Patients 2 ( IV-3) and  3 
( IV- 1 0) ,  a re the 1 9-year-old s ister and 7 -year-old brother of Patient 1 .  Both 
were the products of normal pregnancies and del ivery. Both have 
proportionate short statu res and s imi lar  facial appearances to Patient 1 .  No 
rad iolog ica l examinations were carried out (Table 3 . 1 - 1 ). 
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F igure 3.1 -4. C l i n ical  featu res of some affected members from 
fam i ly  D. a) Pedigree of fami ly 0 showing consanguin ity. b) Patient 1 
( IV9) and her brother ( IV- 1 0) from fami ly D. note triangular face and 
frontal bossing c )  Latera l x-ray of the vertebrae of pat ient 1 ( IV-9) fami ly 
o at 1 2  years of age showing foreshortened vertebrae . 
I I  
I I I  
IV  
1 2 3 4 5 6 7 8 9 1 0  1 1  
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3 . 1 .2 .2 . 1 . Fami ly A 
H omozygosity mapping of fami ly A, with the Affymetrix Gene-Chip 
Human Mapping 250K array, i n  affected ( 1 1 1 - 1 0, 1 1 1 - 1 1 , 1 1 1 - 1 2) ,  healthy chi ldren 
( 1 1 1 -4,  1 1 1 -6) a nd their mother ( 1 1 -2 )  identified a unique homozygous region on 
chromosome 2q33.3-q36 .3 .  Further polymorphic microsatel l i te marker 
ana lyses reduced the crit ica l  region to an 1 1  Mb (2 1 1 -222 Mb)  interval 
encompassing a round 1 08 genes in the UCSC Genome Browser database 
( Figure 3. 1 -5 ;  Table 3 . 1 -2) .  
A l ist of cand idate genes in the reg ion of homozygosity was generated 
us ing the GeneDisti l ie r  software. This showed that 84 genes of the 1 08 total 
were producing prote ins ,  inc lud ing OBSL 1 ,  which had recently been identified 
as a second cause for 3-M syndrome cases. Combin ing the s imi larities in the 
phenotype of 3-M and SRS with recent  molecular find ings and l inkage resu l ts ,  
led t o  sequence OBSL 1 gene being identified a s  the sole target. A 
homozygous non-synonymous mutation was found in  exon 2 of OBSL 1 i n  a l l  
the  screened affected members of  fami ly A,  c. 1 1 1 9G>C (p .W373C) ( Figure 
3. 1 -6A). Screening the whole fami ly  for the detected mutation revea led the 
carrier status of the hea lthy members as wel l  as the mother in  which the 
same mutation was heterozygous. Screening for more than 1 00 n ormal 
contro ls showed no change in  that specific location among the population .  
Most o f  the mutations reported s o  far in  the OBSL 1 gene were 
truncat ing mutations located with in  the first 8 exons of the gene affecti ng a l l  
known isoforms, result ing in  complete loss of  OBSL 1 function 
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F i g u re 3 . 1 -5. H o mozy g os ity m a p p i n g  resu l ts i n  fam i l y  A. A single homozygous region was identified on 
chromosome 2 for the disease in the family. The mapped region found between rs12474633 and rs1834129 and 
contains 108 genes including the OBSL 1 .  
CH R O M O SO M E  2 
A (�------- �-------\ 
rs 144 74633 1 1 . 2  Mb Homozygous Reg ion (1 08) rS 1 814 1 29 
I - -� 
2 1 1  5 1 2 85 4  OBSL t 222 71 2 896 I I I I 
2 3 4 5 6 7 8 9 1 0  1 1  1 2  
� 0:> 
Table 3 .1 -2. STR genotyping resu lts for the homozygous region on chromosome 2 in  fam i ly A.  
1 1-2 - 1 1 1 -4 
MARKER location (mother) ( unaffected) 
AC008 1 72AC 1 5  2 1 1 ,245, 000 2 0 1  2 0 7  2 0 7  207 
GATA4G 1 2  2 1 8 , 1 84 , 7 1 9  264 264 264 264 
AC0 1 0886CA2 1 2 1 8 ,427,000 287 289 289 289 
ACO 1 0886AC20 2 1 8 ,454, 000 229 229 229 229 
AC009469TC 1 6  2 1 8 ,494,000 204 208 - -
AC097483AGAA 302 294 294 294 
AC02 1 0 1 6TC 1 5  2 1 9 , 047 ,000 1 96 1 84 1 84 1 84 
AC02 1 0 1 6TC27AT 456 426 426 426 
--
AC073838AC28 2 1 9, 1 53,000 1 7 1 1 7 1 1 7 1 1 7 1 
ACO 1 25 1  OTG20TC27 2 1 9,273,000 2 1 5  2 1 5  2 1 5  2 1 5 
ACO 1 25 1  OAC20"* 2 1 9 ,294 , 000 1 67 1 69 1 69 1 69 
AC009231 GT1 8*" 222,528,800 1 63 1 59 1 59 1 59 
AC009302TG20 222,628 ,850 2 1 8  2 1 4  2 1 4  2 1 4  
AC009302GT2 1 222 , 739 ,400 1 70 1 55 1 55 1 55 
"The markers were designed by Dr.  Geoff Wood's lab.  
""Markers flanking OBSL 1 gene (chr2:  220426438-220436268) 
1 1 1-6 
(unaffected) 
201  
264 
287 
229 
204 
302 
1 96 
456 
1 7 1 
2 1 5  
1 67 
163 
2 1 8  
1 70 
-- -
207 
264 
289 
229 
208 
294 
1 84 
426 
1 7 1  
2 1 5  
1 69 
1 59 
2 1 4  
1 55 
1 1 1 -1 0 
(affected) 
201  201  
-
264 264 
287 287 
229 229 
204 204 
-
302 302 
1 96 1 96 
456 456 
1 7 1 1 7 1  
2 1 5  2 1 5 
1 67 1 67 
1 63 1 63 
2 1 8  2 1 8  
1 70 1 70 
-
1 1 1 -1 1 
(affected) 
- -
264 264 
287 287 
229 229 
204 204 
f--
302 302 
1 96 1 96 
456 456 
-
1 7 1  1 7 1 
2 1 5  2 1 5  
1 6 7  1 67 
163 1 63 
2 1 8  2 1 8  
1 70 1 70 
r-- 1 1 1 -1 2 
(affected) 
201  201  
264 264 f--. 
287 287 
229 229 
204 204 --
302 302 
1 96 1 96 
456 456 - -
1 7 1 1 71 . 
2 1 5  2 1 5  
1 67 1 67 
1 63 1 63 - -
2 1 8  2 1 8  
1 70 1 70 -
F i g u re 3 . 1 -6 .  The p .W373C mutat ion fou nd i n  fami ly  A. A) D NA 
sequenci ng revealed novel homozygous missense mutation 
(c 1 1 1 9G>C)  in OBSL 1 in a l l  the affected ch i ld ren .  The m utat ion was 
found  to be  heterozygous in the carriers and a bsent in norma l contro ls .  
B)  Schemat ic  d i ag ram of OBSL 1 p rote in  showing the location of the two 
m i ssense m utations detected so fa r. W373C is located in the 
i m m u n og lobu l i n- l i ke 3 ( l g L  3) d oma in ,  whi le F697G found by H uber et a l  
[20 1 0] resided between fibronectin I I I  ( F N 3) and I g L5 d oma ins .  
A) 
S eq ue nc ing  c h romatogram of 
a norm a l  i nd iv id ua l  carries 
the wi Id  type seq uence of 
OBSL 1 
Seq uenc ing c h romatogram 
of a carr ier ind iv idua l  carr ies 
a heterozygous 
c . 1 1 1 9G > C  
• • • • • • • • • 
C' C T G G- T T e e  
! ! ! ! • ! 
2 6 3  2 6 5  2 6 7  
• • 
T C 
2 6 9  
• • 
C G 
2 7 l  
T G C "l T C 
S eq uenc i  ng ch  romatog ra m of �26�3�_�2:t..6=---5 _....:2:.x6....:...7 __ -=-26:i..::9� __ 2 7L-l-. 
a n  affected ind iv idua l  carries 
a homozygous  c . 1 1 1 9G > C  
B)  
W373C F697G 
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[Hanson et a I . , 2009] . The loss of OBSL 1 leads to downregulation of C U L7 
and results in  a primord ia l  g rowth d isorder 3-M syndrome. One other 
m issense m utation (p .F697G) was detected by Huber et al [201 0] in  OBSL 1 
gene i n  one Algerian fami ly with 3-M syndrome. The reported missense 
m utation and the one described here are located in the first exons of the 
OBSL 1 gene and therefore affecting al l the val idated isoforms (NM_01 53 1 1 .2 ,  
N M_00 1 1 73431 . 1 ,  a n d  N M_00 1 1 7340B. 1 ) .  OBSL 1 prote in i s  composed o f  1 4  
immunglobu l in  l i ke ( lgL)  folds and one fibronectin I I I  ( FN3) domain  ( Figure 
3 . 1 -6B) .  The p.W373C resided in  the IgL4 whi le the p . F697G is located 
upstream of I gL5 ( Figure 3. 1 -6B) .  Bioinformatics tools such as PolyPhen-2 
and M utationTaster showed that the substitution of the 373 tryptophan (W) by 
a Cysteine (C) has a destructive effect on the Obscurin- l i ke protein 1 .  
Substitut ions with C were demonstrated to be pathological in  the fibroblast 
g rowth factor receptors because they produce intermolecular d isu lfides which 
alter the i r  function [Wi lk ie et a I . ,  1 995] .  Furthermore, mu lt iple a l ignments 
between species confirmed the importance of the substituted amino acid as a 
reflection to its persistent existence in  a l l  of them (Table 3 . 1 -3). 
3 . 1 .2 .2 .2 .  Fam i ly B 
SNP genome wide genotyping using the Affymetrix 250K array detected 2 
regions of homozygosity in  fami ly  B ( Figure 3. 1 -7 ,  Table 3 . 1 -3). The fi rst 
reg ion was the same one on chromosome 2 found in fam i ly A and conta i ned 
the OBSL 1 gene. The other reg ion was un ique for fami ly B spanning 43. 9  M b  
of chromosome 6 bounded b y  S N Ps rs 1 B067 1 9  a n d  rs6454404. The 
BO 
candidate regions were fu rther i nspected in  a l l  the fami ly members by the use 
of STR markers (Table 3 . 1 -4 and 3. 1 -5). The STR markers in the first reg ion 
on chromosome 2 were not shared by al l the affected ( 1 1 1-5) and one 
unaffected ( 1 1 1 - 1 ) was homozygous as wel l .  However, the STR markers in  the 
second region on chromosome 6 were homozygous in  al l  the affected , but the 
mother ( 1 1 -2 )  and one unaffected ( 1 1 1 - 1 ) were a lso homozygous. Hence, the 
genes in both reg ions were prioritized for sequencing. Within the second 
reg ion ,  CUL l was a cand idate gene because of its known involvement in 3-M 
syndrome as well as OBSL 1 i n  the fi rst one. Both genes were sequenced in 
the whole fami ly  detecting a homozygous nonsense mutation in the CUL l  
gene i n  a l l  the affected members ( 1 1 13 ,  1 1 14 ,  1 1 15 )  a n d  a heterozygous carrier 
status in  both parents ( 1 1 1 ,  1 12) ( Figure 3 . 1 -8) .  The nonsense mutat ion 
occurred in  isoform 2 of CUL l (c.203G>A; p.W68X) ( N M_0 1 4780A )  but 
affected al l  the val idated isoforms ( NM_001 1 68370. 1 ,  NM01 4780A) a nd 
resul ted i n  a truncated protein that most probably wou ld not pass the 
nonsense-mediated decay (NMO)  survei l lance. 
3 . 1 .2 .2 .3 .  Family C 
Genotyp ing of the whole genome for the 1 2  members of fami ly  C 
( Figure 3. 1 -9) has l i n ked their phenotype to the same reg ion on chromosome 
2 with the other 2 fam i l ies (A, B) analyzed in  the same study (Table 3 . 1 -6). 
OBSL 1 was targeted and sequenced reveal ing another novel mutation 
in its fi rst exon c .68 1 _682del i nsTI ( Figure 3. 1 - 1 0) .  This i ndel resulted i n  2 
changes with in  the tra nslated prote in  p. [H227H ;  Q228X] , of which the fi rst is a 
8 1  
co I\) 
Table 3 .1 -3. Conservation  of the 373-tryptophan (W) i n  the OBSL 1 prote in  across s pecies. 
Organism OBSL 1 protein  sequence 
Danio rerio QDSEFRERDVAVLECEVPEESISTA�YLEDQRLQHGNKYNMEQKGTWRRL 
Gallus gallus EDVEVAEREDAVLECQVPLGSI PTA�FLEDRELQPSHKYVMEECGVVRRL 
Mus musculus QDVEGREHGIVVLECKVPNSRI PTA�FREDQRLLPCRKYEQIEEGAVRRL 
Rattus norvegicus QDVEGREHGIVVLECKVPNSRI PTAWFREDQRLLPCRKYEQIEEGTVRRL 
Bos taurus QDVEGREHGIAVLECKVPNSRI PTA�FREDQRLL PCRKYEQIEEGTVRRL 
Canis lupus QDVEGREHGIAVLECKVPNSRIPTAWFREDQRLLPCRKYEQI EEGTVRRL 
Macaca mulatta QDVEGREHGIAVLECKVPNSRI PTA�FREDQRLL PCRKYEQIEEGTVRRL 
Homosapiens QDVEGREHGIAVLECKVPNSRI PTAWFREDQRLLPCRKYEQIEEGTVRRL 
Pan troglodytes QDVEGREHGIAVLECKVPNSRI PTA�FREDQRLLPCRKYEQIEEGTVRRL 
Anolis carolinensis VDVEVLESQDAI LECQVPVATI PTVWYLEDKRLHPSPKYLI EEQGLLRRL 
Xenopus tropicalis LKDIAVREGQDAVLECSVPDGSRTS�YLEDQRLHPDKRHHMEEQGPIRRL 
Myotis brandtii] QDVEGREHGIAVLECKVPNSRI PTAWFREDQRLLPCRKYEQIEEGTVRRL 
00 
w 
F i g u re 3 . 1 -7. Homozygos i ty mapping resu l ts i n  fam i l y  B. Wide Genome genotyping of family B identified a 
region of homozygosity on chromosome 6 between rs1806719 and rs6454404 containing the CUL 7 gene. 
C H RO MOSOM E 6  
rs18067 1 9  rs6454404 
I 43.9 Mb Homozygous Region (342 £lene) I 
41 ,833 ,866 
III 
CULl 
2 
2 3 4 5 
85 ,740 ,223 
co � 
Table 3 .1 -4. STR genotyping resu lts for the homozygous region on chromosome 2 in  fam i ly B.  
CHROMOSOME 2 
MARKER' Coordinates 111 (Father) 1 12 (Mother) 1 1 1 1  1 1 12 1 1 13 1 1 14 1 1 15 (unaffected) ( unaffected) (affected) (affected) (unaffected) 
AC008 1 72AC 1 5  2 1 1 ,245,000 197 201 201 207 1 9 7 201 1 97 207 1 97 201 201 201 201 201 
GATA4G 1 2  2 1 8 , 1 84 , 7 1 9  268 268 268 260 268 268 268 260 268 268 268 268 268 268 
ACO 1 0886CA2 1 2 1 8 ,427 ,000 287 287 291 291  287 291 287 29 1 287 291 287 291 287 291 
- -
ACO 1 0886AC20 2 1 8,454,000 229 237 229 229 229 229 229 229 229 229 229 229 237 229 
AC009469TC 1 6  2 1 8 ,494,000 208 2 1 6  2 1 6  202 208 2 1 6  208 202 208 2 1 6  208 2 1 6  2 1 6  2 1 6  
AC097483AGAA - 283 279 283 287 283 283 283 287 283 283 283 283 279 283 
AC02 1 0 1 6TC 1 5  2 1 9 ,047,000 1 84 188 1 84 1 96 1 84 1 84 1 84 1 96 1 84 1 84 1 84 1 84 1 88 1 84 
AC02 1 0 1 6TC27AT - 426 426 426 456 426 426 426 426 426 426 426 426 426 426 
AC073838AC28 2 1 9 , 1 53,000 1 7 1 1 69 1 7 1  1 52 1 7 1 1 7 1  1 7 1  152 1 7 1  1 7 1  1 7 1  1 7 1  1 69 1 7 1  
AC0 1 2 5 1 0TG20TC27 2 1 9 ,273,000 2 1 7  2 1 5  2 1 7  2 1 9  2 1 7  2 1 7  2 1 7  2 1 9  2 1 7  2 1 7  2 1 7  2 1 7  2 1 5  2 1 7  
ACO 1 2 5 1  OAC20" 2 1 9 ,294,000 167 1 67 1 67 1 65 1 67 1 67 1 6 7  1 65 1 67 1 67 167 1 6 7  1 67 1 67 
AC0092 3 1 GT 1 8·· 222,528,800 1 59 1 55 1 59 1 65 1 59 1 59 1 59 1 65 - - 1 59 1 59 1 55 1 59 
AC009302TG20 222,628,850 226 228 226 2 1 4  226 226 226 2 1 4  226 226 226 226 228 226 
AC009302GT21 222,739,400 1 60 1 68 1 60 1 70 1 60 1 60 1 60 1 70 1 60 1 60 1 60 1 60 1 68 1 60 
-
·The markers were deSigned by Dr. Geoff Wood's lab . 
• •  Markers flanking OaSL 1 gene (chr2 220426438-220436268) 
OJ (J1 
Table 3. 1 -5. STR genotyping resu lts for the homozygous reg ion on chromosome 6 in fami ly B. 
-
CHROMOSOME 6 
-
MARKER' Coordinates 1 1 1  (Father) 112 (Mother) 1111 ( unaffected) 1 1 12 ( unaffected) 1113 (affected) 1114 (affected) 1 1 15  (affected) 
AL355385TG24" 43, 1 92 ,350 231 2 3 1  2 3 1  2 3 1  2 3 1  2 3 1  2 3 1  231 2 3 1  231 231 2 3 1  2 3 1  2 3 1  
-
AL 1 33375GT22 43,346,000 247 2 5 1  2 5 1  2 5 1  247 251 251 2 5 1  2 5 1  2 5 1  2 5 1  2 5 1  2 5 1  2 5 1  
A L  1 39389AC23 54,000 , 1 50 208? 209 209 209 208? 209 209 209 209 209 209 209 209 209 
- -I- -- " AL359539T A24 70,589, 500 1 70 1 84 1 84 1 84 1 70 1 84 1 84 1 84 1 84 1 84 1 84 1 84 1 84 1 84 
A L 1 099 1 5CA2 1 84,463,800 2 1 4  2 1 6  2 1 6  2 1 6  2 1 4  2 1 6  2 1 6  2 1 6  2 1 6  2 1 6  2 1 6  2 1 6  2 1 6  2 1 6  
AL390 1 2 5TC 1 9  87 ,032 ,500 222 224 222 228 222 224 222 222 222 222 222 228 222 222 --"-
"The markers were deSigned by Dr. Geoff Wood's lab . 
•• The nearest marker to CUl l gene (chr6 43005355-4302 1 683) 
F i g u re 3 . 1 -8 .  M utat ion a n a l ys i s  resu l ts i n  fam i l y  B .  A nonsense 
m utat ion c. 203G>A was d etected i n  CUL 7 gene in a l l  the affected 
ch i ld re n  of fami ly B .  The same m utat ion was found to be heterozygous i n  
pa rents  a n d  s o m e  u naffected ch i ldren .  
Sequenc ing chromatogram of  
a normal  i nd iv idua l  carr ies 
the wi l d  type s eq uence of 
C UL 7 
Sequencing chromatogram 
of a Carrie r  i nd iv idua l  carr ies 
a heterozygous c .203G>A 
Sequenc ing chromatogram of 
an affected i nd ividua l  carries 
a homozygous c. 203G>A 
• • • • • • • • 
C T G T G G A T 
3 .J.... 9 3 2 �  3 2 3  3 2 5  
• • • 
C T G 
2 2  3 2 3  3 2 4  
! • 
3 2 5  3 2 6  
• • • 
G A T 
3 2 7  3 2 8  3 2 9  
• 
G 
• 
G 
3 3 0  
• • • • • • • • • 
C T G T A G A T G 
3 2 5  3 2: 7  3 2 9  3 3 �  
86 
00 
" 
F ig u re 3 . 1 -9. Homozygo u s i ty m a p p i n g  res u lts i n  fam i l y  C .  A homozygous region was identified in fami ly C on 
chromosome 2 between rs12474633 and rs1834129 containing the OBSL 1 gene. 
CH R OMOSO ME 2 
A r--- "-- -"\ 
rs1 2474633 1 1 2 Mb Homo zygo us Reg ion ( 1 08) rs1 834 1 29 
21 1 ,51 2 ,854 DBSL 1 222 ,7 1 2 ,896 
2 3 4 5 6 7 8 9 
5 
CP CP 
Table 3.1 -6. STR genotyping resu lts for the homozygous reg ion on chromosome 2 i n  fami ly C .  
MARKER CoordInates 1II3 1'athel) 1114 (mothef' IV6 luHected) 1V7 (aN",,"') Iva (unaffected) IVg falleeted) 1I11 1'Olh.,1 1112 1molhe" !V2 IV) (unaneeted) (unatfKtedJ 
AC008172AC '5 '21 1.245,000 207 207 201 207 20' 207 201 207 207 207 20' 207 207 207 201 207 207 207 
GATMG12 '218,184.719 168 �8 268 26' 26l! 26a �6 2GB lIi8 268 � 2M 26< 268 268 268 26< 268 
AC010886C"21 218 427.000 287 281 287 287 287 287 287 287 287 287 287 287 287 287 287 287 287 'l137 287 281 
AC010886AC20 218 454000 229 227 229 229 229 229 229 229 229 227 ZlII 22� m 229 227 229 :29 ZlII 127 229 
ACOO9469TC 16 218,494 000 208 210 208 2'2 208 208 208 208 208 210 208 208 208 212 208 210 208 212 208 210 
AC09748JAGAA 287 306 287 279 287 287 281 281 287 306 279 287 287 306 279 287 287 306 
AC021Q161C15 219,().47000 184 190 18< 164 1 84 18< 164 164 18. 190 164 184 1 8' 18' 184 190 164 164 184 190 
AC02101STC27AT '26 '26 426 '26 426 '26 '26 426 '28 428 4.16 426 426 '26 426 426 '26 426 426 42<1 
AC073838AC28 219 153,000 17' 1 7 3  1 7' 171 171 1 71 17, 1 i1 17' 173 171 171 1 7 1  171 171 173 171 171 1'1 1/) 
AC012510TG20TC27 219 273,000 217 2'5 217 227 211 217 217 217 211 215 217 217 2'7 227 215 217 21' 227 215 217 
- - -
AC012S'OAC20" 219 29.:1 000 '61 173 '61 165 165 16' 16' 167 161 165 165 173 '65 167 '65 173 165 167 
AC009231GT 1 S'· = 528 800 161 1101 161 161 161 '61 161 In' 161 16' ,61 '6' 16' 161 159 '6' 161 161 159 161 
AC009302TG2D =.628 850 226 226 Z26 214 = 226 226 D! 226 226 226 226 21. 226 226 226 21. ne 226 226 
ACOD9302GT21 222,739 400 160 ,GO '60 170 ,GO 'GO 'GO lGO ,60 160 160 leo 160 170 170 170 170 170 160 110 
'The markers ....ere des1gned by Dr GeoH Wood', tab 
n Marker, Ilanlnng OBSL 1 gene (Chr2 220426438-220436268) 
r- -� �--.. -
JV4 (affected) !VS (unaffeefad) 
207 
2fX> 
281' 
229 
208 
287 
1 64  
4 26  
11, 
217 
-
165 
16' 
226 
160 
207 201 
X,a 26< 
28' 187 
-
229 229 
208 208 
287 279 
'64 ,S< 
207 
268 
287 
- -
22Il 
212 
287 
184 
--- -r--
4:» 426 '26 
-
,7' 171 171 
217 217 n7 
-_ . -
165 165 173 
'61 159 161 
D! ]1. 226 
170 1 70 ITO 
_ _ L_ 
F i g u re 3 . 1 -1 0. M utatio n  a na lys is  res u lts i n  fami ly  C .  Three 
n ucleotides were found to be m utated in OBSL 1 gene in fami ly C 
c . [68 1 _682del insTT; 690delC] . The fi rst one is  s i lent (p .  H227H ) .  the 
second one i s  n onsense ( p . Q228X) m utation whi le the th i rd is  a frame 
sh ift delet ion .  The same m utations were found to be heterozygous in  
parents and  s ome u naffected ch i ld ren.  The m utations were not detected 
in norma l  affected s ibs and  in 1 00 normal healthy contro ls .  
Seq uencing c h romatog ram 
of a normal  i nd iv idua l  
carries the wi l d  type 
seq uence of OBSL 1 
Sequencing c h ro matogram 
of a Carrier ind iv idu a l  
carries a heterozygous form 
of the detected m utations 
Sequencing c h romatog ram 
of an affected i nd ivid ua l  
carries a h om ozygous  
c . [681 _682del insTT;690del 
C] 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
G G T G C A C C A. G C C C C C C G A G G 163 265 267 269 27� 273 275 277 279 2e� 283 
I I I I I I 1 1 1 1 1 . .  A- I G G T G C A I A G C C C C C I A 
6 1.  2 6 3  2 6 5  2 6 7  2 6 9  2 7 1.  2 7 3  2 7 5  2 7 7  2 7 9  
I I  \ 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  
G G T G C A - T A G C C C C C G A G A G 
261. 263 2 6 5  267 269 2 7 1  273 275 277 279 
89 
si lent one whi le the other is a nonsense mutation that is predicted to cause 
premature and truncation of OBSL 1 in those patients . The mutation affects a l l  
the val idated i soforms (NM_0 1 531 1 .2 ,  N M_00 1 1 73431 . 1 , NM_00 1 1 73408. 1 )  
and thus is expected to be abol ished by the N M D  mechanism. I n  addition ,  a 
non-reported S N P  was identified shortly after the nonsense mutation 
c.690de1C which causes a frame shift and premature termination of the 
transcript ( Figure 3. 1 - 1 0).The three changes were found in  all affected 
members ( IV-4, IV-6, IV-7,  IV-9) in a homozygous form and in a l l  the 
unaffected ( IV- 1 , IV-2, IV-3, IV-5, IV-8) as well as both parent pair ( 1 1 1- 1 , 1 1 1 -2, 
1 1 1 -3,  1 1 1-4) in  a heterozygous form. 
3 .1 .2.2.4. Family 0 
Direct DNA Sequencing of CUL 7 and OBSL 1 genes in  fami ly D led to 
the identification of a homozygous deletion in exon 3 of CUL 7. The deletion of 
6 bases occurred i n  isoform 2 of CUL 7 (c.649_654deIAGCCGC) 
( NM_00 1 1 7343 1 . 1 ) , but affected al l the val idated isoforms (NM_01 53 1 1 .2 ,  
N M_00 1 1 7343 1 . 1 ,  N M_00 1 1 73408. 1 )  ( Figure 3 . 1 - 1 1 ) . This mutation resu lted 
in an in-frame deletion of two h igh ly conserved serine (S)  and arg in ine ( R) 
between species, p .2 1 7  _2 1 8de1SR in  isoform 2 of CUL7 protein 
NP _055595.2 (Table 3 . 1 -7).  The mutational screen ing of the deletion that was 
performed on the genomic DNA from a l l  the affected members ( I V-3, IV-9, IV-
1 0 ) and one unaffected ( I V-2) s ib revealed the presence of the homozygous 
delet ion in  a l l  the affected but not  in  the unaffected who has a homozygous 
normal wi ld type sequence of CUL 7. Both parents ( 1 1 1 - 1 , " 1 -2) were found to 
90 
F i g u re 3 . 1 -1 1 .  M utatio n  a na lys is  resu l ts i n  fami ly  D. Sequencing of 
C UL 7 gene i n  fam i ly 0 revea led a n ovel delet ion of 6 n uc leotides in exo n  
3 c 649_654deIAGCCGC.  A l l  the affected i nd iv idua ls have the 
homozygous deletion but the parents were found to have the 
heterozygous form on ly  of the deletion .  Around 1 00 n orma l controls were 
screened for the same delet ion but it was n ot found .  
Sequenc ing  c h romatog ram 
of a normal  i n d iv idua l  carries 
the wild type seq uence of 
CUL 7 
Seq uenc ing  chro m atogram 
of a carrier i n d iv id ua l  carries 
a heterozygous  form of the 
detected m utat ion 
Sequenc ing  c h romatogram of 
an affected i nd iv id ua l  carries a 
homozygous  
c .64 9  _ 6654de lAGCCGC 
I 1 I 1 I 1 I I I 1 I I 1 1 I I 1 1 1  
A T T T T G A C A G C C G C T G T G C 
211 213 Z l �  217 219 221 223 ZZS 227 2. 
/1 
1 1 1 1 1 1 1 1  • • • • 
T G G A T T T T G A C T G I I  
2 1 3  2 1 7  2 2 1  2 2 5  
T ; ; I I T T C T � 
229 233 237 
! ! ! ! ! ! ! ! ! ! � ! !  ! !  
2 �  7 2 2 0  2 2 3  2 2 6  2 2 9  
A A 
A II \ v 
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Table 3 .1 -7. Conservation of the 21 7-ser ine (S )  and 21 8-arg in ine (R )  i n  C U L7 prote in  across s pecies. 
Organism 
Mus musculus 
Rattus norvegicus 
Macaca mulatta 
Homo sapiens 
Pan troglodytes 
Canis lupus 
Bas taurus 
Takifugu rubripes 
Brachydanio rerio 
Monodelphis 
domestica (CUL9) 
CUL7 protein sequence 
SItCALLALFAQATLTEHPMSFEGVQLPQVPGRLLFSLVKRYLHVTFLLDR 
S FtCALLALFAQATLTEHPMS FEGVQLPQVPGRLLFSLVKRYLCVTFLLDR 
SItCALLALFAQATLS EHPMSFEGIQLPQVPGRVLFSLVKRYLHVTSLLDQ 
S FtCALLALFAQATLSEHPMS FEGIQLPQVPGRVLFSLVKRYLHVTSLLDQ 
SItCALLALFAQATLSEHPMS FEGIQLPQVPGRVLFSLVKRYLHVTSLLDQ 
SFtCALLALFAQATLSEHPMSFEGIQLPQVPGRLLFSLVKRYLHVTSLLDQ 
SItCALLALFAQATLSEHPMS FEGIQLPQVPGRLLFSLVKRYLHVTFLLDQ 
�FTLLELFAETTSSEEHG I SFEGIHLPQ I PGKLLFSLVKRYLCVTSLMD 
�YTLLELFAETTSSEEHGISFEGI HLPQ I PGKLLFSLVGVFKETGALDL 
SFtSTLLELFAETTSSEEHCMAFEGIHLPQI PGKLLFS LVKRYLCVTSLLD 
be carners for the mutation as expected in  autosomal recessive inheri tance.  
Furthermore. the deletion was not identified in  a panel  of 1 00 ethnical ly 
matched control samples.  suggesti ng that the sequence variant is not a 
common polymorphism. 
3 . 1 .4. D iscussion 
In  this study four  consanguineous fam i l ies with a tota l of  1 3  chi ld ren 
affected by a g rowth retardation syndrome were investigated and found to 
have mutat ions in two of the th ree genes known to cause 3-M syndrome 
(Summary in Table 3 . 1 -8) .  Three of these fami l ies from different orig ins were 
in i t ia l ly d iagnosed by d ifferent c l in ical geneticists as autosomal recessive SRS 
( Fami l ies A, B, a nd C). As a result  of the fi nd ings in this study, the d iagnoses 
of the studied patients were re-evaluated and reassigned as autosoma l  
recessive 3-M syndrome. 
3. 1 .4. 1 .  The d ifferentia l  d iagnosis of Three-M syndrome 
The 3-M syndrome is a form of autosomal recessive low b i rth weight 
with dwa rfism [Fuhrmann et a I . ,  1 972; M i l ler  et a l . .  1 975]. I t  is  characterized 
by pre- and postnatal g rowth retardation associated with facial  dysmorphic 
features and normal intel l igence [Hennekam et a I . ,  1 987] . The diagnosis is  
usual ly  based on th is pattern of a bnormal it ies and the associated rad iological 
changes [van der Wal et a I . ,  200 1 ] . These include slender long bones with 
narrow d iaphysis and foreshortened vertebrae. The main features of this 
syndrome are nonspecific if taken separately but the combination of g rowth 
retardat ion with the facial  features and the rad iolog ica l  changes distingu ish 
93 
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Table 3. 1 -8. S ummary of genotyping and mutational  screen ing resu lts for a l l  the recruited fam i l ies. 
--
Family 
Autozygosity 
Mutations Found Like l ihood of Pathogenic ity Region/s" 
- -
The mutation resides in the first 8 exons of the OBSL 1 gene 
Non-synonymous mutation was found in and therefore affecting all the val idated Isoforms Chr2'  exon 2 of OBSL 1.  ( N M_0 1 53 1 1 .2 ,  N M_00 1 1 7343 1 . 1 ,  and N M_00 1 1 73408. 1 )  A 2 1 1 , 5 1 2 , 8 54- Furthermore, bioinformatlcs tools showed that the p .W373C c . 1 1 1 9G >C 
222, 7 1 2 ,896 m utation has a destructive effect on OBSL 1 prote in and p .w373C 
m u ltiple a l ignments between species confirmed the importance 
of the substituted ammo acid 
Chr2:  
2 1 1 , 5 1 2 , 854- nonsense m utation was found in CUL l The mutation affected al l  the va l idated isoforms 
B 
222 , 7 1 2 , 896 ( N M_0 1 4780 A)" (N M_00 1 1 68370. 1 ,  NM_0 1 4780 A) and resulted in a truncated 
C hr6: c.203G>A protem that most probably wou ldn't pass the nonsense-
4 1 ,833,866- p .w68X mediated decay (NMO) survei l lance. 
85 ,740,223 
1 .  indel in  the first exon of OBSL 1 This indel resulted in 2 changes within the translated prote in 
c.68 1 _682delinsTT p. [H227H;  Q228Xl p . [H227H;  Q228Xl , of which the first is a Silent one while the 
Chr2: 2 .  A non-reported SNP was identified second is a nonsense mutation that is predicted to cause 
C 2 1 1 , 5 1 2 ,854· immediately after the nonsense m utation prematuration and truncation of OBSL 1 In those patients. The 
222 , 7 1 2 ,896 c.690de1C which cause frame shift and nonsense m utation affects al l  the val idated Isoforms ( N M_0 1 53 1 1 .2 ,  N M_00 1 1 7343 1 . 1 ,  N M_00 1 1 7340B . 1 )  and 
premature term ination of the transcript thus expected to be abol ished by the N M O  mechanism 
deletion in exon 3 of CUL7 Multiple al ignments between species confirmed that this 
0 NA ( N M_0 1 4780A)" c.649_654deIAGCCGC m utation resulted in an In
-frame deletion of two h ighly 
p .2 1 7 _2 1 BdeISR conserved ser ine and arg inine between species 
"Chromosomal positions are based on UCSC Human Mar. 2006 (NCBI36/hg 1 B) assembly. 
"This isoform was used for the m utation's nomenclature. 
th is syndrome from other growth retardation syndromes [Feldmann et a I . ,  
1 989;  Clayton e t  a l . ,  20 1 2] .  More than 9 4  fami l ies with genetical ly confi rmed 
3-M syndrome have been reported in the l iterature [Hanson et a I . ,  201 1 b] .  
The majority of 3-M cases were found to carry mutations i n  CUL l gene 
[Hanson et a I . ,  201 1 b] .  Two other d isorders with simi lar featu res to 3-M were 
a lso found to be caused by m utations in CUL l gene ra ising questions a bout 
their identi ty.  The fi rst one is the sad-appearing face syndrome which was 
described by Le Merrer et a l  [ 1 99 1 ] . Chi ldren with this syndrome have 
pr imord ia l  dwarfism and a round ,  sad-appearing rather than triangular face . I n  
addit ion , rad iological examination o f  the skeleton was normal i n  these 
ch i ldren .  The second d isorder is  Yakut short stature syndrome which was 
identified by Maksimova et a l  [2007] in  a new popu lation isolate in  Asia . 
Affected chi ldren had pre- and postnatal g rowth retardation, a triangular face 
with hypoplastic m idface , fronta l  bossing,  a depressed nasal bridge, a short 
wide thorax,  and short l imbs with brachydactyly. Only a few patients showed 
the rad io logical features of slender bones and ta l l  vertebra l  bodies. A founder 
m utation (p. Q 1 553X) in  the CUL l gene was identified in  these chi ldren .  
The d iagnosis of SRS i n  three out  of  four of the fam i l ies in  th is  study  
was based on the  presence of  pre- and  postnatal severe growth retardation 
together with typica l dysmorphic facial features, c l inodactyly, and feed ing 
d ifficult ies [Price et a I . ,  1 999] . However, s ince SRS is a phenotypica l ly  
heterogeneous cond i tion and may be misdiagnosed [Hanson et  a I . ,  201 1 b ;  
C layton et a I . ,  201 2] ,  the scoring system that was devised by Barthold i et a l  
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[2009] was used for the d iagnosis of SRS in  this study. Al l the chi ldren scored 
between 1 0-1 2 points suggesting that th is d iagnosis is l i kely. In add ition ,  they 
all lacked the radiological changes seen in  3-M syndrome. Although S RS is 
usual ly sporad ic and is l isted in  O M I M  as autosomal dominant ,  there a re 
several reports i n  the l i terature of fami l ies with apparent autosomal recessive 
inheritance .  Teebi [ 1 992] reported a consanguineous Arab fami ly with s ix 
ch i ld ren (5  ma les and 1 fema le) with features suggestive of SRS and 
summarized the data of other s imi lar  fami l ies in  the l i terature [Si lver and 
Gruskay, 1 957;  Gray and Evans,  1 959; Cal laghan ,  1 970; Robichaux et a i . ,  
1 98 1 ; Saal e t  a i . ,  1 985; Partington ,  1 986] . Another fam i ly with two s isters 
having features suggestive of autosomal recessive SRS was described by 
Ounap et al [2004] . However, the s ib l ings in this fam i ly were found to have 
hypomethylation of H19 and IGF2 genes on chromosome 1 1  p 1 5 . One other 
fami ly  with two affected chi ld ren was found to have the same epigenetic 
mutation in  1 1  p 1 5 [Barthold i  et a i . ,  2009] . Methylation ana lys is of the father 
revealed a normal resul t ,  most l ikely reflecting germ cell mosaicism in the 
father [Barthold i et  a i . ,  2009] .  I t  is possib le that the apparent recessive 
inheri tance in  many S RS fam i l ies is explained on this basis. I t  is a l so possible 
that some of those fami l ies have 3-M rather than S RS and therefore the 
identi ty of the autosomal recessive SRS is questionable. Since the 
rad io log ica l  changes in 3-M are not a constant find ing and are age 
dependent, the d iagnosis of 3-M should be considered in  chi ldren with 
pr imord ia l  dwarfism with dysmorphic facial  features suggestive of e i ther SRS 
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or 3-M ,  with or without the X-ray changes seen in  3-M. I n  add it ion, the value 
of the rad iological find ings described in the 3-M syndrome is doubtfu l .  The 
s lenderness of the long bones is not specific to this syndrome as it is seen 
a lso in other forms of pr imary dwarfism [Le Merrer et aL ,  1 99 1 ] .  Also, 
vertebral find ings of foreshorten ing of the vertebral body is only recogn ized in  
o lder  chi ld ren and adults [van der  Wal  et a I . ,  200 1 ]  and therefore do not a l low 
early  recognit ion. 
3.1 .4.2.  The Three-M syndrome pathogenesis 
To date, three cytoplasmic proteins have been impl icated in the 
pathogenesis of the 3-M syndrome. Approximately 67% of mutations 
described i n  3-M syndrome pat ients a re found in  CUL7, with 28% identified in 
OBSL 1 and 5% identified in  CCDC8 [Hanson et aL, 201 1 b ;  Clayton et a L ,  
201 2] .  Most the mutations reported s o  fa r in  a l l  the three proteins were shown 
to be loss of function mutat ions [Hanson et a L ,  201 1 b] .  CUL 7 mutations were 
found throughout the whole gene, with the majority of the reported mutat ions 
creat ing PTC and are therefore l ikely to lead to a complete loss of the C U L7 
prote in  l i ke the mutation I have identified in  fami ly B (Table 3. 1 -8)  [Huber et 
a L ,  2009]. Spl ic ing and non-synonymous mutations were also identi fied i n  
CUL 7 and predicted to lead to the generation o f  a nonfunctional prote in  
product l ike the mutation I have identified in  fami ly D (Table 3. 1 -8) [Huber et 
a L ,  2009]. Most of the mutat ions identified in OBSL 1 so far includ ing the two 
mutations identified in this study were found to cluster at the N-term inal reg ion 
of the prote in ,  thus affecti ng a l l  the known isoforms for this prote in  [Hanson et 
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a I . ,  2009; Huber et a l . ,  201 0] .  The majority of the mutations were presumptive 
nu l l  mutations creating PTC s imi lar  to the one found in  fam i ly C (Table 3 . 1 -8) 
[Hanson et a l . ,  201 1 b] .  Non-synonymous mutations in OBSL 1 were a lso 
detected in  3-M patients resembl ing the one detected in  fami ly A (Table 3 . 1 -8 )  
[Hanson e t  a I . ,  20 1 1 b] .  
CULL lN7  or CUL7 is an essential protein of the ubiqu it in-proteasome 
pathway acting as a structural protein i n  the formation of a SKP1 -CU L7-
FBXW8-ROC1 (SCF) E3 ubiqui t in l igase multi-prote in complex [Hanson et a l . ,  
201 1 b] . The ubiqu it in-proteasome pathway i s  a major protein degradation 
pathway in  which prote ins a re targeted for degradat ion. This process invo lves 
attachment of a sma l l  regu latory prote in  ca l led ubiqu it in to a specific target 
prote in  by the E3 ubiquit in l igase com plex. This b ind ing most commonly is for 
marking the target protein  for degradation by the proteasome, but sometimes 
it may a l ter the cel lu lar  location or  the activity of the target protein [for review 
see Wi l lems et a I . ,  2004] . To date, on ly two proteolytic targets of the CUL7 
SCF com plex have been identified namely cycl in  D 1  and insul in receptor 
substrate 1 ( I RS- 1 ) [Okabe et a I . ,  2006; Xu et a I . ,  2008] .  Cycl i n  D1 is a wel l­
known regu lator of cel l  cycle progression but the importance of its 
degradation mediated by the C U L7 SCF complex is  sti l l  undetermined [Alao,  
2007; L in  et a I . ,  2008] .  On the other hand,  I RS-1 is  a n  adaptor protei n  that 
acts in  both the insu l in  and insu l in- l ike growth factor 1 ( IGF- I )  signa l i ng  
pathways stimu lat ing cel l  g rowth and prol iferation as well as inh ib i t ing 
programmed cel l  death [Dearth et a I . ,  2007] . Targeted d isruption of Cull in  
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mice resu lted in  a reduction in ce l l  prol iferation and induction of senescence 
[Arai et a I . ,  2003] . Those models exhib ited an I UGR phenotype resembl ing 
the 3-M patients apparently d ue to the d isruption of  the CUL7 SCF com plex. 
In add it ion. several knockout studies have shown that the d isruption of the 
IGF- I  pathway results in severe growth restriction in  mouse models  and 
induces cell u lar  senescence [Xu et a I . ,  2008] . Therefore, it was postu lated 
that the pr imary mechanism responsible for the growth restriction seen in 3-M 
patients is  due to the a l teration of  the IGF-1  pathway caused by I RS-1  
unsuccessful u biqu it ination and degradation .  
I t  has been shown through co- immunoprecipitation assays that C U L7 
and OBSL 1 physica l ly in te ract [Hason et a l . ,  2009] . I n  addit ion, s i lencing the 
expression of OBSL 1 i n  mammal ian cel l  l i nes led to a decrease in CUL7 
expression [Hason et a I . ,  2009] . From these find ings it was concluded that 
these two prote ins act i n  the same pathway to control cel l  prol iferation and 
human g rowth .  However, it is  currently unclear as  to how OBSL 1 interacts 
with the IGF- I  pathway. Hanson et al [20 1 1 b) suggested that OBSL 1 as a 
cytoskeletal adaptor prote in  may function as a structura l protei n  l ink ing C U L7 
to I RS-1 . On the other hand,  the function of CCDC8 is st i l l  unknown. 
Recently, it has been shown to interact with p53 and acts as a key co-factor in 
p53-mediated apoptosis [Dai et aI . ,  201 1 ] . Another study has demonstrated 
that CCDC8 interacts with OBSL 1 but not with CUL7.  Taken a l l  together, it 
was concluded tha t  that a l l  th ree proteins exist in a common pathway 
[Hanson et a I . ,  201 1 a] .  
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Several fami l ies with 3-M syndrome are not l inked yet to any of the 
three genes ind icat ing fu rther genetic heterogeneity [Huber et a I . ,  2009] . 
Therefore, i nvestigat ing more 3-M or 3-M l ike cases wi l l  most l ikely lead to the 
identificat ion of more genes causing 3-M syndrome reveal ing other members 
in  the 3-M pathway and expand ing the knowledge of how this pathway 
controls cell g rowth.  
3 . 1 .5. Conclus ion 
I UG R  is a nonspecific fi nd ing that can a lso be a sign ificant feature of 
many recognized genetic syndromes includ ing SRS, 3-M syndrome, Dubowitz 
syndrome,  and M u l ibrey nan ism.  Differentiation of 3-M syndrome from 
a utosomal  recessive SRS has been d ifficult because of the phenotypic 
var iabi l ity of the latter. L imb length asymmetry is seen in over half of those 
with autosomal  recessive SRS, but not in  i nd iv iduals with 3-M syndrome. 
Characteristic rad iologic find ings of 3-M syndrome are not present in  SRS. 
In th is study,  I have identified the genes and the mutations 
underly ingseveral un related I UGR patients who were i n it ia l ly d iagnosed as 
autosoma l  recessive SRS cases . I nterestingly, the identified genes were 
known to cause 3-M syndrome. Therefore, the results of the molecular 
investigation in th is study a l lowed accurate d iagnosis of the exhi bited 
phenotype in fou r  fami l ies with mu lt iple affected members and the 
subsequent genet ic counsel ing.  Identification of these homozygous mutations 
in  CUL 7 and OBSL 1 genes ( i nherited in  an autosomal recessive manner) has 
faci l itated the possib i l i ty of future prenatal d iagnosis for these fami l ies.  I n  
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add it ion, th is study  has ra ised a q uestion regard ing the identity of the 
a utosomal recessive SRS. Molecular investigation of more apparently 
a utosomal  recessive SRS cases wi l l  hopeful ly provide the answer. 
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S ECTI O N  2 :  U n ravel i n g  the genetic defects 
a n d  the pathophys i o logic mec h a n i s m  
u n derly i n g  fi brochond rogenesis i n  patie nts 
from the UAE 
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3.2. 1 .  Background 
Fibrochondrogenesis ( FBCG; OM IM#228520 and # 61 4524) is  a 
severe short- l imbed skeletal dysplasia which was first described by 
Lazzaroni-Fossati et al in  1 978 as a rare autosomal recessive neonatal letha l 
rhizomel ic chondrodysplasia [Lazzaroni-Fossati et a I . ,  1 978]. Since then ,  
severa l cases have been described i n  the l i terature originat ing from d ifferent 
ethn ic backgrounds which include I ta l ian and Japanese [Eteson et a I . ,  1 984] . 
Spanish [Mart inez-Frias et a I . ,  1 996] , German [Sauer et a I . ,  2000] , French 
[Randrianaivo et a I . ,  2002] ,  Turkish [Leeners et a I . ,  2004] , and I nd ian 
[Kulkarn i  et a I . ,  2005; Kundaragi et  a I . ,  201 2] .  I n  the UAE,  FBCG was 
reported in 2003 as a relatively common recessive type of skeletal dysplasia 
among the 38,048 b i rths d u ring a 5-year study period [AI-Gazal i  et a I . ,  2003]. 
Al l  reported cases show d ist inct ive a bnormal i ties such as a f lat face with 
prom inent p rotuberant  eyes, a flat nose with anteverted nares , a smal l  mouth,  
a cleft palate with severe micrognathia and low set ears associated with 
severe shorten ing of the l imbs.  Typical rad iologica l  features include short long 
bones with very broad and s l ight ly i rregu lar  metaphyses, smal l ,  i nferiorly 
broad i l iac bones with the lower marg in  having a caudal ly d i rected bump- l ike 
configurat ion boarded by spurs, short ri bs which a re cupped anteriorly and 
pea r-shaped vertebrae with sagittal  cleft ing [AI-Gazal i  e t  a I . ,  1 997; AI-Gaza l i  
et a I . ,  1 999] .  H istological examination of  d ifferent long bone sections showed 
severe abnormal it ies of chondrocytes and cart i laginous matrix in g rowth 
1 03 
plates and  epiphyseal cart i lages. Spaces of cystic degeneration of the matrix 
cart i lage were a lso observed [Kulkarn i  et a I . ,  2005]. 
3.2 .2 .  The purpose of the study 
Since the genetic defects caus ing FBCG were not yet known, three 
fam i l ies from UAE exhib i t ing autosoma l  recessive FBCG were recru ited . The 
fam il ies were investigated us ing homozygosity mapping and cand idate gene 
sequencing approaches to e lucidate the defective gene(s) underly ing th is 
severe phenotype . 
3 .2 .3. Resu lts 
3 .2 .3 . 1 .  C l i n ical  phenotyping of UAE patients expanded the phenotype 
especia l ly i n  survivors 
3 .2 .3. 1 . 1 . Fami ly  A (FA) 
The parents i n  th is fami ly  are d istantly related Emi rati nationals of 
Omani  o rig in  and  the affected chi ld was their first ( Figure 3.2- 1 ). The parents 
appear to d isplay normal height,  vision and hearing .  The parents reported no 
h istory of deafness or vis ion abnormal it ies i n  the fam i ly. The affected chi ld 
was the product of a normal pregnancy with a normal del ivery by vacuum 
extract ion .  At  b i rth ,  she  was noted to  have typical cl i n ica l  and rad iolog ica l 
features of F BCG (Table 3 .2- 1 ) . At the t ime of examinat ion ,  she was 3 .5  
years o ld  and had  g lobal developmental delay, short l imbs with contractures 
and pectus car inatum with dorsal kyphosis. She had severe b i lateral sensory-
neura l  hearing loss and severe myopia.  She was operated on for a b i lateral 
cleft palate a nd a b i lateral cataract. Deta i led eye examination d id not show 
any vitreous changes. 
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F igure 3.2-1 . Ped igree of fam i ly FA. The proband is the first ch i ld ( 1 \ - 1 ) 
of distantly re lated parent .  
Distant re latives 
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1 \  
1 2 
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Table 3.2- 1 . The c l i n ical  and rad iological  features of the eight F BCG 
patients from three fami l ies from the UAE . 
Families FA F B  F C  
Patients 1 1 1  1 1 1 1  1 1 1 2  1 1 14 1 1 1 5  1 1 1 7  1 1 18 1 1 2  
Alive a t  F ew Few 1 3 Alive 2 Few Surv ival 3 . 5  a t  6 
years hours days day days years days hours 
Origi n  Omanl  I Omani  Yeme ni 
Cl in ica l Features 
Wide anterior I I 
fontanelle + + + + + + + + 
Protu berant eyes + + + + + + + + 
F lat midface + + + + + + + + 
Smal l  fiat nose + + + + + + + + 
Smal l  mouth + + - - + + - + 
C left palate + - + - - + + -
S hort neck + + + + + + + + 
Short l i m bs + + + + + + + + 
Joint contractu res + - - - - + - -
Myopia + NA NA NA NA + NA NA 
Severe S N H L  + NA NA NA NA + NA NA 
Progressive kyphosis + NA NA NA NA + NA NA 
Cataract + - - - - + - -
Radiological Features 
W ide anterior 
fontanelle & sutures + 
+ + + + + + + 
Short wide cupped + 
ri bs 
+ + + + + + + 
Platyspondyly + + + + + + + + 
Pear shaped 
vertebrae on lateral + + + + + + + + 
projection 
Smal l  & broad i l iac + + + + + + + + 
bones 
Small sciatic notch + + + + + + + + 
Caudal ly directed 
b u m p  like + + + + + + + + 
configuration with 
medial & lateral spu rs 
Short d u m b-bel l  long + + + + + + + + 
bones 
I rreg ular metaphysis + + + + + + + + 
Ectopic extra - + + - - + + -
calcification 
NA=Not avai lable 
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3.2 .3 . 1 .2 .  Fami ly  B (FB) 
The parents are Emirati first cousins of Oman i  origin ( Figure 3 .2-2) .  
Both parents a re of normal height and hearing.  The mother has norma l vision 
but the father developed a cataract i n  his right eye at the age of 38 years. 
Both parents have no complaints regard ing their jo ints. They had a total of 
eight ch i ld ren ,  six of whom were affected . Deta i ls  of two of the affected 
chi ld ren have been previously publ ished [AI-Gazal i  et a I . ,  1 997; 2003] . These 
affected ch i ld ren had the typ ical features of FBCG as deta i led in table 3.2-1 
and five of the six affected ch i ldren d ied in  the neonatal period (F igure 3.2-
3a) .  However, one chi ld ( FB- I I I -7) was sti l l  a l ive at the age of 6 years and th is 
chi ld was part of a twin  pregnancy ( Figure 3 .2-3b and c). The other twi n  was 
an unaffected female who developed severe myopia and squint in infancy but 
had no other relevant compla in ts .  The affected chi ld ( FB-I I I -7) was on 
respiratory support for one month after b irth fol lowed by tracheostomy for 
a nother few months. She was able to breathe by herself by 2 years of age. 
This surviving affected chi ld is now 6 years of age but has developmental 
delay, short l imbs with contractures of the large joints, severe pectus 
cari natum with narrow chest and dorsa l kyphosis ( Figure 3.2-3b and c). She 
walks with d ifficu l ty and has no speech. She has severe myopia and bi latera l 
profound sensory-neura l  hearing loss requiring hearing a ids.  She was 
operated on for a cleft palate and a b i lateral cataract. Deta i led 
ophthalmological examination revea led myopia, estropia ,  aphakia and myopic 
degeneration of the retina , but there were no vitreous changes. 
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Figure 3. 2-2. Ped igree of fami ly  FB.  Six chi ldren out of eight of a 
consanguineous couple were affected with F BCG. Al l  the affected 
chi ld ren died except one ( 1 1 1 -7) .  
I I  
1 2 
I I I  
1 2 3 4 5 6 7 8 
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F igure 3.2-3. C l in ica l  features of selected affected members from 
fam i ly FB .  a) The general  appearance of patient 1 1 1 - 1  i n  fami ly FB .  Note 
the typical facia l  appearance with short l imbs and narrow chest. b) & c)  
I mages of  patient FB- I I I -7 at  6 years of  age showing severe skeletal 
abnormal i ties inc lud ing severe kyphosis, pectus cari natum and joint 
contractures. Note also the flat face with prom inent large eyes 
remin iscent of Marshal  syndrome. 
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3.2.3 . 1 .3 .  Fami ly  C (FC)  
The parents a re d istantly related of  Yemeni origin and th is  ch i ld  was 
their first ( F igure 3 .2-4a) .  The parents appeared of normal height, had normal  
hearing and vision .  The ch i ld  was the product of  a pregnancy compl icated by 
polyhydramn ios (Table 3 .2- 1 ) .  The del ivery was normal .  At  b irth the chi ld was 
found to have the typical c l in ica l  and rad iolog ica l featu res of FBCG ( F igure 
3.2-4b) .  He died few days after b irth due to respi ratory insufficiency. 
3.2.3 .2 .  Gene mapping and mutation a nalys is  on UAE fami l ies with 
FBCG revealed homozygous two mutations in COL 1 1A 1  gene 
The genomes of seven affected ( FB-I I I - 1 , FB- I I I-2, FB- I I I -5 ,  FB- I I I -7 ,  
FB- I I I -8,  FA- I I - 1 , FC- I I -2 )  one unaffected ( FB- I I I-6) and two parents ( FB- I I - 1 , 
FB- I I -2 )  were genotyped us ing SNP 6.0 a rray. Homozygosity mapping 
ana lysis o n  the generated genotyping data identified a block of homozygous 
SNPs cover ing a round 4 .5  M b  shared between a l l  the seven affected 
ind ividua ls  from the three fami l ies ( Figure 3 .2-5).  The shared block between 
the affected ch i ldren FB- I I I - 1 , FB- I I I -2, FB- I I I -5, FB- I I I -7,  FB- I I I-8, was 
loca l ized between rs 1 2072388 (Chr1 :99,920, 791 ) and rs 1 1 1 85389 
(chr1 : 1 04,549 ,369) .  FA- I I - 1  was homozygous only between rs 1 2 1 37590 
(chr1 : 1 0 1 77 1 970- 1 0 1 772470) and rs550437 (chr1 : 1 0431 9230-1 043 1 9730) ,  
which narrowed the region further. The two parents ( FB-I I - 1 , FB- I I -2 )  and the 
unaffected ( F B- I I I -6) used for genotyping were heterozygous except for 364 
SNPs covering the ent i re COL 1 1A 1 gene were homozygous in the father of 
the FB fami ly  (FB- I I - 1 ; F igure 3 .2-5). The wider block contained around 42 
genes. D NA sequencing of 20 candidate genes ( includ ing COL 1 1A 1 gene) 
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F igure 3.2-4. C l in ica l  features of the affected ch i ld  from fam i ly FC. 
a )  Pedigree of fami ly Fe. b) Baby gram of Fe -1 1 -2 showing short dumb 
Bel l  appearance of long bones, short cupped r ibs and typical 
appearance of the i l i um.  
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I I  
1 2 
1 1 1  
F igure 3.2-5. Homozygosity mapping of the UAE fam i l ies with FBCG. 
Genome wide SNP genotypmg of seven patients with F BCG (FB- I I I -5 , FB-
1 1 1 -7 ,  F B- I I I -8 , FB- I I I - 1 , FB- I I I -2 , FA-I I - 1  and FC- I I -2 )  from three unrelated 
fam i l ies mapped the d isease to chr1 p2 1 . 1 -p2 1 .2 .  A wide block ( included i n  
a red dotted square) was found to b e  shared between FB- I I I -5,  F B- I I I -7 ,  
FB- I I I -8 ,  FB- I I I - 1 , F B- I I I -2 ,  a n d  FC- I I-2 . FA- I I - 1  was on ly homozygous in  
part of the wide b lock ( incl uded in  a b lue dotted square) .  The mother (FB-
1 1 -2) and an unaffected s ib (FB- I I I -6) were heterozygous in  th is  region 
whi le the father (FB- I I - 1 )  showed part ial homzygosity having 364 
homozygous SNP with i n  the mapped region ( ind icated with a red arrow). 
The homozygous SNPs in patients are designated by green lines, while 
the homozygous SNPs in the unaffected individuals are indicated by red 
lines. 
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located with in  the homozygous block in  fami ly FB revea led no mutation with in  
the exons and their spl ice junctions ( l isted in  table 3 .2-2 and Append ix B) .  
H owever, a homozygous nonsense mutation cA084C> T (p .R1 362X) 
( NM_00 1 854.3) was detected in  fam i ly FA in  exon 54 of COL 1 1A 1 ( Figure 
3 .2-6) that is p red icted to cause pre-maturation and truncation of procol lagen 
cha ins i n  this pat ient and thus expected to be abol ished by the non-med iated 
decay ( N M D )  mechanism.  
Cl in ica l s imi larity of the phenotype between the recruited fami l ies 
h igh l ighted COL 1 1A 1 as the cand idate disease-ca using gene. Therefore, to 
investigate COL 1 1A 1 fu rther i n  fami ly FB,  RNA was extracted from cultured 
fibroblasts from the only surviving patient in this fami ly ( FB- I I I -7). D i rect 
Sequencing of COL 1 1A 1 cDNA revealed a homozygous inclusion of a 50 bp 
pseudo-exon between exon 48 and exon 49 (F igure 3 .2-7) .  Re-sequencing of 
i ntron 48 of COL 1 1A 1 revealed a homozygous genomic mutation 
c .3708+437T>G in  al l  the affected ind ividuals of fami ly  FB ( Figure 3.2 -8) .  
Apparent ly th is transversion created a strong donor spl ice site leading to the 
subsequent selection of a weaker 'opportun istic' acceptor site , as described 
previously in the l iteratu re ( Figure 3 .2-9) [Buratti et a I . ,  2006] . The interesting 
fi nd ing is that the retention of this pseudo-exon has led to premature insert ion 
of a term i nat ion codon in the mature m RNA and most probably resulted in its 
rapid degradation by NMD.  
U nfortunately, sequencing the 67 exons of  COL 1 1A 1 gene in  the affected 
member  of the th ird fami ly  FC ( FC- I I -2 )  d id  not reveal any suspected change 
1 1 3 
Table 3.2-2. L ist of the twenty genes sequenced i n  this study. 
Gene I Ref Seq number Coordinates I Exon cou nt I 
PALMD N M_0 1 7734 1 00 1 1 1 430 8 
A GL N M  000642 1 0031 5639 34 
SLC35A3 N M  00 1 27 1 685 1 0043599 1 8 
HIA T1 N M  033055 1 00503788 1 2  
SASS6 NM 1 94292 1 00549 1 01 1 7  
LRRC39 N M  001 256385 1 006 1 4003 1 0  
DBT NM 001 9 1 8  1 00652477 1 1  
RTCA N M  001 1 3084 1 1 0073 1 7 1 3  1 2  
CDC 14A N M  003672 1 0081 8022 1 6  
GPR88 NM 022049 1 0 1 003727 2 
VCAM 1  N M  001 078 1 0 1 1 85 1 95 9 
EXTL2 N M  001 26 1 441  1 0 1 337927 5 
SLC30A 7 N M  00 1 1 44884 1 0 1 36 1 631  1 1  
DPH5 N M  00 1 077395 1 0 1 4551 79 1 8  
S 1 PR 1  N M  001 400 1 0 1 702304 2 
COL 1 1A 1  N M  080629 1 03342022 67 
RNPC3 N M  0 1 76 1 9  1 04068577 1 4  
AMY2B NM 020978 1 04097265 1 2  
AMY2A N M  000699 1 041 59998 1 0  
AMY1A NM 001 00822 1 1 04 1 98 1 40 1 1  
1 1 4 
F i g u re 3 .2-6. M utat ion a na lys i s  res u lts i n  fami ly  FA. A novel 
nonsense m utation was found  c A084C> T i n  COL 1 1A 1 in the affected 
ch i ld ( FA- 1 1 1 )  i n  a h omozygous form . The s ame m utation was fou nd to be 
heterozygous i n  parents.  The m utation was not detected in norma l  
healthy contro ls .  
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F i g u re 3. 2-7. A n ovel i nsertion of a 53 n u c l eotide between exons 48 a nd 49 of COL 1 1A 1  c D N A  i n  fa m i l y  FB.  
a )  Sequencing chromatogram showing the reg ion between exons  48 a n d  49 of COL 1 1A 1 cDNA seq uence of a 
normal  control  with the exons borders a re u nder l ined .  b) Sequencing chromatogram showing the homozygous 
insert ion of a 50 n ucleot ide ( u n der l ined)  i n  F B- I I I -7  COL 1 1A 1 cDNA.  
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F i g u re 3 .2-8 .  M u tation a n a l ys i s  resu l ts for i n tron 48 of COL 1 1A 1 i n  
fa m i l y  F B .  A n ovel i ntronic c . 3708+437T>G m utat ion was found i n  a l l  the 
affected m e mbers of fam i ly F B  i n  a homozygous  form . The same 
m utat ion was heterozygous  i n  parents and the u naffected s i b  (FB- I I  1 -6 ) .  
The m utat ion was not  found in  1 00 norma l  controls .  
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Figure 3.2-9. Schematic re presentation of the genom ic reg ion encom pass i ng exons E46 to E57 of the 
COL 1 1A 1  gene i ndicating the locations of the two detected m utations i n  the UAE fam i l ies FA and FB.  The 
two m utations detected in th is study, c .4084C>T in FA and c .3708+437T>G in fami ly FB ,  are located in the 
sequences encoding the tr iple hel ical domain of COL 1 1 A 1 protein .  The d rawing demonstrates the effect of the 
c. 3708+437T>G mutation in introducing a pseudo-exon ( labeled as "New") between exons 48 and 49. The d rawing 
a lso shows the genomic sequence of the patient with c. 3708+437T>G mutation a l igned to the sequence of the 
normal control i l l ustrating the T to G change in  red .  The change from AT to AG is pred icted to create a favorable 
consensus sequence strengthening a c ryptic donor sp l ice s ite within the intron .  
c.3708+437T>G cA084C>T 
E46 E47 
\ 1 
� E48 E49 -' .; 
" / "  .... - - - '  
I" " , 
ESO E5 1 ES2 £53 ES4 
Control g t a t t t tc agACTATATAATGTTACAGCAATATGTGCGTGATAGGTGCACCCTTTATCATg t aaaatg t t t t  
Pat ient g t a t t t t cagACTATATAATGTTACAGCAATATGTGCGTGATAGGTGCACCCTTTATCAGgtaaaa tgt t t t  
E55 E56 E57 
inc lud ing absence of the intron ic mutation found in  fami ly B. No cDNA for any 
member in  this fami ly was avai lable to confirm whether a spl icing change in  
COL 1 1A 1 is  the cause of  the corresponding phenotype . Therefore, I was 
unable to confi rm or exclude the involvement of this gene in their phenotype . 
However, genome wide-homozygosity mapping showed a large stretch of 
homozygosity on chromosome 1 with overa l l  homozygosity of 7 .8% 
suggesting a possib le closer parental relationship than that ind icated i n  the 
fami ly  h istory. I n  add it ion , the locus for the COL 1 1A2 gene found to be 
responsib le for some fibrochondrogenesis cases [Tompson et a I . ,  201 2] is 
heterozygous in th is patient. However, I can not exclude the possibi l ity that 
the phenotype is caused by compound heterozygous mutations in COL 1 1A2. 
3.2.3 .3 .  Funct ional  stud ies on the c .3708+437T>G mutat ion confirm the 
predicted loss of fu nction mechanism u nderlyi ng FBCG 
The expression level of COL 1 1A 1 m RNA in  the patient's ( FA- I I I? )  
fi broblasts was investigated by rea l  t ime ( RT)-PCR us ing a specific Taq-Man 
probe for exons 1 4  and 1 5  of human COL 1 1A 1  transcript N M_00 1 854.3 
( Hs01  097626_m 1 ). This pre-designed probe can a lso detect a l l  the other 
known isoforms of human COL 1 1A 1 m RNA. No detectable expression was 
observ.ed for COL 1 1A 1 in the fi broblasts from this patient compared to normal  
healthy control fi broblasts ( Figure 3 .2-1 0a; Append ices B 1  and B2). Absence 
of m RNA for th is gene cou ld  be expla ined by N M D  degradation due to the 
premature terminat ion. 
Col lagen 1 1  A 1 protein expression has been a lso eva luated by western 
b lotting . Total prote in  was extracted from the patient's (FA- I I I?) fibroblasts , 
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F igure 3.2-1 0.  Expression a na lysis of the homozygous 
c .3708+437T>G mutation in  COL 1 1A 1  gene. a )  COL 1 1A 1  mRNA level 
in the patient fi broblasts was not detectable by TaqMan RT-PCR 
compared to i ts expression in the fi broblasts of a healthy control . b) 1 00 
m icrograms of total prote in were extracted from the fibroblasts of the 
patient as wel l  as a normal control and loaded into an SOS-PAGE and 
then analyzed by western b lotting. A COll 1 1  A 1 band at the expected 
s ize (- 1 8 1  KOa) was detectable in the control and tota l ly absent from the 
patient .  
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quantified and resolved by SDS-PAGE followed by western blotting us ing 
rabbi t  polyclonal  anti -col lagen 1 1  A 1 ra ised against human epitope (ab64883). 
This anti body b inds to an internal h ighly conserved sequence of COL 1 1 A 1 
prote in  ( N P  _00 1 845.3 ;  am ino acids 601 to 630) which is s imi lar i n  a l l  the 
known isoforms. A protein band with expected size for human COL 1 1  A 1 
(- 1 8 1  KDa) was detected in  the sample from the healthy control which was 
comp letely absent from the patient's sample ( Figure 3 .2-1  Ob) .  
3.2 .4. Discussion 
H uman chondrodysplasias a re genetical ly and cl in ica l ly heterogeneous 
g roups of cart i lage d isorders where the severity of the phenotypes, i n  part ,  
corre lated with the type of the causative mutation [Matsu i ,  201 0] .  I n  th is study, 
I have d iscovered the novel association of a severe form of chond rodysplasia 
"the FBCG" in  affected fami l ies from UAE with COL 1 1A 1 gene. This find i ng 
was independently confi rmed by Tompson et al [20 1 0] who described two 
patients with FCBG carry ing com pound heterozygous mutations in COL 1 1A 1 .  
I have a lso reported the first homozygous loss-of-function COL 1 1  A 1 
m utations described i n  humans.  
3.2.4. 1 .  C l i n ical  heterogeneity of type XI  col lagenopathies 
The COL 1 1A 1  gene (OM I M * 1 20280) on chromosome 1 p2 1  encodes 
the 01 cha in  of type X I  col lagen . Collagen XI  is a m inor structu ral protein ( 3-
1 0% )  expressed i n  the hya l i ne carti lage, the vitreous of the eye, the nucleus 
pu lposus of the i ntervertebra l  d isc and the inner ear where it forms th in fib ri l s  
together with col lagens I I  and IX [Cremer et a I . ,  1 998] . I n  feta l carti lage, 
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col lagen X I  consists of a 1  (XI )a2(XI)a 1 ( I I )-polypeptide chains encoded by 
COL 1 1A 1 , COL 1 1A2 and COL2A 1 genes, respectively [Kad ler et a I . ,  2008] . 
The on ly exception is in  the ocular vitreous where a2(XI ) is replaced by the a 1  
chain o f  col lagen V, which shares structu ra l homology with co l lagen X I  and 
their  a chains a re interchangeable in  certa in tissues and cel l  l ines [Fernandes 
et a I . ,  2007; Fichard et a I . ,  1 995]. Electron microscopy studies have shown 
that the tr iple hel ica l  or the C-termina l  domains of col lagen XI  and V are 
located in  the core of their fibr i ls with the N-terminal  domains (NTD) a t  the 
fi br i ls '  su rface [F ichard et a I . ,  1 995; Holmes and Kadler et a I . ,  2006; Fa l lah i  et 
a I . ,  2005]. Variable locations of their functional doma ins suggest two roles for 
both col lagens [Wenstrup et a I . ,  2004] , where they act as nucleators for fibr i l  
assembly [Blaschke et a I . ,  2000] as wel l  as contro l l ing fibr i l  d iameters th rough  
the  NTDs by sterica l ly h indering the i r  thickening [Kadler e t  a I . ,  2008 ; B laschke 
et a I . ,  2000] . 
Mu tations in  the genes encod ing col lagen XI cause var ious 
chondrodysplasias. Autosomal dominant  Stickler syndrome type I I  ( STL2; 
OM I M#60484 1 ) and Marshal l  syndrome (OM I M#1 54780) a re caused by 
heterozygous mutations in  the COL 1 1A 1 gene [Fernandes et a I . ,  2007]. 
Compound heterozygous and homozygous mutations i n  COL 1 1A 1 have been 
reported with FBCG 1 (OM I M#228520) [Tompson et a I . ,  201 0] and a s imple 
St ick ler phenotype [Alzahran i  et a I . ,  20 1 2] .  Heterozygous and homozygous 
m utations i n  COL 1 1A 2  were detected in  a number of chondrodysplas ias 
inc lud ing otospondylomegaepiphysea l dysplasia (OSMED;  O M I M  #2 1 5 1 50 & 
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#2776 1 0), STL3 (OM I M#1 84840) and FBCG2 (OMI M#6 1 4524). 
Heterozygous m utations in  COL2A 1 are associated with several 
condrodysplas ias such as achondrogenesis (OMI M#20061 0) ,  Kn iest 
dysplasia (OM I M#1 56550), and STL 1 (OM I M#1 08300). 
3.2 .4.2. Genetic heterogeneity of FBCG 
FBCG has been shown to be genetica l ly heterogeneous result ing from 
m utations in two genes out of three encoding the a cha ins of type XI col lagen , 
COL 1 1A 1  and COL 1 1A 2  [Tompson et a I . ,  20 1 0; 201 2] .  Moreover, a l l  the 
reported cases of FBCG so far show a recessive mode of i nheritance for the 
d isease [Lazzaron i -Fossati et a I . ,  1 978; Eteson et a l . ,  1 984; Martinez-Frias et 
a I . ,  1 996; AI-Gazal i  et a I . ,  1 997; 1 999; Sauer et a I . ,  2000; Randrianaivo et a l . ,  
2002; Leeners e t  a I . ,  2004; Ku lkarn i  e t  a I . ,  2005; Kundaragi e t  a l . ,  201 2] 
except one case reported by Tompson et al [201 2] .  The a uthors have 
suggested an autosomal dominant inheritance for the d isorder after 
identifyi ng a de novo heterozygous 9 bp deletion in exon 40 of COL 1 1A 2  in 
one patient with FBCG. However, in  that study no l i nkage analys is or 
sequencing of the patient's cDNA was performed to exclude any other 
spl ic ing m utation(s)  which might be found in  COL 1 1A2 or in COL 1 1A 1 .  
3.2.4.3.  Phenotypic spectrum of COL 1 1  A 1 mutations 
Mutations in COL 1 1A 1 gene have variable phenotypes ranging from 
the a bsence of any symptoms or mi ld phenotypes to early letha l ity. Numerous 
heterozygous m utations i n  COL 1 1A 1 have been previously reported in  
patients with a utosomal dominant Stickler and Marshal l  syndromes [Griffith et  
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a i . ,  1 998; Richards et a i . ,  2006 ; 201 0; Vijzelaar et a i . ,  201 3] .  I n it ial ly, these 
two dominant condit ions were regarded as d istinct entit ies but more recently 
they have been considered a l le l ic  [Majava et a i . ,  2007] .  The mutations 
reported to  cause these two condit ions include heterozygous non­
synonymous sUbstitutions of g lycine residues and skipping or in-frame 
delet ion of one or more exons (Table 3.2-3) [Richards et a i . ,  2006; 20 1 0;  
Griffith et a i . ,  1 998; Majava et a i . ,  2007 ; Annunen et a i . , 1 999; Mart in et a i . ,  
1 999;  Poulson e t  a i . ,  2004] . 
Four mutations in  COL 1 1A 1 gene have been recently found i n  two unre lated 
America n  FBCG patients [Tompson et a i . ,  201 0] .  The reported mutations 
were in the compound heterozygous states and they introduce a PTC in one 
al le le and a g lycine substitution in the other. The father had an early-onset 
hearing loss but the mother was normal (Table 3.2-3) .  One homozygous 1 bp 
delet ion has been detected in  exon 6 of C0L 1 1A 1 gene creat ing a PTC in  the 
N-term ina l  p ropeptide of the prote in  product [Alzahran i  et a i . ,  20 1 2] .  The 
patient carrying th is mutation exhibited a mi ld phenotype resembl ing Stickler 
while the carrier parents were normal except for a mild myopia in  the father 
(Tab le 3 .2-3) .  In this study, two homozygous mutations in  COL 1 1A 1 have 
been identified in  two u n related fami l ies .  Both mutations created a PTC in the 
h ighly conserved trip le hel ica l  domain of the protein  product. Al l  the affected 
patients in th is study exh ibited a severe FBCG phenotype which was lethal in  
most  of them.  Whi le  the carriers were a lmost normal showing early myopia i n  
o n e  case a n d  adul thood cataracts in  the other (Table 3 .2-3). 
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Table 3.2-3 . Com parison of the phenotypes assoc iated with d isease causing heterozygotes genotypes in  
COL 1 1A 1  gene. 
Cases Mutation Implication Orofaclal Features Ocular Features Auditory Features Other Features Reference 
Cho/+ 1 -nt deletion Frame shift led to PTC -ve -ve -ve Early onset LI et ai , 1 995 
mice Osteoarthntls 
FA- 1 1  p .R1 362X Nonsense mutation -ve -ve -ve -ve This s�_ -- - -
FA-12 p R 1 362X Nonsense mutation -ve -ve -ve -ve This study 
FB-1I 1 c.3708+437T>G Splicing mutation led -ve Cataract of right -ve -ve This study 
to insertion of an exon eye at 38 years 
and PTC 
FB-1I2 c.3708+437T>G = -ve -ve -ve -ve This stu� -
FB-1I 16 c.3708+437T>G - -ve Severe myopia -ve -ve This study 
Since Infancy 
Mother of p.G1 042R Non-synonymous -ve Myopia at 1 0  -ve Average stature Tompson et aI . ,  20 1 0  
famlly_1 mutation years 
Father of p.A596fsX8* Frame shift led to PTC -ve Wore glasses at Hearing loss at age 7 Average stature and Tompson et ai , 20 1 0  
family 1 6 years years JOint pain 
Mother of p G796R Non-synonymous -ve Mild myopia -ve Mild short stature for Tompson et ai , 2 0 1 0  
family 2 mutation her family 
Father of p .G1 3 1 5X Nonsense mutation -ve -ve Mild hearing loss and Average stature Tompson et ai , 20 1 0  
family 2 history of hearing 
loss In the family 
Father p.N398PfsX 1 9  Frame shift led to PTC -ve Mild myopia -ve -ve Alzahram et al 2 0 1 2  
Mother p N398PfsX 1 9  Frame shift led t o  PTC -ve -ve -ve -ve Alzahram et al , 2 0 1 2  
Stickier GlYCine Non-synonymous flat face, small chin, 'beaded' or type Mild to severe Early onset Richards et aI . ,  2006, 
type II substitutions mutation and cleft palate 2 Vitreous, , hearing loss osteoarthrosls 2 0 1 0 ,  Griffith et al 
Gross Deletions Splice site mutations moderate to 1 998, Majava et ai ,  
results In In-frame severe myopia In 2007, Poulson et aI . ,  
deletion of exon/s early childhood 2004 
Marshal Gross Deletions Splice site mutations Prominent forehead, myopia, cataract, congenital hearing short stature and Griffith et a I . ,  1 998, 
results In In-frame protruding eyes With and rarely retinal loss abnormalities In Annunen et al . ,  1 999 
deletion of exon/s marked mldface detachment cranial ossification, 
hypoplasia, short nose 
, and long philtrum 
Slickier GlYCine Non-synonymous Mild phenotype With early-onset hearing short stature Majava et al , 2007 
and substitutions mutation Less pronounced mid loss more 
Marshall Gross Deletions Splice site mutations face hypoplasia 
overlap results in In-frame 
deletion of exon/s -
*The heterozygous status was assumed but not actual ly confi rmed by DNA sequencing 
Sim i larly, Col 1 1a1  homozygous nu l l  mutation in  m ice ' Cho mouse' causes a 
lethal chondrodysplasia with cl in ica l features stri k ingly s imi lar to FBCG in 
humans includ ing the patients in  this study [Li et a I . ,  1 995; Fernandes et a I . ,  
2007] . The homozygous stra ins show abnormal ities in  the cartilages o f  l imbs,  
r ibs,  mandib le and trachea [Li et a I . ,  1 995]. Nonetheless, heterozygous m ice 
Cho/+ survive normal ly and do not exhibit any observable symptoms except 
osteoarthrit is (Tab le 3 .2-3) [Rodriguez et a I . ,  2004] . 
3.2.4.4. Pathophys iological mechanisms u nderlying COL 1 1A 1  
mutations 
The St ick ler and Marsha l l  syndromes causing mutations a re probably 
act ing v ia a dominant negative mechanism result ing i n  the dominant mode of 
inheritance of these chondrodysplasias [Richards et a I . ,  2006 ; 201 0] .  Several 
models have been proposed to expla in  the deleterious effect of such 
m utations inc lud ing the prevention of triple hel ix formation due to the 
incorporation of the defective cha ins and the subsequent accumulation of the 
u nfolded procol lagen molecu les in  the endoplasm ic reticu lum ( ER)  of g rowth 
plate chondrocytes [Prockop et a I . ,  1 989] . This accumu lation is l i kely to lead 
to the rapid degradation of the whole complex [Rod riguez et a I . , 2004; 
Prockop et a I . ,  1 989] and/or the induction of the ER stress s ignal ing pathway 
promoting chondrocyte apoptosis [Wi lson et a I . ,  2005; Nund la l l  et a I . ,  201 0] .  
Moreover, i t  has been suggested that the abnormal 0 1  (XI) chain may fol d  i nto 
a tr iple hel ix which has k inks lead ing to abnormal it ies in  f ibri l formation 
[Prockop et a I . , 1 989; Gaiser et a I . ,  2002] .  I nteresti ngly ,  in  the FBCG cases 
described by Tompson et a l  [20 1 0] ,  the heterozygous carriers (parents) of the 
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g lycine substitutions d id not show the dominant  Stickler or Ma rshal l  
phenotypes. This may reflect the variable effects of the g lycine sUbstitut ions 
and the i r  dependence on the positions of these substitutions with i n  the 
chains. In addit ion ,  variable phenotypes have been reported for d i fferent 
sUbstitutions [Ku ivaniemi et a I . ,  1 99 1 ] . 
For the COL 1 1A 1 homozygous mutations, the Cho mouse is 
considered to be the most appropriate an imal model  for the phenotype of a 
homozygous n u l l  mutation of the Col1 1a1  gene [Li  et a I . ,  1 995; Fernandes et 
a I . ,  2007] . Al l  the symptoms of Cho/Cho mouse described [Li et a I . ,  1 995] a re 
i n  concordance with the FBCG phenotype seen in  the studied patients. I n  
Cho/Cho model ,  a complete knockout of the type X I  co l lagen has been 
assumed because of the lack of 01 (XI) chains. This assumption was 
supported by the prominent presence of abnormal ly thick col lagen fi bri ls in 
the carti lage of Cho/Cho mice [Li et a I . ,  1 995] . On the other hand , cart i lage 
from Cho/+ mice conta i ned a mix of normal th in and three t ime thicker fibr i ls 
[Xu et a I . ,  2003] . Recently, Fernandes et a l  [2007] studied Cho mouse a t  the 
protein  level and identified a mix of 0 1 0/) and 01 (XI) chains in the Cho/+ 
carti lage, whereas 0 1 0/) and 02(XI )  chains were observed in  the Cho/Cho 
cart i lage. Therefore, they concluded that a lternative assembl ies of type X I  
col lagen cha ins were generated in  Cho/Cho carti lage instead of a com plete 
knockout of the type XI molecule. S imi la rly, no m RNA or protein expression 
has been observed in  th is study for the 01 (XI ) cha in  in  one of the investigated 
patients. Therefore,  the two homozygous nu l l  mutations in COL 1 1A 1 gene 
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detected in  this study are considered to be the first to be observed o n  the 
effects of complete loss-of-function of this gene in  humans. 
Although another homozygous nu l l  mutation i n  COL 1 1A 1 has been 
reported with a m i lder phenotype, yet the reported mutation has occurred in 
exon 6 of this gene which is m issing or a lternatively spl iced in  some of its 
known isoforms [ Iyama et a I . ,  200 1 ; Chen et a I . ,  200 1 ] .  By contrast ,  the 
mutat ions reported in this study and in  the Cho mouse are located i n  h ighly 
conserved regions of COL 1 1A 1 found in  a l l  the known isoforms. Furthermore ,  
addit ional  isoforms seem to  exist for COL 1 1A 1 showing t issue-specific 
preferential expression (http://www. un iprot.org/un iprotlP1 2 1 07 ). 
Nevertheless, Yoshioka et a l  [ 1 995] has demonstrated experimenta l ly  that 
Co/1 1 a 1 has a broader spectrum of express ion and concluded that the a l pha 
1 (X I )  chain may participate in the formation of stage- and tissue-specific 
tr imers with d ist inct functional  properties. Taken all together this may expla in 
the phenotypic spectrum of COL 1 1A 1 nu l l  homozygous mutations. 
3 .2 .5. Conclus ion 
I n  th is study, I have local ized and identified the gene underlying FBCG 
i n  2 out  of 3 consanguineous fami l ies from the UAE. I have a lso revea led 
novel recessive mutations in  COL 1 1A 1 and the phenotypes associated with 
them in affected and carrier ind ivid uals .  As out l ined in Chapter 1 ,  identification 
of causative genes and mutations u nderlying heterogenous recessive 
d isorders such as FBCG can be helpfu l in refin ing the diagnosis and the 
subsequent c l in ica l  management of the patients. In add ition ,  identification of 
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these homozygous COL 1 1A 1 mutations ( i nherited i n  an autosomal recessive 
manner) has faci l itated carrier screening and the subsequent appropriate 
genetic counsel ing as wel l  as the possib i l ity of future prenatal diagnosis or 
pre implantation genetic d iagnosis for these fami l ies. The identification of a 
human model of COL 1 1A 1 inactivation has a lso impl icated a novel d isease 
pathway which can be explored in  the future to e lucidate the molecular basis 
of other  unresolved chondrodysplasias. 
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S E CT I O N  3 :  Del i n eati o n  of the c l i n i ca l ,  
m o l ecu l a r  a n d  cel l u l a r  as pects of seve ra l 
n ovel JAM3 m utations u nderlyi n g  the 
a utos o m a l  recess i ve hemorrhag i c  destruct i o n  
of the b ra i n ,  s u bependymal ca lc ifi cat ion , a n d  
co n g e n ita l cata racts 
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3.3. 1 .  Background 
Junctional adhesion molecule 3 (JAM3;  OMI M*6 1 3730) is  a member of 
the JAM subfami ly of proteins,  which include F1 1 R (JAM 1 ,  JAM-A), JAM2 
(JAM-B),  JAM3 (JAM-C), and IGSF5 (JAM4) [Ebnet ,  2008; Weber et a I . ,  
2007] .  Other related members of this subfami ly of proteins i nclude the 
endothel ia l  cell selective adhesion molecule and coxasackie virus and 
adenovirus receptor (CXADR) [Weber et a I . ,  2007] . JAMs and related prote ins 
a re loca l ized at i nterce l lu lar  contacts and participate in  the assembly and 
maintenance of t ight  junct ions (T Js)  and the control of cel lu lar permeabi l ity 
[Ebnet, 2008] . T Js a re morpholog ical ly d i stinct subce l lu lar  structu res that a re 
located closer to the apical s ide (compared with other junctional complexes) 
and are h igh ly reg ulated areas of close contact between the plasma 
membranes of adjacent epithel ia l  and endothel ia l  ce l ls  [Balda and Matter, 
2008] . T Js a re important  for the formation of polarized epithel ia l  and 
endothel ia l  barriers by forming in termembrane diffusion barriers and by 
contro l l ing d iffus ion a long the parace l lu lar  pathway [Cereij ido et a I . ,  2008] . I t  
has  a lso  been found that T J s  a re important for intrace l lu lar  s ignal ing [Matter 
and Balda ,  2007;  Steed et a I . ,  2009; Terry et a I . ,  201 0] . JAMs have been 
found to reg ulate adhesion between leukocytes and endothel ia l  ce l ls and the 
paracel lu lar  t ransmigrat ion of leukocytes across the endothel ium [Bradfie ld et 
a I . ,  2007; Weber et a I . ,  2007] . Moreover, JAMs play a role in  cell polarization 
d ur ing spermatogenesis [Gl ik i  et a I . ,  2004]. In add it ion to JAMs, T Js conta in  
other proteins i nclud ing claud ins ,  occludins,  and trice l lu l ins  [Ebnet e t  a I . ,  
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2004; Ebnet, 2008] . JAMs are sing le-span transmembrane proteins,  whereas 
claud ins ,  occlud ins ,  and trice l lu l ins are tetra span transmembrane proteins 
[Bald a and Matter, 2008; Ebnet, 2008] .  The tetra span proteins form the 
paracel lu lar  permeab i l i ty barrier and therefore determ ine the selectivity and 
extent of paracel lu lar  d i ffus ion.  JAMs on the contrary, are postulated to 
med iate homotypic cel l-cel l  adhesion [Bazzoni et a I . ,  2000; Weber et a I . ,  
2007] . Several inherited condit ions have been shown to be caused by 
mutat ions in genes encoding members of T Js prote in  complexes [O'Oriscol l  
et aL ,  20 1 0] .  Hypomagnesaemia has been shown to be caused by mutations 
in  genes encod ing claud ins 1 6  and 1 9  [Konrad et a L ,  2006 ; Simon et a L ,  
1 999] a n d  fami l i a l  hypercholanemia t o  b e  caused b y  mutations in  the TJP2 
and BAA T genes [Carlton et aL ,  2003] . S imi larly,  mutations in claudin 1 4  and 
trice l lu l i n  have been fou nd to cause hered itary deafness [Riazuddin et  aL , 
2006 ; Wi lcox et a L ,  200 1 ]  and mutations in NHS to cause Nance-Horan 
syndrome [Burdon et a L ,  2003] . The variabi l ity in  the cl in ica l  presentations 
reflects the variable functions of T Js in  various tissues and organs. 
3.3.2 .  The pu rpose of the study 
In  a col laborative study, we mapped a rare recessive d isorder 
segregating i n  an extended consanguineous fami ly  from the UAE to 
chromosome 1 1  q25 us ing a homozygosity mapping approach [Mochida et a l . ,  
201 0] .  The disorder is  characterized by  hemorrhag ic destruction o f  the bra in ,  
subependymal calcification , and congenital cataracts (HOBSCC; 
OM I M#6 1 3730). Sequencing of candidate genes resid ing with in  the 
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homozygous region revealed a homozygous mutation i n  the JAM3 gene 
[Mochida et a I . ,  201 0] .  In this study, add it ional fam i l ies from d ifferent ethnic 
backgrounds exhib it ing s im i la r  phenotypes were recru ited . Subsequently, 
d i rect sequencing of JAM3 gene was carried out i n  al l the affected chi ld ren to 
confi rm the association of th is gene with the aforementioned phenotype. 
Add it ional ly ,  th is study was carried out to identify more mutations in  this gene 
that may expand  the phenotype or provide insights into the pathophysiologica l  
mechan ism underly ing this severe phenotype . 
3.3.3.  Resu lts 
3.3 .3 . 1 .  C l i n ica l  assessment of the stud ied fami l ies 
Three fami l ies from different ethnic backgrounds (one Turkish,  one 
Afghan i ,  and one Moroccan)  were recru ited to participate in this study ( F igure 
3 .3- 1 ) . Consangu in ity is evident i n  two of the fami l ies and the cl in ical features 
of al l  the affected ch i ldren are l isted in  Table 3 .3- 1 . 
3.3.3 . 1 . 1 . Fami ly  1 
The parents of the affected chi ld in this fami ly a re second cous ins of 
Turkish orig i n .  The parents a re normal .  Their first ch i ld ( 1 1 - 1 ) was a preterm 
baby g i rl who had intracran ia l  b leed ing and d ied i n  the neonata l  period . One 
of the mother's s isters d ied with a s imi lar  phenotype but no cl i n ical data were 
avai lab le .  The second chi ld ( 1 1 -2) of the couple was a female who was the 
product of a normal pregnancy and term del ivery. Her b irth weight was 2 , 480 
gm « 1 0th centi le) .  She was admitted to the neonatal in tensive care un i t  on 
day 5 d ue to tonic seizures, which were resistant to treatment. 
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Figure 3.3-1 . Ped igrees of the three fam i l ies i n  this study. Three fami l ies with d i fferent ethnic origins were 
recru ited for th is study. Fami ly 1 is Turkish,  fam i ly 2 is Afghani ,  whereas fami ly 3 is Moroccan .  Fi l led symbols denote 
affected i nd iv iduals with the syndrome of hemorrhagic destruction of the brain ,  subependymal calCification,  and 
congenital cataracts (H DBSCC). Sequenced indiv iduals are ind icated with an asterisk. 
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Table 3.3-1 . C l in ical  features of hemorrhag ic bra in  destruction-JAM3 type. 
-- --- ---
Families Mochida et a l  [201 0] 
Patients 1 2 3 4 5 6 
Ethnic origin UAE (8aluchil 
Consanguinity + + + + + + 
al ive 5 a live 1 1  
al ive 7 years years years 
died 9 died with severe with died with S u rvival days after mental & severe 2 month severe birth physical mental & mental & 
handicap physical physical 
handicap handicap 
Birth head c irc umference 35cm 34cm 33cm NA NA NA 
Seizures NA NA + + NA + 
bilateral bilateral 
Ophtha lmology bilateral bilateral cataracts, cataracts, bi lateral bi lateral cataracts cata racts pale optiC cataracts cata racts microphthalmia d isc 
Renal abnormalities - + NA NA + + 
Hepatomegaly + + NA + NA NA 
Brain MRI 
Intraparanchymal hemorrhage + + + + + + 
Evidence of brain destruction + + + + + + 
Subepe ndymal basal ganglia + + + + + + & wh ite matter ca lcification 
Posterior fossa abnormalities - + - + + + 
--
Present study 
--=- . -, Famlly1 Fam ily 2 
1 1 �. � Turkish l- At hanl 
+ - - -
Died at 2 Died at Died at 5 
months 1 4  days days 
35cm NA 35cm -
r-EEG
--
bi lateral + -
epilepliform 
actIVIty 
bilateral bi lateral bi lateral 
cata racts cataracts cataracts 
- + + 
- - -
+ + + 
+ + + 
+ + + 
- - -
- -
-
Family 3 
1 i- -Moroccan 
+ 
Died at 39 
days 
34.5cm -
status 
epi leptlcus 
on EGG I 
----< 
bilateral 
cataracts 
-
-
+ 
+ 
+ 
-
Physical examination revealed a head circumference of 30 cm, s loping 
forehead prominent ,  bu lg ing anterior fontanel le ,  bitemporal  g rooving ,  and 
b i latera l  nuclear cataracts ( Figure 3.3-2A- 1 ) . Cran ia l  u ltrasound showed a 
prominent expansive bleed ing .  Bra in  computerized tomography showed 
calcification of the subependymal reg ion and multifocal intraparenchymal 
hemorrhage ( Figure 3 .3-2A-2). Serologica l  tests were negative for 
toxoplasmosis, rubel la ,  and cytomega lovirus. Cerebrospinal fl u id PCR for 
cytomegalovirus and toxoplasma were a lso negative. Platelets levels were 
norma l .  The i nfant developed post hemorrhagic hydrocephalus and d ied at  2 
months of age.  
3.3 .3 . 1 .2 .  Fami ly  2 
The parents a re non-consanguineous and healthy of Afghani  or ig i n .  
Patient 1 ( 1 1 - 1 ) was the fi rst ch i ld o f  the fami ly born a t  term b y  emergency 
caesarean section .  H is b i rth weight was 2 ,480 gm « 1 0th cent i le) .  He  was 
noted to have b i lateral cataracts and had feeding problems from b i rth. He  was 
d ischarged home on day 4.  At 2 weeks of age, he presented with vom iti ng ,  
i rr itab i l ity, and a h igh  pitched cry. A bra in  MRI  at the age of  1 5  days showed 
Grade IV i ntraventricu lar  hemorrhage, severe ventricu lar d i latation , and wh ite 
m atter abnormal i ties in  both cerebra l  hemispheres and m u lt ip le 
subependymal cysts ( Figure 3 .3-2B).  Renal u ltrasound showed horseshoe 
k idneys with echogenic cortex and a l tered corticomed ul la ry d ifferentiation .  He  
had  progressive neurologica l  deteriorat ion and  d ied at 2 weeks of  age.  
I nvestigations were a l l  normal  and included blood karyotype, CGH array, and 
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Figure 3.3-2. C l in ica l  features of some affected members in  this 
study. A-1 : Facial  p icture of the affected Ind ividua l  i n  fami ly 1 shows 
b i lateral nuclear cataracts and hypertelorism A-2: Head CT i mage of the 
patient In fam i ly 1 reveals m ultifocal i ntraparenchymal hemorrhages 
(arrows) and subependymal  calCification (arrowheads). B: T2-weighted 
axia l  brain M R I  of patient 1 in fami ly 2 reveals m ultifoca l 
i n traparenchymal hemorrhages of varying ages (arrows) as wel l  as 
in traventricu lar hemorrhage (asterisks). C-1 : Head CT of the patient i n  
fam i ly 3 shows m ultifocal In traparenchyma l  hemorrhages (a rrows) and 
subependymal calcification (arrowheads). Diffusely hypodensity of bra in 
parenchyma IS a lso noted,  suggesting severe edema. C-2:  T2- weighted 
corona l  M R I  image of the same patient shows intraventricular 
hemorrhage with associated en largement of the ventricles. 
A) 
C) 
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a coagu lation study inc lud ing platelets. 
Patient 2 ( 1 1 -3) was the third child of the fami ly, with the fami ly's second 
chi ld being a healthy male.  Pregnancy with patient 2 was normal and del ivery 
was by e lective caesarean section at term . His b irth weight was 3 ,3 1 5 gm 
(25th centi le) ,  length was 52 cm (50-90th centi le) ,  and head c ircumference 
was 35 cm (50th cent i le) .  At b i rth ,  he was noted to have bi lateral cataracts. 
His tone and reflexes were normal and there was no c l in ica l  evidence of 
seizures. Cran ial  u ltrasound showed periventricu lar  echogenicity but there 
was no bleed ing .  However, he deteriorated on day 5 and h is  hemoglob in 
d ropped from 1 80 gIl to 96 dl l ,  and he requ i red venti lat ion. H is  EEG o n  the 
th ird day of l ife showed b i lateral epi leptiform activity. A cran ia l  u l trasound 
revealed extens ive bi latera l intracerebral hemorrhage. He died on the fifth day 
of l ife . Abdomina l  u ltrasound showed pelvica lyceal d i latation of the r ight 
k idney. Ful l  meta bol ic  work up was normal .  
3.3 .3. 1 .3 .  Fami ly  3 
The parents a re fi rst cousins of Moroccan origin who had a total of five 
pregnancies. The fami ly  h istory is s ign ificant in that the mother's brother ( 1 -3) 
d ied on the seventh day of l i fe without any known d iagnosis. This couple's 
fi rst chi ld was a male born at 36 weeks gestation who had cerebra l 
hemorrhage, hydrocephalus,  and d ied at 1 0  days after birth. They then had 
two healthy chi ldren .  The fou rth pregnancy ended with a st i l lborn chi ld who 
had hydrocephalus and the cerebra l  t issues showed n ecrotic degeneration .  
The index case ( 1 1 -5 )  is  28 d a y  old female,  the product o f  a normal pregnancy. 
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Fetal tachycard ia was detected at 37 weeks gestation and therefore the baby 
was de l ivered by caesarean section.  Her b irth weight was 2 , 520 gm ( 1 0-25th 
centi le) ,  length 46 . 5  cm (25th centi le) ,  and head ci rcumference 34.5  cm (50th 
cent i le) .  B i lateral cataracts were detected at b i rth both central and nuclear. 
On the second day of l ife , she presented with i rritab i l i ty, cry ing,  and a bu lg ing 
anterior fontanel le .  Her bra in u ltrasound showed di lated latera l ventr ic les, 
intraventricu lar hemorrhage in the r ight ventricle , and frontal periventricu lar 
cysts . On the eighth day of l ife , she was referred to another hospita l for 
neurosurg ical eva luation . A head CT revealed mu l tifocal intraparenchymal 
hemorrhages, subependymal calcification,  and d iffusely hypodense brain 
parenchyma ( Figure 3.3-2C- 1 ). A MRI of the bra in  revealed intraventricu lar  
and intraparenchymal hemorrhage, edema, and cystic changes of  the b ra in 
parenchyma , d i lated ventricles, and th in corpus cal losum with hemorrhag ic  
damage ( Figure 3 .3-2C-2).  There was normal  ci rcu lat ion in the circle of Wi l l i s  
a rteries .  There were no seizures c l in ical ly .  Metabol ic screening was norma l .  
P latelets levels were norma l .  She had severe anemia .  Her  bra in CT scan 
demonstrated b i latera l  subependymal calcification i n  the lateral ventricles . On 
the e ighteenth day of l ife , her head circumference was 4 1  cm (4 standard 
deviations above the mean)  and she was d ischarged for pal l iat ive care at 
home. She died at home the age of 39 days. 
3 . 3 .3 .2.  JAM3 mutational analys is 
DNA sequencing revealed three novel homozygous non-synonymous 
m utations in JAM3 gene in the three stud ied fam i l ies (Table 3 .3-2; Figure 3 .3-
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3) .  I n  fam i ly 1 ,  a non-synonymous mutation (c.656G>A) in exon 6 of JAM3 
gene was detected , which led to an amino acid substitution at position 2 1 9 
(p .C2 1 9Y). In  fami ly 2 ,  a single nucleotide substitution (c.346G>A) in exon 4 
of JAM3 was identified lead ing to a non-synonymous mutation at position 1 1 6 
(p . E 1 1 6K).  The th ird mutation (c.2T>G) was detected i n  fami ly  3 changing the 
in it iat ion codon ( meth ionine) of JAM3 leading to amino acid substitution  to 
a rg in ine (p . M 1  R). The three mutations were not reported in either the dbSNP 
or  the  1 000 genome project. A l l  the amino acids affected by these mutations 
were h igh ly conserved across species (Table 3 .3-2) and were pred icted to be 
d isease causing by Polyphen2, S I FT, and Mutation taster. Furthermore , the 
detected m utations segregated with d isease status in the three fami l ies ;  the 
parents were heterozygous, consistent with carrier status, and the avai lab le 
unaffected s ib l ings were homozygous for the wild -type (WT) or  heterozygous 
for the m utation .  Al l  the detected mutations were submitted to the LOVD 
database (www . lovd .n l/JAM3) .  
3.3.3 .3 .  The p .C21 9Y mutation resu l ted i n  JAM3 traff icking defect 
To u nderstand the pathophysiologica l  s ign ificance of the two detected 
non-synonymous mutations (p .E 1 1 6K and p .C2 1 9Y), confocal 
immunofluorescence m icroscopy was employed to esta bl ish their subce l lu lar  
local ization relative to  the wi ld  type (WT)-JAM3 prote in .  HeLa cel ls ,  known to  
lack endogenous expression of  JAM3 [Betanzos et a I . ,  2009] , were e ither 
transfected with ind ividual  JAM3 cDNA constructs (WT, p . E 1 1 6K or p .C2 1 9Y; 
see methods 2 .2 .2 .4  and Appendix A )  or co-transfected with GFP-hRas as  
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marker for the plasma membrane.  The cel ls were then sta ined with anti _ 
FLAG ant ibod ies to visual ize the JAM3 prote in .  The cel ls  transfected with 
JAM3 only constructs were co-sta ined with anti-calnexin polyclonal ant ibodies 
to visua l ize the endoplasmic reticu lum ( ER) network. As shown in panels A-F 
of figure 3 .3-4, the WT JAM3 is predominant ly loca l ized to the plasma 
membrane and co-local ized largely with the GFP-hRas. Sim i lar ly, the 
p . E 1 1 6K mutant is  predominantly local ized to the plasma membrane as 
shown in panels G-L of figure 3 .3-4. In  contrast, the p.C2 1 9Y mutan t  co­
local ized predominantly with the ER marker (calnexin)  and not with GFP­
hRas suggesting its retention with in  the E R  (F igure 3 .3-4, panels M-R). This 
retention was observed a lso in different ce l l  l ines (COS7; Figure 3 .3-5) .  
To further investigate the extent of the trafficking defect caused by  the 
p .C2 1 9Y mutat ion, HeLa cel ls were transfected ind ividua l ly with the WT­
JAM3 and the p .C2 1 9Y constructs. Then these cel ls  were sta ined by an  anti­
ca lnexin antibody and counted using Image J software ( F igure 3 .3-6; 3 .3-7) .  
Several confluent fie lds of f luorescently labeled non-transfected cel ls  ( in 
green) were selected and counted (figu re 3 .3-6) .  I n  these fie lds,  the number  
of  transfected cel ls  sta ined with ant i -FLAG antibodies ( red color) was a lso 
counted ( Figu re 3 .3-6; Appendix-C). The percentage of transfected cel ls 
showing plasma membrane local ization versus ER localization of JAM3 
protein were ca lcu lated and assessed in both the WT and the p .C21 9Y 
transfection experiments ( Figure 3 .3-7) .  Around 96% of the cel ls  transfected 
with the p .C2 1 9Y mutant construct showed ER loca l ization pattern whi le the 
1 4 1 
� N 
Table 3.3-2. Summary of a l l  the m utations detected in  JAM3. 
r- -- - - -
E 
'cDNA 'Protein Genotype Mutation Domain "Conservation likelihood of change change type Pathogenicity 
Norma l CAGGCACTTTGGTAAGATCTCTTC 
Mu tated CAGGCACTTTGTTAAGATCTCTTC 
p.v205 Lfs 1 9bp Insertion leads 
5 c.6 1 2+ 1 G>T" (.p V250Lfs Homozyg Splice site C-termlnus Human CAGGCACTTTGGTAAGATCTCTTC to a frame shift and c.747+ 1 G>T X26) ous Chimp CAGGCACTCTGGTAAGATCTCTT created premature 
Ca t  GGCACTCTGGTAAGATCTCTT tennlnatlon codon 
Mouse CAGGCACTCTGGTAAGA 
--- -
Normal fTAVHKDDSGQYYCI ASNDAGSARCEE 
M u t a t e d  fTAVHKDDSGQYYYIASNDAGSARCEE 
G . ga l l us fHAVHKGDTGRYSCIATNDAGfAKCEE 
Mlsfoldlng of the M . muscu l us fNAVHKDDSGQYYCIASNDAGAARCEG 
Homolyg Non- R . norvegicus FSAVHKEDSGQYYCIASNDAGAARCEG protein leads to ItS 6 c.656G>A p.C 2 1 9Y synonymo Ig-like C2-type C . l upus FSAVHKEDSGQYYCI ASNDAGSARCEE retention In the ous us endoplasmic B . t a u rus fSAVHKEDSGQYYCIASNDAGSARCEE 
H .  sapi ens fTAVHKDDSGQYYCIASNDAGSARCEE reticulum 
P . t roglodytes fTAVHKDDSGQYYC IASNDAGSARCEE 
D rerio fSAVRKEDAGEYYCRAKNEAG I S ECGP 
D . rerio FRSVKKEDAGEYYCQARNEAGWSKC I R  
Norma l TRRDSALYRCEVVARNDRKE I DE I V I E 
Mutated TRRDSALYRCKVVARNDRKE I DE IV I E  
G . ga l l us TRMDTATYRCEVAAPSDTKT I D E I N I Q  
M . muscul us TRSDSAIYRCEVVALNDRKEVDE I T I E  
Homozyg Non- R . norvegicus TRSDSAI YRCEVVALNDRKEVDELT I E  protein-protein 4 c.346G>A p .E 1 1 6 K  Ig-like V-type C . l upus TRTDSALYRCEVVARNDRKE I D E I V I E  ous synonymo interactions defects us B . t a u rus TRKDSALYRCEVVARNDRKE I D E I V I E  
H . sapi ens TRRDSALYRCEVVARNDRKE I D E I V I E  
P . troglodytes TRRDSALYRCEVVARNDRKE I D E I V I E  
D . rerio TRSDSADYRCEVTAPNDQKS FDE I L I S  
D . rerio SRSDTAQYRCEVAAIDDQKPFDE I L I S  
-
Ref. 
Mochlda 
et al 2010 
t--
: 
ThiS 
study 
ThiS 
study 
� 
+:.. w 
Normal MALRRPPRLRLCARLPDFFLLLLFRGC 
Mut a t e d  RALRRPPRLRLCARLPDFFLL::'LFRGC 
a . ga l l us - - - - - - - - - - - MSCA I S YSLLFVFPGC 
Non- M . muscul us MALSRRLRLRLYARLPDFFLLLLFRGC 
1 c.2T>G p.M 1 R  
Homozyg synonymo N-termlnus R . norvegi cus MALSRRLRLRLCARL PDFFLLLLFRGC ous us C . l upus FESVE - - - - - - - - - - - - - - - MAVLQGC 
B t a urus MALRRRPSLVL - - - - - - - - LLLLVRGC 
H . sapiens MALRRPPRLRLCARLPDFFLLLLFRGC 
P . t roglodytes MALRRP PRLRLCARLPDFFLLLLFRGC 
D . rer i o  
---
"Mutation nomenclature IS based on NM_032601 .4 and NP _ 1 1 6 1 90.3 starting from A of the ATG as 1 
'The nomenclature used by Mochlda et al [2010]  based on NM_032601 3 . 
TEHFTDSKMALT PLACVLLLLSMQCYI 
Translation 
aberrations leading to This 
loss or abnormal study 
expression 
- -
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Figu re 3.3-3. The identified m utations in  JAM3. A) Schematic presentation of JAM 3  protein was constructed 
using MyDomains software (http : //prosite.expasy org/mydomains). The figu re shows JAM 3  domains including 
Ig- l ike type V and C2 ,  Transmembrane (TM) and PDZ motif. All the reported mutations in JAM3 are ind icated by 
arrows. Red arrows for the m issense m utations detected in th is dissertation and the grey arrow is designated for 
the spl ice s i te m utation reported by Mochida et a ! .  [201 0] .  B )  Genomic DNA ana lysis of JAM3 In the stud ied 
fami l ies: 1 )  in fami ly 3 a novel homozygous non-synonymous m utation c.2T>G in the affected chi ld but the 
parents were heterozygous carriers compared to a normal contro l ,  2) two affected ind ividuals in fam i ly 2 found 
to have a homozygous m issense m utation c .346G>A. The parents and one unaffected s ib were carriers for the 
m utat ion, 3)  sequencing chromatograms d isplaying the substitution c.656G>A detected in fami ly 1 .  The affected 
ind ividua l  carried the m utation in a homozygous form , whi le the parents were heterozygous carriers . 
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F i gure 3 .3-4. The p .C21 9Y mutation d isrupts normal  i ntrace l l u lar 
JAM3 prote in  loca l ization.  HeLa cel ls  transiently transfected with C­
termina l  FLAG-tagged JAM3-pCMV5 vector constructs wi ld type (WT), A­
F; p . E 1 1 6K,  G-L; and p.C2 1 9Y, M-R and sta ined with anti-FLAG 
monoclonal antibodies (red) WT vector local izes to the plasma membrane 
(PM)  with the hRas-GFP-tagged marker (A-C) and not with the 
endoplasmic reticu l u m  (ER) marker calnexin (green;  D-F) . JAM3-
P E 1 1 6K-FLAG construct local ization was s imi lar to the WT with hRas­
G FP-tagged marker (G-I) and the calnexin (J-L) . The p .C21 9Y construct 
do not local ize at  the PM l ike hRas-GFP-tagged marker ( M-O) and 
aDDears to be accumulated or clustered with in  the ER with ca lnexin ( P-R). 
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Figure 3. 3-5. S ubce l lu lar  loca l ization of FLAG-tagged JAM3-WT and 
JAM3-C 2 1 9Y i n  COS7 cel ls.  WT JAM3 co-loca l izes with GFP-hRas at 
the plasma membrane (PM;  panel a-c) whi le C21 9Y mutated prote in is 
reta ined in the endoplasmic reticu lum (ER) compared to the GFP-hRas 
prote in at  the PM (panel d -f) . 
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Figure 3.3-6. S u bcel lu lar  l oca l ization in  HeLa cel ls of FLAG-tagged 
wi ld -type (WT) and  C21 9Y m utant of JAM3 with d ifferent cel l u lar 
confluency. Most of the m utant prote in fa i ls  to reach the p lasma 
membrane (PM) ,  demonstrating a perinuclear d istr ibution with calnexin ,  
consistent with retention i n  the  endoplasmic reticu lum (ER) regard less of 
the n um ber of the surrounding cel ls .  Representative Images were taken 
at 40X magnification from four independent transient transfection 
experiments . 
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Figure 3.3-7. Comparison between subce l lu lar local ization of wi ld 
type (WT) and C21 9Y m utant of JAM3. C2 1 9Y mutated proteins were 
predominantly reta ined I n  the endoplasmic reticu lum (ER), with 96% co­
local izat ion with ER-ca lnexin and the level of cel l surface or plasma 
membrane (PM)  loca l ization of the C21 9Y-JAM3 proteins was significantly 
reduced compared to that of WT -JAM3 as shown in the bar chart .  
Between 2000 to 4000 cells were counted in multiple fields at  a 40X 
magnifIcation using image J software; values are mean ± SO. 
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WT was found at the cel l  surface of approximately 98% of the transfected 
cel ls ( Figure 3.3-7). 
3.3 .4. D iscussion 
I n  this chapter I have investigated three fami l ies with mu ltiple affected 
ch i ld ren exhib it ing autosomal  recessive H OBSCC. I identified three d ifferent, 
nove l ,  homozygous non-synonymous mutations in  JAM3 gene underlying this 
severe phenotype in  a l l  the stud ied patients. 
3.3.4. 1 .  The i mpact of JAM3 mutations on the prote in  product 
Arrate et al [200 1 ]  and Santoso et al [2002] cloned and characterized 
JAM3 as an approximately 43 KOa transmembrane glycoprotein .  This type I 
integral membrane g lycoprotein consists of two immunoglobu l in ( I g )- l i ke 
domains with i ntrachain d isu lfide bonds at the extrace l lu lar  region . By 
sequence analysis,  Arrate et al [200 1 ]  concluded that the N-terminal  domain 
is a V-type ,  whereas the membrane proximal doma in  is a C2-type. Also they 
predicted that the i ntrachain d isu lfide bonds that stab i l ize each Ig domain a re 
between C53-C 1 1 5  and C1 60-C2 1 9. Ig- I ike domains a re impl icated in a 
range of vita l functions,  inc luding cel l-cel l  recognit ion, cel l-surface receptors, 
muscle structure, and the immune system [Teichmann and Chothia ,  2000] . 
The C- term ina l  region of the prote in is composed of a short transmembrane 
domain fol lowed by an  intracel lu lar  domain conta in ing a POZ binding motif 
( Figure 3.3-3A). 
The p .C2 1 9Y m utation detected in fami ly  1 a lters one of the four  h igh ly 
conserved cysteine residues of JAM3 d isrupting one out of two d isulfide 
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bonds known to stabi l ize the Ig-fo lds of the protein [Arrate et a I . ,  200 1 ; 
Santoso et a I . ,  2002] . Several functional studies demonstrated that cysteine­
substitut ions d is rupt the structure of ce l l  surface proteins causing their  m is­
fold ing ,  instab i l i ty, and ER retention [Fukuda et a I . ,  201 1 ;  Rudarakanchana et 
a I . ,  2002]. Consistent with this,  comparison of the subcel lu lar  local ization of 
flag-tagged C2 1 9Y mutants tranSiently expressed in HeLa ( Figure .  3.3-4 and 
3 .3-6 ) and COS7 ( Figure 3 .3-5) clearly showed that most of the mutated 
protein fa i led to reach the cell membrane. ER retention is a well-establ ished 
d isease caus ing mechanism in many human syndromes caused by loss-of­
function mutations [Aridor, 2007 ;  Ali et a I . ,  20 1 0; 20 1 1 ;  Chen et a I . ,  2005] . 
The p. E 1 1 6K m utation found i n  fami ly  2 d id  not seem to affect the 
subcel lu lar  loca l ization or trafficking of the protein ( Figure.  3 .3-4). However, 
its posit ion in the Ig- I ike V-type domain suggests an interferi ng role of th is 
mutation with the d i merization or with the i nteract ion(s) of this prote in with one 
or more of its i nteracting partners ( Figure 3 .3-3A). JAM3 contro ls T J 
maintenance by engaging in homophi l ic and heterophi l ic  in teractions with 
neighboring JAM molecules [Ebnet, 2008] . 
Arrate et a l  [200 1 ]  and Santoso et a l  [2002] predicted the first ATG by 
homology a l ig nments between JAM3, JAM1, JAM2, and mouse Jam3. Arrate 
et al [2001 ]  found  using SignalP V1 . 1  the s igna l  sequence of JAM3, which 
should be cleaved off after g lycine 30 from the putative ATG. The mutated 
methionine in fam i ly 3 is predicted to be the first methionine of the JAM3 
prote in and such mutations a lmost invar iably interfere with the translation of 
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the prote in ( Figure 3 .3-3) .  However, there are two i n-frames ATG's upstream 
of this sta rt codon and the improbable use of one of them or for the next in ­
frame ATG would encode a non-functional or unstable prote in .  
3 .3 .4.2.  C l i n ical  consequences of JAM3 defic iency 
Mouse Jam3 is expressed at the apical junctions of endothel ia l  cel ls ,  
smooth m uscle cel ls ,  fi broblasts, Schwann cel ls ,  spermatids, and 
hematopoietic stem cel ls  [Mochia et a I . , 20 1 0; Scheiermann et a I . ,  2007] . 
More recently, Jam3 expression was detected in the T Js of neura l  stem cel ls  
i n  the embryonic ventricular zone and the adult  ependymal cell layer of  
mouse b ra in  [Stelzer et  a I . ,  201 2] .  More than ha l f  of  m ice with homozygous 
m utation i n  Jam3 exhib i t  postnatal letha l i ty. Jam3 deficient m ice exhib i t  
g rowth retardation, m uscle weakness, abnormal spermatogenesis,  
g ranu locyte homeostasis defects, e lectrophysiological defects, and 
hypersensi tivity to mechanical  stimu l i  [Colom et a I . ,  201 2 ;  Scheiermann et a I . ,  
2007] . Furthermore, mouse Jam3 apical expression was found on the 
e mb ryonic ret inal  neuroepithel ia ,  and its deficiency caused nuclear congenital 
cataracts [Daniele et a I . ,  2007] . The brains of mice lacking Jam3 are 
abnormal  i n  some stra ins rNYss et a l . ,  201 2] but relatively u naffected in 
others [Stelzer et a I . ,  201 2] .  
I n  humans ,  Mochida et a l  [20 1 0] demonstrated that a homozygous 
m utation i n  JAM3 is  the cause of a severe autosomal  recessive H DBSCC 
syndrome segregating i n  a consangu ineous fami ly.  The affected members in 
th is fami ly  were born with congenital cataracts and developed severe brain 
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a bnormal it ies from progressive hemorrhagic  destruction of the brain t issue, 
inc lud ing the cerebra l  white matter and basal gangl ia .  Three out of six 
affected ind ividua ls d ied early in infancy. Brain imaging in al l  the affected 
ind ividuals showed ca lcification in the subependymal reg ion of the bra in  
m u lt ifocal intraparenchymal hemorrhage with associated l iquefaction , and 
massive cystic degeneration result ing in  large ventricles [AI-Gaza l i  et  a i . , 
1 999;  Mochida et a i . ,  20 1 0) .  The phenotype of the chi ldren in this study is 
very s imi lar  to the phenotype of the affected chi ldren in th is previously 
reported fami ly.  A l l  the affected chi ldren in th is study had bi lateral cataracts 
and develop progressive neurological impa i rment, associated with seizures i n  
some ind iv iduals .  I n  addit ion,  neuroimaging in a l l  patients showed 
intraparanchymal hemorrhage with evidence of bra in destruction and 
subependyma l ,  basal gang l ia ,  and white matter ca lcification.  These changes 
are very s im i la r  to those found in the orig inal  fami ly. Some of the other 
features described in the orig inal  fam i l y, such as renal  anomalies and l iver  
en largement, were more variable in this patient group .  A l l  the affected 
ch i ld ren in th is report died . Therefore, of the tota l 1 0  cases reported so far the 
d i sorder was lethal in  7 cases. Death occurred in the fi rst few weeks of l ife . 
Those who survived (three in tota l )  a re severely retarded with severe 
spast ici ty and seizures. 
Other condit ions that cou ld be cons idered in the d ifferential d iagnosis 
i nclude the syndrome of band- l ike intracrania l  calcification ,  s implified cerebra l  
gyri ,  a n d  polymicrogyria [Abdel-Salam e t  a i . ,  2008; O'Driscoll e t  a i . ,  201 0) . 
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This syndrome is caused by mutations in  another T J gene, occlud in ( OCLN; 
O M I M  *602876). However, patients with this syndrome do not have 
i ntracrania l  hemorrhage or congenital cataract [Mochida et a I . ,  201 0] .  
Furthermore,  the patients here d id not show any evidence of developmental 
ma lformation of the cerebral cortex and polym icrogyria . S im i larly mutat ions in 
col lagen type IV a lpha ( COL4A 1; OM IM*1 20 1 30) can cause overlapping 
cl in ical presentation ,  which include antenatal intracran ia l  hemorrhage [de 
Vries et a I . ,  2009] , bra i n  smal l  vessel d isease with hemorrhage or vascular 
leukoencephalopathy, porencephaly [Gould et a I . ,  2006; Sibon et a I . ,  2007] ,  
and hered itary ang iopathy with nephropathy, aneurysms ,  and muscle cramps 
[Plais ier et a I . ,  2007]. Al l these d isorders are inherited as a utosomal dominant 
and the cl in ical presentations are different from the cases in th is study.  
Prol i ferative vasculopathy and hydranencephaly-hydrocephaly syndrome 
( Fowler syndrome) is an autosomal recessive peri nata l lethal d isorder 
characterized by hydrocephalus associated with progressive destruct ion of 
the centra l  nervous system (CNS) tissue as a resul t  of an unusual and 
characteristic prol iferative vasculopathy [Fowler et a I . ,  1 973]. The ha l lmark of 
the syndrome is the m icrovascu lar prol iferation ,  which is associated with 
extensive necrosis and calcification of the CNS tissue.  There are no visceral 
malformations [Lalonde et a I . ,  201 0] .  I t  is  caused by mutations in the FL VCR2 
gene (OM I M  *6 1 0865). Cl in ical ly affected fetuses present with fetal akinesia 
defo rmation sequence with muscular neurogenic atrophy [Fowler et a I . ,  1 973; 
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Meyer et a I . ,  201 0] ,  which is d ifferent from the c l in ica l  presentation of the 
cases in this study.  
3.3 .5. Conclus ion 
I n  this study, I identified severa l non-synonymous mutations scattered 
throughout the coding sequence of the JAM3 gene affecting d ifferent domains 
of the protein product. However, the affected chi ldren shared s imi lar lethal 
phenotype ind icati ng homogeneity of this d isorder at the cl in ica l  and 
molecular leve l .  This is l i kely due to the tota l loss of the protein function as  a 
resul t  of those m utations. Therefore, this study confirms the importance of 
JAM3 as a component of the j unctional complexes and its deficiency leading 
to a d ist inctive and catastrophic neonatal presentation of cataracts and 
hemorrhagic destruction of the bra in .  Furthermore ,  e lucidation of the genetic 
basis of this d isorder is  of cl in ical benefit to patients and fam i l ies .  
I dentification of pathogen ic mutations can confi rm the c l in ica l  and biochemical 
d iagnosis and can a lso contribute to accurate genetic counsel ing ,  prenatal 
d iagnosis and preimplantation genetic diagnosis .  Molecu lar  characterization 
of this syndrome may a lso provide a basis for the future development of 
effective therapeutic strategies. 
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S E CTION 4 :  LINS a n d  TTC23 a re ca n d i date 
g en es for a utosomal  recessive i nte l l ectua l 
d is a b i l ity 
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3.4. 1 .  Background 
I ntel lectual d isabi l i ty ( 1 0) is  a health condition characterized by low 
inte l l igence and associated l im itations in adaptive behavior. 1 0  is a h igh ly 
heterogeneous cond it ion and one of the most important socio-economic 
hea lth care problems worldwide [Ropers, 2008] .  Molecular karyotyping is the 
fi rst d iagnostic test for congenita l 10 as most severe cases occur due to 
chromosoma l  abnormal it ies [Ropers, 201 0] .  H igh resolution comparative 
genomic hybrid ization (CGH) was developed to detect pathogenetica l ly 
re levant deletions and dupl ications too smal l  to be detectable by conventional 
karyotyping [M i l ler et a I . ,  20 1 0] .  Sequencing , on the other hand , has become 
the method of choice to d iagnose causes of 10 that cannot be expla ined by 
rout ine karyotyping or CGH [Topper et a I . ,  201 1 ] . During the past decade, 
hundreds of defective genes have been identified to be the underlying causes 
of 10 [van Bokhoven et a I . ,  201 1 ] . D ifferent modes of Mendel ian inheritance 
have been reported to cause 10 .  The vast majority of cases were inherited as 
autosomal recessive tra its in consanguineous populations [Ropers, 20 1 0] .  
3 .4.2.  T h e  purpose o f  the study 
Several a utosoma l recessive 1 0  genes have been identified from 
investigat ing consangu ineous fam i l ies us ing the concept of homozygosity 
mapping and cand idate gene sequencing approaches [Cantagrel et a I . ,  201 0;  
Garshasbi et a I . ,  201 1 ] .  and more recently using both homozygosity mapping 
and exome sequencing [Al i et a I . ,  201 2a ,  201 2b ;  Mart inez et a I . ,  201 2 ;  
Schuu rs-Hoeijmmakers e t  a I . ,  201 2] . Therefore, this study was carried out  to 
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d iscover a potentia l ly novel gene causing non-specific 10  of autosomal 
recessive mode of inheritance in two chi ldren from a consanguineous fami ly 
from the UAE . The molecular defect in  th is fami ly  was investigated using 
homozygosity mapping and whole-exome sequencing (WES). 
3.4.3. Resu lts 
3.4.3. 1 .  C l i n i ca l  assessment of patients 
The parents of the two affected chi ldren are Emirati first cousins once 
removed of Yemeni or ig in ( Figure 3 .4- 1 A). They have 2 chi ld ren;  both of them 
are affected by inte l lectual d isabi l i ty. In the fami ly  h istory the father's brother 
had a child who d ied at 6 months of age of unknown cause and a 1 4  year old 
child with intellectual d isab i l i ty of unknown etiology. No further information 
was avai lab le on th is chi ld and we were unable to eva luate her because she 
l ives in  Yemen. 
The fi rst ch i ld of th is fami ly  is a boy and currently aged 9 years ( 1 1 - 1 ; 
Figu re 3 .4- 1 A) .  The pregnancy was compl icated by gestational d iabetes and 
mi ld  hypertension, de l ivery was induced but otherwise was norma l .  H is  b i rth 
weight was 3000 gm but no other measurements were avai lable. The 
neonatal period was compl icated by poor feed ing requ i ring admission to the 
Special Baby Care Unit (SCABU )  for several days. At the age of 9 months he 
was not responding to the mother and was noted to have head nodd ing and 
repetitive rotatory hand movements. The hand movements disappeared but 
the head nodd ing has cont inued t i l l  now. He crawled at the age of 16 months 
and walked at the age 1 9  months but he sti l l  has no speech . He was 
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extremely hyperactive with aggressive destructive behavior for which he 
requ i red medications to calm h im down. There was no h istory of seizures.  
Examination at the age of 8 years revealed a weight of 1 8  kg « 3rd centi le) 
and height of 1 05 cm « 3 rd centi le) ,  and head circumference of 5 1  cm « 50th 
centi le) .  He had a s l ightly flat mid-face with a depressed nasal bridge ( Figure 
3 .4-1 B- 1 )  otherwise no other dysmorph ic features were noted . He was 
cont inuously nodding his head from side to side. His neurologica l  examination 
was normal . EEG and skeleta l survey examinations were reported to be 
norma l .  H is bra in  M R I  showed right frontal lobe vascular malformation with 
cort ical and subcort ica l d istri but ion. No associated cortica l abnormal ities were 
observed . There was no hemorrhage or g l iosis and M R I  Spectrometry was 
normal .  B lood and u rine amino acid and organic acid screening,  thyroid 
function tests, mucopolysaccharides screening,  transferrin isoelectric 
focusing,  very long chain fatty acids and phytanic acids,  Fragi le X mutation, 
MECP2 gene ana lysis were a l l  normal .  CGH m icroarray analysis was normal .  
The second chi ld is  a 3 year o ld  female ( 1 1 -2 ;  Figure 3 .4- 1 A; 3.4-1 B-2). She is 
the product of normal pregnancy and del ivery. Her b i rth weight was 2950 g .  
The mother noted head nodd ing in the first few months of l ife. She was 
hypoton ic and had head lag at the age of 7 months. Al l  her developmental 
mi lestones were delayed . She walked at 20 months of age and she has no 
speech ti l l now. Examination at 7 months revealed m i ld flatten ing of the mid­
face. No other dysmorphic features were noted . Neurological examination 
revealed hypotonia with head lag , side to side head nodding ,  otherwise there 
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F igu re 3.4-1 . C l i n ical  Data of the stud ied fam i ly. A) Ped igree showing 
the mode of inhentance for an autosomal recessive intel lectual d isabi l i ty 
phenotype in  a consanguineous fami ly from United Arab Emirates. The 
studied members are I nd icated by numbers and asterisks. B) 
Appearance of the two affected sibs,  1 )  1 1 - 1  at age 8 years and 2) 1 1 -2 at 
age 3 year. Note the flattening of the mid face. 
A) 
I I  
8) 
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were no other abnormal i ties. EEG showed bi latera l centro-temporal d ischarge 
without general ization.  Her bra in MR I  was normal .  Creatine phosphokinase 
(CPK).  u ric acid . lactate . urine and b lood amino acids and organic acids were 
normal .  Transferrin- isoelectric focusing and very long chain fatty acids and 
phytanic acids were normal .  CGH microarray showed interstit ia l  deletion of 4 
o l igonucleotide probes at 7p22. 1 spann ing approximately 1 97 kb. However .  
testi ng the parents showed that the mother has these changes and the other 
affected ch i ld did not have them,  ind icating that this deletion is not related to 
the phenotype. At 3 years her weight was 1 3  kg (3rd centi le), height 92 cm 
( 3rd centile) and head circumference 48 cm (3rd centi le)  (F igure 3 .4-1 B-2). 
3.4.3 .2 .  Genome-wide l inkage a na lysis revealed fou r  homozygous 
reg ions 
The results of the genome-wide SNP genotyping and l inkage ana lysis  
for the studied ped igree a re i l l ustrated in Tab le 3 .4-1  and Figure 3.4-2 . The 
genotyping data showed four  b locks of homozygosity shared between the two 
affected members of the studied fam i ly (F igure 3 .4-2A). One block mapped to 
chromosome 8 between rs7388 1 1 4 and rs4738955 flanking a 2.5 Mb genetic 
interva l ( 8q 1 2 . 1 -q 1 2 .3 )  ( Figure 3 .4-2B).  The second block of homozygosi ty 
mapped to chromosome 1 0  between rs293303 and rs 1 0994485 flanking a 9 .2  
M b  genetic i nterval ( 1 0q2 1 . 1 -q21 .2 )  ( Figure 3 .4-2C). B locks of  homozygosi ty 
were observed on  chromosome 1 3. which together comprised 1 9 . 9  M b  
genetic intervals  ( 1 3q21 . 2-q33 .3)  ( Figure 3 .4-20, Table 3 .4- 1 ). The last b lock 
of homozygosity detected was found on chromosome 1 5  spanning 3 .8  M b  
1 6 1 
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Table 3.4-1 . I nterva ls of shared homozygos ity between the two affected ind ividuals of the stud ied fami ly. 
C h romosome Start E nd S N P  sta rt SNP end 
Genetic 
i nterva l Length (kb) Genes 
8 60 ,74 1 , 289 63 ,260 , 1 82 rs7388 1 1 4  rs4738955 q 1 2. 1 -q 1 2 .  3 2 , 5 1 8 ,893 1 7  
� 
1 0  53 ,237,721  62 ,487 ,332 rs293303 rs 1 0994485 q2 1 . 1 -q2 1 .2 9 ,249,6 1 1  33 
6 1 ,358, 370 74,891 ,328 rs3 1 1 9852 rs9543569 q2 1 .2-q22 . 1  1 3 ,532,958 
1 3  1 00 ,588,543 1 05,390, 934 rs79945 1 5  rs773354 q32.3-q33 .2 4 ,802 ,391  89 
-
1 07 ,638 ,292 1 09 , 1 7 1 , 572 rs 1 1 6 1 6550 rs 1 1 6 1 8877 q33 .3 1 , 533,280 
1 5  97 ,559,785 1 0 1 ,322 ,542 rs 1 588752 rs 1 1 637451 q26.2-q26.3 3 ,762, 757 24 
Total 35 ,399,890 1 63 
-'---
...... 
0> 
(.V 
F i g u re 3.4-2. Genome-wide homozygosity i n  the studied fam i l y. Genotyping a l l  the fam i ly members using 
Affymetrix S N P  6 . 0  a rray revealed mu lt ip le regions of shared homozygosity between the two affected Sibs A) 
HomozygosityMapper view of the Genome wide homozygosity a nalysis resu l ts (Max homozygosity score' 2000, 
868063 markers). B) Zoom in view into the homozygous region detected on chromosome 8 (q 1 2 . 1 -q 1 2 . 3) , C )  
Zoom in  view into the homozygous region detected on chromosome 1 0  (q2 1 . 1 -q2 1 .2) , D) Zoom in  view into the 
homozygous reg ion detected on chromosome 1 3  (q2 1 .2-q22 . 1 ) , (q32.3-q33.2) and (q33.3) .E )  Zoom in view Into 
the homozygous reg ion detected on chro mosome 1 5  (q26.2-q26.3) .  
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between rs 1 588752 and rs 1 1 63745 1 ( Figure 3 .4-2E) .  The parents were 
heterozygous at a l l  the homozygous segments. 
3.4.3.3 .  Whole-exome sequencing identified two spl ic ing mutat ions in 
L1NS and TTC23 genes 
The co-segregating homozygous segments together encompass 
around 1 63 genes (Table 3 .4- 1 ). In order to reveal the molecular basis of the 
10 in the stud ied fami ly, WES was carried out on the two affected chi ldren .  A 
m in imum of 79. 70% of the on-target regions were covered to a depth of at 
least 20x. Around 45,800 variations from the reference genome were 
identified (Table 3 .4-2) .  Among these 3,500 novel variants were recognized 
and approximately 700 variations i nd icative of serious consequences i n  
cod ing  sequences were found .  Across the variations, 1 60 variants were found 
to be homozygous ,  of wh ich on ly two were shared between the two affected 
ch i ldren .  Both variants were within the same homozygous region on 
chromosome 1 5q26. Both were spl ic ing mutations affecting a spl ice donor in  
L1NS ( N M_00 1 0406 1 6 .2 :  c . 1 2 1 9_1 222+ 1 deIAAAGG) and a spl ice acceptor in  
TTC23 (NM_00 1 040655. 1  :c .456- 1 G> T) ( Figure 3 .4-3, F igure 3 .4-4). Both 
variants were confirmed to be homozygous by Sanger sequencing in the two 
affected ch i ld ren,  heterozygous in parents and not found i n  200 heal thy 
controls with matching ethn ic  origin ( Figure 3 .4-5). 
3.4.3.4.  The two sp l ic ing mutations were confi rmed to be deleter ious 
at the mRNA level of both genes 
To investigate the consequences of the molecular defect caused by the 
detected spl ic ing mutation , reverse transcription-peR was performed 
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Table 3.4-2. Summary metrics of a l l  and novel variants identified by the exome sequencing.  
Number of Variations 
- --
Variations Overlapping Genes 
Variations Overlapping Tra nscripts 
Variations Overlapping Regu latory Reg ions 
Variations Overlapping Prote in  Domains 
I ntergenic Variations 
Variations With Pred icted Serious Consequences 
Variations With Other Predicted Consequences 
Homozygous Variations With Predicted Serious Conseq uences 
"i ncluding those in dbSNP re lease 1 32 .  
¥filtering out those conta ined in dbSNP re lease 1 32.  
r-- -Al l  Va riants 
• 
1 1 1  
45 ,9 1 2 
45 ,565 
45, 565 
9 , 3 1 4  
30, 375 
347 
1 0 ,050 
43, 1 54 
8 1 22 
1 12 
45,795 
45 ,476 
45,476 
9,223 
- -
30, 524 
3 1 9  
9 ,940 
43,039 
8096 
Novel  Va ria ntsT 
1 1 1  1 12  
3 ,658 3 ,424 
3, 596 3, 365 
3, 596 3,365 
876 804 
--
2 ,425 2 ,261 
-
62 59 
-
793 680 
-
3,4 1 8  3,2 1 1 
1 65 1 60 
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Figure 3.4-3. In tegrative Genomics Viewer ( IGV) v isua l ization of homozygous m utation 
c . 1 21 9_1 222+1 deIAAAGG in LlNS gene from exome data . All reads show 5 bp deletion ,  sequence of wi ld type 
gene and exon a nnotation at bottom. The adjacent homozygous substitution G>A (C> T on reverse strand) IS a 
common variant  rs 1 27 1 9734G>A. 
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F igure 3.4-4. I ntegrative Genomics Viewer ( IGV) v isual ization of the second novel mutation detected in this 
study by whole exome sequencing.  A homozygous spl ic ing m utation c .456- 1 G> T has been identified i n  the two 
affected s ibs on Chr1 5 :9975891 9C>A in  TTC23 qene. Read depth= 2 1 8. 
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F igure 3.4-5. Sanger sequencing verification of the 
c . 1 21 9_1 222+ 1 delAAAGG m utation in LlNS gene. DNA sequencing 
chromatograms confi rmed the segregation of the AAAGG ( inside the 
brown square) de letion detected by exome data with the assessed 
phenotype The deletion was found to be homozygous in the patients 
( 1 1 1  and 1 1 2) and heterozygous i n  parents ( 1 1 and 12 ) .  The deletion was 
not found in  1 00 normal controls .  The rs 1 27 1 9734G>A (designated with 
a red star) was found in  all the screened ind ividuals . 
• . . • . . . . . . . . . . . . . . . .  
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us ing tota l RNA isolated from a normal contro l ,  parents and patients' 
leukocytes as templates ( Figure 3 .4-6 ) .  The control sample (Con . ;  F igure 3 .4-
6)  showed mu lt ip le bands at a round 1 000 bp ind icating the presence of 
m ult ip le transcripts for this gene in leukocytes. On the other hand , the two 
patients showed s im i lar  mul t iple bands patterns, a lbeit at lower sizes of 
a round 400 bp ( F igure 3 .4-6- 1 1 - 1  and -1 1 -2) .  The parents showed both the 
upper a nd the lower mu lt iple bands which is consistent with being 
heterozygous carriers for the predictable spl icing a berrat ion ( Figure 3.4-6- 1 - 1  
and -1-2) .  
To fu rther characterize the spl iced products, I gel-purified a l l  the PCR 
products and sequenced them using Sanger sequencing .  The ana lys is 
demonstrated that in  the normal  control the upper band ( 1 0 1 4  bp)  
represented the N M_00 1 0406 1 6 .2  cDNA fragment spann ing from exon 3 to 
exon 6 ( Figure 3 .4-7) .  In add ition ,  the higher band was accompanied by at 
least two bands recogn ized to be a lternatively spl iced transcripts that lacked 
some parts of exon 6 ( Figure 3 .4-8). The exon-intron 5 spl ice defect m utat ion 
present  in  the patients '  gene caused the skipping of exon 5 result ing in a 
smal ler  sized band (423 bp) noted i n  the parents and patients but not in  the 
normal control ( Figure 3.4-7) .  This was also accompanied by bands of lower 
s izes representing m ult iple transcripts for the mutated a l lele ( Figure 3 .4-8) .  As 
ind icated above, these add itional  spl ice variants that lack parts of exon 6 a re 
a lso present i n  the control DNA and therefore not related to the pathogenic 
phenotype. 
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On the other hand , sequening of the TTC23 cDNA in a l l  the fami ly  
members revealed a deletion of  7 nucleotides at the beginning of  exon 7 
( Figure 3 .4-9). The delet ion was pred icted to cause a frameshift i n  the 
nascent transcript introducing a p remature termination codon a nd 
subsequently could be e l im inated by the cel lu lar  nonsense mediated decay .  
3.4 .3 .5 .  The impact of  exon 5 sk ipp ing i n  LlNS on the m R N A  
expression 
To investigate the effect of the identified mutation 
c. 1 2 1 9_1 222+1 deIAAAGG on the expression of LlNS m RNA, total RNA was 
extracted from the leukocytes of a l l  the fami ly members and hea lthy contro ls .  
Subsequent ly, the expression of L lNS m RNA was quantified by real t ime-
peR using specific Taq-man probe spanning exons 3 and 4 of LlNS 
( N M_00 1 0406 1 6 .2 ;  Hs01 089850_m 1 ). The levels of LlNS m RNA were 
unexpectedly more than 2-fold h igher in patients compared to the normal  
controls ( Figure 3 .4- 1 0, Appendices E1  and E2) .  LlNS m RNA expression in  
parents was around 1 -fold higher than a normal control and around 1 -fo ld  less 
than the patients' as expected i n  heterozygous carriers ( Figure 3 .4- 1 0 ,  
Append ices E 1  and E2) .  
Katoh [2002] characterized human L l NS (NP _00 1 035706. 1 )  and 
mouse L ins by their s imi larity with Drosophi la l ines.  The two proteins shared a 
homologous domain with Drosophi la l i nes with the human prote in consist ing 
of 757 amino acids (aa) .  Translating N M_00 1 0406 1 6.2  lacking exon 5 by 
Expasy translate tool  predicted a truncated prote in  lacking 1 97 amino acid 
(p .G lu2 1 1 _Lys407de l ) .  Most of these deleted amino ac ids a re evolutionari ly  
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Figure 3.4-6. Exon sk ipp ing a na lys is by reverse transcr iption-peR.  Agarose gel  of RT-PCR reaction products 
from LlNS eDNA ampl ification in a control (con) ,  parents ( 1 - 1 , 1 -2) and patients ( 1 1 - 1 , 1 1 -2) compared to a DNA 1 00 bp 
ladder (M) .  The gel  showed a - 1 0 1 4  bp band of the wi ld type LlNS transcript encompassing exon 5 in a normal 
control (con) accompa nied with m ult ip le isoforms of varying length (- 1 000 bp).  I n  patients' ( 1 1 - 1 , 1 1 -2) lanes ,  only 
smal ler bands were seen (-400 bp) suggesting a homozygous de letion of a round 600bp. The parents ( 1 - 1 , 1-2) have 
both upper and lower bands suggesting that they carry the 600 bp deletion i n  a heterozygous state. 
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Figure 3.4-7. Schematic d ia g ra m  of the sp l ic ing defect seen i n  patients based on Sanger seq uenc ing data of 
the cDNA. The u pper m ost bands of the h igher and lower bands seen in RT -peR ge l  were purified and sequenced 
This higher band noticed in control and parents was found to include exons 3 ,  4 ,  S and 6. On the other hand,  Exon S 
(ES) was found to be m issing i n  the lower-size band seen i n  both patients and parents. These resu lts suggested that 
the genomic deletion at  the end of ES abol ished a canonical spl ic ing site masking the exon from the spl icing 
machinery which considered it  to be part of i ntron 4 and cut it out of the nascent mRNA. 
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Figure 3.4-8. P roposed a lternative spl ic ing variants of LlNS.  Analyzing the accompanying upper and lower 
bands ampl ified by RT-PCR suggested the presence of at  least 3 L lNS transcripts a lternatively sp l iced in exon 6 
with the putative m ult iple spl ice junct ions are shown . Al l  the lower bands lack exon 5 whi le the upper bands Include 
it  compared to the Ref Seq N M_00 1 0406 1 6 .2 .  
[ Alternati�e Spl icing 
• 
• Sequence of NM_001 0406 1 6.2 
TCAAAATTATTCTTCAGCAAGTGAAGTGAAAG I TTGACTTACAGAGGTTCATGTCTGAGTTACTG 
• Seq uence of Higher bands 
TCAAAATTATTCTTCAGCAAGTGAAATGAAAG I TTGACTTACAGAGGTTCATGTCTGAGTTACTG 
TCAAAATTATTCTTCAGCAAGTGAAATGAAAG I CCCTCTCTGCAATTACACAATCCGTGCAAAT 
TCAAAATTATTCTTCAGCAAGTGAAATGAAAG I AACAAGACGATGACATGCTGGAGGCTGCCA 
• Sequence of Lower bands 
AATCTTTAAAGATTCATGTTCACAGAAAACAG I TTGACTTACAGAGGTTCATGTCTGAGTTACT 
AATCTTTAAAGATTCATGTTCACAGAAAACAG I CCCTCTCTGCAATTACACAATCCGTGCAAAT 
AATCTTTAAAGATTCATGTTCACAGAAAACAG I AACAAGACGATGACATGCTGGAGGCTGCCA 
{t 
F i g u re 3 .4-9. Seq u e n c i n g  res uts of the TTC23 cDNA.  S eq u enc ing 
c h ro matog ram s  showing the homozygous de let ion of  7 n ucleot ides 
ATTTAAG ( ins ide  the b rown square )  in the beg i n n ing of exon 7 of TTC23 
m R N A  i n  the pat ients .  The d elet ion was heterozygous in the pare nts and  
absent i n  a norma l  control . 
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F igure 3.4-1 0.  Express ion analys is  of the homozygous 
c. 1 21 9  _1 222+1 delAAAGG m utation in  L1NS gene. Relative 
quantification (RQ ) of LlNS m RNA level was eva l uated through Real 
t ime PCR.  The expression of LlNS mRNA in the patients' leukocytes 
was found to be around 2-fold higher than its express ion in hea lthy 
controls .  The level of LlNS m RNA in parents was also abnorma l .  LlNS 
mRNA levels were quantified in two healthy controls, the two patients as 
well as the parents in duplicates and in two different experiments. RQ 
values were calculated by the SOS software. The normalized RQ values 
represented in the bar graph are the mean values ± SO. 
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Figure 3.4-1 1 .  Conservation across species of the amino acids that are predicted to be deleted from LlNS protein in 
the patients . The representative al ignments were adopted from NCBI HomoloGene (http://www. ncbi . n lm.n ih .gov/homologene) 
and are showing that this part of L lNS protein is highly conserved sign ifying its importance. 
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conserved across species ( Figure 3 .4- 1 1 ), suggest ing an important role for 
this domain in the protein structure and/or function . Part of the deletion (30 
aa)  l ies within the Drosophi la  l ines homologous domain found by Katoh 
[2002] .  The delet ion a lso included Lys407 which is  found experimenta l ly to be 
a potent ial  regu lator of the protein ub iqu it ination and the subsequent 
regulation of its proteasome-med iated degradation [Kim et a I . , 201 1 ] . 
3.4.4. Discussion 
As mentioned in  the introduction of this chapter, the cl i n ical featu res of 
inherited I D  a re not conclusive and may associate with d ifferent genetic 
defects . Therefore, several stud ies were carried out to map the locus of a 
nonspecific autosomal recessive I D  [for example,  Abou Jamra et a I . ,  201 1 ]  
and to e lucidate the genes underlying I D  [for example ,  Najmabadi et  a i . ,  
201 1 ] . I n  this study, I studied two sib l i ngs, a male a n d  a female with early 
onset I D .  I mapped the d isease locus and identified a novel f ive nucleotide 
homozygous deletion in  LlNS gene and a spl icing mutation i n  the TTC23 gene 
in both patients. The mutation i n  LlNS affects a donor spl ice site lead ing  to 
exon skipping a nd a large deletion in the expressed transcripts. On the other 
hand ,  the mutation in  TTC23 affects an acceptor spl ice site lead ing to a 
frameshift and a premature termination of the corresponding transcri pt .  
However, LlNS has been favored over TTC23 as ind icated in  the next section 
because i t  has been recently reported as a d isease-causing gene for an 
a utosomal recessive ID phenotype in  an I ran ian fami ly  [ Najmabad i e t  a i . ,  
1 8 1 
201 1 ] . However ,  the possible involvement of TTC23 or both LlNS and TTC23 
i n  the phenotype can not be categorica l ly excluded . 
I n  humans,  L lNS was described in 2002 by Katoh as a p rotein 
conta in ing Drosophi la l i nes homologous doma in  [Katoh ,  2002] . The au thor 
detected LlNS 2 .8  kb-transcript ( NM_00 1 0406 1 6 .2 )  in  human feta l bra in  and 
kidney. However, s ince then not many experiments have been performed to 
characterize human L lNS further. However, the association between LlNS 
and autosomal recessive I D  was inferred from two l ines of evidence i n  the 
l iteratu re.  The fi rst clue was deduced from a homozygosity mapping study 
that was performed on 64 Syrian consanguineous fami l ies with autosomal 
recessive ID [Abou Jamra et a l . ,  201 1 ] .  This study has revea led 1 1  novel I D  
loci inc lud ing the locus on chromosome 1 5q23-26 in  one of the stud ied 
fam i l ies. The mapped fami ly  was a b ig fami ly with 8 chi ld ren in  tota l of whom 
5 were exhib i t ing moderate ID, delayed speech and epi lepsy. 
The other evidence of association between LlNS and I D  was noticed in  
another col la borative study that was carried out on 1 36 consangu ineous 
I ran ian fami l ies with autosomal recessive ID [Najmabadi  et  a l . ,  201 1 ] .  The 
authors combined homozygosity mapping and targeted exome sequencing of 
the mapped reg ions to unravel the molecular basis of ID in  these fam i l ies. 
This study has revealed new mutations in  23 genes previously imp l icated in  
autosomal recessive ID ,  and potent ial ly d isease causing variants in  50 novel 
candidate genes inc lud ing LlNS (OM I M*6 1 0350). The authors identified a 
homozygous delet ion of four  nucleotides in  LlNS exon 5 
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( N M_00 1 0406 1 6 .2 :c.985_988deICATG) .  This deletion was predicted to cause 
a frame shift producing a truncated protein (p .H is329*). The mutation was 
found in fou r  affected chi ld ren of consanguineous parents exh ib i ting 
m icrocephaly and ear ly onset 10.  The patients under investigation here had 
no m icrocephaly but showed 10 and head nodding as the only c l in ical 
features. In addit ion the deletion identified in this study in L lNS is a lso 
pred icted to produce a truncated protein that may be functional ly abnormal  or 
structura l ly u nstable .  This might expla in the lack of a negative feedback 
contro l  over LlNS gene expression as seen i n  patients and to a lesser extent 
in  their parents ( Figure 3 .4-1 0) .  Moreover, both mutations affected a l l  the 
three known isoforms of LlNS, whi le other reported frame shift mutations 
p . 05 1 1 Ffs*1  0 ,  p .S594Ffs*6, and p .Q71 7* reported in the exome variant  
data base affected on ly one isoform (Append ix-F) 
In add it ion , TTC23 is a cervica l  cancer proto-oncogene 8 prote in  that 
was found to be associated with cerv ica l  cancer and cervicit is (GeneCards 
data base) .  Consistently, TTC23 and s im i la r  prote ins were predicted and 
demonstrated experimenta l ly  to  be cel l  cycle regulators [Wa rnatz et  a I . ,  2 0 1 1 ;  
Izum iyama et a I . ,  201 2] . I n  add it ion, TTC23 is  not expressed i n  feta l bra in  
( NextBio database .com). Yet, the TTC23 can not  be excluded as a candidate 
for the 1 0  phenotype in  th is fami ly  or any other less o bvious cosegregat ing 
phenotype. 
3.4.4. 1 .  L ines/L1 N S  i s  important for segment polarity i n  Drosophi la  and 
p lays a putative dual  role in  WNT canon i ca l  pathway 
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LlNS (fo rmerly known as WINS 1 or LlNS 1)  is the human homologue of the 
Drosophi la segment pola rity gene lin [Katoh , 2002] .  Li nes is the protein 
product of lin which was or ig ina l ly identified in Drosophi la melanogaster in  the 
1 980s [Nusslein-Volhard and Wieschaus, 1 980; Nusslein-Volhard et a I . ,  
1 984]. Drosophi la studies revealed that l ines is a n  essential protein  for 
pattern ing and morphogenesis of Drosophi la dorsal epidermis [Bokor and 
DiNardo, 1 996; Hat in i  et a I . ,  2000; Hat in i  et a I . ,  2005] ,  h indgut [ Iwaki et  a I . ,  
200 1 , Green e t  a I . ,  2002; Johansen e t  a I . ,  2003] and  muscles [Vol k  and  
VijayRaghavan ,  1 994] . L ines was a lso found to  play an important role i n  the 
development of Drosophi la wings [Nusinow et a I . ,  2008; Ben itez et a I . ,  2009] , 
and testis [D iNardo et a I . ,  201 1 ] . Lines is bel ieved to be a transcript ional 
regu lator, p laying a d ua l  ro le as both a n  activator and repressor of 
downstream target genes l isted in  Table 3 .4-3 [Hat in i  et a I . ,  2000, Iwaki et  a I . ,  
200 1 ] . Hatin i  e t  a l  [2000] demonstrated that l ines i s  essential for late wg 
s igna l ing activity in  the developing dorsal epidermis ,  acting downstream of 
a rm but upstream of wg target genes ( Figure 3 .4- 1 2 ). The author showed that 
with wg signa l ing ,  l ines accum ulates in  the nucleus to modulate transcription 
of wg and ve (vein less) that a re known ta rgets of wg s igna l ing .  The a uthor 
a lso proved that there is an interaction between l i nes and Drosophi la 
hedgehog (hh) which exports l i nes from the n ucleus to the cytoplasm 
a ntagonizing wg s igna l ing .  During Drosophi la embryogenesis, l ines was 
found to be impl ica ted in dorsa l muscle patterning by regulati ng g roovin 
expression [Volk  and VijayRaghavan ,  1 994] . In the developing h indgut, Iwaki 
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et a l  [200 1 ]  demonstrated that l ines promotes the expression of genes of the 
large i ntestine (otp, dpp, en, and dn), a nd represses the expression of genes 
of smal l  intestine ( hh, upd, and ser). Castel l i -Ga i r  [ 1 998] proposed l ines to be 
a transcriptional  cofactor for Abdomina l-B for the activation or repression of its 
downstream target genes. These genes include cut that represses a neura l  
cel l fate , spa/t that affects the development of  the fly's g ut ,  and  ems which i s  
necessary for proper head formation and  is a lso involved in  bra in  
morphogenesis (http ://flybase.org/) [Castel l i-Gair, 1 998]. I t  was shown that 
l i nes is part of a molecular regu latory pathway composed of d rm ,  an inh ibitor 
of l ines by export ing i t  to the cytoplasm, and bowl a downstream target of 
l ines in  the n ucleus [Hat in i  et a i ,  2005] . In teresting ly i t  was observed that, hh 
promotes drm expression , whi le wg represses d rm expression regu lat ing the 
d rm/l ines/bowl pathway which consequently regu lates the pattern ing and cel l  
rearra ngement i n  the Drosophi la embryon ic epidermis, foregut, h indgut ,  
gonads and imagina l  d isc [ Iwaki et a i . ,  2001 ; Hat in i  et a i . ,  2005 ; Nusinow et 
a i . , 2008;  D iNardo et a i . ,  201 1 ] . I n  the developing wing ,  Ben itez et a l  [2009] 
noticed that bowl protein  represses Wg pathway and activates Notch ( N )  and 
H h  pathways. Therefore, they concluded that l ines is essential for normal 
function ing of Wg/wNT, Hedgehog (Hh )  and Notch (N) pathways d u ring 
embryogenesis i n  Drosophi la .  I n  the Drosophi la test is ,  l i n  mutant cel ls  were 
not d ifferent iat ing in to cyst stem cel ls  (CySC) and expressed n iche cel l  fate 
markers hh and cactus [D iNardo et a i . ,  201 1 ] . The observation suggested that 
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Table 3.4-3. The reported downstream target genes of l ines in  Drosophi la .  
Gene name Gene Tissue! U plDow Human Putative roles in the development of the central 
symbol System n homologue nervous system in vertebrates 
.-
wingless wg Dorsal Epidermis Up WNT1 WNT1 protein involved In the proliferation and 
differentiation of neural  progenitors Wnt1 deficient 
m ice embryos have showed severe abnormalities In 
the development of the midbrain and cerebellum. 
rhomboid rho (ve) Dorsal Epidermis Down PARL This gene encodes a mitochondrial Integral 
membrane protein that plays an Important regulatory 
role In mitochondria l-mediated apoptosls Pari 
knockout mice undergo progressive multl-llssue 
atrophy, including atrophy in the thalamus and 
striatum, mediated by Increased apoptosls. 
orthopedla otp Hindgut Up OTP This gene encodes a homeodomaln-contalnlng 
transcription factor that IS Implicated In the 
development of the brain, specifically 
hypothalamus, In vertebrates. Otp knockout mice 
displayed progressive Impairment of crucial 
neuroendocrine developmental events. 
decapentaplegic dpp Hindgut Up SMAD3 This protein funcllons as a transcriptional modulator 
thought to play a role In the In neural stem cells 
where it IS essential to activate TGF�-responslve 
genes activating the neural developmental program. 
engralled en HindguVPosterior Up EN1 and Both genes encode homeodomain-conta ln lng 
spiracles EN2 transcription factors that have been Implicated In the 
control of mid-hindbrain pattern formation dUring 
embryogenesIs. E n 1  defiCient mice lack most of the 
cerebellum and midbra in ,  whereas En2 mutants 
survive with cerebellar defects. 
retained retn (dri) Hindgut Up -
hedgehog hh Hindgut Down SHH ThiS gene encodes a protein that IS crUCial In 
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outstretched 
Serrate 
Brother of odd 
with entrails 
l imited 
Cut 
Spalt major 
empty spiracles 
Stripe or Groovin 
Cactus 
as 
(upd) 
ser 
bowl 
ct 
salm 
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sr 
eael 
H indgut Down -
Hlndg�t r-oown-- JAG2 .-
Dorsal epiderm is! Up -
foregut! hindgut! 
gonads! Imaginal 
disc 
Posterior Up -
spiracles 
Posterior Up -
spiracles 
Posterior Up EMX2 
spiracles 
Dorsal epidermis! Up -
muscle 
Testis Down NFKBIA 
patterning and cell-fate specification, particularly In Komada, 20 1 2] 
the central nervous system. SHH plays different roles 
depending on Its concentration, area,  and t iming of 
exposure .  
[Iwakl et  ai , 200 1 ]  
The encoded protein is one o f  several l igands that I-:-[Iwakl et ai ,  200 1 ,  
activate Notch and related receptors I t  was found In Sander et al  2003. 
most neuron subtypes. Notch Signaling plays a Stump et a i , 2002,  , 
pivotal role In the regulation of vertebrate Mead and Yutzey, 20 1 2] neurogenesis and brain development. 
[Hatlnl et a l  , 2005] 
[Castelil-Galr, 1 998) 
[Casteill-Galr, 1 998] 
The encoded protein IS expressed in  the dorsal [Casteill-Galr, 1 998, 
telencephalon dUring development and IS Involved In Yoshida et a l. , 1 997, 
reg ional patterning of the neocortex Into defined Zembrzyckl et a I . ,  2007] 
functional areas. Emx2 deficient mice displayed 
defects In archipall ium structures that are believed to 
play essential roles in learning, memory and 
behavior. 
[Volk and 
V�ayRaghavan, 1 994 
This gene encodes a member of the nuclear factor- [DINardo et a I . ,  201 1 ,  
KB ( N F-KB) inh ib itor family that IS Involved In Bredel et a I . ,  201 1 ,  
inflammatory responses. N F-KB pathway plays a Roussos et a I . ,  20 1 3] 
Significant role In neurite outgrowth, actlvlty-
dependent plastiCity, and cognitive function. N FKBIA 
is often deleted in gl ioblastomas. 
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Figure 3.4-1 2.  Li nes/LiNS plays a putative dual  role i n  WNT canon ical  pathway. I n  WNT canonical pathway, 
the a bsence of a s ignal  leads to the hyper-phosphorylation of a rm/CTNNB1  leading to i ts ubiqit ination and 
degradation by the proteasome in the cytoplasm. Binding of wgIWNT1 l igand to an Fz and arr/LR P  receptor 
complex leads to stabi l ization of hypo-phosphorylated arm/CTNN B 1 ,  translocati ng i t  to the n ucleus. In the nucleus, 
a rm/CT N N B 1  competes with and d isplaces grolTLE interacting with panlTCF proteins to activate transcript ion. In 
Drosophi la ,  l ines/L iNS was found to act as a modu lator of wglWNT canonical pathway acting in para l lel with or 
d ownstream of arm/CTNNB1  in response to wgIWNT1 s ignal ing to enhance or represses the transcription of target 
genes. Frizzled ( Fz) ,  a rrow (arr) , LDL receptor-related prote in (LRP) ,  armal l ido (Arm) ,  f3-caten in (CTN N B 1 ),  groucho 
(gro) ,  tra nsdu cin- l ike enhancer of spl i t  (TLE) ,  pangol in (pan) ,  T -cel lfactor (TCF) .  
arr/L R P  F z  
Cytosol 
Nu cleus 
.�  
l ines represses n iche fate and promotes CySC fate antagonizi ng Bowl and N 
pathways which promotes n iche cell fate. 
3 .4.4.2.  LlNS i n  the cogn it ive pathways 
N umerous stud ies have revealed that correct corticogenesis is a n  
outcome o f  the interplay between mu lt iple s ignal ing pathways includ ing 
WgIWNT, Hedgehog (Hh )  and Notch ( N )  pathways [Lei et a I . ,  2006; Tang et 
a I . ,  201 0; U l loa and Mart i ,  201 0; Dave et a I . ,  201 1 ;  Roussel and Hatten ,  201 1 ;  
Marei  et a I . , 20 1 2 ; Wilson and Stoeckl i ,  20 1 2] .  This crossta lk  provides 
m itogen ic s ignals ,  posit ional information ,  migratory cues and d ifferentiat ion 
s ignals [Dave et a I . ,  201 1 ] . In add it ion , the coord inated interaction between 
these crit ical pathways is a prerequ isite for the precise regulat ion of 
symmetric/asymmetric d ivision d uring neurogenesis in the developing 
vertebrate centra l  nervous system (CNS) .  Many of these pathways were fi rst 
identified i n  genetic studies in Drosophi la [Roussel and Hatten ,  201 1 ] . 
Mamma l ian orthologs were subsequently identified and genes with i n  the 
pathways have been cloned and stud ied .  However, the exact outcomes of 
these i nteractions a re not fu l ly u nderstood .  In addit ion, not all the interactive 
p layers or factors that affect the number and type of d ivisions that a 
neocortica l progenitor ce l l  undergoes are known 
I n  Drosoph i la ,  l ines ( the homologue of L lNS)  has been recognized to 
be a t issue- and a stage-specific modulator of wing less s ignal ing [Hat in i  et  a I . ,  
2000] . L ines was found to b e  activated b y  Drosophi la wingless (wg) [Hat in i  et 
a I . ,  2000] . Wing less-type M MTV integration site fam i ly-1 (WNT1 ) i s  the 
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human homologue of the Drosophi la wg and its d iscovery led to the 
subsequent elucidation of the WNT pathway [Saito-Diaz et a i . ,  20 1 2] .  The 
activation of the canonical winglessIWNTsignal ing pathway occurs through 
the b ind ing of wgIWNT l igand to the seven-pass transmembrane Frizzled ( Fz) 
receptor and its co-receptor, the a rrow (a rr)/Iow-density l i poprotein receptor 
related prote in  ( LRP) ( Figure 3 .4-1 1 )  [MacDonald and He, 20 1 2) .  This b ind ing 
stab i l izes the cytosol ic  co-activator armadi l lo  (arm)/I3-catenin 1 (CTNNB1 ) and  
i ts trans location to  the nucleus [Saito-Diaz et a i . ,  201 2] .  Thus, lead ing  to 
competitive d isplacement of g roucho (gro)/transduci n - l ike enhancer of spl i t  
(TLE) from the transcription factors pangol in (pan)ff cel l -specific transcript ion 
factor (TCF) i n i t iat ing the transcription of the pathway target genes. WNT1 is 
secreted from a signa l ing center located at the boundary between prospective 
mid and h indbra in  (mid-h indbra in  boundary) and med iate development of 
these two bra in  regions [Wittmann et a i . ,  2009] . Disturbed WNT pathways d ue 
to inherited m utations in  posit ive and negative regu lators of s ignal ing have 
been reported to cause autosomal recessive 10 [Ekici  et a i . ,  20 1 0; Buchman 
et a i . ,  201 1 ) . Therefore, my fi nd ing that  a mutation i n  a nother regulator of  the 
WNT s igna l ing pathway is responsible for a form of recessive 1 0  further 
i l l ustrates the importance of this pathway i n  human cogn it ion a nd/or b ra in  
development.  
3 .4.5.  Conclus ions 
I nherited 10 cond it ions a re a g roup of genetica l ly heterogeneous 
d isorders that lead to variable degrees of cogn it ion deficits. I t  has been shown 
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that inherited 1 0  can be caused by mutations in  over 1 00 d ifferent genes and 
there is evidence for the presence of  as yet un identified genes in  a sign ificant 
proportion of patients . Therefore, I a imed in  this study to identify the defective 
gene u nderlying an autosomal  recessive 10 in two sibs of an Emirati fam i ly. 
Using a combined approach involving homozygosity mapping and 
whole-exome sequencing have identified two possible d isease-causing 
genes (UNS and TTC23). The detected mutations in  both genes were 
demonstrated to be damaging to the m RNA. However, fly studies and h u ma n  
m utat ions suggested L l N S  a s  the most l ikely causative. However, more 1 0  
cases are needed to confi rm pathogenicity. 
The d i rect benefit of these find ings is to faci l itate the prenatal and pre­
i mplanting d iagnosis for th is consangui neous couple to have a healthy ch i ld . 
I n  add it ion,  this study shed l ight on new genes in  the cognit ion pathway and  
fu rther h igh l ights the  importance of  WNT pathway in  cogn it ive development.  
Future identi fication of L lNS mutations may expand the phenotypic spectru m ,  
provide further ins ight i nto genotype-phenotype correlations a n d  fac i l i tate 
molecular investigation of the consequences of L lNS dysfunction .  
U n derstand ing L lNS-related d isease mechanisms may then faci l itate the 
development of novel therapeutic strategies. 
1 9 1 
S E CTION 5 :  C h a racteriz ing the ge netic bas i s  
o f  a c l i n i ca l ly h eteroge nous a utosomal  
recess ive con g e n ita l m uscular  dystro phy i n  a 
h i g h ly i n bred Ara b  fa m i ly 
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3.5. 1 .  Background 
Congeni ta l muscular dystrophy (CMD) is a cl i n ica l ly and genetical ly 
heterogeneous group of inherited m uscle d isorders [for review see Bert in i  et 
a I . ,  20 1 1 ] .  CMDs are present at b i rth. Affected i nfants typica l ly have severe 
hypoton ia ,  weakness, feeding difficulty ,  and respiratory insufficiency. Jo int  
contractures can be present at b i rth or develop as muscles weaken .  Spina l  
r ig id i ty and later on sp ina l  deformity such as scol iosis a re com mon 
manifestations i n  the affected chi ld ren .  Muscle weakness is progressive .  
I nfants may d ie early due to  respiratory or feeding problems. 
The classification for the CMD subtypes is mainly based o n  the gene in  
wh ich d isease-causing mutations occur and the protein  encoded by that  gene 
[Sparks et a i . ,  2001 ; Bert in i  e t  a I . ,  201 1 ] . The main subtypes of CMD a re :  1 )  
Lam in in -a2-deficient CMD ( M D C 1 A) ,  2 )  Col lagen VI-deficient C M D ,  3)  
Dystroglycanopathies, 3) SEPN1-related CMD (previously known as  r ig id 
sp ine syndrome,  RSM D 1 ) and 4) LMNA-related CMD ( L-CMD).  Severa l less 
common CMD subtypes have been reported in  a l im i ted number of ind ivi dua ls 
with u n identified molecular cause. Most of the CMD subtypes are recessive ly  
inherited yet dominant i nheritance is a lso establ ished in  some subtypes.  
A phenotypic classification for the CMD subtypes can be a lso used 
with cogn itive impairment rang ing from severe menta l  retardation to m i ld  
developmental delay, structural bra in  and/or eye a nomal ies, and seizures a re 
fou nd a lmost exclus ively in  the dystroglycanopathies [Sparks et a I . ,  200 1 ] .  
Whi le ,  lamin in  a lpha-2-deficient CMDs are characterized b y  white matter 
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abnormal it ies without major cogn itive involvement [Sparks et a I . ,  200 1 ] .  
However, the phenotypes o f  the C M D  subtypes overlap significantly even 
though the genetic defect may d iffer. Also mutations in one of the so far 
identified CMD genes can be associated with a spectrum of cl i n ical 
phenotypes. 
3 .5.2 .  The purpose of the study 
Accurate diagnosis of CMD subtypes has proven d ifficu lt because of 
their  c l in ical and genetic heterogeneity [Valencia et a I . ,  201 3] . Also, many 
CMD patients do not have a mutation in  one of  the known genes, mean ing 
that many more genes could be involved [Valencia et a I . ,  201 3] . Therefore ,  
this study was in itia l ly performed to  identify an anticipated novel gene 
u nderlying a n  autosomal recessive CMD in a consanguineous fam i ly from the 
UAE . 
3.5 .3 .  Resu lts 
3 .5 .3 . 1 .  C l i n ical  assessments of patients 
The parents of the affected chi ld ren in  this fami ly a re fi rst cousins from 
Sudan .  They have a total of s ix chi ldren ;  two of them are affected ( Figure 3 .5-
1 ) . The parents are norma l .  I n  the fami ly  h istory the mother's s ister who 
m arried her cousin had ten chi ldren ;  six of them d ied early i n  infa ncy of 
u n known reasons .  No further information was avai lab le on these chi ld re n  and 
we were unab le to evaluate them because they l ive in  Sudan .  
The i ndex case ( 1 14)  is  a g i rl .  She is the product of  a normal pregnancy 
with normal term del ivery. A large head was d iagnosed prenatal ly. Her b i rth 
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weight was 3000 g (25th percenti le) .  At b i rth a large head was confirmed with 
a head circumference of 36cm (75th percenti le) .  She was a lso noted to have 
a nystagmus and b i lateral cataract which was operated on .  Developmental 
delay and hypotonia were noted in  the first year of her l ife . In add it ion , there 
were genera l ized seizures which were control led with anticonvu lsants.  
Eva luation at the Genetic Cl in ic at the age of 5 years revealed a head 
circumference of 52 .7  cm (90th percent i le) ,  hypotonia with contractu res of  the 
knee, ankle, e lbow, wrist and interphalangeal jo ints and severe psychomotor 
retardat ion . 
The sister of the index case ( 1 1 -3) is a lso the product of a normal  
pregnancy and del ivery. Her b irth weight was 3000 g (25th percenti le) .  She 
was noted to have a left sided cataract which was operated on in  the fi rst year 
of l ife . At two weeks the chi ld developed left s ided seizures which responded 
to anticonvulsants. Evaluation at the age of 1 0  years revea led a severely 
g lobal ly retarded g ir l ,  wheelchair bound with contractu res of most large  and 
smal l  joints. Her creat ine phosphokinase (CPK) was e levated . The magnetic 
resonance imaging ( M R I )  of the bra in  at  the age of 1 3  years showed severa l  
structural bra in  abnormal it ies. The corpus cal losum was hypoplastic and there 
was d iffuse g l iosis with in  the fronto-temporal lobes. There was a d i latat ion of 
all ventricles with a decrease in the amount of white matter. The posterior 
cran ia l  fossa was shown to be enlarged with cystic formation widely 
communicat ing with the fou rth ventricle. The cerebel lum and vermis  appeared 
hypoplastic. 
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Fig ure 3.5-1 . Ped igree of the stud ied fam ily. The Pedigree is showing the mode of inheritance for an autosomal 
recessive congenital m uscular dystrophy phenotype in  an Ara b  consanguineous fam i ly. 
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3 .5.3 .2 .  Molecular  genetic i nvestigations 
3 .5 .3 .2 . 1 . Homozygos ity mapping analys is  revea led mu lt ip le 
homozygous reg ions across the genome 
The results of the genome-wide SNP genotyping and l inkage ana lysis 
for the studied ped igree are shown in  figure 3 .5-2, figure 3 .5-3 and table 3 .5-
1 .  The genotyping data showed n ine blocks of homozygosity shared between 
the two affected members of the studied fami ly ( Figure 3.5-2). The biggest 
homozygous block was observed on chromosome 1 between rs 1 2066 1 9 1  and 
rs 1 7091 690 flank ing a 30 M b  genetic interval ( 1 p34.2-p3 1 . 1 ) ( Figure 3 .5-3) .  
Two b locks of homozygosity were noticed on chromosome 2 with one of them 
located between rs980857 1 and rs 1 29939 1 1 flank ing a 7 M b  genetic i nterval 
(p 1 5-p1 3 .3)  (Table 3 .5- 1 ). The other stretch of homozygosity on chromosome 
2 was less than 1 M b  (2p25 . 1 ). Three b locks of homozygosity were seen on 
chromosome 7 ,  with the b iggest one of them (-7 Mb) bordered by rs6466076 
and rs82 1 783 (7q22.3-q31 . 1 ;  Table 3 .5- 1 ) . Another homozygous reg ion (-1 .6  
M b )  was observed on chromosome 19  between rs 1 1 084444 and rs 1 6988328. 
The last block of homozygosity detected was found on chromosome 2 1  
spanning 3 . 9  M b  between rs9636576 and rs8 1 27726 (Table 3 .5- 1 ) . The 
parents and al l the unaffected sibs were heterozygous at al l the homozygous 
segments. 
3.5.3.2.2 .  Whole-exome sequencing revea led a novel nonsense mutation 
in POMGNT1 gene 
The co-segregating homozygous reg ions together encompass a round 
469 genes (Table 3 .5- 1 ) . I n  order to  reveal the molecular basis of  the 
phenotype in  the stud ied fami ly, WES was carried out on the two affected 
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chi ld ren .  A min imum of 79.70% of the on-target regions were covered to a 
depth of at least 20x. Around 49,000 variations from the reference genome 
were identi fied (Table 3 .5-2). F i ltering out al l  the common SNPs reduced the 
number to 4,365 novel variants generated from each exome. Of these novel 
varia nts, 900 were found in cod ing sequences with serious consequences. 
Approximately 700 variants were homozygous, of which on ly one stop gained 
m utation was identified in POMGNT1 gene (NM_00 1 243766 . 1 :  c . 1 462 C>T; 
p .Arg488*) ( Figure 3 .5-4). Mutations in this gene are known to cause C M O ­
dystroglycanopathies. The mutation was novel , a n d  pred icted t o  cause the 
complete loss of the protein  product by M utation Taster. Moreover, screen ing 
a l l  the fami ly members showed that  the mutation segregated wi th the 
phenotype ( Figure 3.5-5). In carrier screening,  the parents and al l the 
u naffected s ibs were carriers except one ind ividual ( 1 15) .  
3.5 .4. D iscussion 
In  th is chapter, I have characterized the genetic basis of vague cl in ical 
features of an a utosoma l  recessive C M O  with bra in  a nd eye abnorma l i t ies i n  
two affected chi ldren in  a Sudanese extended fami ly .  I mapped the d isease to 
specific chromosomal 1 loci ( 1  p34.2-p31 . 1 )  us ing homozygosity mapp ing 
approach . I n  add ition ,  I found that the phenotype is associated with a 
homozygous loss-of-funct ion mutation i n  the POMGNT1 gene by investigat ing 
the exomes of the two affected chi ld ren.  Combin ing th is genet ic find ing with 
the c l in ica l  features of the stud ied patients, the broad d iagnosis of C M O  was 
refined into a specific phenotype of POMGNT1-related CMO-
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Table 3.5-1 . Intervals of shared homozygos ity between the two affected ind ividua ls of the studied fami ly. 
Chromosome Sta rt End S N P  sta rt S N P  end Genetic interval Length (kb) Genes 
1 42 , 1 65, 1 3 1 72 , 1 95 ,7 1 5  rs 1 2066 1 9 1  rs 1 709 1 690 p34 .2-p3 1 . 1  30, 030,584 2 1 9 - .  - - r--- -62,666, 1 78 70 ,01 1 ,952 rs980857 1 rs 1 29939 1 1 p 1 5-p 1 3.3 7 ,345 .774 
2 
1 1 , 540,489 1 1 , 76 1 ,309 rs4669727 rs2304401  p25. 1 220,820 
5 1  
1 6 1 1 54 1 3  1 64 1 2625 rs 1 0277 1 5 1 rs 1 0253784 p2 1 .2 297 ,2 1 2  
7 --
1 05478527 1 1 2469778 rs6466076 rs82 1 783 q22.3-q3 1 . 1  6 ,991 ,251  5 1  
1 56762248 1 58054285 rs 1 29 1 9  rs 1 3222 1 49 q36.3 1 ,292 ,037 
1 2  1 1 5939302 1 1 9530488 rs 1 1 83496 1 rs 1 1 064657 q24 .21 -q24.23 3 ,591 , 1 86 23 -
1 9  5681 7035 5849 1 733 rs 1 1 084444 rs 1 6988328 q 1 3.43 1 ,674,698 73 
2 1  28563550 325 1 4524 rs9636576 rs8 1 27726 q2 1 .3-q22. 1 1  3 ,950,974 52 
Total 55 ,394,536 469 
I\) o o 
F igure 3.5-2.  HomozygosityMap per  v iew of the Genome wide homozygosity analysis results .  Genotyping all 
the fam ily members using Affymetrix S N P  6 . 0  a rray revealed mult ip le regions of shared homozygosity between the 
two affected sibs.  
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Figure 3.5-3 . Zoom i n  v iew into the homozygous reg ion detected on chromosome 1 .  The b lock of 
homozygosity on chromosome 1 was spann ing 30 Mb genetic Intervals  ( p34.2-p3 1 . 1 )  and flanked by 
rs 1 2066 1 91 and rs 1 7091 690 e ncompassing 2 1 9  genes. 
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Table 3.5-1 . Summary metrics of a l l  and novel varia nts identi fied by the exome sequencing.  
r- f Al l  Va ria nts 
1 13 1 14 
N umber of Variations 48,920 49,35 1  
--
49,002 Variations Overlapp ing Genes 48,544 
Variations Overlapping Transcripts 48,544 49,002 
Variations Overlapping Regu latory Regions 9 ,9 1 1 9, 964 
Variations Overlapping Prote in  Domains 32 ,553 32 ,858 
Intergenic Va riations 376 349 
Variations With Pred icted Serious Consequences 1 0 ,604 1 0 ,689 
Variations With Other Pred icted Consequences 45,989 46 ,400 
Homozygous Variations With Pred icted Serious Consequences 1 0 , 1 57 1 0 ,245 
-- --- ----- ---
' i ncluding those in  dbSNP re lease 1 32.  
¥fi lteri ng out those conta ined in dbSNP release 1 32 .  
-
Nove l Varia ntsT 
1 13 1 14 
4,365 4 ,365 
4 ,295 
-
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1 ,096 1 ,058 
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933 9 1 1 
-
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Figure 3.5-4. I ntegrative Genomics Viewer ( IGV) v isual ization of homozygous m utation c . 1 460 i n  POMGn T1 
gene from exome data. All reads show the homozygous substitution of G>A (C> T on reverse strand) and the 
changed amino acid a rg in ine (R) at  the bottom.  
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F i g u re 3 .5-5. M utati o n  a n a lys is  res u l ts i n  the studied fam i ly.  Novel 
m issense m utat ion was found c . 1 462C>T in  POMGn T1 in al l  the affected 
ch i l d ren in a homozygous form . The same m utation was found  to be 
h eterozygous in parents a nd some u naffected ch i ld ren .  The m utation 
was not detected in norma l  affected sibs or in normal healthy Arab 
controls .  
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dystroglycanopathies with bra in  and eye anomal ies. 
3.5.4. 1 .  Genetic heterogeneity of C MD-dystrog lycanopathy w ith bra i n  
a n d  eye anomal ies 
Dystroglycanopathies with bra in  and eye a nomal ies is a g roup of 
genetical ly heterogeneous autosomal recessive d isorders that can be caused 
by mutations in severa l genes involved in the a lpha-dystroglycan (a-DG) 
g lycosylation pathway. I ncluding the POMT2 gene (OM I M*607439) ,  
POMGNT1 gene (OM IM*606822) ,  FKTN gene (OM I M*607440), FKRP gene 
(OM I M *606596), LARGE gene (OM IM*603590),  ISPD gene (OM IM*6 1 4631 ), 
G TDC2 gene (OM I M*61 4828) ,  TMEM5 gene (OM IM*605862), B3GALNT2 
gene (OM I M*6 1 0 1 94),  SGK196 gene (OM I M*6 1 5247) and B3GNT1 gene 
(OM I M *605 5 1 7) .  The un ifying feature i n  a l l  these d isorders is deficient post-
tra nslat ional g lycosylation of a-DG on the sarcolemma of skeletal m uscle 
fi bers . a-DG is a heavily g lycosylated , peripheral membrane prote in  that 
d i rectly b inds ,  probably through its sugar cha ins ,  to the a lpha-2 chai n  of 
lamin in-2 ( lamin in-a2; an extracel lu lar  matrix prote in )  and to beta-
dystroglycan (I1-DG). I1-DG is a transmembrane prote in  that b inds to 
dystrophin protein which in turn b inds to the i ntrace l lu lar  actin fi laments 
[ I b raghimov-Beskrovnaya et a I . ,  1 992] . The dystroglycan complex works as a 
tra nsmembrane l inkage between the cytoskeleton of the muscle fiber and the 
surrounding extrace l lu lar  matrix [ I braghimov-Beskrovnaya et a I . ,  1 992] . DG 
hypoglycosylation was found to d i rectly abol ish the b ind ing activity of the 
protein with i ts several extracel lu lar matrix l igands such as lamin in -a2 
(OM I M* 1 56225) ,  neurexin (OM I M*600565), and agri n  (OM IM*1 03320) 
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[Michele et a l . ;  2002] . Neurexin and agrin prote ins a re known to be involved in  
synaptic s ignal ing of nerves and muscles neurons [Gingras et  a I . , 2002; 
Reissner et a I . ,  2008] . 
3 .5.4.2.  C l i n ica l  heterogene ity of C M D-dystrog lycanopathy with bra in  
and eye anomal ies 
To date i n  OM IM there are at least 1 2  congenita l  m uscular 
dystrophies-dystroglycanopathies ( M OOG) with bra in  and eye anomal ies 
classified accord ing to the mutated dystrog lycanopathy gene mentioned 
a bove. Namely, M OOGA1 (OM I M#236670), M OOGA2 (OM I M#6 1 3 1 50),  
M OOGA3 (OM I M#253280), M OOGA4 (OM I M#253800), MOOGA5 
(OM I M#6 1 3 1 53) ;  MOOGA6 (OM I M#6 1 3 1 54), M OOGA7 (OM IM#61 4643), 
MOOGA8 (OM I M#6 1 4830), M OOGA 1 0  (OM I M#6 1 5041 ), M OOGA1 1 
( O M I M#6 1 5 1 8 1  ) , M OOGA 1 2  (OM I M#6 1 5249), and MOOGA 1 3  
(OM I M#6 1 5287). These d isorders share the common cl in ical feature of 
m uscular dystrophy with variable neurologic and ophtha lm ic phenotypes .  The 
genetic basis of at  least 40% of MOOG cases sti l l  is un identified [Godfrey et 
a L ,  2007; Mercuri et a L ,  2009; Messina et aL ,  20 1 0 ;  Oevisme et a L ,  20 1 2; 
Cirak et a I . ,  20 1 3] .  Screening known and candidate genes for causative 
m utations in congenital M OOG would most probably m iss the causative 
genes for the unsolved dystroglycanopathy cases [Cira k  et a L ,  201 3] .  
3.5.4.3. Phenotypic spectrum of POMGNT1 mutations 
POMGNT1 gene encodes a g lycosyltra nsferase involved i n  the 
g lycosylation of a-OG and is responsible for the transfer of N-
acetylg lucosamine (GlcNAc) to O-mannose g lycoprote ins [Clement et  a L ,  
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2008b]. M utations in  this gene d isrupt its function and cause a wide spectrum 
of c l in ical severity. POMGNT1 mutations were fi rst identified in  patients with 
M DDGA3 (formerly known as Walker-Warburg syndrome or muscle-eye-bra in  
d isease), a congenital muscular dystrophy with structural eye and bra in  
defects a nd severe mental retardation [Yosh ida et a I . ,  200 1 ] .  POMGNT1 
M utations are also associated with a less severe CMD-dystroglycanopathy 
with mental reta rdation (M DDGB3; OM I M#6 1 31 5 1 )  [Clement et a l . ,  2008a]. 
Clement et a l  [2008b] have broadened the spectrum of POMGNT1 mutat ions 
to include relatively mi ld adul t  onset l imb-gird le muscular dystrophy with no 
m ental reta rdation ( M DDGC3; OM IM#6 1 31 57) .  Due to the wide spectrum of  
POMGNT1 mutations, Taniguchi et  a l  [2003] recommended search ing for 
POMGNT1 m utations in  any CMD patients worldwide.  Having said that, Hehr 
et a l  [2007] studied the cl in ica l  phenotypes of  n ine MEB patients and noticed 
a broad phenotypic variabi l ity between patients i rrespective to the type or  
location of  the  underlying POMGNT1 m utation . The authors concluded that 
the type a nd posit ion of the POMGNT1 mutat ions a re not of pred ictive value 
for the c l in ical severity. Severa l therapeutic approaches are now under study 
such as vira l-med iated gene therapy which has proved to be successfu l 
[Reed ,  2009] . For example, overexpression of LARGE gene was found to 
improve g lycosylation of a-DG requ i red for extrace l lu lar  matrix (ECM)  b ind ing 
even in  d isorders where other genes in  the pathway are m utated inc lud ing  
POMGNT1 [Yu et a I . ,  201 3] .  This treatment rescued the muscular  dystroph ic 
phenotype in  a Pomgnt1-knockout mouse model  [Yu et  a I . ,  201 3] . 
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3.5 .5. Conclusions 
I n  this study I have identified a homozygous loss-of-function mutation 
in  POMGNT1 gene in  two affected chi ld ren of a consanguineous Arab fami ly  
res id ing in  the UAE. This genetic find ing in  addit ion to the i nvolvement of 
bra in and eye a nomal ies in  the phenotype , has refined the in it ial b road 
d iagnosis of CMD in these patients into a specific d isease cal led M DDGA3. 
Understanding the molecular basis of this dystrog lycanopathies had led to a 
more precise d iagnosis and genetic counsel ing in  the fami ly. Moreover, 
therapeutic strategies a re being developed and tested in  the prec l in ical 
models and it is hoped that these observat ions wi l l  pave the way to 
therapeutic interventions in  humans [Reed , 2009] . 
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SECTION 6 :  A n ovel m utat ion i n  PRG4 g e n e  
u n derly i n g  cam ptodactyly-a rt h ro pathy-coxa 
vara-peri ca rd it is syn d rome with the poss i b l e  
expa n s i o n  of t h e  p h e n oty pe to i n cl u d e  
con g e n ita l cata ract 
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3.6. 1 . Backgrou nd 
Camptodactyly-arthropathy-coxa vara-pericard it is (CACP) synd rome 
(OM IM#208250) I S  characterized by congenital flexion contractu res of the 
fi ngers, non-inflammatory swel l ing of the jo ints ,  deform ity of the h ips,  and 
pericard it is. Camptodactyly may be seen in  many other genetic syndromes,  
inc lud ing ocu lo-dental-d ig i ta l ,  orofacial-digita l ,  cere brohepato- renal ,  Catel 
Manzke , and Pena-Shokei r  I syndromes [Choi et a I . ,  2004] .  Camptodactyly in 
CACP is  usual ly present at birth and mostly bi latera l  and progressive [Offiah 
et a l . ,  2005] .  The arthropathy (swol len joint) in  CACP usual ly appears i n  the 
first year of l i fe and main ly involves the large joints such as elbows, h ips ,  
knees, and ankles [Choi e t  a I . ,  2004] . This arthropathy is non-i nflammatory 
because it lacks signs of inflammation , such as heat, and is not responsive to 
anti- inflammatory d rug therapy [Offiah et a I . , 2005] . Synovial hyperplasia is  
a lso prominent in these patients, without any evidence of inflammatory cel l  
i nfi ltration or vascul it is .  Tenosynovectomy of the hands and synovectomy of 
the knee joints have been used in  some patients to maintain mobi l ity of 
affected joints [Och i et a I . ,  1 983; Martin et a I . , 1 985] .  Progressive coxa vara 
was seen in  ha lf of the CACP cases reported , whereby the angle between the 
ball and the shaft of the femur  is reduced , leading to severe impa i rment of h ip  
mobi l ity [Choi e t  a I . ,  2004] . Approximately 30% of  CACP cases develop e ither 
mi ld self- l imit ing or l ife-threaten i ng non- inflammatory pericardit is [Choi et  a I . ,  
2004] . 
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3.6.2.  The purpose of the study 
This study was performed to investigate the molecular cause 
underlying a severe CACP syndrome inherited in an autosomal recessive 
manner in an extended consanguineous fami ly from the UAE. An in it ial part ia l  
Sanger sequencing of the PRG4 gene fa i led to reveal  any pathogen ic 
mutat ion. Therefore , the genetic investigation in th is  fami ly was carried out 
using whole-exome sequencing and STR genotyping approach. 
3.6.3 .  Resu lts 
3.6.3. 1 .  C l i n ical  assessments 
A h igh ly i nbred fami ly with fou r  affected ch i ldren in two branches 
exhib it ing severe autosomal recessive CACP syndrome was recruited i n  th is  
study ( Figure 3 .6- 1 ) . A l l  affected chi ld ren i n  th is fami ly presented at b i rth with 
camptodactyly of either some fingers or a l l  f ingers. Two of them had tr igger 
fingers. Joint swel l ing started in the fi rst few months of l ife start ing with the 
knee joints and progressing to involve the e lbows, ankles, wrists and h ips .  
Some of  the  chi ldren experienced mi ld  pain bu t  there were no s igns  of 
inflammation. Coxa vara was present in a l l  of them.  However, there was no 
h istory of pleuritis ,  pericard it is or spinal abnormal it ies. Camptodactyly was 
operated on successful ly in a l l  of them.  One of the ch i ld ren was found to have 
a b i lateral congenital cataract which was noticed at b i rth .  This was operated 
on successfu l ly. 
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Figure 3.6-1 . Ped igree of the stud ied fami ly. The camptodactyly­
arth ropathy-coxa vara-pericard it is syndrome presented in  fou r  affected 
ch i ld ren in two branches of this consanguineous fam i ly_  
1 2 3 4 
I I  
1 2 3 4 5 6 7 8 
2 1 2  
3.6.3 .2 .  Molecu lar genetic i nvestigation 
In order to revea l the molecular basis of the phenotype in  the studied 
fam i ly ,  whole-exome sequencing (WES) was carried out on th ree affected 
chi ld ren 1 1 -5, 1 1 -7 ,  and 1 1 -8. I n  tota l 68660 variants were generated of which 
29675 were homozygous. Those variants were substantia l ly reduced to 1 350 
novel variants of which approximately 1 1 0 were pred icted to a lter the prote i n  
product. To identify the causative gene and variant, shared homozygous 
regions were i nvestigated us ing the exome data. Two homozygous reg ions 
were noticed to be shared between the th ree affected chi ldren (Table 3 . 6- 1 ) .  
The fi rst block of homozygosity was noticed on chromosome 1 spa n ning  
around 26 Mb ,  whi le the second one was found on chromosome 1 2  spann ing  
5 Mb .  Specific STR markers were used to  confi rm and narrow down the 
homozygous regions in a l l  the avai lab le fam i ly members (Table 3.6- 1 ) . STR 
genotyping refined the homozygous region on chromosome 1 a round 1 4  M b  
flanked b y  the markers AFMA 1 1 6YC5 (chr1 : 1 82 ,873,495) and the m arker 
AFMC023WE9 (chr1 : 1 96,650,533).  On the other hand,  the two STR markers 
flanking the second homozygous b lock were found to be heterozygous in  two 
out of the three affected chi ld ren (Table 3 .6-1 ). 
Within the assigned homozygous reg ion on chromosome 1 ,  on ly a 
homozygous frame shift mutation in  PRG4 gene was found in  a l l  the 
investigated affected i nd iv iduals .  The detected mutation is an insert ion of a 
cytosine mono-nucleotide in  a stretch of five cytosines at the beg inn ing of 
exon 7 of PRG4 gene N M_005807.3 :c . 1 320dupC ( Figure 3.6-2) .  The 
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Table 3.6-1 . STR genotyping resu lts for the two homozygous regions identified in  the studied fami ly. 
Marker Location 1 1  
Chr1 : 1 82,800, 727 -209, 788 , 2 1 3-26Mb 
AFMA1 1 6YC5 1 82 , 8 73 , 495 244/248 
AF MA057VB5 1 89,344 ,581 1 68/1 70 
AFMC023WE9 1 96,650,533 263/265 
AFM B002YA5 201 , 1 2 1 , 1 59 2 1 6/2 1 8  
AFM059YH4 207,759 , 4 1 2  1 40/1 40 
Chr1 2 :  2 1 , 72 7 , 3 1 5-26 ,848 , 663=5Mb 
AFMC027Z D 1  
AFMA 1 1 9X E5 
- - -_.-
22,351 ,420 2 5 1 /255 
24,093,565 276/285 
12 1 1 3  1 14 
242/244 242/244 244/248 
1 66/ 1 68 1 66/1 68 1 68/ 1 70 
263/263 263/265 263/265 
2 1 4/2 1 8  2 1 4/2 1 6  2 1 6/2 1 8  
1 36/ 1 40 1 36/1 40 1 40/1 40 
255/257 255/257 2 5 1 /255 
276/278 2761278 276/285 
1 1 5  13  14  1 16  1 1 7  1 18 
244/244 242/244 244/246 244/246 ' 244/244 244/244 
1 68/1 68 1 66/1 68 1 68/1 72 1 68/1 72 1 68/1 68 1 68/1 68 
263/263 261 /263 261 /263 263/263 26 1 /263 263/263 
2 1 6/2 1 8  2 1 8/2 1 8  2 1 8/2 1 8  2 1 8/2 1 8  2 1 8/2 1 8  2 1 8/2 1 8  
1 40/ 1 40 1 40/1 40 1 40/ 1 42 1 40/1 42 1 40/ 1 42 1 40/ 1 42 
255/255 257/257 24 1 /255 24 1 /257 255/257 255/257 
276/276 278/285 276/285 278/285 276/278 276/278 
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F igure 3.6-2. Representative DNA sequencing chromatograms 
d isplaying the c . 1 320d upC m utation of PRG4. The fi rst chromatogram 
shows the 5 cytosine homopolymers in  the reference sequence of a 
normal contro l ,  whi le the second one shows the dup l ication of the c. 1 320 
cytosine ( ind icated by a star) carried by the two a l le les of the affected . 
The last chromatogram shows the mutation in  one a l le le carried by the 
parents and the unaffected carriers. 
Sequencing 
chromatogram of a 
normal i nd iv idual  
carries the wi ld type 
sequence of PRG4 
gene 
Sequencing 
chromatogram of a 
Carrier ind ividua l  
carries a 
heterozygous form 
of the detected 
m utations 
Sequencing 
chromatogra m  of an 
affected ind ividua l  
carries a 
homozygous 
c . 1 320dupC 
G C C T G C C C C 
C A C C A C C C C C C  G C C T G C C C C 
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dup l icated nucleotide caused a frame shift in  the cod ing DNA sequence of the 
gene and created a PTC in  i ts prote in product p . Lys441 Glnfs* 1 98 .  The 
mutation was verified by Sanger sequenced in  a l i  fam i ly members. Ali the 
unaffected chi ldren and parents were found to be carriers for the mutation . 
This mutation is located at the beg inn ing of the m ucin- l ike domain of the 
protein product ( Figure 3 .6-3). 
3.6.4. Discussion 
I n  this study I investigated a consanguineous fami ly  i n  the UAE with 
four  affected ch i ldren in  two branches exhibit ing severe autosomal recessive 
CACP syndrome. In teresting ly, one of the affected ch i ldren has a b i lateral 
congenital cataract in  add it ion to the typica l CACP phenotype. This feature 
has not been reported previously i n  this syndrome. I identified a novel 
mutat ion in PRG4 gene in this fam i ly by whole-exome sequencing and STR 
genotyping .  
CACP is a rare genetic d isorder inherited i n  a n  autosomal  recessive 
manner  [Alazami  et a I . ,  2006 ; Basit et a I . ,  201 1 ] . I n  1 998, the d isorder was 
l i nked to chromosome 1 q25-31 us ing homozygosity mapping [Bahabri et  a I . ,  
1 998]. I n  1 999, Marcel ino e t  a l  identified the causative gene [Marcel ino e t  a I . ,  
1 999]. A l l  the m utations reported so far in  a l l  the stud ied CACP cases are 
nonsense or frame shift deletions and insertions that premature terminat ion of 
the lubrici n protein which is encoded by the PRG4 gene (OM I M*604283; 
F igure 3 .6-3) [Marcel i no et a I . ,  1 999; Alazami  et a I . ,  2006; Basit et a I . ,  2 0 1 1 ] . 
These mutat ions a re predicted to cause the degradation of the mutated 
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Figure 3.6-3. Schematic prese ntation of PRG4 p rote in  domains showing the position of a l l  the reported 
m utations.  All the detected mutat ions thus fa r in  PRG4 are e i ther nonse nse or d eletions and insert ions that created 
premature termination codons ( PTCs). Our insertion (represented in red) a lso caused a frame shift creating PTC 
shortly after. 
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mRNA by the nonsense med iated decay mechanism of the cel l .  It has been 
documented that complete absence of the truncated prote in  product is  the 
molecular mechanism underlying the mu ltiple phenotypes of CACP [Rhee et 
a I . ,  2005; Alazami  et a i . ,  2006] . Although the mutation in this fami ly has not 
been reported previously i t  is  s imi lar  in  many ways to the previously reported 
ones as the fate of truncated protein is pred icted to be completely lost [ Rhee 
et a i . ,  2005; Alazami  et a i . ,  2006; Basit et a i . ,  20 1 1 ] .  However, the detected 
m utation in th is study is situated in a h igh repetit ive part of the lubricin prote in ,  
the  large m ucin- l ike doma in  that conta ins 4 1  repeats of  the  degenerate 
KEPAPT motif [Alazami  et a i . ,  2006] . For this reason , th is reg ion (p .350-855, 
NP _005798 .2)  was usual ly missed or avoided when performing mutationa l  
screen ing by Sanger sequencing technology [Alazami  et a i . ,  2006; Marcel ino 
et  a i . ,  1 999] . Therefore, I was unable to recognize the d isease caus ing 
m utation us ing Sanger sequencing a l though the d iagnosis was clear .  As a 
resu l t , 1  decided to use the more accurate sequencing technology WES.  
Beca use of the short read sequence nature of  the WES and the sophist icated 
ana lysis methods that fol lows, this technology is more suitable to obta in  h igh­
qua l ity variant ca l ls  [Shiqemizu et a i . ,  201 3] .  
Homozygous Prg4 nu l l  m ice developed with age abnormal 
morphologic changes such as  i rregu lar  endochondra l  g rowth plates and 
a ltered carti lage surface [Rhee et a i . ,  2005] . Also those m ice exhib i ted 
camptodactyly, progressive synovial hyperplasia which eventua l ly led to 
fa i l u re of joint function [Rhee et a i . ,  2005] . The b io logical roles of PRG4 a re 
2 1 8  
the focus of i ntensive stud ies part ly due to i ts possib le usage as  a 
b iotherapeutic target i n  arthrit ic d iseases [Bao et a l . ,  20 1 0] .  Rhee et a l  [2005] 
demonstrated that lubrici n ,  the prote in product of PRG4, is an essential 
boundary lubricant i n  the mouse knee joints. The authors a lso observed that 
decreased lubrication i n  the ankle joints of the mutated a n imals due to the 
absence of lubric in causes abnormal changes with i n  the tendon and tendon 
sheath. The authors suggested that th is  is  the lead ing cause of the 
camptodactyly seen in CACP patients. Novince et a l  [201 1 ]  confi rmed 
experi menta l ly that PRG4 contributes to endochondra l  bone format ion,  
t rabecular bone formation and skeleta l homeostasis .  
Congenita l  camptodyctyly and non- inflam matory a rthropathy are 
characterist ic manifestat ions of CACP seen i n  a l l  reported cases . Other 
man ifestat ions inc lud ing pericard it is ,  p leurit is and coxa vara a re variab le  and 
many patients do not develop them throughout the course of the d isorder .  On 
the other hand, congen ita l  cataracts have never been reported to be 
associated with PRG4 mutations before. In the studied fam i ly here,  one of the 
affected was born with a cataract without any previous h istory of such 
phenotype i n  the fam i ly or i n  any of the others affected . The process lead ing 
to  cataracts actual ly or ig inates with events occurri ng i n  the lens epithe l i um 
which performs important metabol ic functions for the  ent i re lens  [And  ley, 
2008] . PRG4 mRNA was detected in the human lens epithel ia l  cel ls as wel l  
as i n  the cornea , the  conjunctiva , the meibomian g land  secretions,  and  the  i ri s  
of  the eye [Morrison et a I . ,  201 2] 
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(http://www . ncbi . n lm .nih .gov/geo/query/acc.cgi?acc=GPL96 ). I n  add it ion , 
Morrison et a l  [20 1 2] d isplayed that PRG4 is  an effective ocular surface 
boundary lubricant ,  a lone or in combination with hya luronan.  Schmidt  et a l  
[20 1 3] has proved experimenta l ly that PRG4 is transcribed , trans lated , and 
expressed by ocular  surface epithe l ia .  The authors have demonstrated that 
PRG4 presence sign ificant ly reduces friction between the cornea and 
conjunctiva.  Therefore, the authors have concluded that PRG4 defic iency 
may play a role in  promoting cornea l damage. 
3.6 .5 .  Conclus ion 
CACP is a c l in ical ly heterogenous congenital d isorder caused by 
m utations in PRG4 gene encoding a chondroit in su lfate proteoglycan that 
acts as a lubricant for the carti lage surface. In this chapter, I have 
i nvestigated a fami ly from the UAE with typical features of CACP in  whom 
one of the ch i ldren had in  addi tion , a bi lateral congen ital cataract. In  th is  
study, I have identified a novel nu l l  mutation in  PRG4 gene confi rm ing the 
genetic homogeneity of CACP thus fa r. The c l in ica l  and molecu lar f ind ings in  
th is chapter have expanded the spectrum of PRG4 deficiency to inc lude 
ocu lar abnormal it ies. Furthermore , e lucidating the genetic defect i n  th is  fami ly  
confi rmed the d iagnosis and faci l itated carrier screening .  
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SECTION 7 :  M a p p i n g  of a n  a utosomal  
recess i ve p rogeroid sy n d rome with neonata l 
p rese ntati o n  a n d  l o n g  s u rvival  to a s i n g le 
locus o n  c h romosome 1 9p 1 3 . 3- 1 3 . 2  
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3.7. 1 .  Background 
Progeroid syndromes are a g roup of d isorders characterized by an "old 
man" appearance either at b i rth o r  later in  l ife . H utch inson-Gi lford progeria 
syndrome, mandibu loacral dysplasia,  and cockayne syndrome are exam ples 
of progeroid syndromes, which do not manifest at b i rth but later in  l ife [Pol lex 
and Hegele, 2004; Garg et a I . ,  2005] . I n  severa l other syndromes, the 
progeroid phenotype is usual ly seen at b irth.  Examples of the latter g roup 
include Wiedemann-Rautenstrauch syndrome (WRS; O M I M#264090), Petty­
Laxova-Wiedemann synd rome ( PLWS;  OM IM#6 1 2289), Fonta ine-Farriaux 
syndrome [Castori et a I . ,  2009] , Hal lerman-Strief syndrome (OM I M#234 1 00) ,  
and De Barsy syndrome (OM I M#2 1 9 1 50). Other condit ions with neonatal 
presentation include cutis laxa type 1A ( OM IM#2 1 9 1 00) ,  cutis laxa type l i B  
(OM I M#6 1 2940), geroderma osteodysplastica ( O M I M#23 1 070), and some 
forms of Marfan syndrome [Graul-Neumann et a I . ,  20 1 0 ; Goldblatt et  a I . ,  
201 1 ] .  
W R S  i s  a very rare autosomal recessive progeroid syndrome .  The 
syndrome is characterized by an aged appearance at b i rth with relative 
macrocephaly, cran iofacial d isproportion ,  reduced subcutaneous fat, thin sk in ,  
and neonatal teeth [Rautenstrauch et a I . ,  1 994; Courtens et a I . ,  1 997; S to l l  e t  
a I . ,  1 998; Pivnick et  a I . ,  2000] . The syndrome was first described i n  two 
patients by Rautenstrauch a nd Snigula in 1 977,  fo l lowed by a report of two 
more cases by Wiedemann in 1 979 [Rautenstrauch and Sn igu la 1 977 ;  
Wiedemann ,  1 979] .  S ince then ,  more reports have been publ ished with about  
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30 cases being reported so far from d ifferent ethnic backgrounds [Devos et 
a I . ,  1 98 1 ; Bitoun et a l .  1 995; Hou and Wang , 1 995;  Arboleda et a l . ,  1 997,  
201 1 ;  Pivnick et a I . ,  2000; Korn iszewski et a l . ,  200 1 ; Hoppen et a I . ,  2004; 
Hou , 2009; Tunc et a I . ,  2009; Pandey et a I . ,  201 1 ;  Puente et a I . ,  20 1 1 ] . The 
molecular basis of the WRS is sti l l  largely unknown. 
3.7.2.  The purpose of the study 
Progeroid syndromes of infancy and chi ldhood are often associated 
with a wide spectrum of etiolog ies ( i ncluding structura l  abnorma l it ies and 
i n born errors of metabo l ism) and identified genetic defects account for a 
number of cases. I n  many ch i ld ren the underlying cause is not elucidated , 
and it is l i kely that a s ignificant proportion of these cases have a currently 
u ndeterm ined genetic basis. In order to elucidate the genetic d efect 
underlying one of these d isorders ,  I performed homozygosity mapping and 
whole-exome seq uencing on three affected ch i ld ren from a consanguineous 
Ara b  fam i ly resid ing in  the UAE who presented with a syndrome that overlaps 
to a la rge extent with the autosomal recessive progeroid syndrome WRS. 
3.7 .3. Resu lts 
3.7 .3 . 1 .  Cl i nical  assessments of patients. 
The parents of the affected ch i ldren are fi rst cous ins of Palest i n ian 
orig in .  They have a total of  s ix ch i ldren ;  three of them are affected ( Figure 
3 .7- 1 ; Table 3 .7- 1 ) .  The parents appeared normal ,  and there was no h istory 
of s imi lar  cond it ions in  the fami ly. 
Patient 1 ( 1 1 - 1 ) ,  a 27-year-old man, was eva luated i n  the Genetic c l in ic  
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F igure 3.7-1 . Ped igree of the fami ly  affected with autosoma l  
recessive progeroid syndrome. The pedigree of the studied fami ly 
showing the affected members (fi l led symbols) and non-affected 
members (open sym bols) .  The double l ine in midd le generation (the 
parents) ind icates consanguin ity_ 
1 2 
II 
2 3 4 5 6 
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Table 3.7-1 . C l i n ical  features of the three affected s ibs i n  this report compared to Wiedema nn-Rautenstra uch 
syndrome (WRS). 
Features 
.Jilrth Weight 
Length 
Aged appearance at birth 
Relative macrocephaly 
Wide fontanelle & Sutures 
Sparse scalp hair 
Prominent scalp veins 
Small facial bones 
Flat malar reqlon 
Large eyes 
Downslantlnq palpebral fissures 
Large beaked nose 
Short philtrum 
Micrognathia 
Low set prominent ears 
Neonatal teeth 
Altered dentition 
Large hands & feet 
Lack of subcutaneous fat 
Fat accumulation In buttocks 
Contractures at elbow & knee JOints 
ScoliOSis/kyphosIs 
Hyp�plasia of distal phalanqes 
Coronal synostosIs 
Genital anomalies 
CNS anomalies 
Endocrine Abnormalities 
Psychomotor retardation 
ChrOniC lunq disease 
Age at report 
Weight at report 
Height at report 
I UG R = l ntrauterine growth restriction 
GR=Growth retardation 
1 1-1 
2 3kq -
5 1 cm 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
+ 
-
-
-
-
-
+ 
+ 
27y 
32.7kq 
1 4 3cm 
1 1-5 
2 4kg 
47cm 
+ 
+ 
--
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
-
-
+ 
-
-
-
-
-
+ 
-
1 2  y 
20kq 
1 20cm - ---
I I� 
�4wee� 
45cm f-- -
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
-
-
-
-
-
-
-
-
+ 
Repeated Infections 
7y 
1 2kg 
1 05cm 
WRS 
IUGR 
IUGR 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+/-
+ 
+ 
+/-
+/-
+ 
+ 
+ 
+ 
+/-
+/-
- -
+ In survivors --- -
-
-
+/-
+1-
+/-
+ 
-
Blrth- 1 7v 
Failure to thrive 
GR 
-- -
--
--
-
-
-
--
because of h is  appearance. He was the product of a normal pregnancy and 
normal term del ivery. H is  b i rth weight was 2300 g « 1 0 cent i le) and h is length 
was 51 cm (>1 0 centi le) (Table 3 .7- 1 ) .  At b i rth ,  he was noted to have an aged 
appearance,  lacking subcutaneous fat on his face and body, and his skin was 
wrinkled. In add it ion ,  he had severa l dysmorphic features i nclud ing a 
relatively large head with wide fontanel le and sutures. He had v is ib le 
superficial veins ,  sparse scalp hair, eyebrows, and eye lashes with lower 
eyel id entropion .  His face was triangu lar  with a large nose and smal l  
mand ib le .  There were two upper neonatal teeth. He was kept in  a special 
care baby unit for 3 weeks. No further information about h is  neonata l period 
was ava i lab le .  During h is chi ldhood, he was fa i l i ng to thrive a nd he developed 
repeated chest i nfections. He had normal motor m i lestones, but he had 
delayed speech and h is intel l igence was low. He had few primary teeth ,  which 
fe l l  out  at 7 years and were not replaced by permanent teeth except two 
premolar teeth , which fe l l  out later in chi ldhood . Eva luation at 20 yea rs o ld 
revealed an old looking man with a general ized reduction of subcutaneous fat 
and dysmorphic features. He had areas of sparse sca lp  hair ,  l arge eyes ,  and  
a b ig  beaked nose with low insert ion of  the columel la ,  short phi l tru m ,  f lat 
malar  reg ion , and m icrognath ia ( Figure 3 .7-2- 1 ) .  The mouth appeared la rge ,  
and there were no teeth ( Figure 3 . 7-2-2) .  H is  na i l s  were normal .  There were 
contractures a t  the knee and e lbow join ts and sco l iosis.  There was no fat 
accumulat ion in the buttocks. He had low voice s imi lar  to that of old people .  
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F igure 3.7-2. Representative images of patient 1 .  1 )  and 2) Patient 1 
at 20 years of age: note the large eyes, large beaked nose , short 
ph itrum ,  flat malar reg ion , and smal l mand ible ( 1 ), note lack of teeth (2) .  
3 )  and 4) Patient 1 at 27 years of age: front v iew of the patient, note lack 
of sUbcutaneous fat, contractures at the e lbow, and PEG tube (3) ,  latera l 
view of the patient showing the posture and contractures at the knee 
jO ints (4). 
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He had suffered from severe constipation since infancy. He atta ined puberty 
at 1 3  years of age and he had normal secondary sexual characteristics and 
normal genita l ia .  H is  vision and hearing were norma l .  He continued to suffer 
from repeated chest infect ions, which were attributed to aspiration as he had 
some degree of functional dysphagia. At 27 years of age, he was on 
continuous oxygen therapy by mask and used a PEG tube for feeding ( F igure 
3. 7-2-3, 2-4). H is  weight was 32.7 kg (-3 SO) ,  and h is  height was 1 43 cm (-3 
SO) . H is deterioration was because of his chron ic  l ung d isease and h is 
inab i l i ty to swal low. Skeletal survey showed general ized osteopenia .  There 
was no other neurolog ica l  or card iovascular deterioration. Fasting blood l ip ids 
were normal .  Endocrine functions i ncluding thyroid and adrenal  functions 
were norma l .  His karyotype was normal (46XY). H is CGH a rray has shown a 
male p rofi le  with 2 1  copy n umber variants (CNVs)  of no c l in ical s ign ificance.  
Patient 2 ( 1 1-5) is  the s ister of patient 1 ( Figure 3 .7-3A- 1 ) . She was the 
product of a normal pregnancy and a normal  term de l ivery. Her b i rth weight 
was 2400 g « 1 0 cent i le) ,  and her length was 47 cm « 1 0 centi le) .  She was 
noted to have the same phenotype as her brother (Table 3 .7- 1 ) . D u ring 
i nfancy and chi ldhood , she fa i led to th rive. She had few primary teeth , which 
fe l l  out and were not replaced by permanent teeth.  She had normal motor 
m i lestones, but her speech was de layed and her IQ was low. She was 
evaluated by us at the age of 1 2  years. Her weight was 20 kg ( -2 SO) and 
height was 1 20 cm ( -3 SO) .  Her eyes were large with down-slant ing palpebra l  
fissures ( Figure 3 .7  -3A-2).  She had a large nose with a b road nasal  t ip ,  short 
228 
phi ltrum ,  and a flat malar region . Her mouth was large with no teeth ,  and she 
had micrognathia .  Her scalp hair was sparse with a reas of a lopecia ( Figure 
3 .7  -3A-3). The ears were prominent and low set. She is 1 2  years old now and 
has s igns of  puberty including breast development (Tanner stage 2) ,  sparse 
ax i l la ry, and pubic hair .  
Pat ient 3 ( 1 1 -6)  is the brother of patients 1 and 2 ( Figure 3.7 -38- 1 ) . He 
was the product of a normal pregnancy and a normal  del ivery at  34 weeks 
gestation . H is b i rth weight was 1 800 g ( 1 0  centi le) ,  and his length was 45 cm 
(>1 0 centi le) .  He was noted to have s imi lar  features to h is  sib l ings (Table 3 . 7-
1 ). He is now aged 7 years and has delayed speech ( Figure 3 .7-38-2 , 38-3). 
3.7.3 .2 .  Molec u lar  genetic investigation 
3.7.3 .2 . 1 .  Sequencing of LMNA and ZMPS TE24 genes showed negative 
resu lts 
The molecular cause of Hutchinson-Gi lford progeria has been shown 
to be mutations in  the genes encoding nuclear lam i n  A (LMNA )  [De Sandre-
G iovanno l i  et a I . ,  2003; Eriksson et a l . ,  2003] . On the other hand,  it has been 
shown that mand ibu loacra l  dysplasia is caused by mutations in  ZMPS TE24 
gene, which encodes for a metal loprotease involved in  lamin A maturat ion 
[Agarwal et a l . ,  2003; Navarro et a l . ,  2004] . . Sequencing of LMNA and 
ZMPS TE24 genes by the Sanger convent ional method d id not  revea l any  
pathogenic m utation .  
3.7.3 .2 .2 .  Genome-wide homozygosity mapp ing l inked the condit ion to 
1 9p 1 3.3p1 3.2 
The resu l ts of the genome-wide genotyping and l i nkage analysis  for 
the studied ped igree are shown in  figure 3.7-4 and Appendix-G. The 
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F igure 3 .7-3. Representative images of patient 2 and 3 .  A-1 ) Patient 
2. In  the first year of l ife A-2) patient 2 at 1 2  years of age, note the large 
eyes,  large nose with short ph itrum ,  flat malar  reg ion ,  and smal l  
mandib le .  A-3)  Latera l view of patient 2 ,  note sparse ha i r ,  large and low 
set ears, and very smal l  mandib le .  B-1 ) Frontal view of patient 3 at 3 
years of age. B-2) Patient 2 at 7 years of age and B-3)  side view of 
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Figu re 3.7-4. Genome-wide genotyping resu lts . (A) Genome-wide S N P  Genotyping of a l l  the fami ly members 
m apped the d isease locus to chromosome 1 9p 1 3 . 3-p 1 3.2 .  (8)  Visua l iz ing the only b lock of homozygosity shared 
between the three affected sibs ( 1 1 1 ,  1 1 5, and 1 16) .  The shared homozygous interval appears in  red and b lue colors. 
Th is  d iagra m  was constructed using dChip software. (C)  List of all the Ref Seq genes located with in the mapped region 
showing the potent ia l  candidates in bold . 
B) Inferred 
SNP calls 
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genotyping data showed two shared blocks of homozygosity between the 
three affected members of the studied fam i ly.  One b lock mapped to 
chromosome 5 between rs4522972 and rs 1 1 957206 , flank ing a 3 .5-Mb 
genetic interva l (5p 1 3 .2 ;  Appendix-G). However, one of  the unaffected 
ch i ldren ( 1 14) was homozygous at that locus too , and therefore it has been 
excluded. The second block of homozygosity observed to be shared between 
the three affected s ibs was found at a single locus spanni ng 6 .9  centimorgan 
(cM) on chromosome 1 9  ( Figure 3 . 7-4 and Append ix-G).  Al l the non-affected 
s ibs were heterozygous at that locus. The co-segregating segment is  fla nked 
by rs2240743 and rs479448, demarcating a genetic interval of 2 . 3  M b  on  
chromosome 1 9p 1 3.3-p1 3 .2  ( Figure 3 .7-4). CNVs ana lysis detected 
s imu ltaneously by the Affymetrix SNP 6.0 a rray fa i led to identify a ny 
sign ificant shared gains or losses.  
3.7.3.2.3.  Whole-exome sequencing a na lysis fa i led to revea l a 
convi ncing causa l  mutat ion 
To reveal the molecular basis of th is syndrome and to identify the 
causative mutation , the whole coding regions and spl ice s ites of the three 
affected ind ividuals were sequenced by next generation sequencing WES.  A l l  
the detected variants shared between the three affected members were 
fi ltered against dbSNP,  1 000Genome project, NHLB I  exome sequencing 
project, and i n-house exome variants databases. The sequencing data 
confi rmed the l inkage but I could not identify any unreported homozygous 
d isease-causing mutation shared between the three affected individua ls  
within or outside the l inked region.  
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3 .7.3.2.4. Computat ional  priorit izing of the genes with in the mapped 
reg ion 
Expression studies of progeroid syndromes demonstrated that a mong 
the most important mechanisms proposed to be involved i n  induct ion of  ag ing 
a re aberrations in  l ip id synthesis  and cel l u lar metabol ism [Zouboul is and 
Makrantonaki ,  20 1 1 ] .  In  addit ion to a lterations in  DNA repair ,  m itochondria l  
funct ion, cel l  cycle contro l ,  apoptosis,  extrace l lu lar  matrix expressio n ,  
proteolysis ,  and hormonal levels [Zouboul is a n d  Makrantonak i ,  201 1 ] .  The 
potent ia l  d isease loci 1 9p 1 3.3-p 1 3 .2 detected in our study conta ins a rou nd  70 
Ref Seq genes ( Figure 3. 7-4). Prioritiz ing these genes us ing GeneDist i l ler2 
pointed out severa l candidates that a re not associated with known d iseases 
and may play a role in  one or  two of the aforementioned pathways. Among 
these genes are VA V1, XAB2, SAFB, KHSRP, MLL T1, LONP 1, TNFSF14, 
TNFSF9, A CER1 ,  CLPP, ARHGEF18, CRB3, FCER2, and TUBB4A . 
However, extensive exome sequencing showed no pathogenic mutat ion i n  
t h e  coding regions o f  a n y  o f  the nominated genes. U nfortunately, RNA 
samples from the affected patients were not avai lab le to investigate the 
presence of expression and spl ic ing aberrations in any of the cand idate 
genes. 
3.7.4. D iscussion 
A consangu ineous fam i ly of Palestin ian orig in  l iv ing in  the UAE with 
three affected chi ld ren exhibit ing a syndrome that overlaps with autosomal  
recessive WRS to a large extent was recru i ted in  th is  study. To identify the 
d isease locus I performed whole-genome genotyp ing SNP-based and 
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homozygosity mapping on a l l  the fami ly  members and mapped the d isease to 
a novel locus 1 9p1 3 .3-p1 3 .2 .  I n  add ition ,  I i nvestigated the exomes of the 
three patients to identify a shared potentia l ly d isease-ca us ing mutation bu t  my 
attempts were unsuccessfu l .  
The features i n  the three s ib l ings in  this study are very s imi lar  to those 
seen in WRS patients. They a l l  had neonatal teeth and aged appearance 
s ince b i rth. Their scalp ha ir  was spa rse, as well as the ha i r  of the i r  eyebrows 
and eyelashes. They had a lso large beaked noses. Al l  of them had 
developmental delay, and al l  su rvived the fi rst 6 years of l i fe (27 ,  1 2 , a nd 7 
years). The average survival i n  WRS, however, is 7 months. Only two cases 
in the l i terature had survived beyond the age of 1 0  years, and c l in ical deta i ls  
a re avai lable at the ages of 16 and 1 7  years [Rautenstrauch et  a I . ,  1 994; 
Arboleda and Arboleda ,  2005] . Both of these survivi ng patients had a l te red 
denti t ion.  Oral rad iography on the patient reported by Arboleda and Arboleda 
[2005] at 9 years of age showed only fou r  maxi l lary teeth, two premolars at 
each side. There was no dentit ion in  the mandible and only scant  a lveolar 
t issue with very smal l  nuclear teeth [Arboleda and Arboleda , 2005] . S im i la rly, 
the patients in  th is study had a l tered dentit ion. Two of them had on ly  two 
premolar teeth ,  which fe l l  out  d u ring chi ldhood and one had no perm anent 
teeth i ng at a l l .  It was not possible to do oral rad iography to assess if the re a re 
permanent teeth, which have not e rupted . Both survivi ng patients i n  the 
l iterature had delay in  their secondary sexual characteristics and onset of 
puberty. Whereas the 27-year-old patient in  this report developed puberty at 
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the appropriate age ( 1 3  years). I n  addit ion , h is 1 2 -year-old sister had some 
secondary sexual characteristics but had not yet had started her menarche. 
Sco l iosis, which was reported in  the two patients with WRS who survived , 
was also present i n  our  patient. Neurologica l  deterioration was documented in  
the case reported by Rautestrauch et  a l  [ 1 994] but not  in  the case reported by 
Arboleda and Arboleda [2005]. The patients here had no neurological or 
card iovascu lar deterioration . The main deterioration noted in our  patient was 
the repeated chest infections caused by aspirations because of the ina b i l i ty to 
swa l low, which has progressed gradual ly necessitating gastrostomy for 
feeding and cont inuous oxygen therapy. I t  is  possible that the s ib l ings i n  the 
fami ly  stud ied here have a new syndrome, which overlaps with W RS.  
Identification of  the molecular basis of  this syndrome w i l l  revea l i f  it is  p a rt of 
the WRS spectrum or is a new entity.  
The segregation of the syndrome in  the fami ly  described here was in  
favor of  an autosomal recessive mode of  inheritance. Mutations in  LAMNA 
and ZMPS TE24 genes have been excluded . The three affected s ibs shared 
two homozygous regions on chromosomes 1 9  and 5 .  Only the reg ion on 
chromosome 1 9  was fou nd to be heterozygous in  the three non -affected sibs. 
The 2 . 3  Mb l i nked region reported here (chr1 9p1 3 .3-p 1 3.2)  is gene rich 
encompassing around 70 genes. Therefore, I decided to investigate the whole 
cod ing regions of the genome in the three affected sibs by whole-exome 
sequencing ,  which fa i led to reveal any potential ly causal variants. This could 
be because of a deficit i n  the sequence coverage, which may have resu l ted i n  
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missing the causative m utation [Bloch-Zupan et a I . , 201 1 ] .  Alternatively, the 
causative mutation may be located outside the cod ing exons with i n  the 
introns or the regu latory elements of the genes located in  that locus. 
Structural variat ions cannot be excluded , although CGH array and CNVs on 
SNP 6.0 a rray seemed to be normal .  I n  addi tion the causative mutation cou ld 
have been reported in  the dbSNP which may have led into being missed in 
the fi ltering steps. Future work wi l l  attempt to identify a causative mutation in  
candidate genes. Th is  i n  turn may he lp  i n  solving at  least one of  the pieces of  
the complex puzzle of  the molecular mechanisms underlying human ag ing .  
3.7.5 .  Conc lusions 
In  th is chapter, I have described a Palesti n ian fam i ly with three 
affected indiv iduals exh ib it ing progeroid syndrome characterized by 
intra uterine growth retardation ,  a progeroid appearance, fa i l u re to thrive , a 
short stature,  and hypoton ia .  The progeroid features were evident at b irth .  A l l  
the affected members of  th is  fam i ly have surv ived beyond the neonatal period 
and one of them is currently a 27 -year-old adult .  
As parental consangu in ity suggested an autosoma l  recessive mode of 
i nheritance ,  I performed homozygosity mapping using SNP-based a rrays 
fo l lowed by next generation whole-exome sequencing to identify the d i sease 
causing gene. I was able to i dentify a s ingle block of homozygosity shared 
between a l l  the affected members of  the studied fam i ly spann ing 2 .3  M b  on 
chromosome 1 9p 1 3 .3-p1 3 .2 .  However, Sanger sequencing of  known genes 
and whole exome sequencing of the three affected sibs d id  not revea l  a 
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shared causal mutation .  These find ings are anticipated to open the way for 
the Identification of the molecular causes underlying this syndrome .  
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C HAPTER 4 :  G E N E RAL CON C LU S I O N S  & 
F UTU RE P E RS PE CTIVES 
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4. 1 .  General conclus ions 
The prevalence of monogenic autosomal  recessive d isorders i n  the 
population of UAE is re latively h igh.  This is main ly due to the high rates of 
consanguineous marriages among the Emirati people as wel l  as many of the 
subpopulations res id ing in  the country as ind icated i n  chapter 1 .  Many 
autosomal recessive d isorders have catastrophic effects on affected infa nts 
as i l l ustrated in  sections 3.2 and 3.3 of the results; whi le the rest can cause 
severe physica l and intel lectual d isabi l i t ies as seen i n  sections 3 . 1 ,  3 .4 ,  3 .5 ,  
3 .6  and 3 .7 .  Therefore,  mapping and identifying causative genes and 
m utat ions responsible for autosomal recessive d isorders have been the 
primary goals of my PhD d issertat ion. 
Understanding the inheritance mode of a g iven rare genetic d isease 
and ut i l iz ing a su itable mapping strategy are crucial for the identification of the 
causative mutation(s). Autosomal recessive inheritance of the studied 
phenotypes in  the recruited fami l ies has been faci l i tated by the consangu in i ty 
of the apparently hea lthy parents (predominantly first cousins ) .  Moreover, 
most of the fami l ies in  this study were h igh ly i nbred with mu lt iple affected 
offspring with female and male s ib l ings or cous ins being equal ly affected . 
Homozygosity mapping has been shown since its d iscovery by Lander and  
Botstein [ 1 987] to  be  a very powerfu l tool for the identificat ion of  genet ic 
defects underlying recessive d isorders in  consanguineous fami l ies .  I t  has 
been used to map a lmost a l l  the stud ied d isorders in  my d issertation which 
narrowed down the search from genome wide to a l im ited number of genet ic 
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inte rva ls as seen in  sections 3 .4 ,  and 3 .5 .  I n  this d issertation ,  I have 
successfu l ly ma pped fou r  autosomal recessive d isorders to a s ing le 
chromosoma l locus as seen in sections 3. 1 ,  3 .2 ,  3 .6 and 3 .7 . 
Scientists have appl ied successfu l ly the candidate gene d i rect 
sequencing approach to search for causative mutations with in homozygous 
regions for several decades which I a lso achieved in  sections 3. 1 ,  3 .2 ,  and 
3.3 .  Advanced sequencing technologies such as next-generation sequencing 
platforms have pushed the boundaries and made it possible to carry out d i rect 
sequencing of the whole-genome or whole-exome. DNA sequencing us ing 
those technologies generates large volumes of data in  a relatively short 
period of t ime. However, there are many genetic variants across the genome 
to sift through,  which i ncreases the d ifficu lty i n  find ing the rea l  d isease­
causi ng variant. Since the monogenic d isorders studied i n  my d issertat ion 
have a clear mode of autosomal recessive inheritance and the correspond ing  
phenotypes are mostly caused by mutations tha t  d isrupt prote in  functions , I 
have combined homozygosity mapping with whole-exome sequencing to 
identify the causative mutations. This two-step approach proved to be 
successfu l in  find ing the causative mutations in  sections 3.4, 3.5 and 3.6 but 
fa i led to p inpoint  the genetic defect i n  section 3 .7 .  This might be due to the 
low qual ity of the exome sequencing performed at a part icular service 
provider rather than flaws in  the used approach. Therefore,  fu rther 
i nvestigations a re st i l l  ongoing in  this fami ly using higher qual ity sequencing 
data. 
240 
Finding the gene and the genetic variation for a d isease is just  the 
start. Provid ing evidence to confi rm that the genetic variant is causal requ i res 
further work. Therefore, correct segregation of al l  the detected variants with 
the correspond ing d isease phenotypes was confi rmed in  al l the stud ied 
fami l ies. Al l  the non-synonymous variants identified were val idated for novelty 
in  at least 200 chromosomes of hea lthy controls and were absent as norma l  
variants in  publ ic databases . Severa l freely ava i lable bioinformatics tools  
were a lso employed to pred ict the impact of  a l l  the detected variants o n  the 
corresponding proteins functions and/or structures. Functional stud ies a t  the 
RNA or the protein  level were performed when appl icable as seen in sections 
3.2 ,  3 .3 ,  and 3 .4 .  
I n  conclusion,  seven d ifferent rare autosomal  recessive d isorders have 
been investigated in  this d issertation .  The main achievements for each 
section of the project a re as fol lows: 
• I have successfu l ly  mapped and found novel causative mutations for 
an autosomal recessive intrauterine g rowth restriction ( I UGR) i n  fou r  
consanguineous fami l ies with m u lt iple affected chi ldren .  Three o f  the 
four  fami l ies were in i t ia l ly d iagnosed as autosomal recessive S i lver­
Russell syndrome (SRS) cases and after the genetic fi nd ings in  section 
3 . 1  the patients were re-categorized as Three-M syndrome cases. A l l  
the detected mutations were fou nd in  CUL 7 and OBSL 1 genes that  a re 
known to cause the Three-M syndrome.  These find ings put in to 
question the existence of autosomal recessive SRS. 
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• I have successfu l ly mapped and found novel causative mutations for a 
severe autosomal recessive d isorder cal led fibrochondrogenesis 
( FBCG) i n  two fam i l ies out of three in  section 3.2 .  The detected 
mutations d isrupted the COL 1 1A 1 gene that was not associated with 
FBCG before . I have identified a non-sense mutation in one fam i ly  and 
a genomic spl icing defect i n  the other fami ly ,  which I showed 
experimenta l ly  to be destructive to the nascent m RNA sequence. I n  
add it ion, I have elucidated the loss-of-function effect of th is mutat ion by 
proving lack of expression of the mutated transcript and protein . 
• I have successfu l ly identified several novel causative mutat ions for a n  
autosomal recessive catastrophic hemorrhag ic destruction o f  the b ra i n  
i n  three fami l ies in  section 3 .3 .  I n  th is section , three non-synonymous 
mutations were identified in  the JAM3 gene that was mapped and 
characterized previously in  a col laborative study.  I n  th is d issertat io n ,  I 
proved the relative homogeneity of the cl in ical presentations of JAM3 
mutations with the detected mutations d isrupt ing d ifferent domains of 
the JAM3 prote in .  Previous knowledge from the l iteratu re of JAM3 
(structure and function ) and pred ict ion programs were employed to 
pred ict the effect of the three mutat ions. Cel lu lar studies and confocal 
fluorescence m icroscopy were used to detect any cel lu lar  traffick ing 
defects caused by the d isease-causing m utations and this has been 
demonstrated for one of them.  
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• I have successfu l ly mapped and identified 2 candidate sp l ic ing 
mutations for a n  autosomal recessive i ntel lectual d isabi l i ty ( 1 0) i n  the 
two chi ldren of a consangu ineous couple.  The spl ic ing mutation s 
detected in  section 3 .4  were identified in  two unstudied genes n amely 
LlNS and TTC23. Both mutations were demonstrated experimenta ly  to 
be damaging. The TTC23 mutation caused a framesh ift i ntroducing a 
premature termination codon short ly after ,  which is most l ike ly to lead 
to its degradtion by the NMO .  The L 1NS mutation caused skippi ng of 
an exon and the expression level of the transcript ion i n  patients was 
h igher than that of normal controls and parents suggesting a loss of 
negative feedback contro l .  This control m ight be origina l ly brought  
a bout by L 1NS prote in  which is predicted to be misregulated and 
thereby nonfunctional  i n  the patients' bra ins .  
• I have successfu l ly  mapped and found a novel causative m utation for a 
very heterogeneous a utosomal  recessive congenital m u scular dystrophy 
(CMD) i n  a consanguineous fami ly  with m ult iple affected chi ld ren . I 
detected a loss-of-function mutation in  one of the C M O­
dystroglca nopathies-causing genes POMGNT1 . The genetic find ing 
from this study combined with the cl i n ical involvement of the eye and 
bra in  anomal ies in patients have refined the d iagnosis in  th is fam i ly to  
be a specific d isease cal led m uscular dystrophies­
dystroglycanopathies type A3 ( M O OGA3). 
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• have successfu l ly mapped a severe autosomal recessive 
camptodactyly-arthropathy-coxa vara-pericardit is syndrome In a 
consangu ineous fami ly from the UAE with mult iple affected chi ldren . I 
detected a novel nu l l  mutation in  PRG4 gene which confi rmed the 
in it ia l  d iagnosis. Moreover, in  this study the carrier status was 
determined for all the fami ly members from the two branches. 
• I have successfu l ly mapped an autosomal recessive progeroid 
syndrome with neonatal presentation in  a consanguineous fami ly  with 
mu lt iple affected ch i ld ren .  In  th is section a rare most i nteresti ng 
phenotype was described and mapped to a novel s ingle locus on 
chromosome 1 9. The mapping results were publ ished attracting more 
col laborative research to fu rther study the molecular causes of this 
phenotype. 
4.2 .  Future perspectives 
4.2. 1 .  Identifying the genetic bases of addit ional a utosomal 
recessive disorders 
The power to detect the genetic bases of ARDs wi l l  i ncrease with the 
advances in  massively paral le l  sequencing technologies at lower costs. I t  is 
noticed that these technologies a re accelerating the d iscovery of novel genes 
and rare variants using chips that have greater genetic coverage, sensitivity 
and specificity. Nevertheless, several bioinformatics chal lenges rema in  to be 
addressed and improved . The storage and backup of the huge data 
generated from high throughput sequencing is sti l l  chal lenging to most 
laboratories . In add ition ,  many analysis methods requ i re deep methodological 
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knowledge and a powerfu l computational infrastructure . To overcome these 
chal lenges, an automated pipel ine for analyzing the generated data should be 
developed loca l ly. However, choosing appropriate ana lysis tools ,  applying 
sufficient f i l ter ing steps, uti l iz ing su itable parameters, and then implementing 
them al l  in  an automated pipel ine is a chal lenge which requ i res advanced 
b io informatics ski l l s .  
4.2 .2 .  Establ ishing pathogen icity of  the identified genes and 
mutations 
Proving causal ity of recessive mutations in  candidate genes is 
essentia l for proper counsel ing of fami l ies.  Establ ish ing pathogenicity of 
m utations can be achieved us ing funct ional assays and/or an imal models.  
Yet, detection of mutations in  unrelated fam i l ies with s im i lar  o r  overlapping 
phenotypes is the most defin i t ive way to establ ish pathogenicity of novel 
d isease-ca using genes. This wi l l  be usefu l for many of those genes in which a 
defect has only been found i n  a s ingle fam i ly .  The way to f ind add it ional 
fam i l ies with mutations in  cand idate genes is by sharing genetic and 
phenotypic data. Another way of sharing could be ach ieved via estab l ish ing a 
m utation database for rare d isorders with a forum where researchers can 
easi ly communicate and present their  candidate genes and mutat ions. 
Estab l ish ing such a database requ i res advanced bioinformatics sk i l ls ,  a 
strong computational infrastructure and wi l l ingness to share i nformation 
among cl i n icians and scientists. 
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Appendix A - (JAM3 cDNA Cloning Site and A ssociated Tags) .  
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Appendix B - (All the Primers Used in This Dissertation).  
Exon 
1 
2 and 3 
4 
5 
6 
7 
8 
9A 
98 
1 0  and 1 1  
1 2  
1 3  
1 4  
1 5  
1 6  
1 7  and 1 8  
1 9  
20 
21 
1 
2 
3 
4 
5 and 6 
7 
8 and 9 
1 0  and 1 1  
1 2  and 1 3  
1 4 and 1 5  
1 6  
1 7, 1 8 , and 1 9  
20, 2 1 ,  and 22 
23 and 24 
25 and 26 
Forward Primers 
OBSL 1 gene 
CAGTCTGGGCTCTTGTCCTC 
GTCAGGGCTGGATGAGAACT 
TCCCGTACCACTACGCTTCT 
GTGGTGTTCCACGGTTCTG 
TGCTTGGGAATCCAAGAAT 
CTCTGGTGCCACATGATCTC 
GCAGAAAGTCTGCTGTGCTT 
TCTGGAATCCAAAGCATTCTG 
AGCTCTGCTCCACAGCTCAT 
TGGTCAGAGTAACTGATTGAAAAA 
GTGAGTACAGCCTGGGCATT 
TGGGGTGCTAGGCTAGGATT 
GCAGGGACCGTGACTTTG 
ACACTTCTCCCCCTTCCTGT 
TAACCCATTGGCCCTGTG 
AGAGGCTCCTGGCACGAC 
AGCCTCGTCCCTGTTCTTTC 
CAAGAACGCTGCCTCTCTCT 
TATCCCAAATCCCAGCATTC 
CUL 7gene 
CCCCCATGAAGAGTTACGTG 
GTGCAGCATGCAACTCCTG 
GATCGTGTTTATGTGCGTGTG 
AGGGCATTCAGCTACCACAG 
GGAGAAGGCATCCTGTGTGT 
GAGGAGGGGTCTGGAATTTT 
AGCGAGACTCCGTCTCAAAG 
AACCACCTGGCTCTTGTGTC 
CAACCCATCAACATCCCTTT 
TCTTGAGCCCCACAGAAAGT 
I CTCCAGTGGGCTGGGAA T 
CCTCAAGCGATCCTCTCATC 
TGCGCCTGGTCTTATTTTCT 
ATCCTGAGGCTTGCCATAGA 
TCTCTGAAGGCGGTCTCTGT 
PALMDgene 
283 
Reverse Primers 
GGCAGTAAAGCACCTTGAGC 
CTTGTGGCCCTTGAACATCT 
TCTTCCCCGTCGTATACCTG 
TGTTGCATGTGGGTTGAAAT 
TGAGAGCCTGTCTCCAAAAA 
AGGCTTCCTTAGCCAAGACC 
AGGGGCTTGTTTCCTTGAAT 
CGAATGGATGAATGAACGAA 
TAGACTGGCCCTCAACAACC 
AGGCTCAGGGCTTTGAGGA 
AGCCCCTGCTTTTAACCACT 
CAGCAGCTCTGTCTCTGGTG 
GCAAAATCCACATGGACTTCTAA 
CCACACAGGGCCTATGAGTC 
TTACAGTGACAAGACCTACCTCCT 
CTAGAGGTCCGGGACTAGGG 
TTGCACCTCAGACCCAAAGT 
GATCTGAGCCAAGCAGTTCC. 
CCAAACTGTGTGGCCTCTG 
AGGCCCCATAAGCTAGAACC 
TTCCTTTGCATAAAAAGCAACT 
GGAGAAGAGCACCCTTCCTG 
ACCCAGATTTTCCCAGCTCT 
ACCCTCCCACCTCTGAAAAT 
GCTTCTCCGTTTGTTGCTTC 
GCGTTTTGATTTGTGAACCA 
TAGGTCTTGGGGTTGTGGTC 
TCCAGTCCCCTCACTGTTTC 
CAGCCCACTGGAGAAATCTT 
ATGGTGTCCCCTGACACTTG 
CTCCACTTCCTGGGTTCAAA 
CACACCCGGCTAATTTCTGT 
CCGTCTCTTCTCCAAGTTCTG 
CTCTGAGAAGGGGCTGAGTG 
1 CCCCTAGAGCTAGCAAGCAG ACTCGTCCATGAAGGCTGAC 
2 CACTTCGCTCTCCTTTGCTT TGGCCTCCCCTATGGTTATT 
3 GCAAGGCACTGACAGAAAAT TGAAAGCGTGCCTTAAAAA 
4, 5 and 6 CGGGCATTAGGTATCTTCCA CGGTGACTCACATAACTCACAGA 
7 1  CATCTCACATACAAGAACATGAAGG CACTGATCGGGGATGAGG 
7 2  GGACTGGGTATTGGTGTAAATGA AGGTGGTCAGAGAAGCCTGA 
-
8 TCAATGCTCACACTGTTGGA CAAGCTCTTATTAGAAATGCTTTGG 
A GL gene 
2 GAATTTGGGAATGGGGAGAT TGGGAATTAGTACGCAGAGAAA 
2b I TCAGCA TTTGA TGACGGGT A GAATGGGCAGGGGATATTTT 
3 CCATGGTAGCTCCCAAGTTT GCTCTGCAATGGACCATAAAA 
4 CCAACATTCTTGGATATTTTGTG TAAGACATGCCTGCTTCCC 
5 AAACTTGCTTAAAGTCTCTTGTGG GATCACTCTCCTGTATTTATAAGCAA C 
6 and 7 TGCTGAAGCGAATGATAGG TGCCCTTTAGATGTTTCTGC 
8 GAGGAAAACGGGTTCCACTA TGGCTGATGATGTTTTCCAA 
9 and 1 0  CAAACCTTTATGGCTAGTATGATTTTC TGCAGTCCTCCAGAAACATT 
1 1  GATATGCTGTCATGTTAACTCCC TTTGTTGGCTCCATGTTTTC 
1 2  TCCCTTATGATGCGACTTGG TGCACTCCATATTATCAGAAACG 
1 3  TCTCAATATCTTTGCAAAATCTAATC AAATGGTTTTGTTAGTGAGTCTTCAG 
14 and 1 5  TGAGCCATTTCTCCAGTTAAG ACCTGTGTTTGAAGGCAATG 
16 and 1 7  TCAGCGTATGATGCTCTTCC TCATACCTGGCCAAGTTACC 
1 8, 1 9  and 20 TTCCCTAGAGCTAAGCTATTATTTTG TGCATGTAGGCATGTGTGTATC 
2 1  TGGTTTGGGAGTAATGTCGC GAAATTGGCACACAAAGAGG 
22 and 23 I TTCTTGAGA TGCTTTTGGGC GGCAAATTTCATTCATAGTAATAGTG G 
24 AATGGGTGAAATGAAAGCAG CACACATAAATGCCTGGTGC 
25 TGACAAGATAATGGAATCTCATTTG TGACTTCAAAGATTTTCACCCC 
26 GGGAGTCACACAGATTGTTAGC TTCAGGCAAAGACCAATCAC 
27 TTGTATGCTCGTCTGTATTATTTGG TTTCAAACTGGCTGACAAAAG 
28 AATGCAAGCAATGTGGCAG CAACCCACGAGCACTTACAG 
29 TGTGAGGATGATAGACAATGGC CAAAGTTGCGACAAATATGGTTC 
30 TTGGGTGGTGCTACATCTTC TGTTACAGGTTAAAAGTGATACGC 
31  GGCTTTCCTAACTTCTACGGC TACAGCCTTGATCTCCTGGG 
32 and 33 GATTAAAGTCCTGTGAACTCAGTATG AACAACCCAAAATAAGAGAAAGTG 
34 TTCCAAAGATGGAATGTCAAAG TGAACTCAAACACATTTCATTGG 
SLC35A3 gene 
1 TAGGGACAGAGCTGCCAAGT CACCAAGTAAGAAACTGCACCA 
2 GCTGCTGTAGCACCCAAAGT ACTAGGCCATTCGACAATGC 
3 AACTTTGAGATTTTGGCTGTCA CCTGATTTGATCATTACACATTGG 
4 GCATGCTGCCATAGTCCTTA TCACATAAAGGATGCCCTCA 
5 CTCTCCTTTGCAGTCCCAAA AAAGACAAGAGCATTGCCAGA 
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6 CTGGGCAACAGAGCAAGACT CAAAGTTCATTAAAGACCCCTGT 
7 GAGGGCTATTGAACAAAACCTG TTTTCAGGAGAAGACTTTCTTTCA 
8 . 1  CTTAGCCAGATACCTGGAATGTA TTTGCAAAAATTGGTATCTGACA 
8.2 TTGCTGCAGAAATGTCCTATG TGGCAATCTGGAATGTCTCC 
HIA T1 gene 
1 GCGAGGATTTAGCTAGCTGGT GAGCAGCGGAGGACGATT 
2 TTTCGTTGTTGCCTTGTCTG AAATTCAAACACCTCCACGC 
3 CCAATGTAGTGCCCTGTGAC GGTTTATTATTATGCATGATTGGC 
4 GGAGCCCCACAGATGATTC GCCAGAAGTCTAGATGCCTCC 
5 GCTGAGCTGCTATTGAAGGG AAAACTTACATAGCCTCATACCGC 
6 and 7 GCAACAGAAGGCCTGACATA AGGCGTGAGCCACTATACCA 
8 CCCACCATGGATAAGTAGGC CATGAAACTTCTAACTTCATCCAGAC 
.-
9 TCAGCAGAGGGACTTTTCATC AAAATTCAGCCTGTCATTTAGC 
1 0  TTGTGAATTAAGTTGCTGTCTTTG GCCACATATTCTAAGTGAGAGAAAAG 
1 1  TCAGAGCTCATGTTTGCATAGG AGCCAATTTTCACAAGGTGG 
1 2  TTTGCCAGTTGTTATTCCCAG TGGAAAACTGTCTGGTTCTAAGTTC 
SASS6 gene 
1 TAACCGCATCTACCCTCAGC CTCACACCCTTCCTCCAGTC 
2 '  TTACTCACTAGTGGAACAAGAAGAAA ACTCCAGCCTGGTGACAGAG 
3 GAGCGGAATGTCTACCCCTA TCAGCAAAAGCTTCAAACTTCA 
4 AGGTTGCAGTGAGCCAAGAT CGGATGACTTTAGTGCCTTTG 
5 TGGCACTCAGTGAATTTTTGTT GTCCAGATCCATCCCGACTA 
6 TGGGGATCTTGTTAAAATGATTTAG AATGAAGACTCGAGGGAACA 
7 GGCCGTTTTGGGTCTAAGAT GAACAAAACCAAAAACCCATT 
8 CCTTTTCAGAATGGGGATCT CAGCTGTGCCAGTAATCTGC 
9 and 1 0  GAATTATTTTCCCTTGATATGATTGAA TCCTCCTTCTCAGCCAAGAG 
1 0, 1 1 and 1 2  GCCACGAGAAAGAAAAGCAC CGGGAGGATAACTTGAACCA 
1 3  GGTGAACCTATATTGCTCTCCTG TCAGCCTCTGTTCAGAGCAA 
GCAGAGTTGTGTGGCATGAT AGTGCATATATTTCCTGTACACATAG 1 4  A 
1 5  GAAGGATGAGGTGGGAGGAT TGTTGGAGGAGGAAACAGAAA 
1 6  and 1 7  CCATTTGCTTAAGAAACCAGTG GCCATGTTCACAAACCAAAA 
LRRC39 gene 
1 TGCAGATCCATGGTTTACTGG ATGAACACCCCGCAAAAA 
2 GCAATGGGTAGAGCCATGAT AGAATCGCTTGAACCCAAGA 
3 TGAGACCCCCAAGAAAATTG CGCATAGACAAATTTAATTGAGTCAG 
4 TGAAACTGGAAGGCAGAGGT GTTTAGGCAGGGTTGAAGCA 
5 ATCCGGAAGTCACACAAAGC TCCACAAACTTGAATCCCCTA 
6 CAGGAAAATGGCGTGAACC TTTCTCCAGTTAAAACCTGCATT 
7 CCCTGGAGGTCATTTAGCTTT CCCAAACCCTTTTACTTACTTGG 
8 GAGGGGGAGAATAGCCTGAG GGATTCTTTCTTGAATAGACCAGTG 
9 TGCAACTAGACTAACAGTTGCTTTT CCTTCCCCCACTTGAAAGAC 
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1 0  TCCAGATCTGTAGGGAAAAATG GGTCGAATCCAGTATTTGCAG 
OBT gene 
1 TCCTAGGGTTTAGCTCAGGC TTCCACTCCAGACTGGTCG 
2 TCAGAAGGAATTTTGGGTAAGG AAAGGGGTGCCAGTGTTAAG 
3 GGCAGTGCCAGTAAGTCTGTG CACCACTATATCATCAACACAAGG 
4 I TTCTTGCAGAT ACA TTGAAGAGAC TTCTATTTTGTGTTGAACTTGCTACC 
AGGAGTGACATATCCACCAGG AAATGGTAGCTCTTACTGTTATTAGG 5 C 
6 TTACCACATGCATATGTGAACAG GCACTACAGTCTGGACAACAAG 
7 GATGCAGTCAGTGTTCCAGC GTGGCAGGTGCCTGTATTC 
8 TGGCCTGAAGGTAACATTGG TCTGCCATACAGCTATGTATTTCC 
9 and 1 0  CAGGTAATCCAGCCACCTTG CTGTCGTGGGGTCTGGG 
1 1  ATGGGAAGAGTAGGAATCAGC TAAAATGTGACAGCCCCAGG 
RTCA gene 
1 and 2 CCAGGATCCTCGAGAAAACA CTGGATCGCCCATACCTG 
3 TCAGCGGTCTCAGTCTTTTG CCCTCCGTATCTCAGAATGTG 
4 AACTGGTCTGCAAGGAAGTG AGTGAGCAGTGATTGCACCA 
5 AAATACTGTTTTTCTTTAAAATTCAGG AGCCTTGGCAACAGCACT 
6 AAAAATGGAACCAGCCTACA CCCATGCTCCTGCTATTCAT 
7 TCACATATCTCAAGGCTACCACA GCCATATTGCCACAAAGGAC 
8 CATAAGCATATTTAAAAATTCAGTGC GGACAACAGAGCGAGACTCC 
TGGTAAAGGATACTACTGGTCTGA TGAAAGTGTAATTGACTCTAAAAGAG 9 A 
1 0  TTGTGTATCCCAAACACTCAGAA GTCAATTGCGCAAAACACTG 
1 1  TGTCATCTTCTGAGTATGTCTGGA AGCTCAGTGCCTGTCACACA 
1 2  TCATCAATCATTTGATCTTTGTGTC CAGCTATCACACATATCCACCAA 
COC 14A Qene 
1 CTGCTGCGGAGAAAGGAG AAGAAAGAGAAGCCGGAAGC 
2 GAGGGATGAGGTTTCTGCAA CCAGGCACCTGAGTCTTAAA 
3 GAGGGCATTAGGACGAAACC TTCCAGTGACTTCATTCAGCTC 
4 AACCCTCAAATGCCATAGAAA CAGATCAATTCCCAAACTGCT 
5 ATGGCCTCTTCATGGATCTG TCTTGCTAGCTAGGGGGATAAA 
6 ·  GCAATTTCAGAAGTGCTTCAGTT TCATCCTTCAAGAAGTGAAAAGC 
7 AGACAGTCTTAATGCAATATAACCAG CCAAGGCTGAAAGGACAAAA 
8 TTGAGAATCAGGTGCATGTTTT TGGGGGTCAGGTAAAGTGAA 
9 TTCTCTCACACAACACACTTTCC TTGTGTCCCAGTTGTCTGAAA 
1 0  CCTTCATTTTGCCCTTTTCA TGCATTAGCTGTCAAATCAACA 
1 1  TTTTGGCTTTTTGAAAGTGAC TTGCTATATAGACGGATGGCTCT 
1 2  TGACAATGCTGATTCACAGTACC GAGATGGCAGCAGTTGCTTT 
1 3  GATAGCAAGCCTGGTTCTGG AAATCCTTTTCATGGTGAGCA 
1 4  TTAGAACAGTGCCTGGCAGA TCCCTCCACAACCTTGTCTC 
1 5  AGCCATCCTGACATCATTCAC GCTCAGAAGGCTTCCTTGG 
286 
1 6  CCTAGCTAATGCTTTGTGTCTCCT AAATnlTGGTAGCAAACAGCAG 
GPR88 gene 
2.1  CTGCTGAATCCAATGCAAAG CCAGGTAGCAGTGCAGCAG 
2.2 CTCGTGCTGCTGCTCCC GACTTTAGGATTCCTCTAAAACACAG 
VCAM1 gene 
1 TTCTGCAATCAGCATTGTCC CTCAATTGCCTTTGGAAAAA 
2 GCATCAAGGTTGGAACTGAG TTTGGATTCCTGCTCTCTCTC 
3 TTTGCTTCCAATTCTTGTGC AAGCTCAAGCCTTCTCAGTCC 
4 TTACCCTTAAGTGGGAGGTTAAG AAGCAGAGCCATGGAAACTC 
5 TCATTCTTAAAAGATGTGGGCTC AAGGATTGTGGGTGCTGTG 
6 GTCAAGCCATGGCACACAG ACTGCCTAGCTGGTCCCTTC 
7 ACCATGACGTGTCCATGTTC CATGAGAAAAGACAATTTCAGGAG 
8 GAACATGAAAGAAGCATAAGCC CAACTTCCTGGCTAAACTTTATAGG 
9 CAAGTTTGTGGAAGCCAACA CAAAGGTCAGCTGTCAGCAA 
EXTL2 gene 
1 TCTTTCGCTTCCAGGTCATC ACGCTAACAAAGGCAAATACA 
2 AAGGTGCCTGCTTCATCTTC GGGCTGGGAGTAGGAAGAAA 
3 TAACAAGCAGGGCAAGAAGG TAACCTCTTCGCCAGGAAAC 
4 TCCCTTCAGGCAGTTATACAATC CTTTCAGGATGGCTGAACTAAG 
5 TTGTGATGCCATTTGACCTG GGATAAGACCAACTTCTTGGC 
SLC30A 7 gene 
1 and 2 GTAAGCGAATTCCCGGGTG CGTGACAAGAGAGGTTGCAC 
3 CTTGTGCAGGAGGTACGAGG GAAAGTGGTTACCCTTGGGG 
4 TCTGTTTTGTGGCATTCTGC CCAGATTGTGCCTCTACATTTC 
5 CCACATAAGAACAAGTTTTGGACC AGAAGGCACTGAGATGGAGG 
6 GCTTTCATTACCTTCTGGTACTCC AAAAGCGAACATCCACTGC 
7 TGCCACTAAATTTACCTCCACTC GACATGCCAAGTGCACCC 
8 CAACCCCTGTTGATTTGAAAC GCTATGAGCCGAGACAGTGC 
9 TTGAAAATGTGCTGGGTTTAG AACTCTATGTTGAATGAATATCTCTG C 
1 0  AATACTTGTCATGGCACCTGG GGACTATAGGCGCATGTCAC 
1 0b TGGAGTATGGTTTGTACATTATTCTC CACACAATTGTTACATATTCATCCAA A 
1 1  TCACCTGGATATCTGGATAGGG GAAAAGACCAAAAGTCCAGGAG 
DPH5 gene 
2 CTTCTGCGGAAAGGTGGTAG GCTCCCTCCTCCCATAACAT 
3 TGGACCCAGCCTTACCTACA AAAATTTATAAGGATTGCTGTAGTGC 
4 CCCCAAATACAGAGTTTAATTGC ACTAGCTTTTCTTCACTAATCTCAAAG 
5 CCAAGGCTGCTTTAGGAGTG TGCAGCATCACAATGCTCTT 
6 and 7 GAATTGATAATTGCTAGAAGAAAGAA AAGTCTGAGAACCACAGATTTAGG A 
8 and 9 AACACTCCTTCATACACACAGACAT TGGAGATGGTGGAAAAGGAC 
1 0  CCAAAGAAACCTTGGCTGTC ATTTATTGAATGAAAATTTGAGTACCT 
287 
1 1  and 1 2  TGCCTTATGCCTAATGAGTGG GCCTAGTAGTGCCTTGCACA 
1 3  ACCCAAGGCTGAGAAAAGTG CACCCAGGTTCACCATCAC 
1 4  and 1 5  GAGCATTCCCTCAGGCTAGA CTAGGGCAGGGCATAAGAGG 
1 6  TTCCCTTGTCTTCTTTTCCAA TCTCAGTGTTGAATCCACAAAA 
1 7  CCAAATTGCCACTTACTTTGAA CCTCACTTTCTGGAATGGTGT 
1 8  TTCTGAAAGGGTAAAGTTTGGAA AGAGCCAGTAGGGGAAATGC 
S 1PR1 gene 
1 I TTGTTTAAGGCTGCGGTTTC ATGGCGAGGAGACTGAACAC 
2 GCCACCACCTACAAGCTCA TTCGTATTCTCCCCCTTCCT 
C0L 1 1A 1  qene 
1 TCAGCCTGCTTGTCAGTTTC CGGGGAGGAAGGGTAAAGT 
2 GTTAGGGAAGCATGGCAAGT TGGTGACCACAAGGTATTTGG 
3 AAACCTTAATGGAGGACCCCTA TCACCAGCCTCTAGAAAAACC 
4 TGCTTGTGTCCTTTTGGGTA GGTCACCCTTTAGAGTTTTCAA 
5 GCCGATTTGTAAAATAGGTGTTTC AACAGCAAGAAAACAAGTACCAAA 
6a and 7 GGAAATGTGCTTTGTCACTCC GCAAAACCTGAATTGGCATT 
6b GGAAATGTGCTTTGTCACTCC GCTCCCAACTGAGGCTTAAA 
8 and 9 TCCCATCACACGCTATCAAA TCATTGGTAAAACACGAACATACA 
1 2  and 1 3  TAAGGTGGAAAGGGCAAATG AATGGTAGCATCTTCCGTATGT 
1 4  TTTGCAGTTCTTCAGTAACCTGAC ATGCACAATCCCTGGAAGAA 
1 5  TCAATGCAAGTGCTGGAAAA AAACCCTCATACATCAATGGAA 
1 6, 1 7  and 1 8  TGAAACCATCTCTCTTGATGCT TTTTTCTGATTTTGCAAATTGTT 
1 9  and 20 CCTGCCAAATGTCCTGTTTT TTTCGCATGGCAATTATCTG 
21 and 22 TGGACATCACTTTCAGTGTGTTA TTTCCCTCATGAGATTCTGGA 
23 and 24 TGTTTGAGGGTGGGTAGAGG TTTCCATGTCGACTCCAGATT 
25 TTACATGGCATTTCCTCCAA TGCAATATGGAAGTGATATGATGA 
26, 27 and 28 . AGCCATACACACTGATGCAAA TTCAAGAAATAAAATGTCTGTTGAAT 
29 AGTTGGAAAAGGGAGGAGGA TCTCCACAAAAATTAAAATCCTTAAA 
30 I GATCAAGGGCAGTTTGAAGG TTTCTGGAGGCAAATTTTAATG 
31 CTGCAAATCTTCCTTTTGAGTG GGCGTCCACACACTCTATGA 
32, 33, 34 and 
35 TGTGAAAATCACTCTGTTCCAAA GACATGCACATGTATTAGCAGACA 
36 TGTCACTGTGATGAAGAAGCTG TTCAGAAACGATCTATGAACCTTA 
37 GAGCAAAGTAAAATAGCTAATGGAAA AATTTTTCCATTTTTCTCAACCT 
38 TGGCAAGTTTTGAATTTTAATGA TTGATGTACGAAAGCTGCATA 
39,40 and 41 ACTTGGACTGGCCACACTCT CCCACACACTGTGGAATCAC 
42 TGGATTCAACTGTTTCTCTTTGG CCAGGGTATTTACATGCCAGA 
43 TCACAAATGAAGGTAGGGAACA TGTGTGTGAAACTTTGAAAAAGG 
44 GGGAACCCAAGATTTTCCAT AACTGCAGAGGTAATGTAGTATTGG 
45 and 46 TCCAAAGGAGTGCAGAAGTG TTTACATCCACCAGAAAACCTG 
47 CATGTGGTCAACATTTGCAT CCTGCTCCAAATCAAAATCC 
48 and 49 AACCCTGATGTGCTTCACTAAC GGCTTAGAAACACACATACTAGAAGC 
288 
50 and 5 1  CAGCATCAAGCCTGCATATT ATTTCTCTTCTCCCGCCAAA 
52 and 53 TTGGCGGGAGAAGAGAAATA GAGCTATGTTTTTCAAAGGCTGA 
54 TGGAAATGAAGAAAGAGGGTTG AGCACAGAGGAGTGGAAAGC 
55 and 56 AAAA TGGGTTTTGA TTTTCGTT TCCCACAAAATTATCCACGTT 
57 CATATGGTGGAACTTAAGGGTGA TCTGATCAAGTGGTTTATTTTCCA 
58 GAAGCCTTAAAAATAAAGCAACAT TGGGAAGCTAAGGATTGAAGC 
59,60,61  and 
62 CCAATGCTTAATAAAGCCCTCA TGGCAGAATGTGCTTTTTGT 
63 GCTAATGAAAAGCTAAACCAACTC GACAAGGATTTTCCAAAGCAA 
64 . TACCCCAATATGCCCAAAAG TAGTGAGCAAGCAGGTGCAG 
65 CAAATTTTTCTCTTTGTCTCATTTTG GAGACCACAGGGAATCCTCA 
66 TGCTTCTGGCATCACAGTTC AACATGTCAAGATTAAGCAACAAA 
67 CCTCCACTCAGAAGCCCAAG TTCAAAGCTTTTGCCATGTG 
RNPC3 gene 
1 AAGAGTCTTCGAAGGGTTGC CCGATTAAAACTCCACTTCGC 
I GGTTGCAT AGCTTTCATCTCAAG AACACTTGAAACATCTTACCTTGTAA 2 C 
3 TCAGCTGCCTGGGTATAAGC CCCTTGCCACTTCACAATG 
AATACAGAAAGGATTCAGTGAAGG GACAAACTCAACTCAAAATGTTTATT 4 C 
5 CTGCCAAGAAATGCAGTAGC CAAATTACATTTCCCAAACTAGC 
6 ·  CATGTAGAATTGACATTTTAGGAAGG GCATTTCTTTCATATTCCGGC 
7 TTCAGCTGAGGGTAAAGGAAG CAAATAACAAGGCTCGAACG 
8 AAGATGAAAGCTAAGCAAGGC CAGAGAAGAGAGTAGTGGTCAACTG 
9 ATTGACATCGCTGAACCTCG TCTCACCGTTTACCATCAATTTC 
1 0  TCATGGCTAGTCACCCTTTAAC GAAACACTGTATGGAAAGGAACG 
1 1  GGTTTGGGAAA TTCACTTT AAGC TTGTTTCAGCCACTTAGCCC 
1 2  GCGAACTTTCACCTTCCTTG CAACTACAAAACTGAGTAATTCCAAC 
1 3  TTGTAGAATCAATTTTAGTGCAGAAC AATTGAACAACCTCATGCTGC 
1 4  AGGTAAAGAAGCAAAGGCCC GAGTAACAGGCACACTCCCC 
AMY2B gene 
3 CCCAGCAATATATCATTGTGTATG TTGGAGGGCTCTTGTTGAAG 
4 AGGCAACATTTTACTTCACAGG TCTGCTTTAAACTTGTTTCTTTGG 
5 TGTCTAGAAGGCATGTAGGTGTTTAG AAAGTGGGCAAATGTGTATTG 
6 AAGCTCGTCGACTTTATTTCC TTAATTGGCTCACCACCCA 
7 TTTAACCTCCTCTTCACATACAGC GGCATACTCACTTGTGATAGACAC 
8 and 9 GGAGTGCCTCTAAATGATAATGTG TCATATGTCTGAAAAGGCTTGC 
10 and 1 1  TGGCAAAAGAGAACCAGAGG TGAAGGAGTAACAGCCATCATC 
1 2  AAGGTTACTTTTGGTCCTAGAAAGC TCTTCTAAAGCATAACAACTTGCTG 
AMY2A gene 
1 CCTTGAGTTGGAAGGGGTTC GAGGGCTCTTGGTGAAGAAA 
2 ATCTGTGAAGCTTGGGCAAC TTCCGGGAAATACGAACAG 
3 AGGTGTTTAGTTCACATTACTTTCC AGAAGTGGGCAAATGTGTATTG 
289 
4 TCCCAATTAAAAATCTCATCGAC TGTCAAAGATACCTGTTGTCCTG 
5 AGTTTGGGACCATCCTGGAC TTGCCTTGTGACAGACACTC 
I TGCTGAAACCTCTGAAAGGAC -6 and 7 GTTTCCCTGCGGGCTAAG 
8 and 9 I TGCCAGAAGAAAACCAGAGG GCATATGATACTGCAAGGGTG 
1 0  AAGGTTACTTTTGGTCCTAGAAAGC TTTCTGAGACATCCTTTTGCC 
AMY1A gene 
2 GGGCTGTTACTTGCCTTGAG ACATCGGAGGGCTCTTGTT 
3 ·  TGGGCAACATTTTACTTCACAG CAGGAAATATGGATAGTTATAGCGG 
4 TGGTAGTTTCCGGTTCTCTCAG TTTTCAATTGGTTGGGAGC 
5 CTCTTAGGGACAGAGGTTAACAAG CATTCTGTGTACCTCCATAAAACC 
6 GAGAATTCCTTGAGGCCTGG AGCGTTCCTAGGCATACTGTC 
7 and 8 AATGTGCTGAAACCTCTGAAAG TTCCAATTAAACCTGAGGAAGG 
9 and 1 0  TGGCAAAAGAGAACCAGAGG GAAGGAGTAACAGCCATCATCC 
1 1  TGAAAAGGAAATTGGTAGGTTTTC TGTTGGTAGAATGCCAAGGA 
C0L 1 1A 1  eDNA 
AACCATCAAATTTAGAAGAA ATCCGAGCCTGCTGAAGAAT 
ATGGAACAATGGAAAGTTACC AATCCAGTGGAACCCTTTGGA 
GGCCCACCTGGCCCAATGGG GGACCAGTCTCACCGGTTGG 
AACCAGGACTTGCTGGACTT CCATCAGCTCCATTGGGACC 
GTGCTGATGGGCCTCCTGGT AGGACCCGGTTGACCAGGAT 
GACAAGGGTGAAATTGGTGAG CAAGTCTCACCACCAGATGTG 
ATCCTGGTCAACCGGGTCCT GGACCAACTTCAAATCCGAAC 
TTGTGAGTTTGAGTTCACAG GGTAACTTTCCATTGTTCCAT 
TGACAATGATTGTTGATTGT CATGGCCATTTATGCTTGT 
ATGGAACAATGGAAAGTTACC ATCCGAGCCTGCTGAAGAAT 
ACAAGCATAAATGGCCATG AGGACCTTGAGGACCTCGTT 
AACGAGGTCCTCAAGGTCCT AATCCAGTGGAACCCTTTGGA 
GTATGGCAGGTGTAGATGGC GGTCCAGGGAATCCAACTGG 
TCCAAAGGGTTCCACTGGATT CTCACCAATTTCACCCTTGTC 
CCAACCGGTGAGACTGGTCC CCATCAGCTCCATTGGGACC 
GAGGTCTTCCTGGAGCTCAG AGGACCCGGTTGACCAGGAT 
GGTCCCAATGGAGCTGATGG CTGCTTGCATGCCTTCAGTAT 
ATCCTGGTCAACCGGGTCCT CAAGTCTCACCACCAGATGTG 
ATACTGAAGGCATGCAAGCAG GGACCAACTTCAAATCCGAAC 
JAM3 gene 
1 TGGAAATATACCCTGCTTCACTC CATCCCAAATTAGCTCCCC 
2 CTCTTTCCCTTGGCTCCTTC AAAACTGCACAGGGCTCACT 
3 GGGTGTTTAAGGGAGGGGTA ACTGCACTTGTTGATGCTGG 
4 AGTGTGTCTTGCACACCAGG TCAGGCAGTCTCAGCTCTCA 
5 TGGCTTGTCAGTCTGCAGTT TCCCTCTTCGGTCTCAATCT 
6 GGAGCTGTCAGGCAGGTATC TTGCAGTGAAAGTTGCAAGG 
290 
7 TTTCAGTGCGACTGCATTTC AAGGGGGAATGTTGnnTCC 
8 GTACTGGCCCTGATCACGTT CTGCAAAGCCAACACACAGT 
� GTACCCAGCAGGGAAAACAA TTTACCGGGTCCATCTTGAG 
LMNA Qene 
2 CAGCGCTGTTCGACTGG AGAGGGGTCCCTGCCTC 
3 CACTGTCTAGGCACACAGACTC GGGGAGGGCCTAGGTAGAAG 
4 CCCACCTCTCAGCTTCCTTC CCAAGTCTGTCATCACCCAG 
5 CCCTGGGTCTTGGCCTC GGGTAAGGGTAGGGCTGC 
6 GTGATGCCCAACTCAGGC GGCTTCCAGCCTGCATC 
7 TTGTGATGTTCAGAGCTGGC TGGGATGAGTGAGAGGAAGC 
8 GGAGATGGCCGAGATGC GTCTTGCCACTCTCTCCCTG 
9 and 1 0  CCAAGAGCCTGGGTGAGC GCAAACTTGGGTTGGGG 
1 1  GGACAGAGTAAGCAGCAGGC CCAGCGAGTAAAGTTCCAAAAC 
1 2  CCTGAGTGGTCAGTCCCAG CTACCCCTCGATGACCAGG 
1 3  CTCCCTTCTAGGGGCCAG GAGGTGAGGAGGACGCAG 
ZMPS TE24 gene 
1 GCTCTGAAGGGACGAGTGTC GAAGCCAAGGCTACTCCAGG 
2 TGGCAAGCTATAAACCATTCG TTCTGGGACTTGTAAGTGTGG 
3 TGTCCTTTCTTTCTTTATACCATGC TTAGTGGAAAGCCTGCCAAG 
4 AAGCATATTGCTTGGGATGTAG CCCCAAGACTTTCAGCTATG 
5 "  TGCAAGACATTTACCCATTG TGGTCAGTCAATACTCCTGTGTC 
CCTGGGAATACCAGAGCAAG AAGGTAAACTCCTAGCCTTTAAATAA 6 C 
7 CTCTCCAAAGGACCCCAAAC TCCCTGAATTCAACACTCACTG 
8 GAAGGGCTATTACTGGGTTAAAAG CTCTCATGCCTGCCATAGTTC 
9 TGGATGCTACTGATCCCATAG AAGCTCTAGATTTGAAGCAGGC 
1 0  CAGTCTCAGCTCATGGAACC GGAACATGCTGCCAGGAC 
LlNS gene 
CATCATGTAGCGGTGGACAT TGTAGGCACAAAAAGCTGACA 
LlNS eDNA 
CGATTCTAAATTAATCTGCATGTTCC CATCCTCTGGTCAGTGTTAAG 
POMGNT1 gene 
AGTGGCCTACACCGGAAAAG GGATAGCTCTTTCCCCAAGG 
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Appendix C 1 - (Real Time-PCR COL 1 1A 1  Gene Expression Results).  
-
Block Type 96alum 
Chem istry TAQMAN 
Experiment Run E nd T ime 20 1 3-06-26 09:53:47 AM GST 
I nstrument Type sds7500 
Passive Reference ROX 
Reporter FAM 
Quencher N FQ-M G B  
Ct T hreshold 0 . 2  
Sample Name Target Name CT CT Mean CT SD l1CT Mean 
l1CT S E  MGT R Q  
Control HPRT1 24 40 24 48 0.08 
Control HPRT1 24.42 24.48 0.08 
Control HPRT1 24.55 24.48 0.08 
Control HPRT1 24.56 24 48 0 08 
Control COL 1 1 A1 20.78 20.83 0.22 -3.65 
0. 1 2  0 1 
Control COL1 1 A 1  20.91 20.83 0.22 
-3 65 0 1 2 0 1 
Control COL 1 1 A 1 20.54 20.83 0.22 -3.65 0 1 2 0 1 
Control COL 1 1 A 1  2 1 .08 20.83 0.22 -3.65 
0 . 1 2  1 
Patient HPRT1 24 06 24.21 0.20 
Patient HPRT1 24 1 1  24.21 0.20 
Patient HPRT1 24 1 5  24 2 1  
0.20 
Patient HPRT1 24.52 24 2 1  
0.20 
Patient COL 1 1 A 1  29 04 29.37 0 25 5 . 1 6  
0. 1 6  8.81 9986 0.00221 
Patient COL 1 1 A1 29.38 29.37 0 . 25 
5 . 1 6  0. 1 6  8.81 9986 0.00221 
Patient COL 1 1 A 1  29 42 29.37 0.25 
5. 1 6  0. 1 6  8.81 9986 0.00221 
Patient COL 1 1 A 1 29 66 29 37 0.25 
5 . 1 6  0 . 1 6  8.81 9986 0.00221 
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Appendix C2- (Real Time-PCR COL 1 1  A 1 Gene Expression Results) .  
Block Type 96alu m  
Chem istry TAQMAN 
Experiment Run End Time 2 0 1 3-06-25 1 0 :54:40 AM GST 
I nstru ment Type sds7500 
Passive Reference ROX 
Reporter FAM 
Quencher N FQ-MG B  
C t  T hreshold 0 . 2  
Sample Name Target N ame Cr Cr Mean Cr S O  6GT M e a n  6Cr S E  M GT  R Q  
Control HPRT1 
24 7 3  24 78 0. 1 2  
Control HPRT1 24 67 24 7 8  0. 1 2  
Control HPRT1 
24 76 24 7 8  0 1 2 
Control HPRT1 
24.95 24 7 8  0 . 1 2  
Control COL 1 1 A 1  20.88 20.96 0 08 -3.81  0 08 0 1 
Control COL 1 1 A 1  
20 99 20.96 0.08 -3.81 0.08 0 1 
Control COL 1 1 A 1  
20.89 20.96 0.08 -3.81 0.08 0 1 
Control COL 1 1 A 1  
2 1 03 20.96 0.08 -3.81 0.08 0 1 
Patient HPRT1 
24 4 24 45 0.02 
Patient HPRT1 24 4 24.45 0.02 
Patient HPRT1 24.4 24.45 0.02 
Patient HPRT1 
24.4 24 45 0.02 
Patient COL 1 1 A1 29 29 29. 3 1 0  0.074 
4.86 0 04 8 66644 0 00246 1 1  
Patient COL 1 1 A1 29.31 29. 3 1 0  0.074 4.86 0.04 8.66644 
0.00246 1 1 
Patient COL 1 1 A 1 
29.22 29.31 0 0.074 4 86 0.04 8.66644 0.00246 1 1  
Patient COL 1 1 A 1  29.40 29.3 1 0  0.074 4.86 0.04 
8 . 66644 0.00246 1 1  
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Appendix D- (JAM3-Cell Counting Results).  
WT counting, n=6 
no.  of celis/field no. of transfected cells PM ER %PM %ER 
385 27 27 0 1 00 0 
380 29 29 0 1 00 0 
451 30 28 2 93.3 6 .66 
380 1 3  1 3  0 1 00 0 
291 23 23 0 1 00 0 
244 7 7 0 1 00 0 
2 1 31 1 29 1 27 2 
% 98.45 1 55 
SO 2.72 2 72 
C219Y counting, n=12 
no.  of celis/field no. of transfected cells PM ER %PM %ER 
465 8 0 8 0 1 00 
372 6 0 6 0 1 00 
41 0 8 2 6 25 75 
227 7 0 7 0 1 00 
455 3 0 3 0 1 00 
453 4 0 4 0 1 00 
1 56 5 0 5 0 1 00 
209 2 0 2 0 1 00 
226 2 0 2 0 1 00 
368 2 0 2 0 1 00 
31 2 2 0 2 0 1 00 
31 5 2 0 2 0 1 00 
3968 51  2 49 
% 3.92 96.07 
SO 7.21 7.21 
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Appendix E 1 - (Real Time-peR LlNS Gene Expression Results) .  
Block Type 96alum 
Chem istry TAQMAN 
Experiment Run E nd T ime 2 0 1 3-04-24 1 4 :43:50 PM GST 
I n strument Type sds7500 
Passive Reference ROX 
Reporter FAM 
Quencher N FQ-MG B  
Ct Threshold 0 . 2  
Sample Target RQ CT CT CT SD ACT ACT SE MCT Name N ame Mean Mean 
Control1  l INS 1 31 8 1 6 1  3 1  8475 0.04444 5.761 385 0.04391 0 
Control1  l INS 1 31 8789 3 1 .8475 0.04444 5 . 76 1 385 0.04391 0 
Parent1 lINS 2 263409 29 0390 29 0487 0.0 1 360 4 582888 0 07329 - 1  1 785 
Parent1 l I NS 2 263409 29 0583 29 0487 0.01 360 4.582888 0.07329 -1 1 785 
Pallent1 l I NS 3. 1 9 1 75 1  28 3452 28 5400 0.27551 4 087037 0 1 9489 - 1 .6743 
Pallent1 l I NS 3. 1 9 1 75 1  28.7349 28.5400 0.27551 4.087037 0 1 9489 ·1 6743 
Control1 HPRT1 26 0554 26.0861 0.04338 
Control1 HPRT1 26. 1 1 68 26 0861 0,04338 
Parent1 HPRT1 24 5384 24 4658 0.1 0275 
Parent1 HPRT1 24 3931 24 4658 0 1 0275 
Patlent1 HPRT1 24 4474 24.4530 0.00797 
Pallent1 HPRT1 24 4587 24.4530 0.00797 
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Appendix E2- (Real Time-peR LlNS Gene Expression Results) .  
Block Type 96alum 
Chemistry TAQMAN 
Experiment Run End Time 20 1 3-05-06 1 0 :23 :32 AM GST 
I n stru ment Type sds7500 
Pass ive Reference ROX 
Reporter FAM 
Quencher N FQ-MGB 
Ct Threshold 0 . 1  
Sam ple Name Target Name CT CT Mean CT SD ACT Mean ACT S E  t:.t:.CT RQ 
Control1 L lNS 
3 1  1 906 3 1 3 1 39 0 1 2455 4. 498495 0 0996 0 1 
Control1 L lNS 
3 1  4397 31 3 1 39 0 1 2455 4 498495 0.0996 0 1 
Control1 L l NS 
3 1 . 3 1 1 5  3 1 3 1 39 0 1 2455 4.498495 0.0996 0 1 
Control2 LlNS 
30.8503 30 7672 0.07572 4.688981 0 . 3 1 70 0 1 9048 0 87631 
Control2 LlNS 30.7021 30 7672 0.07572 4.688981 0.3 1 70 0. 1 9048 0.87631 
Control2 LlNS 30.7493 30 7672 0.07572 4.688981 0.3 1 70 0. 1 9048 0.87631 
Parent2 L l NS 
27.3032 27.3032 0.0691 0  
4. 1 08 1 23 0.062 -1 091 7  2. 1 3 1 35 
Parent2 L l NS 27 2055 27 2055 0 0691 0  
4. 1 08 1 23 0.062 - 1 .09 1 7  2 . 1 3 1 35 
Pahent2 L lNS 
28.5758 28.4577 0 . 1 0242 2.948256 0 2532 - 1 .5502 2 92865 
Patient2 L lNS 28.4033 28.4577 0.1 0242 
2.948256 0.2532 - 1 .5502 2 92865 
Patlent2 L l NS 28.3939 28 4577 0 1 0242 2 948256 0 2532 - 1 .5502 2 92865 
Control1 HPRT1 
26. 7464 26 8 1 54 0.09757 
Control1 HPRT 1  26.8844 26. 8 1 54 0.09757 
Control2 HPRT1 26.3923 26.0782 0.444 1 0  
Control2 HPRT1 25.7642 26.0782 
0.444 1 0  
Parent2 HPRT1 23.32828 2 3  1 95 1 6  0 1 88264 
Parent2 HPRT1 23.06204 23. 1 95 1 6  0.1 88264 
Patlent2 HPRT1 25.75568 25.50945 
0.348221 
Patlent2 HPRT1 25 26322 25.50945 
0.348221 
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Appendix F- ( The Alignment of the Three Known LlNS Isoforms and 
Showing the Reported Homozygous Mutations) 
uc00 2bwl 3 
u c0 1 0usa . 2  
uc00 2bwg . 3  
u c 0 0 2 b,,·i . 3  
ucO l O us a . 2  
u c 0 0 2 bwg . 3  
uc0 0 2 bwi . 3  
ucO l Ousa . 2  
uc0 0 2 bwg . 3  
uC00 2bwi . 3  
u c O l Ousa . 2  
u c 0 0 2 bwg . 3  
u c 0 0 2 bwl . 3  
u c O l Ousa . 2  
uC0 0 2 bwg . 3  
u c 0 0 2 b""l . 3 
ucO l Ousa . 2  
u C00 2bwg . 3  
u c 0 0 2bwl . 3  
u c 0 1 0usa . 2  
u c 0 0 2 bwg . 3  
u c 0 0 2bwi . 3  
uc0 1 0usa . 2  
uC0 0 2bwg . 3  
u c 0 0 2bwl . 3  
u c 0 1 0 us a . 2  
u C 0 0 2 bwg . 3  
u c 0 0 2 bwi . 3  
u c 0 1 0usa . 2  
u c 0 0 2bwg . 3  
uc0 0 2 bwi . 3  
u c 0 1 0usa . 2  
uc0 0 2 bwg . 3  
u c 0 0 2bwl . 3  
uc O l Ousa . 2  
uC00 2 bwg . 3  
uC0 0 2 bw i . 3  
ucO l Ousa . 2  
uC00 2 bwg . 3  
MKVFCEVLEELYKKVLLGATLENDSHDY I FYLNPAVSDQDCSTATSLEWANTCG I QGRHQ 6 0  
MKVFCEVLEELYKK- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1 4  
MKVFCEVLEELYKKVLLGATLENDSHDY I FYLNPAVSDQDCSTATSLEWANTCG IQGRHQ 6 0  
. "' '' * '' * * '* . * lI' * * 1t  
PI SVGVAPI AVAPVCLKTNSQMSGSREVMLL LTVI KVMTTRI LSVKTEFHAKEQYRDVI 1 2 0  
PISVGVAPI AVAPVCLKTNS MSGSREVMLLQLTV I KVMTTR I LSVKTEFHAKEQYRDVI 1 2 0  
K I LLESAKVDS KL I CMFQNSDKLLS HMAAQCLALLLYFQLREKITLSNSWIAFCQKNLSE 1 8 0  
- - - - - - - - - - - - - I CMFQNSDKLLSHMAAQCLALLLYFQLRE K I TLSNSW IAFCQKNLSE 6 1  
K I LLESAKVDS KLI CMFQNSDKLLSHMAAQCLALLLY FQLRE K I TLSNSWIAFCQKNLSE 1 8 0  
p . E2 1 1 _K407del 
YSESNKAIYCLWTLTA l l KE I FKDSCSQKTE I LKQFLTHFDTI FEVFYNSLFSQHFENCR 2 4 0  
YSESNKAIYCLWTLTAl l KE I FKDSCSQKTEI LKQFLTHFDTI FEVFYNSLFSQHFENCR 1 2 1  
YSESNKAIYCLWTLTA l l KE I FKDSCSQKTE ILKQFLTHFDT I FEVFYNSLFSQHFENCR 2 4 0  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
DTS K I VN I LMCFLDLLELLIAS R I HLKLHFTCQ R I L FLKPSCMLEVITWPIQAFVKRKVI 3 0 0  
DTS K I VN I Ll'lC FLDLLELL IASR I HLKLH FTCQR I L FLKPSCMLEVI TWP I QAFVKRKVI 1 8 1  
DTS K I VN I LMCFLDLLELL I AS R IHLKLHFTCQR I LFLKPSCMLEVITWPIQAFVKRKVI 3 0 0  
. * Y * · * * * · * * · * * * * * * * * * * · * · * · * · * p�H3*29: * * * * * * * * * * * * * * * * * * * * * *  
I FLKKCLLCKVGEDLCRGSVPALMPPD�AVDMLALANAVLQAVNSGLLKTLSVYEKHS 
I FLKKCLLCKVGEDLCRGSVPALMPPD AVDMLALANAVLQAVNSGLLKTLSVYEKHS 
I FLKKCLLCKVGEDLCRGSVPALMPPD AVDMLALANAVLQAVNSGLLKTLSVYEKHS 
. * * � * * * * * * * lI' * * * * * * * * * * * * * * *  .. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
3 6 0  
2 4 1  
3 6 0  
F FGGDEV PECELI T S PDHV ILRAASLVIMKSLEI KFQNYSSASEVKGNSP - - - - - - - - - 4 1 1  
F FGGDEVQPECELI TSPDHVI LRAASLVIMKSLEI KFQNYSSASEVKGNS P - - - - - - - - - 2 9 2  
F FGGDEVQPECEL I T S PDHVI LRAASLVIMKSLE I KFQNYSSAS EMKVDLQRFMSELLTF 4 2 0  
LKPHLQPSLQLHNPCKWLSRVF I EQDDDMLEAAKASLGI YLTLTRGCEATESLTQGKEMW 4 8 0  
- - - - - - NS FCMQCV I IYL - - - - - - - STVIHNYQI SGLV- - - - - - - - - - - - - - - - - - - - - - 4 3 6  
����;;�������������;;�;�����;����;�;�;�����;����;;; 
p . D5 1 1 Ffs* 1 0  
3 1 7  
5 4 0  
���;��;;;����;��;��;��;�;;��;;� ����;�����������;�1j����;� 6 0 0  
p.S594Ffs*6 
LKAVMSKGAHTMCASSLSSPRASQSLVDYDSSDDSDVESTEQCLANS KQTSLHQQATKEI 6 6 0  
;��;;����;��;��������;;�;��;�����������;�;������tj��; 7 2 0  
p . Q 7 1 7* 
DAI C RLQKKNLFPYNPTALLKLLKY I EV I SNKTMNTL 757 
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Appendix G· (Blocks of Shared Homozygosity between the Affected 
Individuals in the Progeoid Family) 
Chromoso #Marke 
me rs 
1 9  538 
5 1 1 34 
1 5  60 
1 8  1 99 
5 1 98 
7 96 
1 1  1 45 
1 6  1 4 7 
5 484 
2 239 
1 5  80 
1 6  258 
5 2 1 9  
1 9  69 
5 1 85 
7 28 
1 4  1 1 4 
8 454 
1 83 
1 6  1 31 
1 6  98 
3 8 1  
2 1 5 1  
1 6  5 1  
1 1 1 9 
1 3  1 06 
1 90 
1 1  87 
8 273 
4 54 
eM 
homozygo 
us 
6.869973 
3.360 1 3 1  
2 5372 
1 963434 
1 690854 
1 43476 
1 354594 
1 .299843 
1 2792 1 3  
1 2 1 7237 
0 635543 
1 1 4732 
1 1 44042 
1 027368 
1 1 34247 
1 1 09348 
1 08893 
1 1 09099 
1 08 1 87 
1 .071 606 
1 0035 1 2  
0.998388 
1 001 
0.940892 
0.956286 
0.949888 
0 9 1 8 1 46 
0.906477 
0.909864 
0.871 355 
Mb 
homozygo 
us 
23278 1 7  
3478008 
856473 
3 1 891 03 
880798 
397722 
24 1 667 
406761 
1 901 1 09 
745831 
2 1 4538 
1 4728452 
486677 
279433 
438269 
1 456646 
493953 
91 2749 
825468 
1 49463 
402941 
360452 
487989 
676479 
325695 
1 83279 
337078 
384678 
7 1 0823 
1 34956 
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First flanking first nanking last flanking last nanking 
affy rs affy rs 
SNP_A- S N P_A-
4242649 rs2240743 8552994 rs479448 
SNP_A- SNP_A-
8294257 rs4522972 4294262 rs2972935 
SNP_A- S N P_A-
4239006 rs2305252 20265 1 4  rs1 828775 
SNP_A- SNP_A-
8340389 rs2775801 4280665 rs4800370 
S N P_A- SNP_A-
8541 326 rs771 1 1 57 1 806657 rs 1 9 1 7753 
S N P_A- SNP_A-
8660044 rs4 7 1 6622 4282407 rs1 0263848 
S N P_A- SNP_A-
8597963 rs 1 4871 85 8443 1 5 1  rs7 1 1 9267 
S N P_A- SNP_A-
871 1 753 rs4784248 2 1 29800 rs1 7302707 
S N P_A- S N P_A-
1 92 1 2 1 0  rs6869276 4243654 rs645 1 656 
S N P_A- S N P_A-
8464 1 69 rs287307 1 9623 1 4  rs3788961 
S N P_A- S N P_A-
421 9989 rs1 828774 871 2802 rs 1 8779 1 1 
SNP_A- S N P_A-
8591 256 rs9931 752 8453942 rs 1 55 1 300 
SNP_A- S N P_A-
2 1 664 1 1  rs1 7295893 8300458 rs32631 
SNP _A- S N P_A-
1 8997 1 9  rs8 1 02561 8405 1 1 0  rs1 0403600 
SNP_A- S N P_A-
8354405 rs4869582 8553759 rs4869458 
SNP_A- SNP_A-
1 8 1 6484 rs376 1 2  1 9901 70 rs 1 1 67829 
S NP_A- SNP_A-
8637820 rs 1 269068 86230 1 3  rs6573632 
S N P_A- SNP _A-
4266781 rs4345557 8489209 rs2952 1 72 
S N P_A- SNP_A-
86253 1 9  rs2990245 1 967458 rs6427299 
S N P_A- S N P_A-
4239889 rs4786804 8356391 rs4786829 
SNP_A- SNP_A-
84 1 06 1 9  rs1 1 642531 8453945 rs71 97420 
S N P_A- SNP _A-
1 893390 rs1 350226 1 9280 1 4  rs1 522938 
S N P_A- S N P_A-
2 1 05394 rs 1 3387359 8356 1 24 rs1 568238 
SNP_A- S N P_A-
2060840 rs1 73236 8405 1 4 1  rs2641 906 
S N P_A- S N P_A-
831 4872 rs33 1 642 2296960 rs1 777958 
SNP_A- SNP_A-
2251 827 rs9586847 8346 1 87 rs1 549058 
SNP_A- SNP_A-
1 852783 rs497 1 264 2 1 25755 rs66976 1 6  
SNP_A- SNP_A-
2045808 rs25 1 0389 87035 1 6  rs 1 2806559 
S N P  _A- S N P_A-
1 920451 rs462986 1 8429469 rs78251 1 3  
SNP_A- S N P_A-
4264 1 03 rs2284659 8690626 rs1 3 1 1 2 1 59 
SNP_A- S N P_A-
20 94 0.835394 263734 2228677 rs28657 1 8  8428647 rs727091 7  
SNP_A- S N P_A- I rs1 498590 1 5  1 35 0 884564 542767 8302872 rs 1 1 639209 1 907056 
SNP_A- SNP_A-
1 5  94 0 881 762 244 1 25 8400845 rs 1 1 637779 4301 578 rs l 05 1 8966 
S N P_A- S N P_A-
20 1 69 0.865832 462428 85707 1 4  rs1 59088 8365695 rs21 2600 
S N P_A- SNP_A-
2 1 62 0.870471 668482 8575630 rs 1 7701 375 8500556 rs758 1 360 
SNP _A- SNP_A-
1 5  1 1 4  0.843549 260896 4273883 rs936532 8645433 rs4924389 
S N P_A- SNP_A-
2 2 1 8  0.847482 8 1 6865 1 7828 1 0  rs1 6847958 4243961 rs1 6858 1 1 5  
S N P_A- SNP_A-
1 5  90 0.833 3 1 3  1 84456 8344505 rs7166757 8289300 rs8034873 
S N P_A- SNP_A-
5 1 66 0.825269 742 1 32 2238942 rs7734243 224 1 969 rs241 6258 
S N P_A- SNP_A-
1 2  98 0 78654 1 47670 8562733 rs7308676 2267526 rs1 6 1 0 1 77 
SNP_A- SNP_A-
2 78 0 793548 422820 8376 1 08 rs7587659 1 8 1 3575 rs424 1 1 1 2  
SNP_A- SNP _A-
1 4  89 0. 783678 4 1 6264 1 928232 rs4901 542 2 1 4 1 881 rs8009660 
SNP_A- SNP_A-
2 350 0 798067 1 42 1 880 8426004 rsl 0204835 2 1 46202 rs67 1 4 1 24 
SNP_A- SNP_A-
1 7  3 1  0743335 1 38451 8507978 rs1 2453336 8361 730 rs9896300 
S N P_A- SNP_A-
1 8  1 26 0 788235 3271 42 8353 1 74 rs9304001 8688 1 01 rs 1 4436 1 4  
S N P_A- S N P_A-
1 4  1 9  0 782552 93768 831 2243 rs 1 1 629400 861 2300 rs277 1 324 
S N P_A- SNP_A-
1 6  1 40 0.763843 297202 1 9050 1 9  rs805541 7 1 787393 rs8049029 
S N P_A- SNP_A-
7 70 0. 764332 385798 4301 558 rs2236426 841 5488 rs887056 
S N P_A- S N P_A-
4 1 03 0.7792 372630 2262947 rs6842825 85 1 8 1 64 rs 1 23 3 1 468 
S N P_A- SNP_A-
1 8  38 0.71 4986 1 528 1 6  4200882 rsl 0502344 8393102 rs41 2604 
S N P_A- S N P  _A-
5 1 65 0761 398 388099 8665235 rs1 362801 201 0842 rs2939335 
S N P_A- SNP _A-
22 24 0 744 1 01 1 85073 8482732 rs138877 2 1 1 7236 rs1 37866 
S N P_A- S N P  _A-
2 1  6 1  0. 728308 234022 8343534 rs283691 2  83440 1 5  rsl 1 088473 
S N P_A- S N P  _A-
1 5  68 0. 753502 1 23 1 24 2 1 1 4261 rs 1 7501 060 1 828272 rs1 1 858005 
S N P_A- SNP_A-
1 3  1 00 0 747969 438391 2244339 rs93 1 8 1 05 2 1 56861 rs1 333099 
SNP_A- SNP_A-
1 2  1 22 0.7294 1 5  1 91 442 2 1 37525 rs439 1 872 8303828 rs7978886 
S N P_A- SNP _A-
2 90 0 707302 4559 1 2  8334 1 69 rs4674301 8583570 rs 1 1 695967 
SNP _A- SNP _A-
1 0  84 0 7 1 7 1 9  271 789 8421 335 rs 1 9542 1 1  8393955 rs 1 1 253896 
SNP_A- SNP_A-
1 0  66 0.71 1 424 269604 8282 1 69 rs 1 934944 83581 86 rs707 1 399 
S N P_A- SNP_A-
1 5  55 0.707444 1 04024 42896 1 6  rs1 058696 2004441 rs1 74274 
S N P_A- S N P_A-
1 8  1 44 0.7295 1 9  406840 2 1 46836 rs1 2960235 1 922875 rs587274 
SNP_A- SNP_A-
1 6  1 30 0. 708305 665065 1 856738 rs 1 3333771 1 885978 rs756 7 1 8  
SNP_A- SNP_A-
1 40 0.691 78227 1 802652 rs947379 8459089 rs2268 1 47 
SNP_A- SNP_A-
1 2  1 55 0.71 4274 796955 2083007 rs1 0506938 4284955 rs2063568 
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SNP_A- SNP_A-
2 1 5 1  0 7 1 1 294 453046 4202663 rs 1 374706 8577227 rs1 0490277 
SNP_A- S N P_A-
8 1 0 1  0 672038 2235 1 1  1 87 1 827 rs7833668 2288165 rs 1 72201 74 
SNP_A- S N P_A-
1 6  1 1 8 0 706724 201 207 8677307 rs1 533822 2055674 rs1 1 0748 1 5  
SNP_A- S N P_A-
5 74 0.71 054 1 78820 8665201 rs930049 2 1 442 1 8  rs1 2 1 866 1 6  
SNP_A- S N P_A-
3 94 0. 706327 281 706 861 9422 rs9828988 4296026 rs9832791 
SNP_A- SNP_A-
7 62 0.703338 272 1 34 85 1 0961 rs6969684 1 796724 rs2893375 
SNP_A- SNP_A-
1 7  82 0.700361 257307 8488533 r52286593 8682473 r58074682 
SNP_A- SNP_A-
8 97 0.697072 475299 4266940 r51 384830 8283345 r5993 1 06 
SNP_A- SNP_A-
1 3  1 59 0.698595 3 1 0055 2306548 r5 1 9986 1 2  8678340 r59533573 
SNP_A- SNP _A-
20 35 0.61 0627 1 92775 2 1 1 8501 r51 3039229 2223591 r5501 9252 
SNP_A- SNP_A-
2 77 0.681 771 345629 8694468 r51 2463788 8675760 r51 729080 
S N P_A- SNP_A-
2 49 0.685898 231 078 4298368 r52251 692 8482377 r5 1 02 1 0963 
SNP_A- SNP_A-
1 4  68 0.647605 1 74679 2240938 r51 7091694 2 1 00205 rs1 4042 
S N P_A- SNP _A-
3 98 0 666032 336930 8493455 r51 0804733 8635652 rs2331 675 
S N P_A- SNP_A-
1 8  96 0 6652 1 3  4853 1 1 8589802 r5299238 1 93 7 1 45 rs7233350 
S N P_A- SNP_A-
1 5  93 0.656077 286336 8445054 r57164548 8604831 r56598242 
S NP_A- S N P_A-
8 1 29 0 663736 1 424992 8697323 r51 3252978 8285471 r56985209 
S N P_A- S N P_A-
1 3  1 92 0.646459 34 1 782 8306221 r52699342 841 1 1 72 r5649 1 764 
S N P_A- SNP_A-
1 2  1 50 0 64 1 95 428501 2060882 r579751 89 4226886 r5491 35 1 8  
S N P_A- S N P_A-
1 2  1 06 0.652405 1 026078 4255 1 53 r5797 1 845 1 86 1 049 rs 1 02 1 9 7 1 7  
SNP_A- SNP_A-
5 1 33 0 643308 300666 8663562 rs2249 1 2  1 982329 r51 0040233 
SNP _A- SNP_A-
1 6  79 0.64 1 2 1 6  257468 863 1 323 r59937099 2222656 r5 1 77721 59 
S N P_A- S N P_A-
20 68 0.646856 207737 8566265 r5 1 82 1 809 4242325 r528707 1 8  
S N P_A- S N P_A-
1 8  27 0_567697 45341 1 834941 r51 1 1 5 1 03 1  8563155 r51 893833 
S N P  _A- SNP_A-
1 2  34 0.59654 1 1 3347 2 1 75 1 87 r51 07737 1 5  2 1 1 7433 r51 675874 
S N P  _A- SNP_A-
1 1 50 0.631 848 4355 1 4  429 1 94 1  r5968304 1 898 1 28 r57542088 
SNP _A- SNP_A-
1 9  72 0.595 1 77 2 1 7721 8695332 r52081 894 8658540 r54802981 
S N P_A- SNP_A-
7 1 37 0.62604 360 1 70 851 72 1 2  rs 1 1 9808 1 6  2 1 90907 ---
S N P_A- SNP_A-
3 33 0 55585 1 33228 8302720 r59863733 2269156 r598587 1 4  
SNP_A- SNP_A-
5 1 55 0.630424 321 046 8666560 rs2099041 2 1 27960 rs68975 1 7  
SNP _A- SNP_A-
2 1  3 3  0.627964 1 07706 421 5562 rs28237 1 8  8342629 r5440294 
SNP_A- SNP _A-
2 1 1 9 0.6 1 7 1 22 4870 1 0  8601 1 98 r5 1 55 1 06 8468836 rs1 3405639 
S N P_A- SNP_A-
2 1  1 32 0.622652 239251 4270622 r52898402 4209 1 48 r52837623 
S N P_A- S N P_A-
1 6  32 0.61 3937 656960 1 7949 1 1 r533957528 851 1 559 r58045689 
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SNP _A- SNP_A-
1 6  1 78 0 592246 326992 8650559 r546 1 4753 8474 1 84 r5 1 2599583 
SNP_A- S N P_A-
2 1 6 3  0 622669 80 1 0 1 7  2035326 r5 1 1 896227 8483255 r5 1 1 694706 
S N P_A- SNP_A-
r-l- 47 0.61 3 1 96 1 750 1 5  8534863 r51 3225903 8691497 r51 3234269 S N P_A- SNP_A-
5 70 0 6 1 7952 1 93 1 52 871 3807 r5 1 1 742964 8462702 r53906345 
SNP_A- SNP _A-
8 30 0.593 1 69 578831 841 5724 r569832 1 4  8360655 r5784 1 468 
S N P_A- SNP A-
2 1  1 1 5  0.61 343 465623 201 7840 r52244721 8578379 rs2898 1 75 
S N P_A- SNP_A-
7 67 0.6072 1 7  1 85040 8386966 r5834433 8337232 rs37788 1 3  
SNP_A- SNP_A-
1 9  28 0.593 1 9  1 86654 2040097 r5 1 246 1 453 8657796 r57250294 
S N P_A- SNP_A-
1 1  70 0 530497 4 1 5466 4279373 r5 1 1 230633 2 1 33800 rs 1 1 230775 
S N P_A- SNP_A-
8 36 0.546771 1 30 1 25 8587261 r544271 35 1 8941 87 rs7014406 
S N P_A- SNP _A-
5 57 0.594322 1 08 1 25 8665085 r51 862581 2232408 rs2 1 36 1 93 
S N P_A- SNP_A-
3 62 0.579503 1 509 1 3  1 844296 rs4686945 8296797 rs7645379 
S N P_A- S N P  _A-
3 47 0 56 1 95 1 40347 2073526 rs1 2696555 4240247 r51 1 720187 
S N P_A- S N P_A-
1 8  69 0 573347 399776 8625867 r54624285 832 1 335 r51 434527 
SNP_A- S N P_A-
1 3  1 78 0.586322 346625 1 90 1 882 r527064 1 0  426 1 207 r54883908 
S N P_A- S N P_A-
4 256 0.579508 733741 8662 1 43 r5 1 05 1 8378 2 1 402 1 8  rs6534279 
S N P_A- S N P_A-
1 3  59 0.551 896 1 9 1 968 8567696 rs 1 4 1 54 1 1 2053 167 rs9573281 
S N P_A- S N P_A-
2 1  1 1 7  0 5536 1 6  299471 201 5339 rs2823059 8341 833 r52823262 
S N P_A- SNP_A-
1 48 0.555842 3 1 1 906 8494641 rs1 000997 841 5696 r5 1 1 2607 1 1  
S N P_A- SNP_A-
1 8  58 0.554748 230670 8541 348 r56 1 6329 8422546 r51 3380899 
S N P_A- S N P_A-
9 1 22 0.564931 2907 1 3  2 1 1 2983 r5 1 08685 1 6  205 1 868 r5927524 
S N P_A- S N P_A-
1 6  95 0 5 1 5708 94 1 37 8360633 r51 1 02967 8427362 r57206547 
S N P_A- S N P_A-
1 1  84 0.549639 203944 2065676 r52 1 03 1 73 2249626 r5 1 1 602446 
S N P_A- S N P_A-
20 58 0.545 1 1 1  232843 2282624 r53827963 8496777 r51 2626071 
S N P_A- SNP_A-
8 1 37 0.552 1 7 1 488622 840 1 245 r51 2678203 4222297 r57842793 
S N P_A- SNP_A-
8 34 0 5 1 0436 2579 1 6  4304357 r57836362 851 8046 r57844699 
S N P_A- S N P_A-
3 75 0.52682 320793 8439239 r576 1 6037 8478724 r51 97849 
S N P  _A- S N P  _A-
1 0  79 0.534242 309687 200 1 383 r5522951 1 85 1 303 r51 1 1 90643 
SNP_A- SNP_A-
3 45 0.538907 4 1 8941 8640809 r54630960 231 2494 r51 6852464 
SNP _A- SNP_A-
4 1 1 8 0 539872 201 1 62 8320864 r5 1 6894263 2273392 r5600940 
S N P_A- SNP_A-
5 36 0.4942 1 5  1 0 1 5 1 3  2287706 r535580 1 872737 r5250350 
S N P_A- S N P_A-
3 1 40 0.53708 769730 421 6907 r51 2485995 1 973688 r598442 1 8  
SNP_A- S N P_A-
4 63 0. 535694 272982 2 1 34 1 8 1  r53795 1 9  841 8952 r51 7792 1 6 1  
S N P  _A- S NP_A-
1 3  1 49 0 53 1 531 660443 2054587 r51 970270 20920 1 0  r51 504432 
30 1 
SNP_A- SNP_A-
5 1 1 5  0 526687 234596 20385 1 9  r5577395 846 1 2 1 0  r52047322 
SNP_A- SNP _A-
5 1 22 0 5 1 6283 6 1 8999 8505 1 48 r54632762 85492 1 0  r56873479 
SNP_A- SNP_A-
4 49 0.51 586 1 1 8 1 06 4245693 r51 0028944 2054 1 8 1  r57694098 
S N P_A- SNP _A-
1 0  25 0.51 7875 73660 1 949159 r5709 1 695 8699730 r51 0998696 
SNP_A- SNP _A-
5 82 0.51 3358 284695 2258350 r56893638 8388863 rs68821 46 
S N P_A- SNP_A-
8 46 0.5 1 1 769 1 896 1 0  1 930592 r5 1 77298 1 6  8645898 rs7843437 
S N P_A- SNP _A-
1 5  62 0.51 0099 322420 22483 1 6  r5 1 025 1 99 1 876769 rs1426721 
SNP_A- SNP_A-
5 1 1 0 0.506285 349460 2 1 36005 r51 2697229 2255648 r545 1 3709 
SNP_A- SNP_A-
20 72 0.5 1 5 1 49 96721 8306556 r56043342 8591 660 r5200745 
SNP_A- S N P  _A-
1 6  1 52 0.503385 449585 20046 1 6  r58050676 2270222 rs1 7256727 
SNP_A- SNP _A-
1 8  1 36 0.485 1 07 496290 8442961 r5680798 8435863 rs878971 
SNP_A- S N P_A-
1 9  38 0 456893 1 50237 231 0289 rs2574764 2 1 53655 rs5536 1 1 
SNP_A- SNP_A-
1 1  1 55 0. 496645 354259 8399281 rs1 1 603534 1 802721 r534869754 
SNP_A- S N P_A-
1 1  1 0 1  0 489891 3934 1 8  8292783 r54939346 1 789702 r5 1 1 230463 
SNP_A- SNP_A-
2 62 0.490528 1 70480 1 8 1 4793 rs3769095 8658230 r5 1 1 898345 
SNP_A- S N P  _A-
1 1  34 0.494443 229 1 73 1 789365 r571 08368 8371 549 r51 0793063 
S N P_A- SNP _A-
1 4  70 0.4579 1 1 3 1 9580 8565893 rs 1 08735 1 5  8550766 rs 1 0 1 5 1 090 
S N P_A- S N P  _A-
5 37 0.463 1 47 1 1 8 1 37 1 920263 r52569094 8603505 rs3095905 
S N P_A- S N P_A-
1 5  39 0.47747 1 95359 8550064 r51 2595826 4240727 rs1 444860 
S N P_A- S N P_A-
1 86 0.489027 259071 2 1 37263 rs 1 2038 1 62 1 803596 rs1 889543 
S N P_A- SNP_A-
8 73 0 43779 1 95432 8583481 rs1 3282231 4202799 rs1 440744 
SNP_A- SNP_A-
1 2  20 0. 399639 1 1 7994 8383045 rs7959658 1 785324 rs 1 23 1 3899 
SNP_A- SNP_A-
22 6 0.299485 1 08609 8523422 rs482231 3 1 795337 rs45 1 1 1 5  
S N P_A- SNP_A-
4 82 0.30739 370683 8345245 rs 1 1 936246 8639376 rs1 2331 558 
S N P  _A- S N P_A-
1 4  4 3  0 24 1 404 5 7 1 5 5  2 1 88880 rs1 7533457 2206884 rs1 2432655 
S N P_A- S N P_A-
1 4  1 7  0 222499 67035 8457061 rs 1 0 1 39382 1 800625 rs1 957684 
S N P_A- SNP_A-
1 4  22 0. 1 6 1 097 1 1 2431 1 927639 r5 1 0 1 47424 8565893 rs1 08735 1 5  
S N P_A- SNP _A-
9 2 0 000604 372 1 960831 rs22 1 1 079 1 997383 r5 1 556858 
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